Item 2. Code of Ethics.
Not applicable for semi-annual reports.
Item 3. Audit Committee Financial Expert.
Not applicable for semi-annual reports.
Item 4. Principal Accountant Fees and Services.
Not applicable for semi-annual reports.
Item 5. Audit Committee of Listed Registrants.
Not applicable for semi-annual reports.
Item 6. Investments.
| (a) | Schedule of Investments is included within the financial statements filed under Item 7 of this Form. |
| (b) | Not applicable. |
Item 7. Financial Statements and Financial Highlights for Open-End Investment Companies.
| (a) |
Financial Statements
October 31, 2025 (Unaudited)
| Tidal Trust II | ||
| ● Defiance 2X Daily Long Pure Quantum ETF | | QPUX | | The Nasdaq Stock Market, LLC |
| ● Defiance Daily Target 2X Long ANET ETF | | ANEL | | The Nasdaq Stock Market, LLC |
| ● Defiance Daily Target 2X Long AVAV ETF | | AVXX | | The Nasdaq Stock Market, LLC |
| ● Defiance Daily Target 2X Long AVGO ETF | | AVGX | | The Nasdaq Stock Market, LLC |
| ● Defiance Daily Target 2X Long CVNA ETF | | CVNX | | The Nasdaq Stock Market, LLC |
| ● Defiance Daily Target 2X Long DKNG ETF | | DKNX | | The Nasdaq Stock Market, LLC |
| ● Defiance Daily Target 2X Long HIMS ETF | | HIMZ | | The Nasdaq Stock Market, LLC |
| ● Defiance Daily Target 2X Long HOOD ETF | | HOOX | | The Nasdaq Stock Market, LLC |
| ● Defiance Daily Target 2X Long IONQ ETF | | IONX | | The Nasdaq Stock Market, LLC |
| ● Defiance Daily Target 2X Long IREN ETF | | IRE | | The Nasdaq Stock Market, LLC |
| ● Defiance Daily Target 2X Long JPM ETF | | JPX | | The Nasdaq Stock Market, LLC |
| ● Defiance Daily Target 2X Long LLY ETF | | LLYX | | NYSE Arca, Inc. |
| ● Defiance Daily Target 2X Long LMND ETF | | LMNX | | The Nasdaq Stock Market, LLC |
| ● Defiance Daily Target 2X Long MP ETF | | MPL | | The Nasdaq Stock Market, LLC |
| ● Defiance Daily Target 2X Long MSTR ETF | | MSTX | | The Nasdaq Stock Market, LLC |
| ● Defiance Daily Target 2X Long NVO ETF | | NVOX | | NYSE Arca, Inc. |
| ● Defiance Daily Target 2X Long OKLO ETF | | OKLL | | The Nasdaq Stock Market, LLC |
| ● Defiance Daily Target 2X Long ORCL ETF | | ORCX | | The Nasdaq Stock Market, LLC |
| ● Defiance Daily Target 2X Long OSCR ETF | | OSCX | | The Nasdaq Stock Market, LLC |
| ● Defiance Daily Target 2X Long PM ETF | | XPM | | The Nasdaq Stock Market, LLC |
| ● Defiance Daily Target 2X Long QS ETF | | QSU | | The Nasdaq Stock Market, LLC |
| ● Defiance Daily Target 2X Long RGTI ETF | | RGTX | | The Nasdaq Stock Market, LLC |
| ● Defiance Daily Target 2X Long RIOT ETF | | RIOX | | NYSE Arca, Inc. |
| ● Defiance Daily Target 2X Long RKLB ETF | | RKLX | | The Nasdaq Stock Market, LLC |
| ● Defiance Daily Target 2X Long SMCI ETF | | SMCX | | The Nasdaq Stock Market, LLC |
| ● Defiance Daily Target 2X Long SOFI ETF | | SOFX | | The Nasdaq Stock Market, LLC |
| ● Defiance Daily Target 2X Long SOUN ETF | | SOUX | | The Nasdaq Stock Market, LLC |
| ● Defiance Daily Target 2X Long VST ETF | | VSTL | | The Nasdaq Stock Market, LLC |
| ● Defiance Daily Target 2X Short IONQ ETF | | IONZ | | The Nasdaq Stock Market, LLC |
| ● Defiance Daily Target 2X Short LLY ETF | | LLYZ | | The Nasdaq Stock Market, LLC |
| ● Defiance Daily Target 2X Short MSTR ETF | | SMST | | The Nasdaq Stock Market, LLC |
| ● Defiance Daily Target 2X Short PLTR ETF | | PLTZ | | The Nasdaq Stock Market, LLC |
| ● Defiance Daily Target 2X Short QBTS ETF | | QBTZ | | The Nasdaq Stock Market, LLC |
| ● Defiance Daily Target 2X Short RGTI ETF | | RGTZ | | The Nasdaq Stock Market, LLC |
| ● Defiance Daily Target 2X Short SMCI ETF | | SMCZ | | The Nasdaq Stock Market, LLC |
Defiance ETFs
Table of Contents
| Schedules of Investments & Total Return Swap Contracts | Defiance ETFs |
October 31, 2025 (Unaudited)
Defiance 2X Daily Long Pure Quantum ETF
Schedule of Investments
| U.S. TREASURY BILLS - 4.1% | Principal | Value | ||||
| 3.93%, 11/20/2025 (a)(b) | $ | 2,075,000 | $ | 2,071,208 | ||
| TOTAL U.S. TREASURY BILLS (Cost $2,070,704) | 2,071,208 | |||||
| MONEY MARKET FUNDS - 1.6% | Shares | |||||
| First American Government Obligations Fund - Class X, 4.03% (c) | 823,899 | 823,899 | ||||
| TOTAL MONEY MARKET FUNDS (Cost $823,899) | 823,899 | |||||
|
TOTAL INVESTMENTS - 5.7% (Cost $2,894,603) |
$ | 2,895,107 | ||||
| Other Assets in Excess of Liabilities - 94.3% | 47,813,079 | |||||
| TOTAL NET ASSETS - 100.0% | $ | 50,708,186 | ||||
Percentages are stated as a percent of net assets.
| (a) | The rate shown is the annualized yield as of October 31, 2025. |
| (b) | All or a portion of security has been pledged as collateral for swap contracts. The fair value of assets committed as collateral as of October 31, 2025 is $2,071,182. |
| (c) | The rate shown represents the 7-day annualized yield as of October 31, 2025. |
Defiance 2X Daily Long Pure Quantum ETF
Schedule of Total Return Swap Contracts
|
Reference Entity |
Counterparty |
Pay/Receive
|
Financing Rate |
Payment
|
Maturity
|
Notional
|
Value/ Unrealized
(Depreciation) |
|||||||||||
| D-Wave Quantum, Inc. | Clear Street LLC | Receive | OBFR + 6.25% | Termination(a) | 09/15/2026 | $ | 21,255,985 | $ | - | |||||||||
| D-Wave Quantum, Inc. | Marex Capital Markets, Inc. | Receive | OBFR + 5.00% | Monthly(b) | 09/08/2026 | 3,966,977 | 942,424 | |||||||||||
| IonQ, Inc. | Clear Street LLC | Receive | OBFR + 3.50% | Termination(a) | 11/23/2027 | 19,146,231 | - | |||||||||||
| IonQ, Inc. | Marex Capital Markets, Inc. | Receive | OBFR + 5.00% | Monthly(b) | 09/08/2026 | 6,162,458 | 648,527 | |||||||||||
| Quantum Computing, Inc. | Clear Street LLC | Receive | OBFR + 12.00% | Termination(a) | 11/23/2027 | 18,463,882 | - | |||||||||||
| Quantum Computing, Inc. | Marex Capital Markets, Inc. | Receive | OBFR + 5.00% | Monthly(b) | 09/08/2026 | 6,855,912 | 705,048 | |||||||||||
| Rigetti Computing, Inc. | Clear Street LLC | Receive | OBFR + 13.00% | Termination(a) | 09/15/2026 | 20,293,147 | - | |||||||||||
| Rigetti Computing, Inc. | Marex Capital Markets, Inc. | Receive | OBFR + 5.00% | Monthly(b) | 09/08/2026 | 5,129,211 | 880,066 | |||||||||||
| Net Unrealized Appreciation (Depreciation) | $ | 3,176,065 | ||||||||||||||||
There are no upfront payments or receipts associated with total return swaps in the Fund as of October 31, 2025.
OBFR - Overnight Bank Funding Rate was 3.86% as of October 31, 2025.
| (a) | Financing reset of the swap is effective on the last day of each month. Equity reset of the swap is effective on termination but also periodically throughout the term. |
| (b) | Financing and equity reset of the swap is effective on the last day of each month and periodically throughout the month. |
| 1 | |
| The accompanying notes are an integral part of these financial statements. |
| Schedules of Investments & Total Return Swap Contracts | Defiance ETFs |
October 31, 2025 (Unaudited)
Defiance Daily Target 2X Long ANET ETF
Schedule of Investments
| U.S. TREASURY BILLS - 13.0% | Principal | Value | ||||
| 3.94%, 11/20/2025 (a)(b) | $ | 1,030,000 | $ | 1,028,117 | ||
| TOTAL U.S. TREASURY BILLS (Cost $1,027,865) | 1,028,117 | |||||
| MONEY MARKET FUNDS - 2.4% | Shares | |||||
| First American Government Obligations Fund - Class X, 4.03% (c) | 190,760 | 190,760 | ||||
| TOTAL MONEY MARKET FUNDS (Cost $190,760) | 190,760 | |||||
|
TOTAL INVESTMENTS - 15.4% (Cost $1,218,625) |
$ | 1,218,877 | ||||
| Other Assets in Excess of Liabilities - 84.6% | 6,702,668 | |||||
| TOTAL NET ASSETS - 100.0% | $ | 7,921,545 | ||||
Percentages are stated as a percent of net assets.
| (a) | The rate shown is the annualized yield as of October 31, 2025. |
| (b) | All or a portion of security has been pledged as collateral for swap contracts. The fair value of assets committed as collateral as of October 31, 2025 is $1,028,105. |
| (c) | The rate shown represents the 7-day annualized yield as of October 31, 2025. |
Defiance Daily Target 2X Long ANET ETF
Schedule of Total Return Swap Contracts
|
Reference Entity |
Counterparty |
Pay/Receive
Entity |
Financing Rate |
Payment
|
Maturity Date |
Notional
|
Value/
(Depreciation) |
|||||||||||
| Arista Networks, Inc. | Cantor Fitzgerald & Co. | Receive | OBFR + 1.00% |
Termination(a) |
09/08/2028 | $ | 5,045,449 | $ | 526,993 | |||||||||
| Arista Networks, Inc. | Clear Street LLC | Receive | OBFR + 1.25% |
Termination(b) |
01/11/2028 |
5,299,961 |
- | |||||||||||
| Arista Networks, Inc. | Marex Capital Markets, Inc. | Receive | OBFR + 3.00% | Monthly(c) | 09/15/2028 | 5,479,728 | 619,232 | |||||||||||
| Net Unrealized Appreciation (Depreciation) | $ | 1,146,225 | ||||||||||||||||
There are no upfront payments or receipts associated with total return swaps in the Fund as of October 31, 2025.
OBFR - Overnight Bank Funding Rate was 3.86% as of October 31, 2025.
| (a) | Financing reset of the swap is effective on the last day of each month. Equity reset of the swap is effective on termination. |
| (b) | Financing reset of the swap is effective on the last day of each month. Equity reset of the swap is effective on termination but also periodically throughout the term. |
| (c) | Financing and equity reset of the swap is effective on the last day of each month and periodically throughout the month. |
| 2 | |
| The accompanying notes are an integral part of these financial statements. |
| Schedules of Investments & Total Return Swap Contracts | Defiance ETFs |
October 31, 2025 (Unaudited)
Defiance Daily Target 2X Long AVAV ETF
Schedule of Investments
| U.S. TREASURY BILLS - 6.1% | Principal | Value | ||||
| 3.88%, 11/20/2025 (a)(b) | $ | 50,000 | $ | 49,909 | ||
| TOTAL U.S. TREASURY BILLS (Cost $49,898) | 49,909 | |||||
| MONEY MARKET FUNDS - 2.1% | Shares | |||||
| First American Government Obligations Fund - Class X, 4.03% (c) | 17,245 | 17,245 | ||||
| TOTAL MONEY MARKET FUNDS (Cost $17,245) | 17,245 | |||||
|
TOTAL INVESTMENTS - 8.2% (Cost $67,143) |
$ | 67,154 | ||||
| Other Assets in Excess of Liabilities - 91.8% | 750,860 | |||||
| TOTAL NET ASSETS - 100.0% | $ | 818,014 | ||||
Percentages are stated as a percent of net assets.
| (a) | The rate shown is the annualized yield as of October 31, 2025. |
| (b) | All or a portion of security has been pledged as collateral for swap contracts. The fair value of assets committed as collateral as of October 31, 2025 is $49,909. |
| (c) | The rate shown represents the 7-day annualized yield as of October 31, 2025. |
Defiance Daily Target 2X Long AVAV ETF
Schedule of Total Return Swap Contracts
|
Reference Entity |
Counterparty |
Pay/Receive
Entity |
Financing Rate |
Payment
|
Maturity
|
Notional
|
Value/ Unrealized Appreciation (Depreciation) |
|||||||||||
| AeroVironment, Inc. | Clear Street LLC | Receive | OBFR + 2.50% | Termination(a) | 12/07/2027 | $ | 1,599,861 | $ | - | |||||||||
| AeroVironment, Inc. | Marex Capital Markets, Inc. | Receive | OBFR + 3.50% | Monthly(b) | 10/30/2028 | 36,991 | 408 | |||||||||||
| Net Unrealized Appreciation (Depreciation) | $ | 408 | ||||||||||||||||
There are no upfront payments or receipts associated with total return swaps in the Fund as of October 31, 2025.
OBFR - Overnight Bank Funding Rate was 3.86% as of October 31, 2025.
| (a) | Financing reset of the swap is effective on the last day of each month. Equity reset of the swap is effective on termination but also periodically throughout the term. |
| (b) | Financing and equity reset of the swap is effective on the last day of each month and periodically throughout the month. |
| 3 | |
| The accompanying notes are an integral part of these financial statements. |
| Schedules of Investments & Total Return Swap Contracts | Defiance ETFs |
October 31, 2025 (Unaudited)
Defiance Daily Target 2X Long AVGO ETF
Schedule of Investments
| U.S. TREASURY BILLS - 11.6% | Principal | Value | ||||
| 3.92%, 11/20/2025 (a)(b) | $ | 16,750,000 | $ | 16,719,389 | ||
| TOTAL U.S. TREASURY BILLS (Cost $16,715,397) | 16,719,389 | |||||
| MONEY MARKET FUNDS - 4.0% | Shares | |||||
| First American Government Obligations Fund - Class X, 4.03% (c) | 5,752,533 | 5,752,533 | ||||
| TOTAL MONEY MARKET FUNDS (Cost $5,752,533) | 5,752,533 | |||||
|
TOTAL INVESTMENTS - 15.6% (Cost $22,467,930) |
$ | 22,471,922 | ||||
| Other Assets in Excess of Liabilities - 84.4% | 121,323,385 | |||||
| TOTAL NET ASSETS - 100.0% | $ | 143,795,307 | ||||
Percentages are stated as a percent of net assets.
| (a) | The rate shown is the annualized yield as of October 31, 2025. |
| (b) | All or a portion of security has been pledged as collateral for swap contracts. The fair value of assets committed as collateral as of October 31, 2025 is $14,750,000. |
| (c) | The rate shown represents the 7-day annualized yield as of October 31, 2025. |
Defiance Daily Target 2X Long AVGO ETF
Schedule of Total Return Swap Contracts
|
Reference Entity |
Counterparty |
Pay/Receive
Entity |
Financing Rate |
Payment
|
Maturity
|
Notional
|
Value/
(Depreciation) |
|||||||||||
| Broadcom, Inc. | BMO Capital Markets Corp. | Receive | OBFR + 2.50% | Termination(a) | 05/29/2026 | $ | 47,312,640 | $ | 9,133,210 | |||||||||
| Broadcom, Inc. | Cantor Fitzgerald & Co. | Receive | OBFR + 3.00% | Termination(b) | 09/08/2028 | 46,603,690 | 16,242,352 | |||||||||||
| Broadcom, Inc. | Clear Street LLC | Receive | OBFR + 1.25% | Termination(a) | 12/14/2027 | 47,657,505 | - | |||||||||||
| Broadcom, Inc. | Marex Capital Markets, Inc. | Receive | OBFR + 2.00% | Monthly(c) | 11/10/2025 | 48,975,975 | 5,716,791 | |||||||||||
| Broadcom, Inc. | Morgan Stanley | Receive | OBFR + 4.50% | Termination(d) | 10/03/2028 | 50,458,191 | 764,376 | |||||||||||
| Broadcom, Inc. | Nomura Securities International, Inc. | Receive | OBFR + 4.00% | Termination(d) | 01/20/2026 | 46,758,195 | 11,219,432 | |||||||||||
| Net Unrealized Appreciation (Depreciation) | $ | 43,076,161 | ||||||||||||||||
There are no upfront payments or receipts associated with total return swaps in the Fund as of October 31, 2025.
OBFR - Overnight Bank Funding Rate was 3.86% as of October 31, 2025.
| (a) | Financing reset of the swap is effective on the last day of each month. Equity reset of the swap is effective on termination but also periodically throughout the term. |
| (b) | Financing reset of the swap is effective on the last day of each month. Equity reset of the swap is effective on termination. |
| (c) | Financing and equity reset of the swap is effective on the last day of each month and periodically throughout the month. |
| (d) | Financing reset of swap is effective on the last day of each month. Equity reset of swap is effective on termination. |
| 4 | |
| The accompanying notes are an integral part of these financial statements. |
| Schedules of Investments & Total Return Swap Contracts | Defiance ETFs |
October 31, 2025 (Unaudited)
Defiance Daily Target 2X Long CVNA ETF
Schedule of Investments
| U.S. TREASURY BILLS - 15.5% | Principal | Value | ||||
| 3.94%, 11/20/2025 (a)(b) | $ | 679,000 | $ | 677,759 | ||
| TOTAL U.S. TREASURY BILLS (Cost $677,593) | 677,759 | |||||
| MONEY MARKET FUNDS - 1.2% | Shares | |||||
| First American Government Obligations Fund - Class X, 4.03% (c) | 53,317 | 53,317 | ||||
| TOTAL MONEY MARKET FUNDS (Cost $53,317) | 53,317 | |||||
|
TOTAL INVESTMENTS - 16.7% (Cost $730,910) |
$ | 731,076 | ||||
| Other Assets in Excess of Liabilities - 83.3% | 3,654,142 | |||||
| TOTAL NET ASSETS - 100.0% | $ | 4,385,218 | ||||
Percentages are stated as a percent of net assets.
| (a) | The rate shown is the annualized yield as of October 31, 2025. |
| (b) | All or a portion of security has been pledged as collateral for swap contracts. The fair value of assets committed as collateral as of October 31, 2025 is $224,586. |
| (c) | The rate shown represents the 7-day annualized yield as of October 31, 2025. |
Defiance Daily Target 2X Long CVNA ETF
Schedule of Total Return Swap Contracts
|
Reference Entity |
Counterparty |
Pay/Receive
Entity |
Financing Rate |
Payment
|
Maturity
|
Notional
|
Value/
(Depreciation) |
|||||||||||
| Carvana Co. | Cantor Fitzgerald & Co. | Receive | OBFR + 1.95% | Termination(a) | 09/08/2028 | $ | 3,231,545 | $ | 13,659 | |||||||||
| Carvana Co. | Clear Street LLC | Receive | OBFR + 1.75% | Termination(b) | 11/16/2027 | 2,737,402 | - | |||||||||||
| Carvana Co. | Marex Capital Markets, Inc. | Receive | OBFR + 3.00% | Monthly(c) | 06/29/2026 | 1,291,146 | 6,192 | |||||||||||
| Carvana Co. | Nomura Securities International, Inc. | Receive | OBFR + 11.00% | Termination(d) | 07/30/2026 | 1,578,681 | 7,571 | |||||||||||
| Net Unrealized Appreciation (Depreciation) | $ | 27,422 | ||||||||||||||||
There are no upfront payments or receipts associated with total return swaps in the Fund as of October 31, 2025.
OBFR - Overnight Bank Funding Rate was 3.86% as of October 31, 2025.
| (a) | Financing reset of the swap is effective on the last day of each month. Equity reset of the swap is effective on termination. |
| (b) | Financing reset of the swap is effective on the last day of each month. Equity reset of the swap is effective on termination but also periodically throughout the term. |
| (c) | Financing and equity reset of the swap is effective on the last day of each month and periodically throughout the month. |
| (d) | Financing reset of swap is effective on the last day of each month. Equity reset of swap is effective on termination. |
| 5 | |
| The accompanying notes are an integral part of these financial statements. |
| Schedules of Investments & Total Return Swap Contracts | Defiance ETFs |
October 31, 2025 (Unaudited)
Defiance Daily Target 2X Long DKNG ETF
Schedule of Investments
| U.S. TREASURY BILLS - 10.7% | Principal | Value | ||||
| 3.95%, 11/20/2025 (a)(b) | $ | 775,000 | $ | 773,584 | ||
| TOTAL U.S. TREASURY BILLS (Cost $773,391) | 773,584 | |||||
| MONEY MARKET FUNDS - 2.1% | Shares | |||||
| First American Government Obligations Fund - Class X, 4.03% (c) | 149,894 | 149,894 | ||||
| TOTAL MONEY MARKET FUNDS (Cost $149,894) | 149,894 | |||||
|
TOTAL INVESTMENTS - 12.8% (Cost $923,285) |
$ | 923,478 | ||||
| Other Assets in Excess of Liabilities - 87.2% | 6,315,006 | |||||
| TOTAL NET ASSETS - 100.0% | $ | 7,238,484 | ||||
Percentages are stated as a percent of net assets.
| (a) | The rate shown is the annualized yield as of October 31, 2025. |
| (b) | All or a portion of security has been pledged as collateral for swap contracts. The fair value of assets committed as collateral as of October 31, 2025 is $149,724. |
| (c) | The rate shown represents the 7-day annualized yield as of October 31, 2025. |
Defiance Daily Target 2X Long DKNG ETF
Schedule of Total Return Swap Contracts
|
Reference Entity |
Counterparty |
Pay/Receive
Entity |
Financing Rate |
Payment
|
Maturity
|
Notional
|
Value/
(Depreciation) |
|||||||||||
| DraftKings, Inc. | Cantor Fitzgerald & Co. | Receive | OBFR + 1.00% | Termination(a) | 09/07/2026 | $ | 4,833,189 | $ | 69,625 | |||||||||
| DraftKings, Inc. | Marex Capital Markets, Inc. | Receive | OBFR + 3.50% | Monthly(b) | 09/18/2026 | 3,508,673 | 50,247 | |||||||||||
| DraftKings, Inc. | Nomura Securities International, Inc. | Receive | OBFR + 7.00% | Termination(c) | 08/31/2026 | 6,122,680 | 90,069 | |||||||||||
| Net Unrealized Appreciation (Depreciation) | $ | 209,941 | ||||||||||||||||
There are no upfront payments or receipts associated with total return swaps in the Fund as of October 31, 2025.
OBFR - Overnight Bank Funding Rate was 3.86% as of October 31, 2025.
| (a) | Financing reset of the swap is effective on the last day of each month. Equity reset of the swap is effective on termination. |
| (b) | Financing and equity reset of the swap is effective on the last day of each month and periodically throughout the month. |
| (c) | Financing reset of swap is effective on the last day of each month. Equity reset of swap is effective on termination. |
| 6 | |
| The accompanying notes are an integral part of these financial statements. |
| Schedules of Investments & Total Return Swap Contracts | Defiance ETFs |
October 31, 2025 (Unaudited)
Defiance Daily Target 2X Long HIMS ETF
Schedule of Investments
| U.S. TREASURY BILLS - 13.1% | Principal | Value | ||||
| 3.93%, 11/20/2025 (a)(b) | $ | 26,425,000 | $ | 26,376,708 | ||
| TOTAL U.S. TREASURY BILLS (Cost $26,372,746) | 26,376,708 | |||||
| MONEY MARKET FUNDS - 0.2% | Shares | |||||
| First American Government Obligations Fund - Class X, 4.03% (c) | 334,821 | 334,821 | ||||
| TOTAL MONEY MARKET FUNDS (Cost $334,821) | 334,821 | |||||
|
TOTAL INVESTMENTS - 13.3% (Cost $26,707,567) |
$ | 26,711,529 | ||||
| Other Assets in Excess of Liabilities - 86.7% | 173,773,373 | |||||
| TOTAL NET ASSETS - 100.0% | $ | 200,484,902 | ||||
Percentages are stated as a percent of net assets.
| (a) | The rate shown is the annualized yield as of October 31, 2025. |
| (b) | All or a portion of security has been pledged as collateral for swap contracts. The fair value of assets committed as collateral as of October 31, 2025 is $2,994,480. |
| (c) | The rate shown represents the 7-day annualized yield as of October 31, 2025. |
Defiance Daily Target 2X Long HIMS ETF
Schedule of Total Return Swap Contracts
|
Reference Entity |
Counterparty |
Pay/Receive
|
Financing Rate |
Payment
|
Maturity
|
Notional
|
Value/
(Depreciation) |
|||||||||||
| Hims & Hers Health, Inc. | BMO Capital Markets Corp. | Receive | OBFR + 13.00% | Termination(a) | 09/30/2026 | $ | 68,644,600 | $ | 3,815,350 | |||||||||
| Hims & Hers Health, Inc. | Cantor Fitzgerald & Co. | Receive | OBFR + 15.00% | Termination(b) | 09/08/2028 | 57,577,408 | 1,773,171 | |||||||||||
| Hims & Hers Health, Inc. | Clear Street LLC | Receive | OBFR + 5.00% | Termination(a) | 01/11/2028 | 120,391,718 | - | |||||||||||
| Hims & Hers Health, Inc. | Marex Capital Markets, Inc. | Receive | OBFR + 5.00% | Monthly(c) | 10/02/2026 | 107,842,212 | 2,651,823 | |||||||||||
| Hims & Hers Health, Inc. | Nomura Securities International, Inc. | Receive | OBFR + 17.50% | Termination(d) | 09/18/2028 | 47,278,400 | 1,456,000 | |||||||||||
| Net Unrealized Appreciation (Depreciation) | $ | 9,696,344 | ||||||||||||||||
There are no upfront payments or receipts associated with total return swaps in the Fund as of October 31, 2025.
OBFR - Overnight Bank Funding Rate was 3.86% as of October 31, 2025.
| (a) | Financing reset of the swap is effective on the last day of each month. Equity reset of the swap is effective on termination but also periodically throughout the term. |
| (b) | Financing reset of the swap is effective on the last day of each month. Equity reset of the swap is effective on termination. |
| (c) | Financing and equity reset of the swap is effective on the last day of each month and periodically throughout the month. |
| (d) | Financing reset of swap is effective on the last day of each month. Equity reset of swap is effective on termination. |
| 7 | |
| The accompanying notes are an integral part of these financial statements. |
| Schedules of Investments & Total Return Swap Contracts | Defiance ETFs |
October 31, 2025 (Unaudited)
Defiance
Daily Target 2X Long HOOD ETF
Schedule of Investments
| COMMON STOCKS - 3.6% | Shares | Value | ||||
|
Internet - 3.6% Robinhood Markets, Inc. - Class A (a) |
7,182 | $ | 1,054,174 | |||
| TOTAL COMMON STOCKS (Cost $907,708) | 1,054,174 | |||||
|
SHORT-TERM INVESTMENTS |
||||||
| U.S. TREASURY BILLS - 5.9% | Principal | |||||
| 3.93%, 11/20/2025 (b)(c) | $ | 1,745,000 | 1,741,811 | |||
| TOTAL U.S. TREASURY BILLS (Cost $1,741,389) | 1,741,811 | |||||
| MONEY MARKET FUNDS - 2.5% | Shares | |||||
| First American Government Obligations Fund - Class X, 4.03% (d) | 739,901 | 739,901 | ||||
| TOTAL MONEY MARKET FUNDS (Cost $739,901) | 739,901 | |||||
|
TOTAL INVESTMENTS - 12.0% (Cost $3,388,998) |
$ | 3,535,886 | ||||
| Other Assets in Excess of Liabilities - 88.0% | 25,988,779 | |||||
| TOTAL NET ASSETS - 100.0% | $ | 29,524,665 | ||||
Percentages are stated as a percent of net assets.
| (a) | Non-income producing security. |
| (b) | The rate shown is the annualized yield as of October 31, 2025. |
| (c) | All or a portion of security has been pledged as collateral for swap contracts. The fair value of assets committed as collateral as of October 31, 2025 is $249,540. |
| (d) | The rate shown represents the 7-day annualized yield as of October 31, 2025. |
Defiance Daily Target 2X Long HOOD ETF
Schedule of Total Return Swap Contracts
|
Reference Entity |
Counterparty |
Pay/Receive
|
Financing Rate |
Payment
|
Maturity
|
Notional
|
Value/ Unrealized Appreciation (Depreciation) |
|||||||||||
| Robinhood Markets, Inc. | BMO Capital Markets Corp. | Receive | OBFR + 6.00% | Termination(a) | 09/30/2026 | $ | 16,145,800 | $ | 2,095,635 | |||||||||
| Robinhood Markets, Inc. | Cantor Fitzgerald & Co. | Receive | OBFR + 7.00% | Termination(b) | 09/08/2028 | 6,981,737 | 1,466,630 | |||||||||||
| Robinhood Markets, Inc. | Clear Street LLC | Receive | OBFR + 3.50% | Termination(a) | 11/16/2027 | 10,568,160 | - | |||||||||||
| Robinhood Markets, Inc. | Marex Capital Markets, Inc. | Receive | OBFR + 3.50% | Monthly(c) | 04/19/2026 | 11,221,037 | 2,779,841 | |||||||||||
| Robinhood Markets, Inc. | Nomura Securities International, Inc. | Receive | OBFR + 7.00% | Termination(d) | 07/30/2026 | 13,063,420 | 2,739,800 | |||||||||||
| Net Unrealized Appreciation (Depreciation) | $ | 9,081,906 | ||||||||||||||||
There are no upfront payments or receipts associated with total return swaps in the Fund as of October 31, 2025.
OBFR - Overnight Bank Funding Rate was 3.86% as of October 31, 2025.
| (a) | Financing reset of the swap is effective on the last day of each month. Equity reset of the swap is effective on termination but also periodically throughout the term. |
| (b) | Financing reset of the swap is effective on the last day of each month. Equity reset of the swap is effective on termination. |
| 8 | |
| The accompanying notes are an integral part of these financial statements. |
| Schedules of Investments & Total Return Swap Contracts | Defiance ETFs |
October 31, 2025 (Unaudited)
| (c) | Financing and equity reset of the swap is effective on the last day of each month and periodically throughout the month. |
| (d) | Financing reset of swap is effective on the last day of each month. Equity reset of swap is effective on termination. |
Defiance Daily Target 2X Long IONQ ETF
Schedule of Investments
| COMMON STOCKS - 3.2% | Shares | Value | ||||
|
Software - 3.2% IonQ, Inc. (a) |
114,162 | $ | 7,121,426 | |||
| TOTAL COMMON STOCKS (Cost $6,978,659) | 7,121,426 | |||||
|
SHORT-TERM INVESTMENTS |
||||||
| U.S. TREASURY BILLS - 6.0% | Principal | |||||
| 3.92%, 11/20/2025 (b)(c) | $13,575,000 | 13,550,192 | ||||
| TOTAL U.S. TREASURY BILLS (Cost $13,546,985) | 13,550,192 | |||||
| MONEY MARKET FUNDS - 0.9% | Shares | |||||
| First American Government Obligations Fund - Class X, 4.03% (d) | 2,044,792 | 2,044,792 | ||||
| TOTAL MONEY MARKET FUNDS (Cost $2,044,792) | 2,044,792 | |||||
|
TOTAL INVESTMENTS - 10.1% (Cost $22,570,436) |
$ | 22,716,410 | ||||
| Other Assets in Excess of Liabilities - 89.9% | 203,168,261 | |||||
| TOTAL NET ASSETS - 100.0% | $ | 225,884,671 | ||||
Percentages are stated as a percent of net assets.
| (a) | Non-income producing security. |
| (b) | The rate shown is the annualized yield as of October 31, 2025. |
| (c) | All or a portion of security has been pledged as collateral for swap contracts. The fair value of assets committed as collateral as of October 31, 2025 is $1,497,240. |
| (d) | The rate shown represents the 7-day annualized yield as of October 31, 2025. |
Defiance Daily Target 2X Long IONQ ETF
Schedule of Total Return Swap Contracts
|
Reference Entity |
Counterparty |
Pay/Receive
|
Financing Rate |
Payment
|
Maturity
|
Notional
|
Value/
(Depreciation) |
|||||||||||
| IonQ, Inc. | BMO Capital Markets Corp. | Receive | OBFR + 13.00% | Termination(a) | 06/30/2026 | $ | 97,312,800 | $ | 14,762,825 | |||||||||
| IonQ, Inc. | Cantor Fitzgerald & Co. | Receive | OBFR + 20.00% | Termination(b) | 09/08/2028 | 56,416,285 | 11,776,704 | |||||||||||
| IonQ, Inc. | Cantor Fitzgerald & Co. | Receive | OBFR + 20.00% | Termination(b) | 09/18/2028 | 66,746,600 | 7,415,100 | |||||||||||
| IonQ, Inc. | Clear Street LLC | Receive | OBFR + 3.50% | Termination(a) | 11/23/2027 | 132,629,736 | - | |||||||||||
| IonQ, Inc. | Marex Capital Markets, Inc. | Receive | OBFR + 4.50% | Monthly(c) | 04/12/2026 | 65,944,580 | 19,223,550 | |||||||||||
| IonQ, Inc. | Marex Capital Markets, Inc. | Receive | OBFR + 5.50% | Monthly(c) | 10/03/2028 | 311,900 | 34,650 | |||||||||||
| IonQ, Inc. | Nomura Securities International, Inc. | Receive | OBFR + 15.00% | Termination(d) | 09/15/2028 | 24,952,000 | 2,772,000 | |||||||||||
| Net Unrealized Appreciation (Depreciation) | $ | 55,984,829 | ||||||||||||||||
| 9 | |
| The accompanying notes are an integral part of these financial statements. |
| Schedules of Investments & Total Return Swap Contracts | Defiance ETFs |
October 31, 2025 (Unaudited)
There are no upfront payments or receipts associated with total return swaps in the Fund as of October 31, 2025.
OBFR - Overnight Bank Funding Rate was 3.86% as of October 31, 2025.
| (a) | Financing reset of the swap is effective on the last day of each month. Equity reset of the swap is effective on termination but also periodically throughout the term. |
| (b) | Financing reset of the swap is effective on the last day of each month. Equity reset of the swap is effective on termination. |
| (c) | Financing and equity reset of the swap is effective on the last day of each month and periodically throughout the month. |
| (d) | Financing reset of swap is effective on the last day of each month. Equity reset of swap is effective on termination. |
Defiance Daily Target 2X Long IREN ETF
Schedule of Investments
| COMMON STOCKS - 0.3% | Shares | Value | ||||
|
Investment Companies - 0.3% IREN Ltd. (a) |
5,443 | $ | 330,662 | |||
| TOTAL COMMON STOCKS (Cost $300,481) | 330,662 | |||||
|
SHORT-TERM INVESTMENTS |
||||||
| U.S. TREASURY BILLS - 9.2% | Principal | |||||
| 3.91%, 11/20/2025 (b)(c) | $10,225,000 | 10,206,314 | ||||
| TOTAL U.S. TREASURY BILLS (Cost $10,205,137) | 10,206,314 | |||||
| MONEY MARKET FUNDS - 0.1% | Shares | |||||
| First American Government Obligations Fund - Class X, 4.03% (d) | 58,173 | 58,173 | ||||
| TOTAL MONEY MARKET FUNDS (Cost $58,173) | 58,173 | |||||
|
TOTAL INVESTMENTS - 9.6% (Cost $10,563,791) |
$ | 10,595,149 | ||||
| Other Assets in Excess of Liabilities - 90.4% | 100,008,775 | |||||
| TOTAL NET ASSETS - 100.0% | $ | 110,603,924 | ||||
Percentages are stated as a percent of net assets.
| (a) | Non-income producing security. |
| (b) | The rate shown is the annualized yield as of October 31, 2025. |
| (c) | All or a portion of security has been pledged as collateral for swap contracts. The fair value of assets committed as collateral as of October 31, 2025 is $648,804. |
| (d) | The rate shown represents the 7-day annualized yield as of October 31, 2025. |
Defiance Daily Target 2X Long IREN ETF
Schedule of Total Return Swap Contracts
|
Reference Entity |
Counterparty |
Pay/Receive
|
Financing Rate |
Payment
|
Maturity
|
Notional
|
Value/
(Depreciation) |
|||||||||||
| IREN Ltd. | Cantor Fitzgerald & Co. | Receive | OBFR + 30.00% | Termination(a) | 11/01/2028 | $ | 65,187,180 | $ | 1,952,146 | |||||||||
| IREN Ltd. | Clear Street LLC | Receive | OBFR + 5.00% | Termination(b) | 11/23/2027 | 69,132,832 | - | |||||||||||
| IREN Ltd. | Marex Capital Markets, Inc. | Receive | OBFR + 4.00% | Monthly(c) | 10/20/2028 | 67,371,750 | 1,916,018 | |||||||||||
| IREN Ltd. | Nomura Securities International, Inc. | Receive | OBFR + 21.00% | Termination(d) | 10/30/2028 | 18,832,500 | 373,668 | |||||||||||
| Net Unrealized Appreciation (Depreciation) | $ | 4,241,832 |
| 10 | |
| The accompanying notes are an integral part of these financial statements. |
| Schedules of Investments & Total Return Swap Contracts | Defiance ETFs |
October 31, 2025 (Unaudited)
There are no upfront payments or receipts associated with total return swaps in the Fund as of October 31, 2025.
OBFR - Overnight Bank Funding Rate was 3.86% as of October 31, 2025.
| (a) | Financing reset of the swap is effective on the last day of each month. Equity reset of the swap is effective on termination. |
| (b) | Financing reset of the swap is effective on the last day of each month. Equity reset of the swap is effective on termination but also periodically throughout the term. |
| (c) | Financing and equity reset of the swap is effective on the last day of each month and periodically throughout the month. |
| (d) | Financing reset of swap is effective on the last day of each month. Equity reset of swap is effective on termination. |
Defiance Daily Target 2X Long JPM ETF
Schedule of Investments
| COMMON STOCKS - 1.7% | Shares | Value | ||||
|
Banks - 1.7% JPMorgan Chase & Co. |
149 | $ | 46,357 | |||
| TOTAL COMMON STOCKS (Cost $43,596) | 46,357 | |||||
|
SHORT-TERM INVESTMENTS |
||||||
| U.S. TREASURY BILLS - 31.1% | Principal | |||||
| 3.94%, 11/20/2025 (a)(b) | $865,000 | 863,419 | ||||
| TOTAL U.S. TREASURY BILLS (Cost $863,208) | 863,419 | |||||
| MONEY MARKET FUNDS - 0.8% | Shares | |||||
| First American Government Obligations Fund - Class X, 4.03% (c) | 22,439 | 22,439 | ||||
| TOTAL MONEY MARKET FUNDS (Cost $22,439) | 22,439 | |||||
|
TOTAL INVESTMENTS - 33.6% (Cost $929,243) |
$ | 932,215 | ||||
| Other Assets in Excess of Liabilities - 66.4% | 1,844,167 | |||||
| TOTAL NET ASSETS - 100.0% | $ | 2,776,382 | ||||
Percentages are stated as a percent of net assets.
| (a) | The rate shown is the annualized yield as of October 31, 2025. |
| (b) | All or a portion of security has been pledged as collateral for swap contracts. The fair value of assets committed as collateral as of October 31, 2025 is $249,540. |
| (c) | The rate shown represents the 7-day annualized yield as of October 31, 2025. |
Defiance Daily Target 2X Long JPM ETF
Schedule of Total Return Swap Contracts
|
Reference Entity |
Counterparty |
Pay/Receive
|
Financing Rate |
Payment
|
Maturity
|
Notional
|
Value/
(Depreciation) |
|||||||||||
| JPMorgan Chase & Co. | Clear Street LLC | Receive | OBFR + 1.25% | Termination(a) | 09/15/2026 | $ | 3,066,710 | $ | - | |||||||||
| JPMorgan Chase & Co. | Marex Capital Markets, Inc. | Receive | OBFR + 1.50% | Monthly(b) | 09/18/2026 | 2,437,625 | 121,512 | |||||||||||
| Net Unrealized Appreciation (Depreciation) | $ | 121,512 | ||||||||||||||||
There are no upfront payments or receipts associated with total return swaps in the Fund as of October 31, 2025.
| 11 | |
| The accompanying notes are an integral part of these financial statements. |
| Schedules of Investments & Total Return Swap Contracts | Defiance ETFs |
October 31, 2025 (Unaudited)
OBFR - Overnight Bank Funding Rate was 3.86% as of October 31, 2025.
| (a) | Financing reset of the swap is effective on the last day of each month. Equity reset of the swap is effective on termination but also periodically throughout the term. |
| (b) | Financing and equity reset of the swap is effective on the last day of each month and periodically throughout the month. |
Defiance Daily Target 2X Long LLY ETF
Schedule of Investments
| U.S. TREASURY BILLS - 16.0% | Principal | Value | ||||
| 3.93%, 11/20/2025 (a)(b) | $ | 9,050,000 | $ | 9,033,461 | ||
| TOTAL U.S. TREASURY BILLS (Cost $9,031,269) | 9,033,461 | |||||
| MONEY MARKET FUNDS - 1.3% | Shares | |||||
| First American Government Obligations Fund - Class X, 4.03% (c) | 705,273 | 705,273 | ||||
| TOTAL MONEY MARKET FUNDS (Cost $705,273) | 705,273 | |||||
|
TOTAL INVESTMENTS - 17.3% (Cost $9,736,542) |
$ | 9,738,734 | ||||
| Other Assets in Excess of Liabilities - 82.7% | 46,652,729 | |||||
| TOTAL NET ASSETS - 100.0% | $ | 56,391,463 | ||||
Percentages are stated as a percent of net assets.
| (a) | The rate shown is the annualized yield as of October 31, 2025. |
| (b) | All or a portion of security has been pledged as collateral for swap contracts. The fair value of assets committed as collateral as of October 31, 2025 is $6,840,000. |
| (c) | The rate shown represents the 7-day annualized yield as of October 31, 2025. |
Defiance Daily Target 2X Long LLY ETF
Schedule of Total Return Swap Contracts
|
Reference Entity |
Counterparty |
Pay/Receive
|
Financing Rate |
Payment
|
Maturity
|
Notional
|
Value/
(Depreciation) |
|||||||||||
| Eli Lilly & Co. | BMO Capital Markets Corp. | Receive | OBFR + 3.00% | Termination(a) | 10/30/2026 | $ | 7,334,310 | $ | 155,933 | |||||||||
| Eli Lilly & Co. | Cantor Fitzgerald & Co. | Receive | OBFR + 2.50% | Termination(b) | 09/08/2028 | 21,927,861 | 5,848,481 | |||||||||||
| Eli Lilly & Co. | Clear Street LLC | Receive | OBFR + 1.25% | Termination(a) | 10/13/2026 | 23,217,837 | - | |||||||||||
| Eli Lilly & Co. | Marex Capital Markets, Inc. | Receive | OBFR + 2.00% | Monthly(c) | 10/02/2026 | 22,406,748 | 3,273,205 | |||||||||||
| Eli Lilly & Co. | Morgan Stanley | Receive | OBFR + 2.50% | Termination(d) | 10/15/2028 | 3,020,010 | 128,117 | |||||||||||
| Eli Lilly & Co. | Nomura Securities International, Inc. | Receive | OBFR + 4.00% | Termination(d) | 08/03/2026 | 34,859,544 | 9,117,146 | |||||||||||
| Net Unrealized Appreciation (Depreciation) | $ | 18,522,882 | ||||||||||||||||
There are no upfront payments or receipts associated with total return swaps in the Fund as of October 31, 2025.
OBFR - Overnight Bank Funding Rate was 3.86% as of October 31, 2025.
| 12 | |
| The accompanying notes are an integral part of these financial statements. |
| Schedules of Investments & Total Return Swap Contracts | Defiance ETFs |
October 31, 2025 (Unaudited)
| (a) | Financing reset of the swap is effective on the last day of each month. Equity reset of the swap is effective on termination but also periodically throughout the term. |
| (b) | Financing reset of the swap is effective on the last day of each month. Equity reset of the swap is effective on termination. |
| (c) | Financing and equity reset of the swap is effective on the last day of each month and periodically throughout the month. |
| (d) | Financing reset of swap is effective on the last day of each month. Equity reset of swap is effective on termination. |
Defiance Daily Target 2X Long LMND ETF
Schedule of Investments
| COMMON STOCKS - 2.4% | Shares | Value | ||||
|
Insurance - 2.4% Lemonade, Inc. (a) |
699 | $ | 41,996 | |||
| TOTAL COMMON STOCKS (Cost $34,281) | 41,996 | |||||
|
SHORT-TERM INVESTMENTS |
||||||
| MONEY MARKET FUNDS - 10.9% | ||||||
| First American Government Obligations Fund - Class X, 4.03% (b) | 191,371 | 191,371 | ||||
| TOTAL MONEY MARKET FUNDS (Cost $191,371) | 191,371 | |||||
| U.S. TREASURY BILLS - 3.7% | Principal | |||||
| 3.90%, 11/20/2025 (c)(d) | $65,000 | 64,881 | ||||
| TOTAL U.S. TREASURY BILLS (Cost $64,867) | 64,881 | |||||
|
TOTAL INVESTMENTS - 17.0% (Cost $290,519) |
$ | 298,248 | ||||
| Other Assets in Excess of Liabilities - 83.0% | 1,456,397 | |||||
| TOTAL NET ASSETS - 100.0% | $ | 1,754,645 | ||||
Percentages are stated as a percent of net assets.
| (a) | Non-income producing security. |
| (b) | The rate shown represents the 7-day annualized yield as of October 31, 2025. |
| (c) | The rate shown is the annualized yield as of October 31, 2025. |
| (d) | All or a portion of security has been pledged as collateral for swap contracts. The fair value of assets committed as collateral as of October 31, 2025 is $4,991. |
Defiance Daily Target 2X Long LMND ETF
Schedule of Total Return Swap Contracts
|
Reference Entity |
Counterparty |
Pay/Receive
|
Financing
|
Payment |
Maturity Date |
Notional
|
Value/
(Depreciation) |
|||||||||||
| Lemonade, Inc. | Cantor Fitzgerald & Co. | Receive | OBFR + 12.50% | Termination(a) | 09/08/2028 | $ | 2,407,766 | $ | 428,721 | |||||||||
| Lemonade, Inc. | Clear Street LLC | Receive | OBFR + 5.00% | Termination(b) | 01/04/2028 | 38,893 | 99 | |||||||||||
| Lemonade, Inc. | Marex Capital Markets, Inc. | Receive | OBFR + 3.00% | Monthly(c) | 10/23/2028 | 1,015,352 | 18,083 | |||||||||||
| Net Unrealized Appreciation (Depreciation) | $ | 446,903 | ||||||||||||||||
There are no upfront payments or receipts associated with total return swaps in the Fund as of October 31, 2025.
OBFR - Overnight Bank Funding Rate was 3.86% as of October 31, 2025.
| 13 | |
| The accompanying notes are an integral part of these financial statements. |
| Schedules of Investments & Total Return Swap Contracts | Defiance ETFs |
October 31, 2025 (Unaudited)
| (a) | Financing reset of the swap is effective on the last day of each month. Equity reset of the swap is effective on termination. |
| (b) | Financing reset of the swap is effective on the last day of each month. Equity reset of the swap is effective on termination but also periodically throughout the term. |
| (c) | Financing and equity reset of the swap is effective on the last day of each month and periodically throughout the month. |
Defiance Daily Target 2X Long MP ETF
Schedule of Investments
| U.S. TREASURY BILLS - 5.1% | Principal | Value | ||||
| 3.91%, 11/20/2025 (a)(b) | $ | 375,000 | $ | 374,315 | ||
| TOTAL U.S. TREASURY BILLS (Cost $374,228) | 374,315 | |||||
| MONEY MARKET FUNDS - 0.3% | Shares | |||||
| First American Government Obligations Fund - Class X, 4.03% (c) | 22,245 | 22,245 | ||||
| TOTAL MONEY MARKET FUNDS (Cost $22,245) | 22,245 | |||||
|
TOTAL INVESTMENTS - 5.4% (Cost $396,473) |
$ | 396,560 | ||||
| Other Assets in Excess of Liabilities - 94.6% | 6,994,569 | |||||
| TOTAL NET ASSETS - 100.0% | $ | 7,391,129 | ||||
Percentages are stated as a percent of net assets.
| (a) | The rate shown is the annualized yield as of October 31, 2025. |
| (b) | All or a portion of security has been pledged as collateral for swap contracts. The fair value of assets committed as collateral as of October 31, 2025 is $324,402. |
| (c) | The rate shown represents the 7-day annualized yield as of October 31, 2025. |
Defiance
Daily Target 2X Long MP ETF
Schedule of Total Return Swap
Contracts
|
Reference Entity |
Counterparty |
Pay/Receive
|
Financing Rate |
Payment
|
Maturity
|
Notional
|
Value/
(Depreciation) |
|||||||||||
| MP Materials Corp. | Cantor Fitzgerald & Co. | Receive | OBFR + 8.00% | Termination(a) | 11/01/2028 | $ | 4,942,029 | $ | (144,350 | ) | ||||||||
| MP Materials Corp. | Clear Street LLC | Receive | OBFR + 2.50% | Termination(b) | 11/23/2027 | 5,718,856 | - | |||||||||||
| MP Materials Corp. | Marex Capital Markets, Inc. | Receive | OBFR + 3.50% | Monthly(c) | 10/26/2028 | 4,100,850 | (106,934 | ) | ||||||||||
| Net Unrealized Appreciation (Depreciation) | $ | (251,284 | ) | |||||||||||||||
There are no upfront payments or receipts associated with total return swaps in the Fund as of October 31, 2025.
OBFR - Overnight Bank Funding Rate was 3.86% as of October 31, 2025.
| (a) | Financing reset of the swap is effective on the last day of each month. Equity reset of the swap is effective on termination. |
| (b) | Financing reset of the swap is effective on the last day of each month. Equity reset of the swap is effective on termination but also periodically throughout the term. |
| (c) | Financing and equity reset of the swap is effective on the last day of each month and periodically throughout the month. |
| 14 | |
| The accompanying notes are an integral part of these financial statements. |
| Schedules of Investments & Total Return Swap Contracts | Defiance ETFs |
October 31, 2025 (Unaudited)
Defiance Daily Target 2X Long MSTR ETF
Schedule of Investments
| U.S. TREASURY BILLS - 13.9% | Principal | Value | ||||
| 3.89%, 11/20/2025 (a)(b) | $ | 81,000,000 | $ | 80,851,973 | ||
| TOTAL U.S. TREASURY BILLS (Cost $80,836,166) | 80,851,973 | |||||
| MONEY MARKET FUNDS - 1.5% | Shares | Value | ||||
| Dreyfus Government Cash Management - Institutional Class, 4.00% (c) | 7,970,693 | 7,970,693 | ||||
| First American Government Obligations Fund - Class X, 4.03% (c) | 924,320 | 924,320 | ||||
| TOTAL MONEY MARKET FUNDS (Cost $8,895,013) | 8,895,013 | |||||
|
TOTAL INVESTMENTS - 15.4% (Cost $89,731,179) |
$ | 89,746,986 | ||||
| Other Assets in Excess of Liabilities - 84.6% | 492,294,581 | |||||
| TOTAL NET ASSETS - 100.0% | $ | 582,041,567 | ||||
Percentages are stated as a percent of net assets.
| (a) | The rate shown is the annualized yield as of October 31, 2025. |
| (b) | All or a portion of security has been pledged as collateral for swap contracts. The fair value of assets committed as collateral as of October 31, 2025 is $66,377,640. |
| (c) | The rate shown represents the 7-day annualized yield as of October 31, 2025. |
Defiance Daily Target 2X Long MSTR ETF
Schedule of Total Return Swap Contracts
|
Reference Entity |
Counterparty |
Pay/Receive
|
Financing Rate |
Payment
|
Maturity
|
Notional
|
Value/
(Depreciation) |
|||||||||||
| Strategy, Inc. | BMO Capital Markets Corp. | Receive | OBFR + 10.00% | Termination(a) | 09/30/2026 | $ | 311,418,805 | $ | - | |||||||||
| Strategy, Inc. | Cantor Fitzgerald & Co. | Receive | OBFR + 12.50% | Termination(b) | 10/05/2026 | 286,469,456 | 15,730,190 | |||||||||||
| Strategy, Inc. | Clear Street LLC | Receive | OBFR + 17.00% | Termination(a) | 11/09/2027 | 310,918,325 | - | |||||||||||
| Strategy, Inc. | Marex Capital Markets, Inc. | Receive | OBFR + 10.00% | Monthly(c) | 09/25/2028 | 255,606,518 | 14,169,275 | |||||||||||
| Net Unrealized Appreciation (Depreciation) | $ | 29,899,465 | ||||||||||||||||
There are no upfront payments or receipts associated with total return swaps in the Fund as of October 31, 2025.
OBFR - Overnight Bank Funding Rate was 3.86% as of October 31, 2025.
| (a) | Financing reset of the swap is effective on the last day of each month. Equity reset of the swap is effective on termination but also periodically throughout the term. |
| (b) | Financing reset of the swap is effective on the last day of each month. Equity reset of the swap is effective on termination. |
| (c) | Financing and equity reset of the swap is effective on the last day of each month and periodically throughout the month. |
| 15 | |
| The accompanying notes are an integral part of these financial statements. |
| Schedules of Investments & Total Return Swap Contracts | Defiance ETFs |
| October 31, 2025 (Unaudited) |
Defiance Daily Target 2X Long NVO ETF
Schedule of Investments
| COMMON STOCKS - 2.2% | Shares | Value | ||||||
| Pharmaceuticals - 2.2% | ||||||||
| Novo Nordisk AS - ADR | 36,376 | $ | 1,799,157 | |||||
| TOTAL COMMON STOCKS (Cost $1,876,106) | 1,799,157 | |||||||
| SHORT-TERM INVESTMENTS | ||||||||
| U.S. TREASURY BILLS - 14.9% | Principal | |||||||
| 3.94%, 11/20/2025 (a)(b) | $12,200,000 | 12,177,704 | ||||||
| TOTAL U.S. TREASURY BILLS (Cost $12,174,723) | 12,177,704 | |||||||
| MONEY MARKET FUNDS - 0.0%(c) | Shares | |||||||
| First American Government Obligations Fund - Class X, 4.03% (d) | 33,955 | 33,955 | ||||||
| TOTAL MONEY MARKET FUNDS (Cost $33,955) | 33,955 | |||||||
| TOTAL INVESTMENTS - 17.1% (Cost $14,084,784) | $ | 14,010,816 | ||||||
| Other Assets in Excess of Liabilities - 82.9% | 68,007,147 | |||||||
| TOTAL NET ASSETS - 100.0% | $ | 82,017,963 | ||||||
Percentages are stated as a percent of net assets.
ADR - American Depositary Receipt
| (a) | The rate shown is the annualized yield as of October 31, 2025. |
| (b) | All or a portion of security has been pledged as collateral for swap contracts. The fair value of assets committed as collateral as of October 31, 2025 is $1,996,320. |
| (c) | Represents less than 0.05% of net assets. |
| (d) | The rate shown represents the 7-day annualized yield as of October 31, 2025. |
Defiance Daily Target 2X Long NVO ETF
Schedule of Total Return Swap Contracts
| Value/ | |||||||||||||||
| Pay/Receive | Unrealized | ||||||||||||||
| Reference Entity | Counterparty | Reference Entity | Financing Rate | Payment Frequency | Maturity Date | Notional Amount | Appreciation (Depreciation) | ||||||||
| Novo Nordisk AS | Cantor Fitzgerald & Co. | Receive | OBFR + 5.00% | Termination(a) | 09/08/2028 | $ 35,264,535 | $ | (410,684) | |||||||
| Novo Nordisk AS | Clear Street LLC | Receive | OBFR + 1.25% | Termination(b) | 08/25/2026 | 42,847,495 | - | ||||||||
| Novo Nordisk AS | Marex Capital Markets, Inc. | Receive | OBFR + 3.00% | Monthly(c) | 09/25/2026 | 14,553,556 | (170,664) | ||||||||
| Novo Nordisk AS | Morgan Stanley | Receive | OBFR + 3.50% | Termination(d) | 10/06/2028 | 28,686,800 | (1,201,973) | ||||||||
| Novo Nordisk AS | Nomura Securities International, Inc. | Receive | OBFR + 7.00% | Termination(d) | 01/12/2026 | 40,839,122 | (478,906) | ||||||||
| Net Unrealized Appreciation (Depreciation) | $ | (2,262,227) | |||||||||||||
There are no upfront payments or receipts associated with total return swaps in the Fund as of October 31, 2025.
OBFR - Overnight Bank Funding Rate was 3.86% as of October 31, 2025.
| (a) | Financing reset of the swap is effective on the last day of each month. Equity reset of the swap is effective on termination. |
| (b) | Financing reset of the swap is effective on the last day of each month. Equity reset of the swap is effective on termination but also periodically throughout the term. |
16
The accompanying notes are an integral part of these financial statements.
| Schedules of Investments & Total Return Swap Contracts | Defiance ETFs |
October 31, 2025 (Unaudited)
| (c) | Financing and equity reset of the swap is effective on the last day of each month and periodically throughout the month. |
| (d) | Financing reset of swap is effective on the last day of each month. Equity reset of swap is effective on termination. |
Defiance Daily Target 2X Long OKLO ETF
Schedule of Investments
| COMMON STOCKS - 3.0% | Shares | Value | ||||||
| Electric - 3.0% | ||||||||
| Oklo, Inc. (a) | 46,794 | $ | 6,212,840 | |||||
| TOTAL COMMON STOCKS (Cost $6,529,167) | 6,212,840 | |||||||
| SHORT-TERM INVESTMENTS | ||||||||
| U.S. TREASURY BILLS - 10.9% | Principal | |||||||
| 3.94%, 11/20/2025 (b)(c) | $22,190,000 | 22,149,448 | ||||||
| TOTAL U.S. TREASURY BILLS (Cost $22,146,465) | 22,149,448 | |||||||
| MONEY MARKET FUNDS - 0.0%(d) | Shares | |||||||
| First American Government Obligations Fund - Class X, 4.03% (e) | 8,499 | 8,499 | ||||||
| TOTAL MONEY MARKET FUNDS (Cost $8,499) | 8,499 | |||||||
| TOTAL INVESTMENTS - 13.9% (Cost $28,684,131) | $ | 28,370,787 | ||||||
| Other Assets in Excess of Liabilities - 86.1% | 175,676,820 | |||||||
| TOTAL NET ASSETS - 100.0% | $ | 204,047,607 | ||||||
Percentages are stated as a percent of net assets.
| (a) | Non-income producing security. |
| (b) | The rate shown is the annualized yield as of October 31, 2025. |
| (c) | All or a portion of security has been pledged as collateral for swap contracts. The fair value of assets committed as collateral as of October 31, 2025 is $6,213,546. |
| (d) | Represents less than 0.05% of net assets. |
| (e) | The rate shown represents the 7-day annualized yield as of October 31, 2025. |
Defiance Daily Target 2X Long OKLO ETF
Schedule of Total Return Swap Contracts
| Value/ | |||||||||||||||
| Pay/Receive | Unrealized | ||||||||||||||
| Reference Entity | Counterparty | Reference Entity | Financing Rate | Payment Frequency | Maturity Date | Notional Amount | Appreciation (Depreciation) | ||||||||
| Oklo, Inc. | Cantor Fitzgerald & Co. | Receive | OBFR + 20.00% | Termination(a) | 09/23/2026 | $ 85,065,341 | $ | 8,641,863 | |||||||
| Oklo, Inc. | Cantor Fitzgerald & Co. | Receive | OBFR + 20.00% | Termination(a) | 09/18/2028 | 49,788,750 | 4,743,750 | ||||||||
| Oklo, Inc. | Clear Street LLC | Receive | OBFR + 2.50% | Termination(b) | 01/25/2028 | 146,061,737 | - | ||||||||
| Oklo, Inc. | Marex Capital Markets, Inc. | Receive | OBFR + 5.50% | Monthly(c) | 07/24/2026 | 106,441,709 | 40,929,078 | ||||||||
| Oklo, Inc. | Marex Capital Markets, Inc. | Receive | OBFR + 5.50% | Termination(c) | 10/03/2028 | 663,850 | 27,050 | ||||||||
| Oklo, Inc. | Nomura Securities International, Inc. | Receive | OBFR + 12.50% | Termination(d) | 09/18/2028 | 13,277,000 | 1,230,354 | ||||||||
| Net Unrealized Appreciation (Depreciation) | $ | 55,572,095 | |||||||||||||
17
The accompanying notes are an integral part of these financial statements.
| Schedules of Investments & Total Return Swap Contracts | Defiance ETFs |
October 31, 2025 (Unaudited)
There are no upfront payments or receipts associated with total return swaps in the Fund as of October 31, 2025.
OBFR - Overnight Bank Funding Rate was 3.86% as of October 31, 2025.
| (a) | Financing reset of the swap is effective on the last day of each month. Equity reset of the swap is effective on termination. |
| (b) | Financing reset of the swap is effective on the last day of each month. Equity reset of the swap is effective on termination but also periodically throughout the term. |
| (c) | Financing and equity reset of the swap is effective on the last day of each month and periodically throughout the month. |
| (d) | Financing reset of swap is effective on the last day of each month. Equity reset of swap is effective on termination. |
Defiance Daily Target 2X Long ORCL ETF
Schedule of Investments
| U.S. TREASURY BILLS - 9.3% | Principal | Value | ||||||
| 3.93%, 11/20/2025 (a)(b) | $ | 22,850,000 | $ | 22,808,242 | ||||
| TOTAL U.S. TREASURY BILLS (Cost $22,802,676) | 22,808,242 | |||||||
| MONEY MARKET FUNDS - 0.0%(c) | Shares | |||||||
| First American Government Obligations Fund - Class X, 4.03% (d) | 11,917 | 11,917 | ||||||
| TOTAL MONEY MARKET FUNDS (Cost $11,917) | 11,917 | |||||||
| TOTAL INVESTMENTS - 9.3% (Cost $22,814,593) | $ | 22,820,159 | ||||||
| Other Assets in Excess of Liabilities - 90.7% | 223,271,657 | |||||||
| TOTAL NET ASSETS - 100.0% | $ | 246,091,816 | ||||||
Percentages are stated as a percent of net assets.
| (a) | The rate shown is the annualized yield as of October 31, 2025. |
| (b) | All or a portion of security has been pledged as collateral for swap contracts. The fair value of assets committed as collateral as of October 31, 2025 is $8,234,820. |
| (c) | Represents less than 0.05% of net assets. |
| (d) | The rate shown represents the 7-day annualized yield as of October 31, 2025. |
Defiance Daily Target 2X Long ORCL ETF
Schedule of Total Return Swap Contracts
| Value/ | |||||||||||||||
| Pay/Receive | Unrealized | ||||||||||||||
| Reference Entity | Counterparty | Reference Entity | Financing Rate | Payment Frequency | Maturity Date | Notional Amount | Appreciation (Depreciation) | ||||||||
| Oracle Corp. | BMO Capital Markets Corp. | Receive | OBFR + 3.00% | Termination(a) | 09/30/2026 | $ 186,453,100 | $ | - | |||||||
| Oracle Corp. | Cantor Fitzgerald & Co. | Receive | OBFR + 3.50% | Termination(b) | 03/09/2026 | 97,290,177 | 4,574,724 | ||||||||
| Oracle Corp. | Clear Street LLC | Receive | OBFR + 1.25% | Termination(a) | 01/04/2028 | 110,103,707 | - | ||||||||
| Oracle Corp. | Marex Capital Markets, Inc. | Receive | OBFR + 2.00% | Monthly(c) | 03/13/2026 | 56,906,274 | 950,869 | ||||||||
| Oracle Corp. | Nomura Securities International, Inc. | Receive | OBFR + 4.00% | Termination(d) | 07/30/2026 | 43,855,870 | 2,811,653 | ||||||||
| Net Unrealized Appreciation (Depreciation) | $ | 8,337,246 | |||||||||||||
There are no upfront payments or receipts associated with total return swaps in the Fund as of October 31, 2025.
18
The accompanying notes are an integral part of these financial statements.
| Schedules of Investments & Total Return Swap Contracts | Defiance ETFs |
October 31, 2025 (Unaudited)
OBFR - Overnight Bank Funding Rate was 3.86% as of October 31, 2025.
| (a) | Financing reset of the swap is effective on the last day of each month. Equity reset of the swap is effective on termination but also periodically throughout the term. |
| (b) | Financing reset of the swap is effective on the last day of each month. Equity reset of the swap is effective on termination. |
| (c) | Financing and equity reset of the swap is effective on the last day of each month and periodically throughout the month. |
| (d) | Financing reset of swap is effective on the last day of each month. Equity reset of swap is effective on termination. |
Defiance Daily Target 2X Long OSCR ETF
Schedule of Investments
| U.S. TREASURY BILLS - 7.5% | Principal | Value | ||||||
| 3.95%, 11/20/2025 (a)(b) | $ | 615,000 | $ | 613,877 | ||||
| TOTAL U.S. TREASURY BILLS (Cost $613,723) | 613,877 | |||||||
| MONEY MARKET FUNDS - 0.2% | Shares | |||||||
| First American Government Obligations Fund - Class X, 4.03% (c) | 20,381 | 20,381 | ||||||
| TOTAL MONEY MARKET FUNDS (Cost $20,381) | 20,381 | |||||||
| TOTAL INVESTMENTS - 7.7% (Cost $634,104) | $ | 634,258 | ||||||
| Other Assets in Excess of Liabilities - 92.3% | 7,571,893 | |||||||
| TOTAL NET ASSETS - 100.0% | $ | 8,206,151 | ||||||
Percentages are stated as a percent of net assets.
| (a) | The rate shown is the annualized yield as of October 31, 2025. |
| (b) | All or a portion of security has been pledged as collateral for swap contracts. The fair value of assets committed as collateral as of October 31, 2025 is $424,218. |
| (c) | The rate shown represents the 7-day annualized yield as of October 31, 2025. |
Defiance Daily Target 2X Long OSCR ETF
Schedule of Total Return Swap Contracts
| Value/ | |||||||||||||||
| Pay/Receive | Unrealized | ||||||||||||||
| Reference Entity | Counterparty | Reference Entity | Financing Rate | Payment Frequency | Maturity Date | Notional Amount | Appreciation (Depreciation) | ||||||||
| Oscar Health, Inc. | Clear Street LLC | Receive | OBFR + 8.00% | Termination(a) | 11/09/2027 | $ 5,822,370 | $ | - | |||||||
| Oscar Health, Inc. | Marex Capital Markets, Inc. | Receive | OBFR + 3.50% | Monthly(b) | 09/29/2028 | 6,060,186 | (30,301) | ||||||||
| Oscar Health, Inc. | Nomura Securities International, Inc. | Receive | OBFR + 17.50% | Termination(c) | 10/03/2028 | 4,500,000 | (22,500) | ||||||||
| Net Unrealized Appreciation (Depreciation) | $ | (52,801) | |||||||||||||
There are no upfront payments or receipts associated with total return swaps in the Fund as of October 31, 2025.
OBFR - Overnight Bank Funding Rate was 3.86% as of October 31, 2025.
| (a) | Financing reset of the swap is effective on the last day of each month. Equity reset of the swap is effective on termination but also periodically throughout the term. |
19
The accompanying notes are an integral part of these financial statements.
| Schedules of Investments & Total Return Swap Contracts | Defiance ETFs |
October 31, 2025 (Unaudited)
| (b) | Financing and equity reset of the swap is effective on the last day of each month and periodically throughout the month. |
| (c) | Financing reset of swap is effective on the last day of each month. Equity reset of swap is effective on termination. |
Defiance Daily Target 2X Long PM ETF
Schedule of Investments
| U.S. TREASURY BILLS - 8.6% | Principal | Value | ||||||
| 3.92%, 11/20/2025 (a)(c) | $ | 40,000 | $ | 39,927 | ||||
| TOTAL U.S. TREASURY BILLS (Cost $39,917) | 39,927 | |||||||
| MONEY MARKET FUNDS - 2.3% | Shares | |||||||
| First American Government Obligations Fund - Class X, 4.03% (b) | 10,502 | 10,502 | ||||||
| TOTAL MONEY MARKET FUNDS (Cost $10,502) | 10,502 | |||||||
| TOTAL INVESTMENTS - 10.9% (Cost $50,419) | $ | 50,429 | ||||||
| Other Assets in Excess of Liabilities - 89.1% | 412,934 | |||||||
| TOTAL NET ASSETS - 100.0% | $ | 463,363 | ||||||
Percentages are stated as a percent of net assets.
| (a) | The rate shown is the annualized yield as of October 31, 2025. |
| (b) | The rate shown represents the 7-day annualized yield as of October 31, 2025. |
| (c) | All or a portion of security has been pledged as collateral for swap contracts. The fair value of assets committed as collateral as of October 31, 2025 is $39,927. |
Defiance Daily Target 2X Long PM ETF
Schedule of Total Return Swap Contracts
| Value/ | |||||||||||||||
| Pay/Receive | Unrealized | ||||||||||||||
| Reference Entity | Counterparty | Reference Entity | Financing Rate | Payment Frequency | Maturity Date | Notional Amount | Appreciation (Depreciation) | ||||||||
| Philip Morris International, Inc. | Cantor Fitzgerald & Co. | Receive | OBFR + 1.00% | Termination(a) | 10/05/2026 | $ 506,887 | $ | (38,048) | |||||||
| Philip Morris International, Inc. | Clear Street LLC | Receive | OBFR + 1.25% | Termination(b) | 10/13/2026 | 404,990 | - | ||||||||
| Philip Morris International, Inc. | Marex Capital Markets, Inc. | Receive | OBFR + 3.50% | Monthly(c) | 10/30/2028 | 14,433 | (247) | ||||||||
| Net Unrealized Appreciation (Depreciation) | $ | (38,295) | |||||||||||||
There are no upfront payments or receipts associated with total return swaps in the Fund as of October 31, 2025.
OBFR - Overnight Bank Funding Rate was 3.86% as of October 31, 2025.
| (a) | Financing reset of the swap is effective on the last day of each month. Equity reset of the swap is effective on termination. |
| (b) | Financing reset of the swap is effective on the last day of each month. Equity reset of the swap is effective on termination but also periodically throughout the term. |
| (c) | Financing and equity reset of the swap is effective on the last day of each month and periodically throughout the month. |
20
The accompanying notes are an integral part of these financial statements.
| Schedules of Investments & Total Return Swap Contracts | Defiance ETFs |
October 31, 2025 (Unaudited)
Defiance Daily Target 2X Long QS ETF
Schedule of Investments
| U.S. TREASURY BILLS - 5.1% | Principal | Value | ||||||
| 3.89%, 11/20/2025 (a)(c) | $ | 500,000 | $ | 499,086 | ||||
| TOTAL U.S. TREASURY BILLS (Cost $498,976) | 499,086 | |||||||
| MONEY MARKET FUNDS - 1.4% | Shares | |||||||
| First American Government Obligations Fund - Class X, 4.03% (b) | 140,152 | 140,152 | ||||||
| TOTAL MONEY MARKET FUNDS (Cost $140,152) | 140,152 | |||||||
| TOTAL INVESTMENTS - 6.5% (Cost $639,128) | $ | 639,238 | ||||||
| Other Assets in Excess of Liabilities - 93.5% | 9,269,884 | |||||||
| TOTAL NET ASSETS - 100.0% | $ | 9,909,122 | ||||||
Percentages are stated as a percent of net assets.
| (a) | The rate shown is the annualized yield as of October 31, 2025. |
| (b) | The rate shown represents the 7-day annualized yield as of October 31, 2025. |
| (c) | All or a portion of security has been pledged as collateral for swap contracts. The fair value of assets committed as collateral as of October 31, 2025 is $499,086. |
Defiance Daily Target 2X Long QS ETF
Schedule of Total Return Swap Contracts
| Value/ | |||||||||||||||
| Pay/Receive | Unrealized | ||||||||||||||
| Reference Entity | Counterparty | Reference Entity | Financing Rate | Payment Frequency | Maturity Date | Notional Amount | Appreciation (Depreciation) | ||||||||
| QuantumScape Corp. | Cantor Fitzgerald & Co. | Receive | OBFR + 21.00% | Termination(a) | 11/01/2028 | $ 6,075,630 | $ | 858,201 | |||||||
| QuantumScape Corp. | Clear Street LLC | Receive | OBFR + 8.00% | Termination(b) | 01/04/2028 | 3,125,562 | 324,927 | ||||||||
| QuantumScape Corp. | Marex Capital Markets, Inc. | Receive | OBFR + 4.00% | Monthly(c) | 10/20/2028 | 5,973,620 | 1,362,711 | ||||||||
| QuantumScape Corp. | Nomura Securities International, Inc. | Receive | OBFR + 22.50% | Termination(d) | 10/30/2028 | 4,610,000 | 710,162 | ||||||||
| Net Unrealized Appreciation (Depreciation) | $ | 3,256,001 | |||||||||||||
There are no upfront payments or receipts associated with total return swaps in the Fund as of October 31, 2025.
OBFR - Overnight Bank Funding Rate was 3.86% as of October 31, 2025.
| (a) | Financing reset of the swap is effective on the last day of each month. Equity reset of the swap is effective on termination. |
| (b) | Financing reset of the swap is effective on the last day of each month. Equity reset of the swap is effective on termination but also periodically throughout the term. |
| (c) | Financing and equity reset of the swap is effective on the last day of each month and periodically throughout the month. |
| (d) | Financing reset of swap is effective on the last day of each month. Equity reset of swap is effective on termination. |
21
The accompanying notes are an integral part of these financial statements.
| Schedules of Investments & Total Return Swap Contracts | Defiance ETFs |
October 31, 2025 (Unaudited)
Defiance Daily Target 2X Long RGTI ETF
Schedule of Investments
| U.S. TREASURY BILLS - 7.2% | Principal | Value | ||||||
| 3.94%, 11/20/2025 (a)(b) | $ | 10,675,000 | $ | 10,655,491 | ||||
| TOTAL U.S. TREASURY BILLS (Cost $10,652,859) | 10,655,491 | |||||||
| MONEY MARKET FUNDS - 0.1% | Shares | |||||||
| First American Government Obligations Fund - Class X, 4.03% (c) | 89,340 | 89,340 | ||||||
| TOTAL MONEY MARKET FUNDS (Cost $89,340) | 89,340 | |||||||
| TOTAL INVESTMENTS - 7.3% (Cost $10,742,199) | $ | 10,744,831 | ||||||
| Other Assets in Excess of Liabilities - 92.7% | 136,710,488 | |||||||
| TOTAL NET ASSETS - 100.0% | $ | 147,455,319 | ||||||
Percentages are stated as a percent of net assets.
| (a) | The rate shown is the annualized yield as of October 31, 2025. |
| (b) | All or a portion of security has been pledged as collateral for swap contracts. The fair value of assets committed as collateral as of October 31, 2025 is $5,489,880. |
| (c) | The rate shown represents the 7-day annualized yield as of October 31, 2025. |
Defiance Daily Target 2X Long RGTI ETF
Schedule of Total Return Swap Contracts
| Value/ | |||||||||||||||
| Pay/Receive | Unrealized | ||||||||||||||
| Reference Entity | Counterparty | Reference Entity | Financing Rate | Payment Frequency | Maturity Date | Notional Amount | Appreciation (Depreciation) | ||||||||
| Rigetti Computing, Inc. | BMO Capital Markets Corp. | Receive | OBFR + 20.00% | Monthly(a) | 06/30/2026 | $ 54,452,100 | $ | 14,435,950 | |||||||
| Rigetti Computing, Inc. | Cantor Fitzgerald & Co. | Receive | OBFR + 40.00% | Termination(b) | 09/08/2028 | 60,205,562 | 34,406,132 | ||||||||
| Rigetti Computing, Inc. | Cantor Fitzgerald & Co. | Receive | OBFR + 40.00% | Termination(b) | 09/18/2028 | 13,723,700 | 4,532,200 | ||||||||
| Rigetti Computing, Inc. | Clear Street LLC | Receive | OBFR + 13.00% | Termination(a) | 08/18/2026 | 69,973,339 | - | ||||||||
| Rigetti Computing, Inc. | Marex Capital Markets, Inc. | Receive | OBFR + 4.50% | Monthly(c) | 05/01/2026 | 57,498,717 | 38,964,570 | ||||||||
| Rigetti Computing, Inc. | Nomura Securities International, Inc. | Receive | OBFR + 25.00% | Termination(d) | 09/15/2028 | 38,736,250 | 7,680,456 | ||||||||
| Net Unrealized Appreciation (Depreciation) | $ | 100,019,308 | |||||||||||||
There are no upfront payments or receipts associated with total return swaps in the Fund as of October 31, 2025.
OBFR - Overnight Bank Funding Rate was 3.86% as of October 31, 2025.
| (a) | Financing reset of the swap is effective on the last day of each month. Equity reset of the swap is effective on termination but also periodically throughout the term. |
| (b) | Financing reset of the swap is effective on the last day of each month. Equity reset of the swap is effective on termination. |
| (c) | Financing and equity reset of the swap is effective on the last day of each month and periodically throughout the month. |
| (d) | Financing reset of swap is effective on the last day of each month. Equity reset of swap is effective on termination. |
22
The accompanying notes are an integral part of these financial statements.
| Schedules of Investments & Total Return Swap Contracts | Defiance ETFs |
October 31, 2025 (Unaudited)
Defiance Daily Target 2X Long RIOT ETF
Schedule of Investments
| COMMON STOCKS - 2.8% | Shares | Value | ||||||
| Investment Companies - 2.8% | ||||||||
| Riot Platforms, Inc. (a) | 60,265 | $ | 1,192,042 | |||||
| TOTAL COMMON STOCKS (Cost $1,262,307) | 1,192,042 | |||||||
| SHORT-TERM INVESTMENTS | ||||||||
| U.S. TREASURY BILLS - 5.9% | Principal | |||||||
| 3.94%, 11/20/2025 (b)(c) | $2,450,000 | 2,445,522 | ||||||
| TOTAL U.S. TREASURY BILLS (Cost $2,444,921) | 2,445,522 | |||||||
| MONEY MARKET FUNDS - 0.4% | Shares | |||||||
| First American Government Obligations Fund - Class X, 4.03% (d) | 186,553 | 186,553 | ||||||
| TOTAL MONEY MARKET FUNDS (Cost $186,553) | 186,553 | |||||||
| TOTAL INVESTMENTS - 9.1% (Cost $3,893,781) | $ | 3,824,117 | ||||||
| Other Assets in Excess of Liabilities - 90.9% | 38,273,729 | |||||||
| TOTAL NET ASSETS - 100.0% | $ | 42,097,846 | ||||||
Percentages are stated as a percent of net assets.
| (a) | Non-income producing security. |
| (b) | The rate shown is the annualized yield as of October 31, 2025. |
| (c) | All or a portion of security has been pledged as collateral for swap contracts. The fair value of assets committed as collateral as of October 31, 2025 is $499,080. |
| (d) | The rate shown represents the 7-day annualized yield as of October 31, 2025. |
Defiance Daily Target 2X Long RIOT ETF
Schedule of Total Return Swap Contracts
| Value/ | |||||||||||||||
| Pay/Receive | Unrealized | ||||||||||||||
| Reference Entity | Counterparty | Reference Entity | Financing Rate | Payment Frequency | Maturity Date | Notional Amount | Appreciation (Depreciation) | ||||||||
| Riot Platforms, Inc. | BMO Capital Markets Corp. | Receive | OBFR + 20.00% | Termination(a) | 08/31/2026 | $ 16,219,600 | $ | (237,700) | |||||||
| Riot Platforms, Inc. | Cantor Fitzgerald & Co. | Receive | OBFR + 25.00% | Termination(b) | 09/08/2028 | 24,849,990 | 14,426,422 | ||||||||
| Riot Platforms, Inc. | Cantor Fitzgerald & Co. | Receive | OBFR + 25.00% | Termination(b) | 09/18/2028 | 791,200 | 83,246 | ||||||||
| Riot Platforms, Inc. | Clear Street LLC | Receive | OBFR + 8.50% | Termination(a) | 09/22/2026 | 17,431,817 | - | ||||||||
| Riot Platforms, Inc. | Clear Street LLC | Receive | OBFR + 8.50% | Termination(a) | 11/16/2027 | 989,000 | - | ||||||||
| Riot Platforms, Inc. | Marex Capital Markets, Inc. | Receive | OBFR + 5.00% | Monthly(c) | 02/03/2026 | 22,532,110 | 5,868,608 | ||||||||
| Net Unrealized Appreciation (Depreciation) | $ | 20,140,576 | |||||||||||||
There are no upfront payments or receipts associated with total return swaps in the Fund as of October 31, 2025.
OBFR - Overnight Bank Funding Rate was 3.86% as of October 31, 2025.
| (a) | Financing reset of the swap is effective on the last day of each month. Equity reset of the swap is effective on termination but also periodically throughout the term. |
23
The accompanying notes are an integral part of these financial statements.
| Schedules of Investments & Total Return Swap Contracts | Defiance ETFs |
October 31, 2025 (Unaudited)
| (b) | Financing reset of the swap is effective on the last day of each month. Equity reset of the swap is effective on termination. |
| (c) | Financing and equity reset of the swap is effective on the last day of each month and periodically throughout the month. |
Defiance Daily Target 2X Long RKLB ETF
Schedule of Investments
| COMMON STOCKS - 1.9% | Shares | Value | ||||||
| Aerospace/Defense - 1.9% | ||||||||
| Rocket Lab Corp. (a) | 32,367 | $ | 2,038,474 | |||||
| TOTAL COMMON STOCKS (Cost $2,005,819) | 2,038,474 | |||||||
| SHORT-TERM INVESTMENTS | ||||||||
| U.S. TREASURY BILLS - 8.3% | Principal | |||||||
| 3.93%, 11/20/2025 (b)(c) | $8,950,000 | 8,933,644 | ||||||
| TOTAL U.S. TREASURY BILLS (Cost $8,931,489) | 8,933,644 | |||||||
| MONEY MARKET FUNDS - 0.9% | Shares | |||||||
| First American Government Obligations Fund - Class X, 4.03% (d) | 971,828 | 971,828 | ||||||
| TOTAL MONEY MARKET FUNDS (Cost $971,828) | 971,828 | |||||||
| TOTAL INVESTMENTS - 11.1% (Cost $11,909,136) | $ | 11,943,946 | ||||||
| Other Assets in Excess of Liabilities - 88.9% | 95,486,360 | |||||||
| TOTAL NET ASSETS - 100.0% | $ | 107,430,306 | ||||||
Percentages are stated as a percent of net assets.
| (a) | Non-income producing security. |
| (b) | The rate shown is the annualized yield as of October 31, 2025. |
| (c) | All or a portion of security has been pledged as collateral for swap contracts. The fair value of assets committed as collateral as of October 31, 2025 is $6,987,120. |
| (d) | The rate shown represents the 7-day annualized yield as of October 31, 2025. |
Defiance Daily Target 2X Long RKLB ETF
Schedule of Total Return Swap Contracts
| Value/ | |||||||||||||||
| Pay/Receive | Unrealized | ||||||||||||||
| Reference Entity | Counterparty | Reference Entity | Financing Rate | Payment Frequency | Maturity Date | Notional Amount | Appreciation (Depreciation) | ||||||||
| Rocket Lab Corp. | BMO Capital Markets Corp. | Receive | OBFR + 15.00% | Termination(a) | 09/30/2026 | $ 22,043,000 | $ | - | |||||||
| Rocket Lab Corp. | Cantor Fitzgerald & Co. | Receive | OBFR + 18.00% | Termination(b) | 09/21/2026 | 41,205,673 | 12,121,317 | ||||||||
| Rocket Lab Corp. | Cantor Fitzgerald & Co. | Receive | OBFR + 18.00% | Termination(b) | 09/18/2028 | 12,596,000 | 3,344,000 | ||||||||
| Rocket Lab Corp. | Clear Street LLC | Receive | OBFR + 1.25% | Termination(a) | 08/25/2026 | 42,652,134 | - | ||||||||
| Rocket Lab Corp. | Marex Capital Markets, Inc. | Receive | OBFR + 5.00% | Monthly(c) | 04/13/2026 | 75,594,138 | 26,478,353 | ||||||||
| Rocket Lab Corp. | Nomura Securities International, Inc. | Receive | OBFR + 8.00% | Termination(d) | 09/15/2028 | 18,579,100 | 2,240,697 | ||||||||
| Net Unrealized Appreciation (Depreciation) | $ | 44,184,367 | |||||||||||||
24
The accompanying notes are an integral part of these financial statements.
| Schedules of Investments & Total Return Swap Contracts | Defiance ETFs |
October 31, 2025 (Unaudited)
There are no upfront payments or receipts associated with total return swaps in the Fund as of October 31, 2025.
OBFR - Overnight Bank Funding Rate was 3.86% as of October 31, 2025.
| (a) | Financing reset of the swap is effective on the last day of each month. Equity reset of the swap is effective on termination but also periodically throughout the term. |
| (b) | Financing reset of the swap is effective on the last day of each month. Equity reset of the swap is effective on termination. |
| (c) | Financing and equity reset of the swap is effective on the last day of each month and periodically throughout the month. |
| (d) | Financing reset of swap is effective on the last day of each month. Equity reset of swap is effective on termination. |
Defiance Daily Target 2X Long SMCI ETF
Schedule of Investments
| COMMON STOCKS - 0.0%(a) | Shares | Value | ||||||
| Computers - 0.0%(a) | ||||||||
| Super Micro Computer, Inc. (b) | 1,554 | $ | 80,746 | |||||
| TOTAL COMMON STOCKS (Cost $74,499) | 80,746 | |||||||
| SHORT-TERM INVESTMENTS | ||||||||
| U.S. TREASURY BILLS - 10.8% | Principal | |||||||
| 3.94%, 11/20/2025 (c)(d) | $25,750,000 | 25,702,942 | ||||||
| TOTAL U.S. TREASURY BILLS (Cost $25,699,142) | 25,702,942 | |||||||
| MONEY MARKET FUNDS - 0.5% | Shares | |||||||
| Dreyfus Government Cash Management - Institutional Class, 4.00% (e) | 183,722 | 183,722 | ||||||
| First American Government Obligations Fund - Class X, 4.03% (e) | 1,126,404 | 1,126,404 | ||||||
| TOTAL MONEY MARKET FUNDS (Cost $1,310,126) | 1,310,126 | |||||||
| TOTAL INVESTMENTS - 11.3% (Cost $27,083,767) | $ | 27,093,814 | ||||||
| Other Assets in Excess of Liabilities - 88.7% | 212,824,560 | |||||||
| TOTAL NET ASSETS - 100.0% | $ | 239,918,374 | ||||||
Percentages are stated as a percent of net assets.
| (a) | Represents less than 0.05% of net assets. |
| (b) | Non-income producing security. |
| (c) | The rate shown is the annualized yield as of October 31, 2025. |
| (d) | All or a portion of security has been pledged as collateral for swap contracts. The fair value of assets committed as collateral as of October 31, 2025 is $499,080. |
| (e) | The rate shown represents the 7-day annualized yield as of October 31, 2025. |
Defiance Daily Target 2X Long SMCI ETF
Schedule of Total Return Swap Contracts
| Value/ | |||||||||||||||
| Pay/Receive | Unrealized | ||||||||||||||
| Reference Entity | Counterparty | Reference Entity | Financing Rate | Payment Frequency | Maturity Date | Notional Amount | Appreciation (Depreciation) | ||||||||
| Super Micro Computer, Inc. | BMO Capital Markets Corp. | Receive | OBFR + 10.00% | Termination (a) | 09/30/2026 | $ 43,906,200 | $ | 5,188,300 | |||||||
| Super Micro Computer, Inc. | Cantor Fitzgerald & Co. | Receive | OBFR + 18.00% | Termination(b) | 09/08/2028 | 94,757,166 | 28,910,784 | ||||||||
| Super Micro Computer, Inc. | Clear Street LLC | Receive | OBFR + 6.00% | Termination(a) | 12/14/2027 | 58,273,348 | - | ||||||||
25
The accompanying notes are an integral part of these financial statements.
| Schedules of Investments & Total Return Swap Contracts | Defiance ETFs |
October 31, 2025 (Unaudited)
| Super Micro Computer, Inc. | Marex Capital Markets, Inc. | Receive | OBFR + 4.00% | Monthly(c) | 09/18/2028 | 30,082,086 | 5,993,155 | ||||||||
| Super Micro Computer, Inc. | Morgan Stanley | Receive | OBFR + 9.00% | Termination(d) | 10/06/2028 | 90,930,000 | 5,297,095 | ||||||||
| Super Micro Computer, Inc. | Nomura Securities International, Inc. | Receive | OBFR + 17.50% | Termination(d) | 03/10/2026 | 161,751,480 | 57,212,816 | ||||||||
| Net Unrealized Appreciation (Depreciation) | $ | 102,602,150 | |||||||||||||
There are no upfront payments or receipts associated with total return swaps in the Fund as of October 31, 2025.
OBFR - Overnight Bank Funding Rate was 3.86% as of October 31, 2025.
| (a) | Financing reset of the swap is effective on the last day of each month. Equity reset of the swap is effective on termination but also periodically throughout the term. |
| (b) | Financing reset of the swap is effective on the last day of each month. Equity reset of the swap is effective on termination. |
| (c) | Financing and equity reset of the swap is effective on the last day of each month and periodically throughout the month. |
| (d) | Financing and equity reset of the swap is effective on the last day of each month and periodically throughout the month. |
Defiance Daily Target 2X Long SOFI ETF
Schedule of Investments
| U.S. TREASURY BILLS - 15.2% | Principal | Value | ||||||
| 3.92%, 11/20/2025 (a)(b) | $ | 15,700,000 | $ | 15,671,309 | ||||
| TOTAL U.S. TREASURY BILLS (Cost $15,667,564) | 15,671,309 | |||||||
| MONEY MARKET FUNDS - 0.3% | Shares | |||||||
| First American Government Obligations Fund - Class X, 4.03% (c) | 271,113 | 271,113 | ||||||
| TOTAL MONEY MARKET FUNDS (Cost $271,113) | 271,113 | |||||||
| TOTAL INVESTMENTS - 15.5% (Cost $15,938,677) | $ | 15,942,422 | ||||||
| Other Assets in Excess of Liabilities - 84.5% | 86,877,404 | |||||||
| TOTAL NET ASSETS - 100.0% | $ | 102,819,826 | ||||||
Percentages are stated as a percent of net assets.
| (a) | The rate shown is the annualized yield as of October 31, 2025. |
| (b) | All or a portion of security has been pledged as collateral for swap contracts. The fair value of assets committed as collateral as of October 31, 2025 is $2,744,940. |
| (c) | The rate shown represents the 7-day annualized yield as of October 31, 2025. |
Defiance Daily Target 2X Long SOFI ETF
Schedule of Total Return Swap Contracts
| Value/ | |||||||||||||||
| Pay/Receive | Unrealized | ||||||||||||||
| Reference Entity | Counterparty | Reference Entity | Financing Rate | Payment Frequency | Maturity Date | Notional Amount | Appreciation (Depreciation) | ||||||||
| SoFi Technologies, Inc. | BMO Capital Markets Corp. | Receive | OBFR + 12.00% | Termination(a) | 09/30/2026 | $ 5,936,000 | $ | 649,500 | |||||||
| SoFi Technologies, Inc. | Cantor Fitzgerald & Co. | Receive | OBFR + 12.00% | Termination(b) | 09/08/2028 | 46,833,467 | 19,195,815 | ||||||||
| SoFi Technologies, Inc. | Cantor Fitzgerald & Co. | Receive | OBFR + 12.00% | Termination(b) | 09/18/2028 | 42,739,200 | 6,308,612 | ||||||||
| SoFi Technologies, Inc. | Clear Street LLC | Receive | OBFR + 1.25% | Termination(a) | 09/22/2026 | 19,055,539 | - | ||||||||
26
The accompanying notes are an integral part of these financial statements.
| Schedules of Investments & Total Return Swap Contracts | Defiance ETFs |
October 31, 2025 (Unaudited)
| SoFi Technologies, Inc. | Marex Capital Markets, Inc. | Receive | OBFR + 3.00% | Monthly(c) | 02/16/2026 | 47,415,254 | 6,438,193 | ||||||||
| SoFi Technologies, Inc. | Nomura Securities International, Inc. | Receive | OBFR + 7.00% | Termination(d) | 07/30/2026 | 43,036,000 | 8,457,816 | ||||||||
| Net Unrealized Appreciation (Depreciation) | $ | 41,049,936 | |||||||||||||
There are no upfront payments or receipts associated with total return swaps in the Fund as of October 31, 2025.
OBFR - Overnight Bank Funding Rate was 3.86% as of October 31, 2025.
| (a) | Financing reset of the swap is effective on the last day of each month. Equity reset of the swap is effective on termination but also periodically throughout the term. |
| (b) | Financing reset of the swap is effective on the last day of each month. Equity reset of the swap is effective on termination. |
| (c) | Financing and equity reset of the swap is effective on the last day of each month and periodically throughout the month. |
| (d) | Financing reset of swap is effective on the last day of each month. Equity reset of swap is effective on termination. |
Defiance Daily Target 2X Long SOUN ETF
Schedule of Investments
| COMMON STOCKS - 2.3% | Shares | Value | ||||||
| United States - 2.3% | ||||||||
| SoundHound AI, Inc. - Class A (a) | 49,060 | $ | 864,437 | |||||
| TOTAL COMMON STOCKS (Cost $900,777) | 864,437 | |||||||
| SHORT-TERM INVESTMENTS | ||||||||
| U.S. TREASURY BILLS - 7.0% | Principal | |||||||
| 3.94%, 11/20/2025 (b)(c) | $2,675,000 | 2,670,111 | ||||||
| TOTAL U.S. TREASURY BILLS (Cost $2,669,451) | 2,670,111 | |||||||
| MONEY MARKET FUNDS - 0.0% (d) | Shares | |||||||
| First American Government Obligations Fund - Class X, 4.03% (e) | 16,452 | 16,452 | ||||||
| TOTAL MONEY MARKET FUNDS (Cost $16,452) | 16,452 | |||||||
| TOTAL INVESTMENTS - 9.3% (Cost $3,586,680) | $ | 3,551,000 | ||||||
| Other Assets in Excess of Liabilities - 90.7% | 34,516,303 | |||||||
| TOTAL NET ASSETS - 100.0% | $ | 38,067,303 | ||||||
Percentages are stated as a percent of net assets.
| (a) | Non-income producing security. |
| (b) | The rate shown is the annualized yield as of October 31, 2025. |
| (c) | All or a portion of security has been pledged as collateral for swap contracts. The fair value of assets committed as collateral as of October 31, 2025 is $149,724. |
| (d) | Represents less than 0.05% of net assets. |
| (e) | The rate shown represents the 7-day annualized yield as of October 31, 2025. |
27
The accompanying notes are an integral part of these financial statements.
| Schedules of Investments & Total Return Swap Contracts | Defiance ETFs |
October 31, 2025 (Unaudited)
Defiance Daily Target 2X Long SOUN ETF
Schedule of Total Return Swap Contracts
| Value/ | |||||||||||||||
| Pay/Receive | Unrealized | ||||||||||||||
| Reference Entity | Counterparty | Reference Entity | Financing Rate | Payment Frequency | Maturity Date | Notional Amount | Appreciation (Depreciation) | ||||||||
| SoundHound AI, Inc. | Cantor Fitzgerald & Co. | Receive | OBFR + 25.00% | Termination(a) | 09/08/2028 | $ 12,818,110 | $ | 3,083,875 | |||||||
| SoundHound AI, Inc. | Cantor Fitzgerald & Co. | Receive | OBFR + 25.00% | Termination(a) | 09/18/2028 | 7,048,000 | 776,000 | ||||||||
| SoundHound AI, Inc. | Clear Street LLC | Receive | OBFR + 10.00% | Termination(b) | 09/08/2026 | 18,135,068 | - | ||||||||
| SoundHound AI, Inc. | Marex Capital Markets, Inc. | Receive | OBFR + 5.50% | Monthly(c) | 07/24/2026 | 19,073,298 | 4,286,488 | ||||||||
| SoundHound AI, Inc. | Nomura Securities International, Inc. | Receive | OBFR + 20.00% | Termination(d) | 09/22/2026 | 18,060,500 | 1,599,779 | ||||||||
| Net Unrealized Appreciation (Depreciation) | $ | 9,746.142 | |||||||||||||
There are no upfront payments or receipts associated with total return swaps in the Fund as of October 31, 2025.
OBFR - Overnight Bank Funding Rate was 3.86% as of October 31, 2025.
| (a) | Financing reset of the swap is effective on the last day of each month. Equity reset of the swap is effective on termination. |
| (b) | Financing reset of the swap is effective on the last day of each month. Equity reset of the swap is effective on termination but also periodically throughout the term. |
| (c) | Financing and equity reset of the swap is effective on the last day of each month and periodically throughout the month. |
| (d) | Financing reset of swap is effective on the last day of each month. Equity reset of swap is effective on termination. |
Defiance Daily Target 2X Long VST ETF
Schedule of Investments
| COMMON STOCKS - 2.3% | Shares | Value | ||||||
| Electric - 2.3% | ||||||||
| Vistra Corp. | 828 | $ | 155,912 | |||||
| TOTAL COMMON STOCKS (Cost $158,856) | 155,912 | |||||||
| SHORT-TERM INVESTMENTS | ||||||||
| U.S. TREASURY BILLS - 20.3% | Principal | |||||||
| 3.94%, 11/20/2025 (a)(b) | $1,360,000 | 1,357,515 | ||||||
| TOTAL U.S. TREASURY BILLS (Cost $1,357,182) | 1,357,515 | |||||||
| MONEY MARKET FUNDS - 8.4% | Shares | |||||||
| First American Government Obligations Fund - Class X, 4.03% (c) | 560,932 | 560,932 | ||||||
| TOTAL MONEY MARKET FUNDS (Cost $560,932) | 560,932 | |||||||
| TOTAL INVESTMENTS - 31.0% (Cost $2,076,970) | $ | 2,074,359 | ||||||
| Other Assets in Excess of Liabilities - 69.0% | 4,607,215 | |||||||
| TOTAL NET ASSETS - 100.0% | $ | 6,681,574 | ||||||
Percentages are stated as a percent of net assets.
| (a) | The rate shown is the annualized yield as of October 31, 2025. |
| (b) | All or a portion of security has been pledged as collateral for swap contracts. The fair value of assets committed as collateral as of October 31, 2025 is $823,482. |
28
The accompanying notes are an integral part of these financial statements.
| Schedules of Investments & Total Return Swap Contracts | Defiance ETFs |
October 31, 2025 (Unaudited)
(c) The rate shown represents the 7-day annualized yield as of October 31, 2025.
Defiance Daily Target 2X Long VST ETF
Schedule of Total Return Swap Contracts
| Value/ | |||||||||||||||
| Pay/Receive | Unrealized | ||||||||||||||
| Reference Entity | Counterparty | Reference Entity | Financing Rate | Payment Frequency | Maturity Date | Notional Amount | Appreciation (Depreciation) | ||||||||
| Vistra Corp. | Clear Street LLC | Receive | OBFR + 1.25% | Termination(a) | 08/25/2026 | $ 4,513,739 | $ | - | |||||||
| Vistra Corp. | Marex Capital Markets, Inc. | Receive | OBFR + 3.50% | Monthly(b) | 10/02/2026 | 4,801,650 | 31,984 | ||||||||
| Vistra Corp. | Nomura Securities International, Inc. | Receive | OBFR + 5.50% | Termination(c) | 09/21/2026 | 3,878,980 | 19,360 | ||||||||
| Net Unrealized Appreciation (Depreciation) | $ | 51,344 | |||||||||||||
There are no upfront payments or receipts associated with total return swaps in the Fund as of October 31, 2025.
OBFR - Overnight Bank Funding Rate was 3.86% as of October 31, 2025.
| (a) | Financing reset of the swap is effective on the last day of each month. Equity reset of the swap is effective on termination but also periodically throughout the term. |
| (b) | Financing and equity reset of the swap is effective on the last day of each month and periodically throughout the month. |
| (c) | Financing reset of swap is effective on the last day of each month. Equity reset of swap is effective on termination. |
Defiance Daily Target 2X Short IONQ ETF
Schedule of Investments
| U.S. TREASURY BILLS - 10.8% | Principal | Value | ||||||
| 3.93%, 11/20/2025 (a)(b) | $ | 4,760,000 | $ | 4,751,301 | ||||
| TOTAL U.S. TREASURY BILLS (Cost $4,750,152) | 4,751,301 | |||||||
| MONEY MARKET FUNDS - 0.9% | Shares | |||||||
| First American Government Obligations Fund - Class X, 4.03% (c) | 410,546 | 410,546 | ||||||
| TOTAL MONEY MARKET FUNDS (Cost $410,546) | 410,546 | |||||||
| TOTAL INVESTMENTS - 11.7% (Cost $5,160,698) | $ | 5,161,847 | ||||||
| Other Assets in Excess of Liabilities - 88.3% | 39,040,545 | |||||||
| TOTAL NET ASSETS - 100.0% | $ | 44,202,392 | ||||||
Percentages are stated as a percent of net assets.
| (a) | The rate shown is the annualized yield as of October 31, 2025. |
| (b) | All or a portion of security has been pledged as collateral for swap contracts. The fair value of assets committed as collateral as of October 31, 2025 is $3,743,100. |
| (c) | The rate shown represents the 7-day annualized yield as of October 31, 2025. |
29
The accompanying notes are an integral part of these financial statements.
| Schedules of Investments & Total Return Swap Contracts | Defiance ETFs |
October 31, 2025 (Unaudited)
Defiance Daily Target 2X Short IONQ ETF
Schedule of Total Return Swap Contracts
| Value/ | |||||||||||||||
| Pay/Receive | Unrealized | ||||||||||||||
| Reference Entity | Counterparty | Reference Entity | Financing Rate | Payment Frequency | Maturity Date | Notional Amount | Appreciation (Depreciation) | ||||||||
| IonQ, Inc. | Cantor Fitzgerald & Co. | Pay | OBFR + (20.00)% | Termination(a) | 01/11/2028 | $ (24,874,586) | $ | (2,075,955) | |||||||
| IonQ, Inc. | Clear Street LLC | Pay | OBFR + (5.00)% | Termination(b) | 11/16/2027 | (29,241,436) | - | ||||||||
| IonQ, Inc. | Marex Capital Markets, Inc. | Pay | OBFR + 3.00% | Monthly(c) | 09/25/2026 | (17,326,482) | (990,565) | ||||||||
| IonQ, Inc. | Nomura Securities International, Inc. | Pay | OBFR + (1.50)% | Termination(d) | 09/28/2026 | (18,963,520) | 793,104 | ||||||||
| Net Unrealized Appreciation (Depreciation) | $ | (2,273,416) | |||||||||||||
There are no upfront payments or receipts associated with total return swaps in the Fund as of October 31, 2025.
OBFR - Overnight Bank Funding Rate was 3.86% as of October 31, 2025.
| (a) | Financing reset of the swap is effective on the last day of each month. Equity reset of the swap is effective on termination. |
| (b) | Financing reset of the swap is effective on the last day of each month. Equity reset of the swap is effective on termination but also periodically throughout the term. |
| (c) | Financing and equity reset of the swap is effective on the last day of each month and periodically throughout the month. |
| (d) | Financing reset of swap is effective on the last day of each month. Equity reset of swap is effective on termination. |
Defiance Daily Target 2X Short LLY ETF
Schedule of Investments
| U.S. TREASURY BILLS - 22.8% | Principal | Value | ||||||
| 3.95%, 11/20/2025 (a)(c) | $ | 315,000 | $ | 314,424 | ||||
| TOTAL U.S. TREASURY BILLS (Cost $314,346) | 314,424 | |||||||
| MONEY MARKET FUNDS - 3.1% | Shares | |||||||
| First American Government Obligations Fund - Class X, 4.03% (b) | 43,045 | 43,045 | ||||||
| TOTAL MONEY MARKET FUNDS (Cost $43,045) | 43,045 | |||||||
| TOTAL INVESTMENTS - 25.9% (Cost $357,391) | $ | 357,469 | ||||||
| Other Assets in Excess of Liabilities - 74.1% | 1,023,837 | |||||||
| TOTAL NET ASSETS - 100.0% | $ | 1,381,306 | ||||||
Percentages are stated as a percent of net assets.
| (a) | The rate shown is the annualized yield as of October 31, 2025. |
| (b) | The rate shown represents the 7-day annualized yield as of October 31, 2025. |
| (c) | All or a portion of security has been pledged as collateral for swap contracts. The fair value of assets committed as collateral as of October 31, 2025 is $314,424. |
30
The accompanying notes are an integral part of these financial statements.
| Schedules of Investments & Total Return Swap Contracts | Defiance ETFs |
October 31, 2025 (Unaudited)
Defiance Daily Target 2X Short LLY ETF
Schedule of Total Return Swap Contracts
| Value/ | |||||||||||||||
| Pay/Receive | Unrealized | ||||||||||||||
| Reference Entity | Counterparty | Reference Entity | Financing Rate | Payment Frequency | Maturity Date | Notional Amount | Appreciation (Depreciation) | ||||||||
| Eli Lilly & Co. | Cantor Fitzgerald & Co. | Pay | OBFR + (1.50)% | Termination(a) | 09/08/2028 | $ (1,123,444) | $ | (48,802) | |||||||
| Eli Lilly & Co. | Clear Street LLC | Pay | OBFR + (1.25)% | Termination(b) | 01/04/2028 | (86,286) | (4,949) | ||||||||
| Eli Lilly & Co. | Marex Capital Markets, Inc. | Pay | OBFR + 1.50% | Monthly(c) | 10/02/2026 | (1,552,285) | (33,030) | ||||||||
| Net Unrealized Appreciation (Depreciation) | $ | (86,781) | |||||||||||||
There are no upfront payments or receipts associated with total return swaps in the Fund as of October 31, 2025.
OBFR - Overnight Bank Funding Rate was 3.86% as of October 31, 2025.
| (a) | Financing reset of the swap is effective on the last day of each month. Equity reset of the swap is effective on termination. |
| (b) | Financing reset of the swap is effective on the last day of each month. Equity reset of the swap is effective on termination but also periodically throughout the term. |
| (c) | Financing and equity reset of the swap is effective on the last day of each month and periodically throughout the month. |
Defiance Daily Target 2X Short MSTR ETF
Schedule of Investments
| U.S. TREASURY BILLS - 11.7% | Principal | Value | ||||||
| 3.95%, 11/20/2025 (a)(b) | $ | 2,530,000 | $ | 2,525,376 | ||||
| TOTAL U.S. TREASURY BILLS (Cost $2,524,745) | 2,525,376 | |||||||
| MONEY MARKET FUNDS - 0.6% | Shares | |||||||
| First American Government Obligations Fund - Class X, 4.03% (c) | 125,532 | 125,532 | ||||||
| TOTAL MONEY MARKET FUNDS (Cost $125,532) | 125,532 | |||||||
| TOTAL INVESTMENTS - 12.3% (Cost $2,650,277) | $ | 2,650,908 | ||||||
| Other Assets in Excess of Liabilities - 87.7% | 18,841,739 | |||||||
| TOTAL NET ASSETS - 100.0% | $ | 21,492,647 | ||||||
Percentages are stated as a percent of net assets.
| (a) | The rate shown is the annualized yield as of October 31, 2025. |
| (b) | All or a portion of security has been pledged as collateral for swap contracts. The fair value of assets committed as collateral as of October 31, 2025 is $1,028,105. |
| (c) | The rate shown represents the 7-day annualized yield as of October 31, 2025. |
31
The accompanying notes are an integral part of these financial statements.
| Schedules of Investments & Total Return Swap Contracts | Defiance ETFs |
October 31, 2025 (Unaudited)
Defiance Daily Target 2X Short MSTR ETF
Schedule of Total Return Swap Contracts
| Value/ | |||||||||||||||
| Pay/Receive | Unrealized | ||||||||||||||
| Reference Entity | Counterparty | Reference Entity | Financing Rate | Payment Frequency | Maturity Date | Notional Amount | Appreciation (Depreciation) | ||||||||
| Strategy, Inc. | Cantor Fitzgerald & Co. | Pay | OBFR + (7.50)% | Termination(a) | 02/17/2026 | $ (23,285,934) | $ | 638,308 | |||||||
| Strategy, Inc. | Marex Capital Markets, Inc. | Pay | OBFR + 5.00% | Monthly(b) | 09/25/2026 | (19,690,401) | 793,247 | ||||||||
| Net Unrealized Appreciation (Depreciation) | $ | 1,431,555 | |||||||||||||
There are no upfront payments or receipts associated with total return swaps in the Fund as of October 31, 2025.
OBFR - Overnight Bank Funding Rate was 3.86% as of October 31, 2025.
| (a) | Financing reset of the swap is effective on the last day of each month. Equity reset of the swap is effective on termination. |
| (b) | Financing and equity reset of the swap is effective on the last day of each month and periodically throughout the month. |
Defiance Daily Target 2X Short PLTR ETF
Schedule of Investments
| U.S. TREASURY BILLS - 22.1% | Principal | Value | ||||||
| 3.94%, 11/20/2025 (a)(b) | $ | 15,250,000 | $ | 15,222,130 | ||||
| TOTAL U.S. TREASURY BILLS (Cost $15,218,406) | 15,222,130 | |||||||
| MONEY MARKET FUNDS - 0.3% | Shares | |||||||
| First American Government Obligations Fund - Class X, 4.03% (c) | 175,949 | 175,949 | ||||||
| TOTAL MONEY MARKET FUNDS (Cost $175,949) | 175,949 | |||||||
| TOTAL INVESTMENTS - 22.4% (Cost $15,394,355) | $ | 15,398,079 | ||||||
| Other Assets in Excess of Liabilities - 77.6% | 53,224,945 | |||||||
| TOTAL NET ASSETS - 100.0% | $ | 68,623,024 | ||||||
Percentages are stated as a percent of net assets.
| (a) | The rate shown is the annualized yield as of October 31, 2025. |
| (b) | All or a portion of security has been pledged as collateral for swap contracts. The fair value of assets committed as collateral as of October 31, 2025 is $8,484,360. |
| (c) | The rate shown represents the 7-day annualized yield as of October 31, 2025. |
Defiance Daily Target 2X Short PLTR ETF
Schedule of Total Return Swap Contracts
| Value/ | |||||||||||||||
| Pay/Receive | Unrealized | ||||||||||||||
| Reference Entity | Counterparty | Reference Entity | Financing Rate | Payment Frequency | Maturity Date | Notional Amount | Appreciation (Depreciation) | ||||||||
| Palantir Technologies, Inc. | Cantor Fitzgerald & Co. | Pay | OBFR + (4.20)% | Termination(a) | 09/21/2026 | $ (73,070,313) | $ | (793,861) | |||||||
| Palantir Technologies, Inc. | Clear Street LLC | Pay | OBFR + (1.25)% | Termination(b) | 01/04/2028 | (200,470) | (1,700) | ||||||||
32
The accompanying notes are an integral part of these financial statements.
| Schedules of Investments & Total Return Swap Contracts | Defiance ETFs |
October 31, 2025 (Unaudited)
| Palantir Technologies, Inc. | Marex Capital Markets, Inc. | Pay | OBFR + (3.50)% | Monthly(c) | 10/05/2026 | (63,836,664) | (657,569) | ||||||||
| Net Unrealized Appreciation (Depreciation) | $ | (1,453,130) | |||||||||||||
There are no upfront payments or receipts associated with total return swaps in the Fund as of October 31, 2025.
OBFR - Overnight Bank Funding Rate was 3.86% as of October 31, 2025.
| (a) | Financing reset of the swap is effective on the last day of each month. Equity reset of the swap is effective on termination. |
| (b) | Financing reset of the swap is effective on the last day of each month. Equity reset of the swap is effective on termination but also periodically throughout the term. |
| (c) | Financing and equity reset of the swap is effective on the last day of each month and periodically throughout the month. |
Defiance Daily Target 2X Short QBTS ETF
Schedule of Investments
| MONEY MARKET FUNDS - 6.1% | Shares | Value | ||||||
| First American Government Obligations Fund - Class X, 4.03% (a) | 2,265,248 | $ | 2,265,248 | |||||
| TOTAL MONEY MARKET FUNDS (Cost $2,265,248) | 2,265,248 | |||||||
| U.S. TREASURY BILLS - 4.3% | Principal | |||||||
| 3.93%, 11/20/2025 (b)(c) | $ | 1,630,000 | 1,627,021 | |||||
| TOTAL U.S. TREASURY BILLS (Cost $1,626,631) | 1,627,021 | |||||||
| TOTAL INVESTMENTS - 10.4% (Cost $3,891,879) | $ | 3,892,269 | ||||||
| Other Assets in Excess of Liabilities - 89.6% | 33,505,213 | |||||||
| TOTAL NET ASSETS - 100.0% | $ | 37,397,482 | ||||||
Percentages are stated as a percent of net assets.
| (a) | The rate shown represents the 7-day annualized yield as of October 31, 2025. |
| (b) | The rate shown is the annualized yield as of October 31, 2025. |
| (c) | All or a portion of security has been pledged as collateral for swap contracts. The fair value of assets committed as collateral as of October 31, 2025 is $648,804. |
Defiance Daily Target 2X Short QBTS ETF
Schedule of Total Return Swap Contracts
| Value/ | |||||||||||||||
| Pay/Receive | Unrealized | ||||||||||||||
| Reference Entity | Counterparty | Reference Entity | Financing Rate | Payment Frequency | Maturity Date | Notional Amount | Appreciation (Depreciation) | ||||||||
| D-Wave Quantum, Inc. | Cantor Fitzgerald & Co. | Pay | OBFR + (42.50)% | Termination(a) | 09/08/2028 | $ (12,834,767) | $ | (305,555) | |||||||
| D-Wave Quantum, Inc. | Clear Street LLC | Pay | OBFR + (2.50)% | Termination(b) | 11/16/2027 | (28,452,222) | - | ||||||||
| D-Wave Quantum, Inc. | Marex Capital Markets, Inc. | Pay | OBFR + (3.00)% | Monthly© | 10/10/2028 | (32,984,994) | (4,462,820) | ||||||||
| Net Unrealized Appreciation (Depreciation) | $ | (4,768,375) | |||||||||||||
There are no upfront payments or receipts associated with total return swaps in the Fund as of October 31, 2025.
OBFR - Overnight Bank Funding Rate was 3.86% as of October 31, 2025.
33
The accompanying notes are an integral part of these financial statements.
| Schedules of Investments & Total Return Swap Contracts | Defiance ETFs |
October 31, 2025 (Unaudited)
| (a) | Financing reset of the swap is effective on the last day of each month. Equity reset of the swap is effective on termination. |
| (b) | Financing reset of the swap is effective on the last day of each month. Equity reset of the swap is effective on termination but also periodically throughout the term. |
| (c) | Financing and equity reset of the swap is effective on the last day of each month and periodically throughout the month. |
Defiance Daily Target 2X Short RGTI ETF
Schedule of Investments
| U.S. TREASURY BILLS - 23.8% | Principal | Value | ||||||
| 3.92%, 11/20/2025 (a)(b) | $ | 18,600,000 | $ | 18,566,009 | ||||
| TOTAL U.S. TREASURY BILLS (Cost $18,563,999) | 18,566,009 | |||||||
| MONEY MARKET FUNDS - 0.3% | Shares | |||||||
| First American Government Obligations Fund - Class X, 4.03% (c) | 230,630 | 230,630 | ||||||
| TOTAL MONEY MARKET FUNDS (Cost $230,630) | 230,630 | |||||||
| TOTAL INVESTMENTS - 24.1% (Cost $18,794,629) | $ | 18,796,639 | ||||||
| Other Assets in Excess of Liabilities - 75.9% | 59,067,136 | |||||||
| TOTAL NET ASSETS - 100.0% | $ | 77,863,775 | ||||||
Percentages are stated as a percent of net assets.
| (a) | The rate shown is the annualized yield as of October 31, 2025. |
| (b) | All or a portion of security has been pledged as collateral for swap contracts. The fair value of assets committed as collateral as of October 31, 2025 is $7,735,740. |
| (c) | The rate shown represents the 7-day annualized yield as of October 31, 2025. |
Defiance Daily Target 2X Short RGTI ETF
Schedule of Total Return Swap Contracts
| Value/ | |||||||||||||||
| Pay/Receive | Unrealized | ||||||||||||||
| Reference Entity | Counterparty | Reference Entity | Financing Rate | Payment Frequency | Maturity Date | Notional Amount | Appreciation (Depreciation) | ||||||||
| Rigetti Computing, Inc. | Cantor Fitzgerald & Co. | Pay | OBFR + (35.00)% | Termination(a) | 09/08/2028 | $ (4,889,400) | $ | (784,425) | |||||||
| Rigetti Computing, Inc. | Clear Street LLC | Pay | OBFR + (2.50)% | Termination(b) | 11/16/2027 | (31,055,007) | - | ||||||||
| Rigetti Computing, Inc. | Marex Capital Markets, Inc. | Pay | OBFR + (3.00)% | Monthly(c) | 10/13/2028 | (82,288,678) | (13,309,926) | ||||||||
| Rigetti Computing, Inc. | Nomura Securities International, Inc. | Pay | OBFR + (0.00)% | Termination(d) | 10/10/2028 | (36,080,050) | (1,426,250) | ||||||||
| Net Unrealized Appreciation (Depreciation) | $ | (15,520,601) | |||||||||||||
There are no upfront payments or receipts associated with total return swaps in the Fund as of October 31, 2025.
OBFR - Overnight Bank Funding Rate was 3.86% as of October 31, 2025.
| (a) | Financing reset of the swap is effective on the last day of each month. Equity reset of the swap is effective on termination. |
| (b) | Financing reset of the swap is effective on the last day of each month. Equity reset of the swap is effective on termination but also periodically throughout the term. |
| (c) | Financing and equity reset of the swap is effective on the last day of each month and periodically throughout the month. |
| (d) | Financing reset of swap is effective on the last day of each month. Equity reset of swap is effective on termination. |
34
The accompanying notes are an integral part of these financial statements.
| Schedules of Investments & Total Return Swap Contracts | Defiance ETFs |
October 31, 2025 (Unaudited)
Defiance Daily Target 2X Short SMCI ETF
Schedule of Investments
| U.S. TREASURY BILLS - 12.9% | Principal | Value | ||||||
| 3.93%, 11/20/2025 (a)(b) | $ | 770,000 | $ | 768,592 | ||||
| TOTAL U.S. TREASURY BILLS (Cost $768,407) | 768,592 | |||||||
| MONEY MARKET FUNDS - 0.5% | Shares | |||||||
| First American Government Obligations Fund - Class X, 4.03% (c) | 26,964 | 26,964 | ||||||
| TOTAL MONEY MARKET FUNDS (Cost $26,964) | 26,964 | |||||||
| TOTAL INVESTMENTS - 13.4% (Cost $795,371) | $ | 795,556 | ||||||
| Other Assets in Excess of Liabilities - 86.6% | 5,142,793 | |||||||
| TOTAL NET ASSETS - 100.0% | $ | 5,938,349 | ||||||
Percentages are stated as a percent of net assets.
| (a) | The rate shown is the annualized yield as of October 31, 2025. |
| (b) | All or a portion of security has been pledged as collateral for swap contracts. The fair value of assets committed as collateral as of October 31, 2025 is $399,264. |
| (c) | The rate shown represents the 7-day annualized yield as of October 31, 2025. |
Defiance Daily Target 2X Short SMCI ETF
Schedule of Total Return Swap Contracts
| Value/ | |||||||||||||||
| Pay/Receive | Unrealized | ||||||||||||||
| Reference Entity | Counterparty | Reference Entity | Financing Rate | Payment Frequency | Maturity Date | Notional Amount | Appreciation (Depreciation) | ||||||||
| Super Micro Computer, Inc. | Cantor Fitzgerald & Co. | Pay | OBFR + (4.20)% | Termination(a) | 09/21/2026 | $ (4,071,118) | $ | (21,382) | |||||||
| Super Micro Computer, Inc. | Marex Capital Markets, Inc. | Pay | OBFR + 2.00% | Monthly(b) | 09/25/2026 | (4,174,934) | 49,909 | ||||||||
| Super Micro Computer, Inc. | Nomura Securities International, Inc. | Pay | OBFR + (0.00)% | Termination(c) | 09/21/2026 | (3,637,200) | 470,400 | ||||||||
| Net Unrealized Appreciation (Depreciation) | $ | 498,927 | |||||||||||||
There are no upfront payments or receipts associated with total return swaps in the Fund as of October 31, 2025.
OBFR - Overnight Bank Funding Rate was 3.86% as of October 31, 2025.
| (a) | Financing reset of the swap is effective on the last day of each month. Equity reset of the swap is effective on termination. |
| (b) | Financing and equity reset of the swap is effective on the last day of each month and periodically throughout the month. |
| (c) | Financing reset of swap is effective on the last day of each month. Equity reset of swap is effective on termination. |
35
The accompanying notes are an integral part of these financial statements.
| Statements of Assets and Liabilities | Defiance ETFs |
October 31, 2025 (Unaudited)
| Defiance 2X Daily | Defiance Daily | Defiance Daily | Defiance Daily | Defiance Daily | ||||||||||||||||
| Long Pure | Target 2X Long | Target 2X Long | Target 2X Long | Target 2X Long | ||||||||||||||||
| Quantum ETF | ANET ETF | AVAV ETF | AVGO ETF | CVNA ETF | ||||||||||||||||
| ASSETS: | ||||||||||||||||||||
| Investments, at value (Note 2) | $ | 2,895,107 | $ | 1,218,877 | $ | 67,154 | $ | 22,471,922 | $ | 731,076 | ||||||||||
| Segregated cash for swap contracts | 28,091,584 | 5,164,029 | 714,633 | 71,135,193 | 3,825,790 | |||||||||||||||
| Unrealized appreciation on swap contracts | 3,176,065 | 1,146,225 | 408 | 43,076,161 | 27,422 | |||||||||||||||
| Receivable for swap contracts | 16,238,251 | 506,429 | 23,803 | 5,879,294 | 477,029 | |||||||||||||||
| Receivable for investments sold | 13,517,252 | 21,174 | 16,064 | 2,944,236 | 6,122 | |||||||||||||||
| Dividends receivable | 2,808 | 1,577 | 63 | 21,668 | 816 | |||||||||||||||
| Receivable for fund shares sold | – | – | – | 1,205,640 | 149,967 | |||||||||||||||
| Interest receivable | – | 53 | – | – | – | |||||||||||||||
| Other assets | 973 | 1,190 | – | 25,109 | – | |||||||||||||||
| Total assets | 63,922,040 | 8,059,554 | 822,125 | 146,759,223 | 5,218,222 | |||||||||||||||
| LIABILITIES: | ||||||||||||||||||||
| Payable for investments purchased | 6,977,071 | 76,985 | – | 74,640 | 22,772 | |||||||||||||||
| Payable for swap contracts | 6,154,204 | 53,660 | 3,937 | 1,496,908 | 807,129 | |||||||||||||||
| Due to broker | 45,706 | – | – | – | – | |||||||||||||||
| Payable to adviser (Note 4) | 36,873 | 7,345 | 174 | 186,639 | 3,103 | |||||||||||||||
| Interest payable | – | 19 | – | 89 | – | |||||||||||||||
| Payable for capital shares redeemed | – | – | – | 1,205,640 | – | |||||||||||||||
| Total liabilities | 13,213,854 | 138,009 | 4,111 | 2,963,916 | 833,004 | |||||||||||||||
| NET ASSETS | $ | 50,708,186 | $ | 7,921,545 | $ | 818,014 | $ | 143,795,307 | $ | 4,385,218 | ||||||||||
| NET ASSETS CONSISTS OF: | ||||||||||||||||||||
| Paid-in capital | $ | 42,238,293 | $ | 6,583,939 | $ | 783,263 | $ | 62,633,886 | $ | 5,816,742 | ||||||||||
| Total distributable earnings/(accumulated losses) | 8,469,893 | 1,337,606 | 34,751 | 81,161,421 | (1,431,524 | ) | ||||||||||||||
| Total net assets | $ | 50,708,186 | $ | 7,921,545 | $ | 818,014 | $ | 143,795,307 | $ | 4,385,218 | ||||||||||
| Net assets | $ | 50,708,186 | $ | 7,921,545 | $ | 818,014 | $ | 143,795,307 | $ | 4,385,218 | ||||||||||
| Shares issued and outstanding(a) | 1,025,000 | 320,000 | 40,000 | 2,480,000 | 295,000 | |||||||||||||||
| Net asset value per share | $ | 49.47 | $ | 24.75 | $ | 20.45 | $ | 57.98 | $ | 14.87 | ||||||||||
| COST: | ||||||||||||||||||||
| Investments, at cost | $ | 2,894,603 | $ | 1,218,625 | $ | 67,143 | $ | 22,467,930 | $ | 730,910 | ||||||||||
| (a) | Unlimited shares authorized. |
36
The accompanying notes are an integral part of these financial statements.
| Statements of Assets and Liabilities | Defiance ETFs |
October 31, 2025 (Unaudited)
| Defiance Daily | Defiance Daily | Defiance Daily | Defiance Daily | Defiance Daily | ||||||||||||||||
| Target 2X Long | Target 2X Long | Target 2X Long | Target 2X Long | Target 2X Long | ||||||||||||||||
| DKNG ETF | HIMS ETF | HOOD ETF | IONQ ETF | IREN ETF | ||||||||||||||||
| ASSETS: | ||||||||||||||||||||
| Investments, at value (Note 2) | $ | 923,478 | $ | 26,711,529 | $ | 3,535,886 | $ | 22,716,410 | $ | 10,595,149 | ||||||||||
| Segregated cash for swap contracts | 6,192,617 | 131,976,326 | 13,203,283 | 135,569,098 | 71,428,211 | |||||||||||||||
| Unrealized appreciation on swap contracts | 209,941 | 9,696,344 | 9,081,906 | 55,984,829 | 4,241,832 | |||||||||||||||
| Receivable for swap contracts | 234,434 | – | 1,486,487 | 11,090,032 | 1,606,579 | |||||||||||||||
| Dividends receivable | 1,142 | 11,832 | 1,735 | 12,004 | 1,716 | |||||||||||||||
| Interest receivable | 7 | – | 7,138 | – | – | |||||||||||||||
| Receivable for investments sold | – | 41,480,040 | 2,777,216 | 4,965,538 | – | |||||||||||||||
| Receivable for fund shares sold | – | 6,915,892 | – | – | 29,227,070 | |||||||||||||||
| Other assets | 1,047 | 4,319 | 2,673 | 27,024 | 4,253 | |||||||||||||||
| Total assets | 7,562,666 | 216,796,282 | 30,096,324 | 230,364,935 | 117,104,810 | |||||||||||||||
| LIABILITIES: | ||||||||||||||||||||
| Payable for swap contracts | 309,946 | 4,367,917 | 393,387 | 2,709,708 | 923,728 | |||||||||||||||
| Payable for investments purchased | 9,347 | 11,741,387 | 145,225 | 488,859 | 5,563,544 | |||||||||||||||
| Payable to adviser (Note 4) | 4,626 | 195,614 | 32,908 | 204,448 | 13,555 | |||||||||||||||
| Interest payable | 263 | 6,462 | 139 | 20,442 | 59 | |||||||||||||||
| Payable for capital shares redeemed | – | – | – | 1,056,807 | – | |||||||||||||||
| Total liabilities | 324,182 | 16,311,380 | 571,659 | 4,480,264 | 6,500,886 | |||||||||||||||
| NET ASSETS | $ | 7,238,484 | $ | 200,484,902 | $ | 29,524,665 | $ | 225,884,671 | $ | 110,603,924 | ||||||||||
| NET ASSETS CONSISTS OF: | ||||||||||||||||||||
| Paid-in capital | $ | 9,379,118 | $ | 167,630,388 | $ | (4,896,418 | ) | $ | 129,884,442 | $ | 107,914,448 | |||||||||
| Total distributable earnings/(accumulated losses) | (2,140,634 | ) | 32,854,514 | 34,421,083 | 96,000,229 | 2,689,476 | ||||||||||||||
| Total net assets | $ | 7,238,484 | $ | 200,484,902 | $ | 29,524,665 | $ | 225,884,671 | $ | 110,603,924 | ||||||||||
| Net assets | $ | 7,238,484 | $ | 200,484,902 | $ | 29,524,665 | $ | 225,884,671 | $ | 110,603,924 | ||||||||||
| Shares issued and outstanding(a) | 900,000 | 15,625,000 | 660,000 | 4,280,000 | 5,490,000 | |||||||||||||||
| Net asset value per share | $ | 8.04 | $ | 12.83 | $ | 44.73 | $ | 52.78 | $ | 20.15 | ||||||||||
| COST: | ||||||||||||||||||||
| Investments, at cost | $ | 923,285 | $ | 26,707,567 | $ | 3,388,998 | $ | 22,570,436 | $ | 10,563,791 | ||||||||||
| (a) | Unlimited shares authorized. |
37
The accompanying notes are an integral part of these financial statements.
| Statements of Assets and Liabilities | Defiance ETFs |
October 31, 2025 (Unaudited)
| Defiance Daily | Defiance Daily | Defiance Daily | Defiance Daily | Defiance Daily | ||||||||||||||||
| Target 2X Long | Target 2X Long | Target 2X Long | Target 2X Long | Target 2X Long | ||||||||||||||||
| JPM ETF | LLY ETF | LMND ETF | MP ETF | MSTR ETF | ||||||||||||||||
| ASSETS: | ||||||||||||||||||||
| Investments, at value (Note 2) | $ | 932,215 | $ | 9,738,734 | $ | 298,248 | $ | 396,560 | $ | 89,746,986 | ||||||||||
| Segregated cash for swap contracts | 1,550,360 | 19,729,736 | 1,026,982 | 7,914,103 | 484,065,063 | |||||||||||||||
| Receivable for swap contracts | 216,733 | 3,508,167 | 348,886 | 1,356,946 | 33,552,904 | |||||||||||||||
| Unrealized appreciation on swap contracts | 121,512 | 18,522,882 | 446,903 | – | 29,899,465 | |||||||||||||||
| Dividends receivable | 1,019 | 7,824 | 104 | 217 | 74,052 | |||||||||||||||
| Receivable for investments sold | 682 | 7,653,862 | 2,719 | – | – | |||||||||||||||
| Interest receivable | – | 12,333 | – | – | 4 | |||||||||||||||
| Deposit at broker for option contracts | – | – | – | – | 490,211 | |||||||||||||||
| Other assets | 70 | 6,116 | – | 584 | – | |||||||||||||||
| Total assets | 2,822,591 | 59,179,654 | 2,123,842 | 9,668,410 | 637,828,685 | |||||||||||||||
| LIABILITIES: | ||||||||||||||||||||
| Payable for swap contracts | 32,926 | 707,493 | 340,279 | 1,420,987 | 20,865,326 | |||||||||||||||
| Payable for investments purchased | 10,866 | 268,438 | 28,163 | 154,024 | 13,832,301 | |||||||||||||||
| Unrealized depreciation on swap contracts | – | – | – | 251,284 | – | |||||||||||||||
| Payable to adviser (Note 4) | 2,417 | 73,110 | 647 | 1,275 | 826,775 | |||||||||||||||
| Interest payable | – | – | 108 | 1,751 | 5,070 | |||||||||||||||
| Payable for capital shares redeemed | – | 1,739,150 | – | 447,960 | 20,257,646 | |||||||||||||||
| Total liabilities | 46,209 | 2,788,191 | 369,197 | 2,277,281 | 55,787,118 | |||||||||||||||
| NET ASSETS | $ | 2,776,382 | $ | 56,391,463 | $ | 1,754,645 | $ | 7,391,129 | $ | 582,041,567 | ||||||||||
| NET ASSETS CONSISTS OF: | ||||||||||||||||||||
| Paid-in capital | $ | 2,537,003 | $ | 22,048,608 | $ | 1,353,886 | $ | 9,222,384 | $ | 1,754,708,867 | ||||||||||
| Total distributable earnings/(accumulated losses) | 239,379 | 34,342,855 | 400,759 | (1,831,255 | ) | (1,172,667,300 | ) | |||||||||||||
| Total net assets | $ | 2,776,382 | $ | 56,391,463 | $ | 1,754,645 | $ | 7,391,129 | $ | 582,041,567 | ||||||||||
| Net assets | $ | 2,776,382 | $ | 56,391,463 | $ | 1,754,645 | $ | 7,391,129 | $ | 582,041,567 | ||||||||||
| Shares issued and outstanding(a) | 130,000 | 3,245,000 | 70,000 | 660,000 | 42,045,000 | |||||||||||||||
| Net asset value per share | $ | 21.36 | $ | 17.38 | $ | 25.07 | $ | 11.20 | $ | 13.84 | ||||||||||
| COST: | ||||||||||||||||||||
| Investments, at cost | $ | 929,243 | $ | 9,736,542 | $ | 290,519 | $ | 396,473 | $ | 89,731,179 | ||||||||||
| (a) | Unlimited shares authorized. |
38
The accompanying notes are an integral part of these financial statements.
| Statements of Assets and Liabilities | Defiance ETFs |
October 31, 2025 (Unaudited)
| Defiance Daily | Defiance Daily | Defiance Daily | Defiance Daily | Defiance Daily | ||||||||||||||||
| Target 2X Long | Target 2X Long | Target 2X Long | Target 2X Long | Target 2X Long | ||||||||||||||||
| NVO ETF | OKLO ETF | ORCL ETF | OSCR ETF | PM ETF | ||||||||||||||||
| ASSETS: | ||||||||||||||||||||
| Investments, at value (Note 2) | $ | 14,010,816 | $ | 28,370,787 | $ | 22,820,159 | $ | 634,257 | $ | 50,429 | ||||||||||
| Segregated cash for swap contracts | 66,213,247 | 111,132,872 | 192,547,556 | 7,716,422 | 511,086 | |||||||||||||||
| Unrealized appreciation on swap contracts | – | 55,572,095 | 8,337,246 | – | – | |||||||||||||||
| Receivable for swap contracts | 4,539,348 | 16,646,048 | 6,182,933 | 1,620,252 | 13,722 | |||||||||||||||
| Receivable for investments sold | 1,542,450 | 53,029,904 | 235,875 | 1,238,459 | 1,950 | |||||||||||||||
| Dividends receivable | 13,255 | 8,266 | 131,907 | 1,114 | 139 | |||||||||||||||
| Interest receivable | – | – | 5 | – | – | |||||||||||||||
| Receivable for fund shares sold | – | 9,027,564 | 20,166,425 | – | – | |||||||||||||||
| Other assets | – | 29,413 | 20,869 | 18 | 182 | |||||||||||||||
| Total assets | 86,319,116 | 273,816,949 | 250,442,975 | 11,210,522 | 577,508 | |||||||||||||||
| LIABILITIES: | ||||||||||||||||||||
| Unrealized depreciation on swap contracts | 2,262,227 | – | – | 52,801 | 38,295 | |||||||||||||||
| Payable for swap contracts | 1,813,631 | 3,450,151 | 2,135,548 | 2,538,655 | 44,943 | |||||||||||||||
| Payable for investments purchased | 120,883 | 55,737,059 | 1,914,678 | 405,923 | 30,087 | |||||||||||||||
| Payable to adviser (Note 4) | 100,397 | 223,312 | 298,967 | 6,992 | 795 | |||||||||||||||
| Interest payable | 1,063 | 52,108 | 1,966 | – | 25 | |||||||||||||||
| Payable for capital shares redeemed | – | 10,306,712 | – | – | – | |||||||||||||||
| Payable for expenses and other liabilities | 2,952 | – | – | – | – | |||||||||||||||
| Total liabilities | 4,301,153 | 69,769,342 | 4,351,159 | 3,004,371 | 114,145 | |||||||||||||||
| NET ASSETS | $ | 82,017,963 | $ | 204,047,607 | $ | 246,091,816 | $ | 8,206,151 | $ | 463,363 | ||||||||||
| NET ASSETS CONSISTS OF: | ||||||||||||||||||||
| Paid-in capital | $ | 102,946,734 | $ | 116,604,780 | $ | 292,167,266 | $ | 10,855,186 | $ | 620,184 | ||||||||||
| Total distributable earnings/(accumulated losses) | (20,928,771 | ) | 87,442,827 | (46,075,450 | ) | (2,649,035 | ) | (156,821 | ) | |||||||||||
| Total net assets | $ | 82,017,963 | $ | 204,047,607 | $ | 246,091,816 | $ | 8,206,151 | $ | 463,363 | ||||||||||
| Net assets | $ | 82,017,963 | $ | 204,047,607 | $ | 246,091,816 | $ | 8,206,151 | $ | 463,363 | ||||||||||
| Shares issued and outstanding(a) | 3,744,375 | 2,765,000 | 7,360,000 | 470,000 | 30,000 | |||||||||||||||
| Net asset value per share | $ | 21.90 | $ | 73.80 | $ | 33.44 | $ | 17.46 | $ | 15.45 | ||||||||||
| COST: | ||||||||||||||||||||
| Investments, at cost | $ | 14,084,784 | $ | 28,684,131 | $ | 22,814,593 | $ | 634,104 | $ | 50,419 | ||||||||||
| (a) | Unlimited shares authorized. |
39
The accompanying notes are an integral part of these financial statements.
| Statements of Assets and Liabilities | Defiance ETFs |
October 31, 2025 (Unaudited)
| Defiance Daily | Defiance Daily | Defiance Daily | Defiance Daily | Defiance Daily | ||||||||||||||||
| Target 2X Long QS | Target 2X Long | Target 2X Long | Target 2X Long | Target 2X Long | ||||||||||||||||
| ETF | RGTI ETF | RIOT ETF | RKLB ETF | SMCI ETF | ||||||||||||||||
| ASSETS: | ||||||||||||||||||||
| Investments, at value (Note 2) | $ | 639,238 | $ | 10,744,831 | $ | 3,824,117 | $ | 11,943,946 | $ | 27,093,814 | ||||||||||
| Segregated cash for swap contracts | 7,021,339 | 58,154,218 | 17,760,925 | 28,479,359 | 94,815,865 | |||||||||||||||
| Unrealized appreciation on swap contracts | 3,256,001 | 100,019,308 | 20,378,576 | 44,184,367 | 102,602,150 | |||||||||||||||
| Receivable for swap contracts | – | 39,904,397 | 4,293,267 | 11,380,340 | 4,253,631 | |||||||||||||||
| Receivable for investments sold | 5,645 | 23,041,975 | 8,648,925 | 14,873,037 | 32,307,731 | |||||||||||||||
| Dividends receivable | 237 | 11,583 | 3,195 | 8,775 | 28,620 | |||||||||||||||
| Receivable for fund shares sold | – | 6,314 | 1,938,126 | – | – | |||||||||||||||
| Interest receivable | – | – | – | 6,979 | 10,276 | |||||||||||||||
| Deposit at broker for option contracts | – | – | – | – | 9,986 | |||||||||||||||
| Other assets | – | 25,539 | 14,834 | 19,316 | 50,462 | |||||||||||||||
| Total assets | 10,922,460 | 231,908,165 | 56,861,965 | 110,896,119 | 261,172,535 | |||||||||||||||
| LIABILITIES: | ||||||||||||||||||||
| Payable for capital shares redeemed | 966,868 | 15,567,636 | – | – | 1,266,711 | |||||||||||||||
| Payable for swap contracts | 32,944 | 7,581,864 | 1,085,970 | 2,549,363 | 7,946,413 | |||||||||||||||
| Payable for investments purchased | 12,490 | 61,012,819 | 13,364,445 | 738,991 | 11,710,732 | |||||||||||||||
| Payable to adviser (Note 4) | 1,030 | 209,242 | 48,731 | 177,437 | 329,228 | |||||||||||||||
| Unrealized depreciation on swap contracts | – | – | 237,700 | – | – | |||||||||||||||
| Interest payable | 6 | 81,285 | 27,273 | 22 | 1,077 | |||||||||||||||
| Total liabilities | 1,013,338 | 84,452,846 | 14,764,119 | 3,465,813 | 21,254,161 | |||||||||||||||
| NET ASSETS | $ | 9,909,122 | $ | 147,455,319 | $ | 42,097,846 | $ | 107,430,306 | $ | 239,918,374 | ||||||||||
| NET ASSETS CONSISTS OF: | ||||||||||||||||||||
| Paid-in capital | $ | 7,002,069 | $ | (38,391,182 | ) | $ | 6,197,627 | $ | (50,748,805 | ) | $ | 165,764,299 | ||||||||
| Total distributable earnings | 2,907,053 | 185,846,501 | 35,900,219 | 158,179,111 | 74,154,075 | |||||||||||||||
| Total net assets | $ | 9,909,122 | $ | 147,455,319 | $ | 42,097,846 | $ | 107,430,306 | $ | 239,918,374 | ||||||||||
| Net assets | $ | 9,909,122 | $ | 147,455,319 | $ | 42,097,846 | $ | 107,430,306 | $ | 239,918,374 | ||||||||||
| Shares issued and outstanding(a) | 410,000 | 2,280,000 | 1,305,000 | 2,370,000 | 5,692,477 | |||||||||||||||
| Net asset value per share | $ | 24.17 | $ | 64.67 | $ | 32.26 | $ | 45.33 | $ | 42.15 | ||||||||||
| COST: | ||||||||||||||||||||
| Investments, at cost | $ | 639,128 | $ | 10,742,199 | $ | 3,893,781 | $ | 11,909,136 | $ | 27,083,767 | ||||||||||
| (a) | Unlimited shares authorized. |
40
The accompanying notes are an integral part of these financial statements.
| Statements of Assets and Liabilities | Defiance ETFs |
October 31, 2025 (Unaudited)
| Defiance Daily | Defiance Daily | Defiance Daily | Defiance Daily | Defiance Daily | ||||||||||||||||
| Target 2X Long | Target 2X Long | Target 2X Long | Target 2X Short | Target 2X Short | ||||||||||||||||
| SOFI ETF | SOUN ETF | VST ETF | IONQ ETF | LLY ETF | ||||||||||||||||
| ASSETS: | ||||||||||||||||||||
| Investments, at value (Note 2) | $ | 15,942,422 | $ | 3,551,000 | $ | 2,074,359 | $ | 5,161,847 | $ | 357,469 | ||||||||||
| Receivable for swap contracts | 2,005,619 | 2,299,874 | 30,408 | – | 57,440 | |||||||||||||||
| Segregated cash for swap contracts | 41,475,896 | 20,840,778 | 4,631,208 | 23,630,309 | 1,113,969 | |||||||||||||||
| Unrealized appreciation on swap contracts | 41,049,936 | 9,746,142 | 51,344 | 793,104 | – | |||||||||||||||
| Receivable for investments sold | 4,725,614 | 2,751,613 | 7,887 | 32,717,385 | 13,397 | |||||||||||||||
| Dividends receivable | 12,343 | 3,887 | 1,330 | 5,611 | 777 | |||||||||||||||
| Interest receivable | 1,137 | 1,491 | – | 4,635 | – | |||||||||||||||
| Receivable for fund shares sold | – | 952,468 | – | – | – | |||||||||||||||
| Deposit at broker for other investments | – | 72,799 | – | – | – | |||||||||||||||
| Other assets | 20,570 | 6,793 | 360 | 21,511 | 45 | |||||||||||||||
| Total assets | 105,233,537 | 40,226,845 | 6,796,896 | 62,334,402 | 1,543,097 | |||||||||||||||
| LIABILITIES: | ||||||||||||||||||||
| Payable for swap contracts | 1,374,342 | 1,623,537 | 107,825 | 5,807,615 | 44,142 | |||||||||||||||
| Payable for capital shares redeemed | 458,511 | – | – | 8,256,798 | – | |||||||||||||||
| Unrealized depreciation on swap contracts | – | – | – | 3,066,520 | 86,781 | |||||||||||||||
| Payable for investments purchased | 453,143 | 485,301 | 1,714 | 891,014 | 29,290 | |||||||||||||||
| Payable to adviser (Note 4) | 127,715 | 50,271 | 5,783 | 109,859 | 1,542 | |||||||||||||||
| Interest payable | – | 433 | – | 204 | 36 | |||||||||||||||
| Total liabilities | 2,413,711 | 2,159,542 | 115,322 | 18,132,010 | 161,791 | |||||||||||||||
| NET ASSETS | $ | 102,819,826 | $ | 38,067,303 | $ | 6,681,574 | $ | 44,202,392 | $ | 1,381,306 | ||||||||||
| NET ASSETS CONSISTS OF: | ||||||||||||||||||||
| Paid-in capital | $ | 12,670,430 | $ | 6,197,253 | $ | 7,743,436 | $ | 50,756,484 | $ | 1,892,504 | ||||||||||
| Total distributable earnings/(accumulated losses) | 90,149,396 | 31,870,050 | (1,061,862 | ) | (6,554,092 | ) | (511,198 | ) | ||||||||||||
| Total net assets | $ | 102,819,826 | $ | 38,067,303 | $ | 6,681,574 | $ | 44,202,392 | $ | 1,381,306 | ||||||||||
| Net assets | $ | 102,819,826 | $ | 38,067,303 | $ | 6,681,574 | $ | 44,202,392 | $ | 1,381,306 | ||||||||||
| Shares issued and outstanding(a) | 2,240,000 | 800,000 | 370,000 | 2,223,333 | 100,000 | |||||||||||||||
| Net asset value per share | $ | 45.90 | $ | 47.58 | $ | 18.06 | $ | 19.88 | $ | 13.81 | ||||||||||
| COST: | ||||||||||||||||||||
| Investments, at cost | $ | 15,938,677 | $ | 3,586,680 | $ | 2,076,970 | $ | 5,160,698 | $ | 357,391 | ||||||||||
| (a) | Unlimited shares authorized. |
41
The accompanying notes are an integral part of these financial statements.
| Statements of Assets and Liabilities | Defiance ETFs |
October 31, 2025 (Unaudited)
| Defiance Daily | Defiance Daily | Defiance Daily | Defiance Daily | Defiance Daily | ||||||||||||||||
| Target 2X Short | Target 2X Short | Target 2X Short | Target 2X Short | Target 2X Short | ||||||||||||||||
| MSTR ETF | PLTR ETF | QBTS ETF | RGTI ETF | SMCI ETF | ||||||||||||||||
| ASSETS: | ||||||||||||||||||||
| Investments, at value (Note 2) | $ | 2,650,908 | $ | 15,398,079 | $ | 3,892,269 | $ | 18,796,639 | $ | 795,556 | ||||||||||
| Segregated cash for swap contracts | 10,581,667 | 54,866,075 | 27,042,789 | 51,694,608 | 3,306,087 | |||||||||||||||
| Receivable for investments sold | 8,079,965 | – | 8,285,001 | 56,093,081 | 3,034,278 | |||||||||||||||
| Unrealized appreciation on swap contracts | 1,431,555 | – | – | – | 520,309 | |||||||||||||||
| Receivable for swap contracts | – | 7,656 | 3,962,097 | 745,688 | 11,935 | |||||||||||||||
| Dividends receivable | 5,506 | 14,729 | 1,809 | 3,327 | 1,327 | |||||||||||||||
| Interest receivable | 4,523 | 917 | – | 123 | – | |||||||||||||||
| Receivable for fund shares sold | – | – | 7,985,396 | – | – | |||||||||||||||
| Other assets | 16,565 | 2,785 | 2 | 7 | 6,697 | |||||||||||||||
| Total assets | 22,770,689 | 70,290,241 | 51,169,363 | 127,333,473 | 7,676,189 | |||||||||||||||
| LIABILITIES: | ||||||||||||||||||||
| Payable for capital shares redeemed | 1,106,739 | – | 1,050,710 | 3,226,598 | 1,640,352 | |||||||||||||||
| Unrealized depreciation on swap contracts | – | 1,453,130 | 4,768,375 | 15,520,601 | 21,382 | |||||||||||||||
| Payable for swap contracts | 146,704 | 7,373 | 7,130,238 | 7,796,697 | 25,096 | |||||||||||||||
| Payable to adviser (Note 4) | 24,298 | 86,829 | 17,176 | 67,055 | 11,977 | |||||||||||||||
| Interest payable | 301 | 879 | 437 | – | – | |||||||||||||||
| Payable for investments purchased | – | 119,006 | 804,945 | 22,858,747 | 39,033 | |||||||||||||||
| Total liabilities | 1,278,042 | 1,667,217 | 13,771,881 | 49,469,698 | 1,737,840 | |||||||||||||||
| NET ASSETS | $ | 21,492,647 | $ | 68,623,024 | $ | 37,397,482 | $ | 77,863,775 | $ | 5,938,349 | ||||||||||
| NET ASSETS CONSISTS OF: | ||||||||||||||||||||
| Paid-in capital | $ | 26,986,730 | $ | 92,800,940 | $ | 41,491,383 | $ | 57,175,163 | $ | 7,069,850 | ||||||||||
| Total distributable earnings/(accumulated losses) | (5,494,083 | ) | (24,177,916 | ) | (4,093,901 | ) | 20,688,612 | (1,131,501 | ) | |||||||||||
| Total net assets | $ | 21,492,647 | $ | 68,623,024 | $ | 37,397,482 | $ | 77,863,775 | $ | 5,938,349 | ||||||||||
| Net assets | $ | 21,492,647 | $ | 68,623,024 | $ | 37,397,482 | $ | 77,863,775 | $ | 5,938,349 | ||||||||||
| Shares issued and outstanding(a) | 582,976 | 3,056,250 | 3,560,000 | 7,000,000 | 253,750 | |||||||||||||||
| Net asset value per share | $ | 36.87 | $ | 22.45 | $ | 10.50 | $ | 11.12 | $ | 23.40 | ||||||||||
| COST: | ||||||||||||||||||||
| Investments, at cost | $ | 2,650,277 | $ | 15,394,355 | $ | 3,891,879 | $ | 18,794,629 | $ | 795,371 | ||||||||||
| (a) | Unlimited shares authorized. |
42
The accompanying notes are an integral part of these financial statements.
| Statements of Operations | Defiance ETFs |
For the Periods Ended October 31, 2025 (Unaudited)
| Defiance 2X Daily | Defiance Daily | Defiance Daily | Defiance Daily | Defiance Daily | ||||||||||||||||
| Long Pure Quantum | Target 2X Long | Target 2X Long | Target 2X Long | Target 2X Long | ||||||||||||||||
| ETF(a) | ANET ETF(b) | AVAV ETF(c) | AVGO ETF | CVNA ETF(d) | ||||||||||||||||
| INVESTMENT INCOME: | ||||||||||||||||||||
| Dividend income | $ | 3,485 | $ | 2,545 | $ | 63 | $ | 113,465 | $ | 2,957 | ||||||||||
| Interest income | 1,986 | 900 | 11 | 25,595 | 4,759 | |||||||||||||||
| Total investment income | 5,471 | 3,445 | 74 | 139,060 | 7,718 | |||||||||||||||
| EXPENSES: | ||||||||||||||||||||
| Investment advisory fee (Note 4) | 49,302 | 10,805 | 174 | 680,226 | 11,200 | |||||||||||||||
| Interest expense | – | 60 | – | 1,185 | – | |||||||||||||||
| Total expenses | 49,302 | 10,865 | 174 | 681,411 | 11,200 | |||||||||||||||
| NET INVESTMENT LOSS | (43,831 | ) | (7,420 | ) | (100 | ) | (542,351 | ) | (3,482 | ) | ||||||||||
| REALIZED AND UNREALIZED GAIN (LOSS) | ||||||||||||||||||||
| Net realized gain (loss) from: | ||||||||||||||||||||
| Investments | – | 12,686 | – | (6,316,482 | ) | (10,632 | ) | |||||||||||||
| Swap contracts | 5,337,155 | 185,863 | 34,432 | 58,955,299 | (1,444,998 | ) | ||||||||||||||
| Net realized gain (loss) | 5,337,155 | 198,549 | 34,432 | 52,638,817 | (1,455,630 | ) | ||||||||||||||
| Net change in unrealized appreciation (depreciation) on: | ||||||||||||||||||||
| Investments | 504 | 252 | 11 | (767,910 | ) | 166 | ||||||||||||||
| Swap contracts | 3,176,065 | 1,146,225 | 408 | 46,745,643 | 27,422 | |||||||||||||||
| Net change in unrealized appreciation (depreciation) | 3,176,569 | 1,146,477 | 419 | 45,977,733 | 27,588 | |||||||||||||||
| Net realized and unrealized gain (loss) | 8,513,724 | 1,345,026 | 34,851 | 98,616,550 | (1,428,042 | ) | ||||||||||||||
| NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS | $ | 8,469,893 | $ | 1,337,606 | $ | 34,751 | $ | 98,074,199 | $ | (1,431,524 | ) | |||||||||
| (a) | Inception date of the Fund was August 6, 2025. |
| (b) | Inception date of the Fund was September 3, 2025. |
| (c) | Inception date of the Fund was October 23, 2025. |
| (d) | Inception date of the Fund was May 28, 2025. |
43
The accompanying notes are an integral part of these financial statements.
| Statements of Operations | Defiance ETFs |
For the Periods Ended October 31, 2025 (Unaudited)
| Defiance Daily | Defiance Daily | Defiance Daily | Defiance Daily | Defiance Daily | ||||||||||||||||
| Target 2X Long | Target 2X Long | Target 2X Long | Target 2X Long | Target 2X Long | ||||||||||||||||
| DKNG ETF(a) | HIMS ETF | HOOD ETF | IONQ ETF | IREN ETF(b) | ||||||||||||||||
| INVESTMENT INCOME: | ||||||||||||||||||||
| Dividend income | $ | 2,498 | $ | 130,732 | $ | 30,138 | $ | 63,276 | $ | 1,716 | ||||||||||
| Interest income | 724 | 44,249 | 3,992 | 13,909 | 1,918 | |||||||||||||||
| Total investment income | 3,222 | 174,981 | 34,130 | 77,185 | 3,634 | |||||||||||||||
| EXPENSES: | ||||||||||||||||||||
| Investment advisory fee (Note 4) | 8,954 | 811,223 | 122,697 | 634,668 | 13,555 | |||||||||||||||
| Interest expense | 304 | 13,500 | 151 | 30,408 | 59 | |||||||||||||||
| Total expenses | 9,258 | 824,723 | 122,848 | 665,076 | 13,614 | |||||||||||||||
| NET INVESTMENT LOSS | (6,036 | ) | (649,742 | ) | (88,718 | ) | (587,891 | ) | (9,980 | ) | ||||||||||
| REALIZED AND UNREALIZED GAIN (LOSS) | ||||||||||||||||||||
| Net realized gain (loss) from: | ||||||||||||||||||||
| Investments | (17,503 | ) | 4,859,276 | 3,247,547 | (13,321,378 | ) | – | |||||||||||||
| Swap contracts | (2,327,229 | ) | 16,956,500 | 21,187,472 | 50,510,537 | (1,573,734 | ) | |||||||||||||
| Net realized gain (loss) | (2,344,732 | ) | 21,815,776 | 24,435,019 | 37,189,159 | (1,573,734 | ) | |||||||||||||
| Net change in unrealized appreciation (depreciation) on: | ||||||||||||||||||||
| Investments | 193 | (110,912 | ) | 99,387 | (31,417 | ) | 31,358 | |||||||||||||
| Swap contracts | 209,941 | 9,696,344 | 9,081,906 | 55,984,829 | 4,241,832 | |||||||||||||||
| Net change in unrealized appreciation (depreciation) | 210,134 | 9,585,432 | 9,181,293 | 55,953,412 | 4,273,190 | |||||||||||||||
| Net realized and unrealized gain (loss) | (2,134,598 | ) | 31,401,208 | 33,616,312 | 93,142,571 | 2,699,456 | ||||||||||||||
| NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS | $ | (2,140,634 | ) | $ | 30,751,466 | $ | 33,527,594 | $ | 92,554,680 | $ | 2,689,476 | |||||||||
| (a) | Inception date of the Fund was July 30, 2025. |
| (b) | Inception date of the Fund was October 20, 2025. |
44
The accompanying notes are an integral part of these financial statements.
| Statements of Operations | Defiance ETFs |
For the Periods Ended October 31, 2025 (Unaudited)
| Defiance Daily | Defiance Daily | Defiance Daily | Defiance Daily | Defiance Daily | ||||||||||||||||
| Target 2X Long | Target 2X Long | Target 2X Long | Target 2X Long MP | Target 2X Long | ||||||||||||||||
| JPM ETF(a) | LLY ETF | LMND ETF(b) | ETF(c) | MSTR ETF | ||||||||||||||||
| INVESTMENT INCOME: | ||||||||||||||||||||
| Dividend income | $ | 4,864 | $ | 66,978 | $ | 104 | $ | 217 | $ | 989,405 | ||||||||||
| Interest income | 5,150 | 32,465 | 31 | 163 | 60,587 | |||||||||||||||
| Total investment income | 10,014 | 99,443 | 135 | 380 | 1,049,992 | |||||||||||||||
| EXPENSES: | ||||||||||||||||||||
| Investment advisory fee (Note 4) | 6,611 | 344,108 | 648 | 1,275 | 6,911,811 | |||||||||||||||
| Interest expense | – | – | 108 | 1,744 | 21,362 | |||||||||||||||
| Total expenses | 6,611 | 344,108 | 756 | 3,019 | 6,933,173 | |||||||||||||||
| NET INVESTMENT INCOME/(LOSS) | 3,403 | (244,665 | ) | (621 | ) | (2,639 | ) | (5,883,181 | ) | |||||||||||
| REALIZED AND UNREALIZED GAIN (LOSS) | ||||||||||||||||||||
| Net realized gain (loss) from: | ||||||||||||||||||||
| Investments | (2,072 | ) | 1,344,344 | 126 | (2,993 | ) | (21,269,203 | ) | ||||||||||||
| Swap contracts | 113,564 | 15,027,534 | (53,378 | ) | (1,574,426 | ) | (310,697,836 | ) | ||||||||||||
| Net realized gain (loss) | 111,492 | 16,371,878 | (53,252 | ) | (1,577,419 | ) | (331,967,039 | ) | ||||||||||||
| Net change in unrealized appreciation (depreciation) on: | ||||||||||||||||||||
| Investments | 2,972 | (72,236 | ) | 7,729 | 87 | (11,673,385 | ) | |||||||||||||
| Swap contracts | 121,512 | 17,425,569 | 446,903 | (251,284 | ) | (422,783,569 | ) | |||||||||||||
| Net change in unrealized appreciation (depreciation) | 124,484 | 17,353,333 | 454,632 | (251,197 | ) | (434,456,954 | ) | |||||||||||||
| Net realized and unrealized gain (loss) | 235,976 | 33,725,211 | 401,380 | (1,828,609 | ) | (766,423,993 | ) | |||||||||||||
| NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS | $ | 239,379 | $ | 33,480,545 | $ | 400,759 | $ | (1,831,255 | ) | $ | (772,307,174 | ) | ||||||||
| (a) | Inception date of the Fund was July 23, 2025. |
| (b) | Inception date of the Fund was October 15, 2025. |
| (c) | Inception date of the Fund was October 20, 2025. |
45
The accompanying notes are an integral part of these financial statements.
| Statements of Operations | Defiance ETFs |
For the Periods Ended October 31, 2025 (Unaudited)
| Defiance Daily | Defiance Daily | Defiance Daily | Defiance Daily | Defiance Daily | ||||||||||||||||
| Target 2X Long | Target 2X Long | Target 2X Long | Target 2X Long | Target 2X Long PM | ||||||||||||||||
| NVO ETF | OKLO ETF(a) | ORCL ETF | OSCR ETF(b) | ETF(c) | ||||||||||||||||
| INVESTMENT INCOME: | ||||||||||||||||||||
| Dividend income | $ | 90,459 | $ | 24,216 | $ | 77,870 | $ | 1,116 | $ | 373 | ||||||||||
| Less: Issuance fees | (645 | ) | – | – | – | – | ||||||||||||||
| Less: Dividend withholding taxes | (7,132 | ) | – | – | – | – | ||||||||||||||
| Interest income | 23,395 | 23,888 | 42,206 | 604 | 25 | |||||||||||||||
| Total investment income | 106,077 | 48,104 | 120,076 | 1,720 | 398 | |||||||||||||||
| EXPENSES: | ||||||||||||||||||||
| Investment advisory fee (Note 4) | 288,716 | 405,539 | 533,449 | 7,167 | 1,693 | |||||||||||||||
| Interest expense | 1,060 | 75,729 | 6,539 | – | 62 | |||||||||||||||
| Total expenses | 289,776 | 481,268 | 539,988 | 7,167 | 1,755 | |||||||||||||||
| NET INVESTMENT LOSS | (183,699 | ) | (433,164 | ) | (419,912 | ) | (5,447 | ) | (1,357 | ) | ||||||||||
| REALIZED AND UNREALIZED GAIN (LOSS) | ||||||||||||||||||||
| Net realized gain (loss) from: | ||||||||||||||||||||
| Investments | 33,106 | (6,364,007 | ) | (645,814 | ) | (30,514 | ) | 325 | ||||||||||||
| Swap contracts | (17,007,734 | ) | 38,981,247 | (52,262,006 | ) | (2,560,427 | ) | (117,504 | ) | |||||||||||
| Net realized gain (loss) | (20,913,710 | ) | 32,617,240 | (52,907,820 | ) | (2,590,941 | ) | (117,179 | ) | |||||||||||
| Net change in unrealized appreciation (depreciation) on: | ||||||||||||||||||||
| Investments | (89,471 | ) | (313,344 | ) | (12,325 | ) | 154 | 10 | ||||||||||||
| Swap contracts | (1,799,355 | ) | 55,572,095 | 8,212,302 | (52,801 | ) | (38,295 | ) | ||||||||||||
| Net change in unrealized appreciation (depreciation) | (1,888,826 | ) | 55,258,751 | 8,199,977 | (52,647 | ) | (38,285 | ) | ||||||||||||
| Net realized and unrealized gain (loss) | (18,863,454 | ) | 87,875,991 | (44,707,843 | ) | (2,643,588 | ) | (155,464 | ) | |||||||||||
| NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS | $ | (19,047,153 | ) | $ | 87,442,827 | $ | (45,127,755 | ) | $ | (2,649,035 | ) | $ | (156,821 | ) | ||||||
| (a) | Inception date of the Fund was June 23, 2025. |
| (b) | Inception date of the Fund was September 24, 2025. |
| (c) | Inception date of the Fund was September 3, 2025. |
46
The accompanying notes are an integral part of these financial statements.
| Statements of Operations | Defiance ETFs |
For the Periods Ended October 31, 2025 (Unaudited)
| Defiance Daily | Defiance Daily | Defiance Daily | Defiance Daily | Defiance Daily | ||||||||||||||||
| Target 2X Long QS | Target 2X Long | Target 2X Long | Target 2X Long | Target 2X Long | ||||||||||||||||
| ETF(a) | RGTI ETF | RIOT ETF | RKLB ETF | SMCI ETF | ||||||||||||||||
| INVESTMENT INCOME: | ||||||||||||||||||||
| Dividend income | $ | 238 | $ | 32,703 | $ | 33,678 | $ | 72,727 | $ | 232,806 | ||||||||||
| Interest income | 141 | 16,397 | 2,905 | 24,632 | 25,777 | |||||||||||||||
| Total investment income | 379 | 49,100 | 36,583 | 97,359 | 258,583 | |||||||||||||||
| EXPENSES: | ||||||||||||||||||||
| Investment advisory fee (Note 4) | 1,031 | 428,222 | 159,595 | 441,023 | 1,927,940 | |||||||||||||||
| Interest expense | 6 | 87,145 | 37,898 | 166 | 22,468 | |||||||||||||||
| Total expenses | 1,037 | 515,367 | 197,493 | 441,189 | 1,950,408 | |||||||||||||||
| NET INVESTMENT LOSS | (658 | ) | (466,267 | ) | (160,910 | ) | (343,830 | ) | (1,691,825 | ) | ||||||||||
| REALIZED AND UNREALIZED GAIN (LOSS) | ||||||||||||||||||||
| Net realized gain (loss) from: | ||||||||||||||||||||
| Investments | (2,052 | ) | 37,076,959 | 7,490,081 | 43,473,717 | 58,955 | ||||||||||||||
| Swap contracts | (346,348 | ) | 48,769,849 | 25,174,916 | 70,398,539 | 89,578,645 | ||||||||||||||
| Net realized gain (loss) | (348,400 | ) | 85,846,808 | 32,664,997 | 113,872,256 | 89,637,600 | ||||||||||||||
| Net change in unrealized appreciation (depreciation) on: | ||||||||||||||||||||
| Investments | 110 | (8,147 | ) | (93,353 | ) | (12,464 | ) | (179,869 | ) | |||||||||||
| Swap contracts | 3,256,001 | 100,019,308 | 20,244,526 | 44,184,367 | 126,306,614 | |||||||||||||||
| Net change in unrealized appreciation (depreciation) | 3,256,111 | 100,011,161 | 20,151,173 | 44,171,903 | 126,126,745 | |||||||||||||||
| Net realized and unrealized gain (loss) | 2,907,711 | 185,857,969 | 52,816,170 | 158,044,159 | 215,764,345 | |||||||||||||||
| NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS | $ | 2,907,053 | $ | 185,391,702 | $ | 52,655,260 | $ | 157,700,329 | $ | 214,072,520 | ||||||||||
| (a) | Inception date of the Fund was October 20, 2025. |
47
The accompanying notes are an integral part of these financial statements.
| Statements of Operations | Defiance ETFs |
For the Periods Ended October 31, 2025 (Unaudited)
| Defiance Daily | Defiance Daily | Defiance Daily | Defiance Daily | Defiance Daily | ||||||||||||||||
| Target 2X Long | Target 2X Long | Target 2X Long | Target 2X Short | Target 2X Short | ||||||||||||||||
| SOFI ETF | SOUN ETF(a) | VST ETF(b) | IONQ ETF(a) | LLY ETF(c) | ||||||||||||||||
| INVESTMENT INCOME: | ||||||||||||||||||||
| Dividend income | $ | 87,924 | $ | 13,697 | $ | 2,876 | $ | 16,247 | $ | 1,704 | ||||||||||
| Interest income | 23,960 | 4,290 | 8,576 | 29,118 | 311 | |||||||||||||||
| Total investment income | 111,884 | 17,987 | 11,452 | 45,365 | 2,015 | |||||||||||||||
| EXPENSES: | ||||||||||||||||||||
| Investment advisory fee (Note 4) | 383,921 | 98,380 | 12,777 | 168,415 | 2,568 | |||||||||||||||
| Interest expense | 148 | 534 | – | 368 | 36 | |||||||||||||||
| Total expenses | 384,069 | 98,914 | 12,777 | 168,783 | 2,604 | |||||||||||||||
| NET INVESTMENT LOSS | (272,185 | ) | (80,927 | ) | (1,325 | ) | (123,418 | ) | (589 | ) | ||||||||||
| REALIZED AND UNREALIZED GAIN (LOSS) | ||||||||||||||||||||
| Net realized gain (loss) from: | ||||||||||||||||||||
| Investments | 21,327,281 | 13,158,529 | (33,195 | ) | 1,468 | – | ||||||||||||||
| Swap contracts | 33,809,483 | 9,081,986 | (1,076,075 | ) | (4,159,875 | ) | (423,906 | ) | ||||||||||||
| Net realized gain (loss) | 55,136,764 | 22,240,515 | (1,109,270 | ) | (4,158,407 | ) | (423,906 | ) | ||||||||||||
| Net change in unrealized appreciation (depreciation) on: | ||||||||||||||||||||
| Investments | (185,144 | ) | (35,680 | ) | (2,611 | ) | 1,149 | 78 | ||||||||||||
| Swap contracts | 42,223,036 | 9,746,142 | 51,344 | (2,273,416 | ) | (86,781 | ) | |||||||||||||
| Net change in unrealized appreciation (depreciation) | 42,037,892 | 9,710,462 | 48,733 | (2,272,267 | ) | (86,703 | ) | |||||||||||||
| Net realized and unrealized gain (loss) | 97,174,656 | 31,950,977 | (1,060,537 | ) | (6,430,674 | ) | (510,609 | ) | ||||||||||||
| NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS | $ | 96,902,471 | $ | 31,870,050 | $ | (1,061,862 | ) | $ | (6,554,092 | ) | $ | (511,198 | ) | |||||||
| (a) | Inception date of the Fund was June 23, 2025. |
| (b) | Inception date of the Fund was July 21, 2025. |
48
The accompanying notes are an integral part of these financial statements.
| Statements of Operations | Defiance ETFs |
For the Periods Ended October 31, 2025 (Unaudited)
| Defiance Daily | Defiance Daily | Defiance Daily | Defiance Daily | Defiance Daily | ||||||||||||||||
| Target 2X Short | Target 2X Short | Target 2X Short | Target 2X Short | Target 2X Short | ||||||||||||||||
| MSTR ETF | PLTR ETF(a) | QBTS ETF(b) | RGTI ETF(c) | SMCI ETF | ||||||||||||||||
| INVESTMENT INCOME: | ||||||||||||||||||||
| Dividend income | $ | 72,848 | $ | 94,112 | $ | 1,811 | $ | 3,334 | $ | 21,789 | ||||||||||
| Interest income | 20,604 | 34,732 | 1,080 | 8,802 | 710 | |||||||||||||||
| Total investment income | 93,452 | 128,844 | 2,891 | 12,136 | 22,499 | |||||||||||||||
| EXPENSES: | ||||||||||||||||||||
| Investment advisory fee (Note 4) | 220,727 | 231,469 | 17,176 | 67,055 | 78,258 | |||||||||||||||
| Interest expense | 395 | 2,158 | 437 | 42 | 272 | |||||||||||||||
| Total expenses | 221,122 | 233,627 | 17,613 | 67,097 | 78,530 | |||||||||||||||
| NET INVESTMENT LOSS | (127,670 | ) | (104,783 | ) | (14,722 | ) | (54,961 | ) | (56,031 | ) | ||||||||||
| REALIZED AND UNREALIZED GAIN (LOSS) | ||||||||||||||||||||
| Net realized gain (loss) from: | ||||||||||||||||||||
| Investments | – | 3 | – | – | – | |||||||||||||||
| Swap contracts | 6,507,992 | (22,623,730 | ) | 688,806 | 36,262,164 | (1,758,965 | ) | |||||||||||||
| Net realized gain (loss) | 6,507,992 | (22,623,727 | ) | 688,806 | 36,262,164 | (1,758,965 | ) | |||||||||||||
| Net change in unrealized appreciation (depreciation) on: | ||||||||||||||||||||
| Investments | 631 | 3,724 | 390 | 2,010 | 185 | |||||||||||||||
| Swap contracts | 2,692,932 | (1,453,130 | ) | (4,768,375 | ) | (15,520,601 | ) | 498,927 | ||||||||||||
| Net change in unrealized appreciation (depreciation) | 2,693,563 | (1,449,406 | ) | (4,767,985 | ) | (15,518,591 | ) | 499,112 | ||||||||||||
| Net realized and unrealized gain (loss) | 9,201,555 | (24,073,133 | ) | (4,079,179 | ) | 20,743,573 | (1,259,853 | ) | ||||||||||||
| NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS | $ | 9,073,885 | $ | (24,177,916 | ) | $ | (4,093,901 | ) | $ | 20,688,612 | $ | (1,315,884 | ) | |||||||
| (a) | Inception date of the Fund was June 5, 2025. |
| (b) | Inception date of the Fund was October 6, 2025. |
| (c) | Inception date of the Fund was October 8, 2025. |
49
The accompanying notes are an integral part of these financial statements.
| Statements of Changes in Net Assets | Defiance ETFs |
For the Periods Ended October 31, 2025 (Unaudited)
|
Defiance 2X Daily Long Pure Quantum ETF |
Defiance Daily Target 2X Long ANET ETF |
Defiance Daily Target 2X Long AVAV ETF | ||||||||||
|
Period ended October 31, 2025(a) (Unaudited) |
Period ended October 31, 2025(b) (Unaudited) |
Period ended October 31, 2025(c) (Unaudited) | ||||||||||
| OPERATIONS: | ||||||||||||
| Net investment income (loss) | $ | (43,831 | ) | $ | (7,420 | ) | $ | (100 | ) | |||
| Net realized gain (loss) | 5,337,155 | 198,549 | 34,432 | |||||||||
| Net change in unrealized appreciation (depreciation) | 3,176,569 | 1,146,477 | 419 | |||||||||
| Net increase (decrease) in net assets from operations | 8,469,893 | 1,337,606 | 34,751 | |||||||||
| CAPITAL TRANSACTIONS: | ||||||||||||
| Shares sold | 42,623,778 | 7,909,053 | 1,433,474 | |||||||||
| Shares redeemed | (385,485 | ) | (1,325,114 | ) | (650,211 | ) | ||||||
| Net increase (decrease) in net assets from capital transactions | 42,238,293 | 6,583,939 | 783,263 | |||||||||
| NET INCREASE (DECREASE) IN NET ASSETS | 50,708,186 | 7,921,545 | 818,014 | |||||||||
| NET ASSETS: | ||||||||||||
| Beginning of the period | – | – | – | |||||||||
| End of the period | $ | 50,708,186 | $ | 7,921,545 | $ | 818,014 | ||||||
| SHARES TRANSACTIONS | ||||||||||||
| Shares sold | 1,050,000 | 380,000 | 70,000 | |||||||||
| Shares redeemed | (25,000 | ) | (60,000 | ) | (30,000 | ) | ||||||
| Total increase (decrease) in shares outstanding | 1,025,000 | 320,000 | 40,000 | |||||||||
| (a) | Inception date of the Fund was August 6, 2025. |
| (b) | Inception date of the Fund was September 3, 2025. |
| (c) | Inception date of the Fund was October 23, 2025. |
50
The accompanying notes are an integral part of these financial statements.
| Statements of Changes in Net Assets | Defiance ETFs |
For the Periods Ended October 31, 2025 (Unaudited)
|
Defiance Daily Target 2X Long AVGO ETF |
Defiance Daily Target 2X Long CVNA ETF |
Defiance Daily Target 2X Long DKNG ETF |
||||||||||||||
|
Period ended October 31, 2025 (Unaudited) |
Period ended April 30, 2025(a) |
Period ended October 31, 2025(b) (Unaudited) |
Period ended October 31, 2025(c) (Unaudited) |
|||||||||||||
| OPERATIONS: | ||||||||||||||||
| Net investment income (loss) | $ | (542,351 | ) | $ | (240,336 | ) | $ | (3,482 | ) | $ | (6,036 | ) | ||||
| Net realized gain (loss) | 52,638,817 | (12,972,027 | ) | (1,455,630 | ) | (2,344,732 | ) | |||||||||
| Net change in unrealized appreciation (depreciation) | 45,977,733 | (2,897,610 | ) | 27,588 | 210,134 | |||||||||||
| Net increase (decrease) in net assets from operations | 98,074,199 | (16,109,973 | ) | (1,431,524 | ) | (2,140,634 | ) | |||||||||
| DISTRIBUTIONS TO SHAREHOLDERS: | ||||||||||||||||
| From earnings | – | (806,878 | ) | – | – | |||||||||||
| Total distributions to shareholders | – | (806,878 | ) | – | – | |||||||||||
| CAPITAL TRANSACTIONS: | ||||||||||||||||
| Shares sold | 645,866,102 | 200,800,441 | 13,198,836 | 10,153,580 | ||||||||||||
| Shares redeemed | (672,261,953 | ) | (111,766,631 | ) | (7,382,094 | ) | (774,462 | ) | ||||||||
| Net increase (decrease) in net assets from capital transactions | (26,395,851 | ) | 89,033,810 | 5,816,742 | 9,379,118 | |||||||||||
| NET INCREASE (DECREASE) IN NET ASSETS | 71,678,348 | 72,116,959 | 4,385,218 | 7,238,484 | ||||||||||||
| NET ASSETS: | ||||||||||||||||
| Beginning of the period | 72,116,959 | – | – | – | ||||||||||||
| End of the period | $ | 143,795,307 | $ | 72,116,959 | $ | 4,385,218 | $ | 7,238,484 | ||||||||
| SHARES TRANSACTIONS | ||||||||||||||||
| Shares sold | 12,810,000 | 8,435,000 | 620,000 | 915,000 | ||||||||||||
| Shares redeemed | (14,300,000 | ) | (4,465,000 | ) | (325,000 | ) | (40,000 | ) | ||||||||
| Total increase (decrease) in shares outstanding | (1,490,000 | ) | 3,970,000 | 295,000 | 875,000 | |||||||||||
| (a) | Inception date of the Fund was August 21, 2024. |
| (b) | Inception date of the Fund was May 28, 2025. |
| (c) | Inception date of the Fund was July 30, 2025. |
51
The accompanying notes are an integral part of these financial statements.
| Statements of Changes in Net Assets | Defiance ETFs |
For the Periods Ended October 31, 2025 (Unaudited)
|
Defiance Daily Target 2X Long HIMS ETF |
Defiance Daily Target 2X Long HOOD ETF |
|||||||||||||||
|
Period ended October 31, 2025 (Unaudited) |
Period ended April 30, 2025(a) |
Period ended October 31, 2025 (Unaudited) |
Period ended April 30, 2025(b) |
|||||||||||||
| OPERATIONS: | ||||||||||||||||
| Net investment income (loss) | $ | (649,742 | ) | $ | (6,670 | ) | $ | (88,718 | ) | $ | (2,516 | ) | ||||
| Net realized gain (loss) | 21,815,776 | 1,994,844 | 24,435,019 | 848,504 | ||||||||||||
| Net change in unrealized appreciation (depreciation) | 9,585,432 | 114,874 | 9,181,293 | 47,501 | ||||||||||||
| Net increase (decrease) in net assets from operations | 30,751,466 | 2,103,048 | 33,527,594 | 893,489 | ||||||||||||
| CAPITAL TRANSACTIONS: | ||||||||||||||||
| Shares sold | 1,087,251,473 | 18,981,155 | 150,720,832 | 5,070,805 | ||||||||||||
| Shares redeemed | (935,082,443 | ) | (3,519,797 | ) | (158,661,335 | ) | (2,026,720 | ) | ||||||||
| Net increase (decrease) in net assets from capital transactions | 152,169,030 | 15,461,358 | (7,940,503 | ) | 3,044,085 | |||||||||||
| NET INCREASE (DECREASE) IN NET ASSETS | 182,920,496 | 17,564,406 | 25,587,091 | 3,937,574 | ||||||||||||
| NET ASSETS: | ||||||||||||||||
| Beginning of the period | 17,564,406 | – | 3,937,574 | – | ||||||||||||
| End of the period | $ | 200,484,902 | $ | 17,564,406 | $ | 29,524,665 | $ | 3,937,574 | ||||||||
| SHARES TRANSACTIONS | ||||||||||||||||
| Shares sold | 54,415,000 | 1,400,000 | 1,135,000 | 250,000 | ||||||||||||
| Shares redeemed | (39,915,000 | ) | (275,000 | ) | (1,120,000 | ) | (100,000 | ) | ||||||||
| Stock split | – | – | 495,000 | (c) | – | |||||||||||
| Total increase (decrease) in shares outstanding | 14,500,000 | 1,125,000 | 510,000 | 150,000 | ||||||||||||
| (a) | Inception date of the Fund was March 12, 2025. |
| (b) | Inception date of the Fund was March 18, 2025. |
| (c) | Share amounts for the Fund have been adjusted for a 4 for 1 stock split effective on December 9, 2025 (Note 11) |
52
The accompanying notes are an integral part of these financial statements.
| Statements of Changes in Net Assets | Defiance ETFs |
For the Periods Ended October 31, 2025 (Unaudited)
|
Defiance Daily Target 2X Long IONQ ETF |
Defiance Daily Target 2X Long IREN ETF |
Defiance Daily Target 2X Long JPM ETF |
||||||||||||||
|
Period ended October 31, 2025 (Unaudited) |
Period ended April 30, 2025(a) |
Period ended October 31, 2025(b) (Unaudited) |
Period ended October 31, 2025(c) (Unaudited) |
|||||||||||||
| OPERATIONS: | ||||||||||||||||
| Net investment income (loss) | $ | (587,891 | ) | $ | (21,294 | ) | $ | (9,980 | ) | $ | 3,403 | |||||
| Net realized gain (loss) | 37,189,159 | 3,289,453 | (1,573,734 | ) | 111,492 | |||||||||||
| Net change in unrealized appreciation (depreciation) | 55,953,412 | 177,390 | 4,273,190 | 124,484 | ||||||||||||
| Net increase (decrease) in net assets from operations | 92,554,680 | 3,445,549 | 2,689,476 | 239,379 | ||||||||||||
| CAPITAL TRANSACTIONS: | ||||||||||||||||
| Shares sold | 887,199,899 | 28,285,865 | 107,914,448 | 2,537,003 | ||||||||||||
| Shares redeemed | (778,022,957 | ) | (7,578,365 | ) | – | – | ||||||||||
| Net increase (decrease) in net assets from capital transactions | 109,176,942 | 20,707,500 | 107,914,448 | 2,537,003 | ||||||||||||
| NET INCREASE (DECREASE) IN NET ASSETS | 201,731,622 | 24,153,049 | 110,603,924 | 2,776,382 | ||||||||||||
| NET ASSETS: | ||||||||||||||||
| Beginning of the period | 24,153,049 | – | – | – | ||||||||||||
| End of the period | $ | 225,884,671 | $ | 24,153,049 | $ | 110,603,924 | $ | 2,776,382 | ||||||||
| SHARES TRANSACTIONS | ||||||||||||||||
| Shares sold | 7,990,000 | 975,000 | 5,490,000 | 130,000 | ||||||||||||
| Shares redeemed | (6,550,000 | ) | (275,000 | ) | – | – | ||||||||||
| Stock split | 2,140,000 | (d) | – | – | – | |||||||||||
| Total increase (decrease) in shares outstanding | 3,580,000 | 700,000 | 5,490,000 | 130,000 | ||||||||||||
| (a) | Inception date of the Fund was March 11, 2025. |
| (b) | Inception date of the Fund was October 20, 2025. |
| (c) | Inception date of the Fund was July 23, 2025. |
| (d) | Share amounts for the Fund have been adjusted for a 2 for 1 stock split effective on December 9, 2025 (Note 11). |
53
The accompanying notes are an integral part of these financial statements.
| Statements of Changes in Net Assets | Defiance ETFs |
For the Periods Ended October 31, 2025 (Unaudited)
|
Defiance Daily Target 2X Long LLY ETF |
Defiance Daily Target 2X Long LMND ETF |
Defiance Daily Target 2X Long MP ETF |
||||||||||||||
|
Period ended October 31, 2025 (Unaudited) |
Period ended April 30, 2025(a) |
Period ended October 31, 2025(b) (Unaudited) |
Period ended October 31, 2025(c) (Unaudited) |
|||||||||||||
| OPERATIONS: | ||||||||||||||||
| Net investment income (loss) | $ | (244,666 | ) | $ | (80,796 | ) | $ | (621 | ) | $ | (2,639 | ) | ||||
| Net realized gain (loss) | 16,371,878 | (228,635 | ) | (53,153 | ) | (1,577,419 | ) | |||||||||
| Net change in unrealized appreciation (depreciation) | 17,353,333 | 1,171,741 | 454,533 | (251,197 | ) | |||||||||||
| Net increase (decrease) in net assets from operations | 33,480,545 | 862,310 | 400,759 | (1,831,255 | ) | |||||||||||
| CAPITAL TRANSACTIONS: | ||||||||||||||||
| Shares sold | 171,276,379 | 34,604,179 | 1,353,886 | 9,670,344 | ||||||||||||
| Shares redeemed | (167,595,742 | ) | (16,236,208 | ) | – | (447,960 | ) | |||||||||
| Net increase (decrease) in net assets from capital transactions | 3,680,637 | 18,367,971 | 1,353,886 | 9,222,384 | ||||||||||||
| NET INCREASE (DECREASE) IN NET ASSETS | 37,161,182 | 19,230,281 | 1,754,645 | 7,391,129 | ||||||||||||
| NET ASSETS: | ||||||||||||||||
| Beginning of the period | 19,230,281 | – | – | – | ||||||||||||
| End of the period | $ | 56,391,463 | $ | 19,230,281 | $ | 1,754,645 | $ | 7,391,129 | ||||||||
| SHARES TRANSACTIONS | ||||||||||||||||
| Shares sold | 13,860,000 | 1,635,000 | 70,000 | 700,000 | ||||||||||||
| Shares redeemed | (11,480,000 | ) | (770,000 | ) | – | (40,000 | ) | |||||||||
| Total increase (decrease) in shares outstanding | 2,380,000 | 865,000 | 70,000 | 660,000 | ||||||||||||
| (a) | Inception date of the Fund was August 7, 2024. |
| (b) | Inception date of the Fund was October 15, 2025. |
| (c) | Inception date of the Fund was October 20, 2025. |
54
The accompanying notes are an integral part of these financial statements.
| Statements of Changes in Net Assets | Defiance ETFs |
For the Periods Ended October 31, 2025 (Unaudited)
|
Defiance Daily Target 2X Long MSTR ETF |
Defiance Daily Target 2X Long NVO ETF |
|||||||||||||||
|
Period ended October 31, 2025 (Unaudited) |
Period ended April 30, 2025(a) |
Period ended October 31, 2025 (Unaudited) |
Period ended April 30, 2025(b) |
|||||||||||||
| OPERATIONS: | ||||||||||||||||
| Net investment income (loss) | $ | (5,883,181 | ) | $ | (5,830,687 | ) | $ | (183,699 | ) | $ | (2,691 | ) | ||||
| Net realized gain (loss) | (331,967,039 | ) | (506,146,629 | ) | (16,974,628 | ) | (1,431,558 | ) | ||||||||
| Net change in unrealized appreciation (depreciation) | (434,456,954 | ) | 464,372,226 | (1,888,826 | ) | (447,369 | ) | |||||||||
| Net increase (decrease) in net assets from operations | (772,307,174 | ) | (47,605,090 | ) | (19,047,153 | ) | (1,881,618 | ) | ||||||||
| DISTRIBUTIONS TO SHAREHOLDERS: | ||||||||||||||||
| From earnings | – | (352,755,036 | ) | – | – | |||||||||||
| Total distributions to shareholders | – | (352,755,036 | ) | – | – | |||||||||||
| CAPITAL TRANSACTIONS: | ||||||||||||||||
| Shares sold | 1,087,677,44 | 2,916,653,743 | 166,797,900 | 6,661,135 | ||||||||||||
| Shares redeemed | (1,399,752,797 | ) | (849,869,525 | ) | (69,147,482 | ) | (1,364,819 | ) | ||||||||
| Net increase (decrease) in net assets from capital transactions | (312,075,351 | ) | 2,066,784,218 | 97,650,418 | 5,296,316 | |||||||||||
| NET INCREASE (DECREASE) IN NET ASSETS | (1,084,382,525 | ) | 1,666,424,092 | 78,603,265 | 3,414,698 | |||||||||||
| NET ASSETS: | ||||||||||||||||
| Beginning of the period | 1,666,424,092 | – | 3,414,698 | – | ||||||||||||
| End of the period | $ | 582,041,567 | $ | 1,666,424,092 | $ | 82,017,963 | $ | 3,414,698 | ||||||||
| SHARES TRANSACTIONS | ||||||||||||||||
| Shares sold | 44,770,000 | 62,375,000 | 48,310,000 | 700,000 | ||||||||||||
| Shares redeemed | (45,300,000 | ) | (19,800,000 | ) | (18,900,000 | ) | (155,000 | ) | ||||||||
| Reverse stock split | – | – | (26,210,625 | )(c) | – | |||||||||||
| Total increase (decrease) in shares outstanding | (530,000 | ) | 42,575,000 | 3,199,375 | 545,000 | |||||||||||
| (a) | Inception date of the Fund was August 14, 2024. |
| (b) | Inception date of the Fund was December 2, 2024. |
| (c) | Share amounts for the Fund have been adjusted for a 1 for 8 reverse stock split effective on December 9, 2025 (Note 11). |
55
The accompanying notes are an integral part of these financial statements.
| Statements of Changes in Net Assets | Defiance ETFs |
For the Periods Ended October 31, 2025 (Unaudited)
|
Defiance Daily Target 2X Long OKLO ETF |
Defiance Daily Target 2X Long ORCL ETF |
Defiance Daily Target 2X Long OSCR ETF |
||||||||||||||
|
Period ended October 31, 2025(a) (Unaudited) |
Period ended October 31, 2025 (Unaudited) |
Period ended April 30, 2025(b) |
Period ended October 31, 2025(c) (Unaudited) |
|||||||||||||
| OPERATIONS: | ||||||||||||||||
| Net investment income (loss) | $ | (433,164 | ) | $ | (419,912 | ) | $ | (3,390 | ) | $ | (5,447 | ) | ||||
| Net realized gain (loss) | 32,617,240 | (52,907,820 | ) | (1,087,140 | ) | (2,590,941 | ) | |||||||||
| Net change in unrealized appreciation (depreciation) | 55,258,751 | 8,199,977 | 142,835 | (52,647 | ) | |||||||||||
| Net increase (decrease) in net assets from operations | 87,442,827 | (45,127,755 | ) | (947,695 | ) | (2,649,035 | ) | |||||||||
| CAPITAL TRANSACTIONS: | ||||||||||||||||
| Shares sold | 1,022,215,015 | 376,868,752 | 4,990,968 | 10,855,186 | ||||||||||||
| Shares redeemed | (905,610,235 | ) | (88,467,340 | ) | (1,225,114 | ) | – | |||||||||
| Net increase (decrease) in net assets from capital transactions | 116,604,780 | 288,401,412 | 3,765,854 | 10,855,186 | ||||||||||||
| NET INCREASE (DECREASE) IN NET ASSETS | 204,047,607 | 243,273,657 | 2,818,159 | 8,206,151 | ||||||||||||
| NET ASSETS: | ||||||||||||||||
| Beginning of the period | – | 2,818,159 | – | – | ||||||||||||
| End of the period | $ | 204,047,607 | $ | 246,091,816 | $ | 2,818,159 | $ | 8,206,151 | ||||||||
| SHARES TRANSACTION | ||||||||||||||||
| Shares sold | 13,955,000 | 9,210,000 | 315,000 | 470,000 | ||||||||||||
| Shares redeemed | (11,190,000 | ) | (2,080,000 | ) | (85,000 | ) | – | |||||||||
| Total increase (decrease) in shares outstanding | 2,765,000 | 7,130,000 | 230,000 | 470,000 | ||||||||||||
| (a) | Inception date of the Fund was June 23, 2025. |
| (b) | Inception date of the Fund was February 6, 2025. |
| (c) | Inception date of the Fund was September 24, 2025. |
56
The accompanying notes are an integral part of these financial statements.
| Statements of Changes in Net Assets | Defiance ETFs |
For the Periods Ended October 31, 2025 (Unaudited)
|
Defiance Daily Target 2X Long PM ETF |
Defiance Daily Target 2X Long QS ETF |
Defiance Daily Target 2X Long RGTI ETF |
||||||||||||||
|
Period ended October 31, 2025(a) (Unaudited) |
Period ended October 31, 2025(b) (Unaudited) |
Period ended October 31, 2025 (Unaudited) |
Period ended April 30, 2025(c) |
|||||||||||||
| OPERATIONS: | ||||||||||||||||
| Net investment income (loss) | $ | (1,357 | ) | $ | (658 | ) | $ | (466,267 | ) | $ | (974 | ) | ||||
| Net realized gain (loss) | (117,179 | ) | (348,400 | ) | 85,846,808 | 444,994 | ||||||||||
| Net change in unrealized appreciation (depreciation) | (38,285 | ) | 3,256,111 | 100,011,161 | 10,779 | |||||||||||
| Net increase (decrease) in net assets from operations | (156,821 | ) | 2,907,053 | 185,391,702 | 454,799 | |||||||||||
| CAPITAL TRANSACTIONS: | ||||||||||||||||
| Shares sold | 1,770,124 | 7,968,937 | 852,825,143 | 3,511,515 | ||||||||||||
| Shares redeemed | (1,149,940 | ) | (966,868 | ) | (893,040,960 | ) | (1,686,880 | ) | ||||||||
| Net increase (decrease) in net assets from capital transactions | 620,184 | 7,002,069 | (40,215,817 | ) | 1,824,635 | |||||||||||
| NET INCREASE (DECREASE) IN NET ASSETS | 463,363 | 9,909,122 | 145,175,885 | 2,279,434 | ||||||||||||
| NET ASSETS: | ||||||||||||||||
| Beginning of the period | – | – | 2,279,434 | – | ||||||||||||
| End of the period | $ | 463,363 | $ | 9,909,122 | $ | 147,455,319 | $ | 2,279,434 | ||||||||
| SHARES TRANSACTIONS | ||||||||||||||||
| Shares sold | 90,000 | 450,000 | 5,675,000 | 175,000 | ||||||||||||
| Shares redeemed | (60,000 | ) | (40,000 | ) | (5,205,000 | ) | (75,000 | ) | ||||||||
| Stock split | – | – | 1,710,000 | (d) | – | |||||||||||
| Total increase (decrease) in shares outstanding | 30,000 | 410,000 | 2,180,000 | 100,000 | ||||||||||||
| (a) | Inception date of the Fund was September 3, 2025. |
| (b) | Inception date of the Fund was October 20, 2025. |
| (c) | Inception date of the Fund was March 31, 2025. |
| (d) | Share amounts for the Fund have been adjusted for a 4 for 1 stock split effective on December 9, 2025 (Note 11). |
57
The accompanying notes are an integral part of these financial statements.
| Statements of Changes in Net Assets | Defiance ETFs |
For the Periods Ended October 31, 2025 (Unaudited)
|
Defiance Daily Target 2X Long RIOT ETF |
Defiance Daily Target 2X Long RKLB ETF |
|||||||||||||||
|
Period ended October 31, 2025 (Unaudited) |
Period ended April 30, 2025(a) |
Period ended October 31, 2025 (Unaudited) |
Period ended April 30, 2025(b) |
|||||||||||||
| OPERATIONS: | ||||||||||||||||
| Net investment income (loss) | $ | (160,910 | ) | $ | (21,886 | ) | $ | (343,830 | ) | $ | (2,850 | ) | ||||
| Net realized gain (loss) | 32,664,997 | (16,652,894 | ) | 113,872,256 | 434,358 | |||||||||||
| Net change in unrealized appreciation (depreciation) | 20,151,173 | (80,261 | ) | 44,171,903 | 47,274 | |||||||||||
| Net increase (decrease) in net assets from operations | 52,655,260 | (16,755,041 | ) | 157,700,329 | 478,782 | |||||||||||
| CAPITAL TRANSACTIONS: | ||||||||||||||||
| Shares sold | 218,034,053 | 37,207,140 | 743,363,975 | 10,540,610 | ||||||||||||
| Shares redeemed | (242,663,705 | ) | (6,379,861 | ) | (800,981,538 | ) | (3,671,852 | ) | ||||||||
| Net increase (decrease) in net assets from capital transactions | (24,629,652 | ) | 30,827,279 | (57,617,563 | ) | 6,868,758 | ||||||||||
| NET INCREASE (DECREASE) IN NET ASSETS | 28,025,608 | 14,072,238 | 100,082,766 | 7,347,540 | ||||||||||||
| NET ASSETS: | ||||||||||||||||
| Beginning of the period | 14,072,238 | – | 7,347,540 | – | ||||||||||||
| End of the period | $ | 42,097,846 | $ | 14,072,238 | $ | 107,430,306 | $ | 7,347,540 | ||||||||
| SHARES TRANSACTIONS | ||||||||||||||||
| Shares sold | 7,510,000 | 2,415,000 | 6,805,000 | 500,000 | ||||||||||||
| Shares redeemed | (8,250,000 | ) | (370,000 | ) | (6,315,000 | ) | (200,000 | ) | ||||||||
| Shares redeemed | – | – | 1,580,000 | (c) | – | |||||||||||
| Total increase (decrease) in shares outstanding | (740,000 | ) | 2,045,000 | 490,000 | 300,000 | |||||||||||
| (a) | Inception date of the Fund was January 2, 2025. |
| (b) | Inception date of the Fund was March 12, 2025. |
| (c) | Share amounts for the Fund have been adjusted for a 3 for 1 stock split effective on December 9, 2025 (Note 11). |
58
The accompanying notes are an integral part of these financial statements.
| Statements of Changes in Net Assets | Defiance ETFs |
For the Periods Ended October 31, 2025 (Unaudited)
|
Defiance Daily Target 2X Long SMCI ETF |
Defiance Daily Target 2X Long SOFI ETF |
|||||||||||||||
|
Period ended October 31, 2025 (Unaudited) |
Period ended April 30, 2025(a) |
Period ended October 31, 2025 (Unaudited) |
Period ended April 30, 2025(b) |
|||||||||||||
| OPERATIONS: | ||||||||||||||||
| Net investment income (loss) | $ | (1,691,825 | ) | $ | (1,090,954 | ) | $ | (272,185 | ) | $ | (26,015 | ) | ||||
| Net realized gain (loss) | 89,637,600 | (136,478,544 | ) | 55,136,764 | (5,742,849 | ) | ||||||||||
| Net change in unrealized appreciation (depreciation) | 126,126,745 | (23,514,548 | ) | 42,037,892 | (984,211 | ) | ||||||||||
| Net increase (decrease) in net assets from operations | 214,072,520 | (161,084,046 | ) | 96,902,471 | (6,753,075 | ) | ||||||||||
| CAPITAL TRANSACTIONS: | ||||||||||||||||
| Shares sold | 687,684,474 | 637,056,630 | 486,194,708 | 31,750,786 | ||||||||||||
| Shares redeemed | (895,139,390 | ) | (242,671,814 | ) | (499,602,499 | ) | (5,672,565 | ) | ||||||||
| Net increase (decrease) in net assets from capital transactions | (207,454,916 | ) | 394,384,816 | (13,407,791 | ) | 26,078,221 | ||||||||||
| NET INCREASE (DECREASE) IN NET ASSETS | 6,617,604 | 233,300,770 | 83,494,680 | 19,325,146 | ||||||||||||
| NET ASSETS: | ||||||||||||||||
| Beginning of the period | 233,300,770 | – | 19,325,146 | – | ||||||||||||
| End of the period | $ | 239,918,374 | $ | 233,300,770 | $ | 102,819,826 | $ | 19,325,146 | ||||||||
| SHARES TRANSACTIONS | ||||||||||||||||
| Shares sold | 16,665,000 | 40,400,000 | 12,420,000 | 2,590,000 | ||||||||||||
| Shares redeemed | (20,490,000 | ) | (10,125,023 | ) | (12,070,000 | ) | (700,000 | ) | ||||||||
| Reverse stock split | – | (20,757,500 | )(c) | – | – | |||||||||||
| Total increase (decrease) in shares outstanding | (3,825,000 | ) | 9,517,477 | 350,000 | 1,890,000 | |||||||||||
| (a) | Inception date of the Fund was August 21, 2024. |
| (b) | Inception date of the Fund was January 15, 2025. |
| (c) | Share amounts for the Fund have been adjusted for a 1 for 20 reverse stock split effective on November 15, 2024. |
59
The accompanying notes are an integral part of these financial statements.
| Statements of Changes in Net Assets | Defiance ETFs |
For the Periods Ended October 31, 2025 (Unaudited)
|
Defiance Daily Target 2X Long SOUN ETF |
Defiance Daily Target 2X Long VST ETF |
Defiance Daily Target 2X Short IONQ ETF |
Defiance Daily Target 2X Short LLY ETF |
|||||||||||||
|
Period ended October 31, 2025(a) (Unaudited) |
Period ended October 31, 2025(b) (Unaudited) |
Period ended October 31, 2025(a) (Unaudited) |
Period ended October 31, 2025(c) (Unaudited) |
|||||||||||||
| OPERATIONS: | ||||||||||||||||
| Net investment income (loss) | $ | (80,927 | ) | $ | (1,325 | ) | $ | (123,418 | ) | $ | (589 | ) | ||||
| Net realized gain (loss) | 22,240,515 | (1,109,270 | ) | (4,158,407 | ) | (423,906 | ) | |||||||||
| Net change in unrealized appreciation (depreciation) | 9,710,462 | 48,733 | (2,272,267 | ) | (86,703 | ) | ||||||||||
| Net increase (decrease) in net assets from operations | 31,870,050 | (1,061,862 | ) | (6,554,092 | ) | (511,198 | ) | |||||||||
| CAPITAL TRANSACTIONS: | ||||||||||||||||
| Shares sold | 194,498,514 | 8,165,610 | 409,110,556 | 1,892,504 | ||||||||||||
| Shares redeemed | (188,301,261 | ) | (422,174 | ) | (358,354,072 | ) | – | |||||||||
| Net increase (decrease) in net assets from capital transactions | 6,197,253 | 7,743,436 | 50,756,484 | 1,892,504 | ||||||||||||
| NET INCREASE (DECREASE) IN NET ASSETS | 38,067,303 | 6,681,574 | 44,202,392 | 1,381,306 | ||||||||||||
| NET ASSETS: | ||||||||||||||||
| Beginning of the period | – | – | – | – | ||||||||||||
| End of the period | $ | 38,067,303 | $ | 6,681,574 | $ | 44,202,392 | $ | 1,381,306 | ||||||||
| SHARES TRANSACTIONS | ||||||||||||||||
| Shares sold | 4,140,000 | 390,000 | 110,355,000 | 100,000 | ||||||||||||
| Shares redeemed | (3,340,000 | ) | (20,000 | ) | (97,015,000 | ) | – | |||||||||
| Reverse stock split | – | – | (11,116,667 | )(d) | – | |||||||||||
| Total increase (decrease) in shares outstanding | 800,000 | 370,000 | 13,340,000 | 100,000 | ||||||||||||
| (a) | Inception date of the Fund was June 23, 2025. |
| (b) | Inception date of the Fund was July 21, 2025. |
| (c) | Inception date of the Fund was September 2, 2025. |
| (d) | Share amounts for the Fund have been adjusted for a 1 for 6 reverse stock split effective on December 9, 2025 (Note 11). |
60
The accompanying notes are an integral part of these financial statements.
| Statements of Changes in Net Assets | Defiance ETFs |
For the Periods Ended October 31, 2025 (Unaudited)
|
Defiance Daily Target 2X Short MSTR ETF |
Defiance Daily Target 2X Short PLTR ETF |
Defiance Daily Target 2X Short QBTS ETF |
||||||||||||||
|
Period ended October 31, 2025 (Unaudited) |
Period ended April 30, 2025(a) |
Period ended October 31, 2025(b) (Unaudited) |
Period ended October 31, 2025(c) (Unaudited) |
|||||||||||||
| OPERATIONS: | ||||||||||||||||
| Net investment income (loss) | $ | (127,670 | ) | $ | (80,199 | ) | $ | (104,783 | ) | $ | (14,722 | ) | ||||
| Net realized gain (loss) | 6,507,992 | (13,226,392 | ) | (22,625,441 | ) | 688,806 | ||||||||||
| Net change in unrealized appreciation (depreciation) | 2,693,563 | (1,261,377 | ) | (1,447,692 | ) | (4,767,985 | ) | |||||||||
| Net increase (decrease) in net assets from operations | 9,073,885 | (14,567,968 | ) | (24,177,916 | ) | (4,093,901 | ) | |||||||||
| CAPITAL TRANSACTIONS: | ||||||||||||||||
| Shares sold | 94,765,524 | 431,005,735 | 292,123,952 | 75,624,977 | ||||||||||||
| Shares redeemed | (124,091,158 | ) | (374,693,371 | ) | (199,323,012 | ) | (34,133,594 | ) | ||||||||
| Net increase (decrease) in net assets from capital transactions | (29,325,634 | ) | 56,312,364 | 92,800,940 | 41,491,383 | |||||||||||
| NET INCREASE (DECREASE) IN NET ASSETS | (20,251,749 | ) | 41,744,396 | 68,623,024 | 37,397,482 | |||||||||||
| NET ASSETS: | ||||||||||||||||
| Beginning of the period | 41,744,396 | – | – | – | ||||||||||||
| End of the period | $ | 21,492,647 | $ | 41,744,396 | $ | 68,623,024 | $ | 37,397,482 | ||||||||
| SHARES TRANSACTIONS | ||||||||||||||||
| Shares sold | 11,195,000 | 103,050,000 | 35,530,000 | 5,760,000 | ||||||||||||
| Shares redeemed | (10,120,023 | ) | (71,325,015 | ) | (23,305,000 | ) | (2,200,000 | ) | ||||||||
| Reverse stock split | (28,176,986 | )(e) | (4,040,000 | )(d) | – | – | ||||||||||
| Reverse stock split | – | (26,300,736 | )(e) | (9,168,750 | )(f) | – | ||||||||||
| Total increase (decrease) in shares outstanding | (27,102,009 | ) | 1,384,249 | 12,225,000 | 3,560,000 | |||||||||||
| (a) | Inception date of the Fund was August 20, 2024. |
| (b) | Inception date of the Fund was June 5, 2025. |
| (c) | Inception date of the Fund was October 6, 2025. |
| (d) | Share amounts for the Fund have been adjusted for a 1 for 5 reverse stock split effective on November 15, 2024. |
| (e) | Share amounts for the Fund have been adjusted for a 1 for 20 reverse stock split effective on May 23, 2025 (Note 8). |
| (f) | Share amounts for the Fund have been adjusted for a 1 for 4 reverse stock split effective on December 9, 2025 (Note 11). |
61
The accompanying notes are an integral part of these financial statements.
| Statements of Changes in Net Assets | Defiance ETFs |
For the Periods Ended October 31, 2025 (Unaudited)
|
Defiance Daily Target 2X Short RGTI ETF |
Defiance Daily Target 2X Short SMCI ETF |
|||||||||||
|
Period ended October 31, 2025(a) (Unaudited) |
Period ended October 31, 2025 (Unaudited) |
Period ended April 30, 2025(b) |
||||||||||
| OPERATIONS: | ||||||||||||
| Net investment income (loss) | $ | (54,961 | ) | $ | (56,031 | ) | $ | (1,233 | ) | |||
| Net realized gain (loss) | 36,262,164 | (1,758,965 | ) | 185,616 | ||||||||
| Net change in unrealized appreciation (depreciation) | (15,518,591 | ) | 499,112 | – | ||||||||
| Net increase (decrease) in net assets from operations | 20,688,612 | (1,315,884 | ) | 184,383 | ||||||||
| CAPITAL TRANSACTIONS: | ||||||||||||
| Shares sold | 212,915,078 | 125,097,676 | 6,457,920 | |||||||||
| Shares redeemed | (155,739,915 | ) | (121,682,588 | ) | (2,803,158 | ) | ||||||
| Net increase (decrease) in net assets from capital transactions | 57,175,163 | 3,415,088 | 3,654,762 | |||||||||
| NET INCREASE (DECREASE) IN NET ASSETS | 77,863,775 | 2,099,204 | 3,839,145 | |||||||||
| NET ASSETS: | ||||||||||||
| Beginning of the period | – | 3,839,145 | – | |||||||||
| End of the period | $ | 77,863,775 | $ | 5,938,349 | $ | 3,839,145 | ||||||
| SHARES TRANSACTIONS | ||||||||||||
| Shares sold | 18,460,000 | 28,075,000 | 375,000 | |||||||||
| Shares redeemed | (11,460,000 | ) | (26,270,000 | ) | (150,000 | ) | ||||||
| Reverse stock split | – | (1,776,250 | )(c) | – | ||||||||
| Total increase (decrease) in shares outstanding | 7,000,000 | 1,805,000 | 225,000 | |||||||||
| (a) | Inception date of the Fund was October 8, 2025. |
| (b) | Inception date of the Fund was March 31, 2025. |
| (c) | Share amounts for the Fund have been adjusted for a 1 for 8 reverse stock split effective on December 9, 2025 (Note 11). |
62
The accompanying notes are an integral part of these financial statements.
| Financial Highlights | Defiance ETFs |
For a share outstanding throughout the periods presented.
| Defiance 2X Daily Long Pure Quantum ETF | |||
|
Period ended October 31, 2025(a) (Unaudited) | |||
| PER SHARE DATA: | |||
| Net asset value, beginning of period | $20.00 | ||
| INVESTMENT OPERATIONS: | |||
| Net investment loss(b) | (0.12) | ||
| Net realized and unrealized gain (loss) on investments(c) | 29.59 | ||
| Total from investment operations | 29.47 | ||
| – | |||
| Net asset value, end of period | $49.47 | ||
| TOTAL RETURN(d) | 147.36% | ||
| SUPPLEMENTAL DATA AND RATIOS: | |||
| Net assets, end of period (in thousands) | $50,708 | ||
| Ratio of expenses to average net assets(e) | 1.29% | ||
| Ratio of net investment income (loss) to average net assets(e) | (1.15)% | ||
| Portfolio turnover rate(d)(f) | –% | ||
| (a) | Inception date of the Fund was August 6, 2025. |
| (b) | Net investment income per share has been calculated based on average shares outstanding during the period. |
| (c) | Realized and unrealized gains and losses per share in the caption are balancing amounts necessary to reconcile the change in net asset value per share for the period, and may not reconcile with the aggregate gains and losses in the Statements of Operations due to share transactions for the period. |
| (d) | Not annualized for periods less than one year. |
| (e) | Annualized for periods less than one year. |
| (f) | Portfolio turnover rate excludes in-kind transactions, if any. |
63
The accompanying notes are an integral part of these financial statements.
| Financial Highlights | Defiance ETFs |
For a share outstanding throughout the periods presented.
| Defiance Daily Target 2X Long ANET ETF | |||
|
Period ended October 31, 2025(a) (Unaudited) | |||
| PER SHARE DATA: | |||
| Net asset value, beginning of period | $20.00 | ||
| INVESTMENT OPERATIONS: | |||
| Net investment loss(b) | (0.03) | ||
| Net realized and unrealized gain (loss) on investments(c) | 4.78 | ||
| Total from investment operations | 4.75 | ||
| – | |||
| Net asset value, end of period | $24.75 | ||
| TOTAL RETURN(d) | 23.77% | ||
| SUPPLEMENTAL DATA AND RATIOS: | |||
| Net assets, end of period (in thousands) | $7,922 | ||
| Ratio of expenses to average net assets(e) | 1.30% | ||
| Ratio of interest expense to average net assets(e) | 0.01% | ||
| Ratio of operational expenses to average net assets excluding interest expense(e) | 1.29% | ||
| Ratio of net investment income (loss) to average net assets(e) | (0.89)% | ||
| Portfolio turnover rate(d)(f) | 272% | ||
| (a) | Inception date of the Fund was September 3, 2025. |
| (b) | Net investment income per share has been calculated based on average shares outstanding during the period. |
| (c) | Realized and unrealized gains and losses per share in the caption are balancing amounts necessary to reconcile the change in net asset value per share for the periods, and may not reconcile with the aggregate gains and losses in the Statement of Operations due to share transactions for the periods. |
| (d) | Not annualized for periods less than one year. |
| (e) | Annualized for periods less than one year. |
| (f) | Portfolio turnover rate excludes in-kind transactions, if any. |
64
The accompanying notes are an integral part of these financial statements.
| Financial Highlights | Defiance ETFs |
For a share outstanding throughout the periods presented.
| Defiance Daily Target 2X Long AVAV ETF | |||
|
Period ended October 31, 2025(a) (Unaudited) | |||
| PER SHARE DATA: | |||
| Net asset value, beginning of period | $20.00 | ||
| INVESTMENT OPERATIONS: | |||
| Net investment income(b) | (0.00)(c) | ||
| Net realized and unrealized gain (loss) on investments(d) | 0.45 | ||
| Total from investment operations | 0.45 | ||
| – | |||
| Net asset value, end of period | $20.45 | ||
| TOTAL RETURN(e) | 2.40% | ||
| SUPPLEMENTAL DATA AND RATIOS: | |||
| Net assets, end of period (in thousands) | $818 | ||
| Ratio of expenses to average net assets(f) | 0.92% | ||
| Ratio of net investment income (loss) to average net assets(f) | (0.53)% | ||
| Portfolio turnover rate(e)(g) | –% | ||
| (a) | Inception date of the Fund was October 23, 2025. |
| (b) | Net investment income per share has been calculated based on average shares outstanding during the period. |
| (c) | Amount represents less than $0.005 per share. |
| (d) | Realized and unrealized gains and losses per share in the caption are balancing amounts necessary to reconcile the change in net asset value per share for the periods, and may not reconcile with the aggregate gains and losses in the Statement of Operations due to share transactions for the periods. |
| (e) | Not annualized for periods less than one year. |
| (f) | Annualized for periods less than one year. |
| (g) | Portfolio turnover rate excludes in-kind transactions, if any. |
65
The accompanying notes are an integral part of these financial statements.
| Financial Highlights | Defiance ETFs |
For a share outstanding throughout the periods presented.
| Defiance Daily Target 2X Long AVGO ETF | ||||
|
Period ended October 31, 2025 (Unaudited) |
Period ended April 30, 2025(a) | |||
| PER SHARE DATA: | ||||
| Net asset value, beginning of period | $18.17 | $20.00 | ||
| INVESTMENT OPERATIONS: | ||||
| Net investment loss(b) | (0.20) | (0.11) | ||
| Net realized and unrealized gain (loss) on investments(c) | 40.01 | (1.46) | ||
| Total from investment operations | 39.81 | (1.57) | ||
| LESS DISTRIBUTIONS FROM: | ||||
| Net investment income | – | (0.26) | ||
| Total distributions | – | (0.26) | ||
| Net asset value, end of period | $57.98 | $18.17 | ||
| TOTAL RETURN(d) | 219.11% | -8.41% | ||
| SUPPLEMENTAL DATA AND RATIOS: | ||||
| Net assets, end of period (in thousands) | $143,795 | $72,117 | ||
| Ratio of expenses to average net assets(e) | 1.29% | 1.29% | ||
| Ratio of interest expense to average net assets(e) | 0.00%(f) | 0.00%(f) | ||
| Ratio of net investment income (loss) to average net assets(e) | (1.03)% | (0.70)% | ||
| Portfolio turnover rate(d)(g) | 34,201% | 1,661% |
| (a) | Inception date of the Fund was August 21, 2024. |
| (b) | Net investment income per share has been calculated based on average shares outstanding during the periods. |
| (c) | Realized and unrealized gains and losses per share in the caption are balancing amounts necessary to reconcile the change in net asset value per share for the periods, and may not reconcile with the aggregate gains and losses in the Statement of Operations due to share transactions for the periods. |
| (d) | Not annualized for periods less than one year. |
| (e) | Annualized for periods less than one year. |
| (f) | Amount represents less than 0.005%. |
| (g) | Portfolio turnover rate excludes in-kind transactions, if any. |
66
The accompanying notes are an integral part of these financial statements.
| Financial Highlights | Defiance ETFs |
For a share outstanding throughout the periods presented.
| Defiance Daily Target 2X Long CVNA ETF | ||
|
Period ended October 31, 2025(a) (Unaudited) | ||
| PER SHARE DATA: | ||
| Net asset value, beginning of period | $20.00 | |
| INVESTMENT OPERATIONS: | ||
| Net investment loss(b) | (0.04) | |
| Net realized and unrealized gain (loss) on investments(c) | (5.09) | |
| Total from investment operations | (5.13) | |
| – | ||
| Net asset value, end of period | $14.87 | |
| TOTAL RETURN(d) | -25.27% | |
| SUPPLEMENTAL DATA AND RATIOS: | ||
| Net assets, end of period (in thousands) | $4,385 | |
| Ratio of expenses to average net assets(e) | 1.29% | |
| Ratio of net investment income (loss) to average net assets(e) | (0.40)% | |
| Portfolio turnover rate(d)(f) | 16,967% |
| (a) | Inception date of the Fund was May 28, 2025. |
| (b) | Net investment income per share has been calculated based on average shares outstanding during the period. |
| (c) | Realized and unrealized gains and losses per share in the caption are balancing amounts necessary to reconcile the change in net asset value per share for the periods, and may not reconcile with the aggregate gains and losses in the Statement of Operations due to share transactions for the periods. |
| (d) | Not annualized for periods less than one year. |
| (e) | Annualized for periods less than one year. |
| (f) | Portfolio turnover rate excludes in-kind transactions, if any. |
67
The accompanying notes are an integral part of these financial statements.
| Financial Highlights | Defiance ETFs |
For a share outstanding throughout the periods presented.
| Defiance Daily Target 2X Long DKNG ETF | ||
|
Period ended October 31, 2025(a) (Unaudited) | ||
| PER SHARE DATA: | ||
| Net asset value, beginning of period | $20.00 | |
| INVESTMENT OPERATIONS: | ||
| Net investment loss(b) | (0.03) | |
| Net realized and unrealized gain (loss) on investments(c) | (11.93) | |
| Total from investment operations | (11.96) | |
| – | ||
| Net asset value, end of period | $8.04 | |
| TOTAL RETURN(d) | -59.79% | |
| SUPPLEMENTAL DATA AND RATIOS: | ||
| Net assets, end of period (in thousands) | $7,238 | |
| Ratio of expenses to average net assets(e) | 1.33% | |
| Ratio of interest expense to average net assets(e) | 0.04% | |
| Ratio of operational expenses to average net assets excluding interest expense(e) | 1.29% | |
| Ratio of net investment income (loss) to average net assets(e) | (0.87)% | |
| Portfolio turnover rate(d)(f) | 1,984% |
| (a) | Inception date of the Fund was July 30, 2025. |
| (b) | Net investment income per share has been calculated based on average shares outstanding during the period. |
| (c) | Realized and unrealized gains and losses per share in the caption are balancing amounts necessary to reconcile the change in net asset value per share for the periods, and may not reconcile with the aggregate gains and losses in the Statement of Operations due to share transactions for the periods. |
| (d) | Not annualized for periods less than one year. |
| (e) | Annualized for periods less than one year. |
| (f) | Portfolio turnover rate excludes in-kind transactions, if any. |
68
The accompanying notes are an integral part of these financial statements.
| Financial Highlights | Defiance ETFs |
For a share outstanding throughout the periods presented.
| Defiance Daily Target 2X Long HIMS ETF | ||||
|
Period ended October 31, 2025 (Unaudited) |
Period ended April 30, 2025(a) | |||
| PER SHARE DATA: | ||||
| Net asset value, beginning of period | $15.61 | $20.00 | ||
| INVESTMENT OPERATIONS: | ||||
| Net investment loss(b) | (0.11) | (0.02) | ||
| Net realized and unrealized gain (loss) on investments(c) | (2.67) | (4.37) | ||
| Total from investment operations | (2.78) | (4.39) | ||
| Net asset value, end of period | $12.83 | $15.61 | ||
| TOTAL RETURN(d) | -17.80% | -21.94% | ||
| SUPPLEMENTAL DATA AND RATIOS: | ||||
| Net assets, end of period (in thousands) | $200,485 | $17,564 | ||
| Ratio of expenses to average net assets(e) | 1.31% | 1.29% | ||
| Ratio of interest expense to average net assets(e) | 0.02% | –% | ||
| Ratio of operational expenses to average net assets excluding interest expense(e) | 1.29% | 1.29% | ||
| Ratio of net investment income (loss) to average net assets(e) | (1.03)% | (1.07)% | ||
| Portfolio turnover rate(d)(f) | 33,431% | 251% |
| (a) | Inception date of the Fund was March 12, 2025. |
| (b) | Net investment income per share has been calculated based on average shares outstanding during the period. |
| (c) | Realized and unrealized gains and losses per share in the caption are balancing amounts necessary to reconcile the change in net asset value per share for the periods, and may not reconcile with the aggregate gains and losses in the Statement of Operations due to share transactions for the periods. |
| (d) | Not annualized for periods less than one year. |
| (e) | Annualized for periods less than one year. |
| (f) | Portfolio turnover rate excludes in-kind transactions, if any. |
69
The accompanying notes are an integral part of these financial statements.
| Financial Highlights | Defiance ETFs |
For a share outstanding throughout the periods presented.
| Defiance Daily Target 2X Long HOOD ETF | ||||
|
Period ended October 31, 2025(h) (Unaudited) |
Period ended April 30, 2025(a) | |||
| PER SHARE DATA: | ||||
| Net asset value, beginning of period | $6.56 | $5.00 | ||
| INVESTMENT OPERATIONS: | ||||
| Net investment loss(b) | (0.12) | (0.01) | ||
| Net realized and unrealized gain (loss) on investments(c) | 38.29 | 1.57 | ||
| Total from investment operations | 38.17 | 1.56 | ||
| – | – | |||
| Net asset value, end of period | $44.73 | $6.56 | ||
| TOTAL RETURN(d) | 581.67% | 31.25% | ||
| SUPPLEMENTAL DATA AND RATIOS: | ||||
| Net assets, end of period (in thousands) | $29,525 | $3,938 | ||
| Ratio of expenses to average net assets(e) | 1.29% | 1.29% | ||
| Ratio of interest expense to average net assets(e) | 0.00%(f) | –% | ||
| Ratio of net investment income (loss) to average net assets(e) | (0.93)% | (0.90)% | ||
| Portfolio turnover rate(d)(g) | 32,932% | 210% |
| (a) | Inception date of the Fund was March 18, 2025. |
| (b) | Net investment income per share has been calculated based on average shares outstanding during the period. |
| (c) | Realized and unrealized gains and losses per share in the caption are balancing amounts necessary to reconcile the change in net asset value per share for the periods, and may not reconcile with the aggregate gains and losses in the Statement of Operations due to share transactions for the periods. |
| (d) | Not annualized for periods less than one year. |
| (e) | Annualized for periods less than one year. |
| (f) | Amount represents less than 0.005%. |
| (g) | Portfolio turnover rate excludes in-kind transactions, if any. |
| (h) | After the period ended October 31, 2025, the Fund effected the following stock split: December 9, 2025, 4 for 1. All historical per share information has been retroactively adjusted to reflect this stock split. |
70
The accompanying notes are an integral part of these financial statements.
| Financial Highlights | Defiance ETFs |
For a share outstanding throughout the periods presented.
| Defiance Daily Target 2X Long IONQ ETF | ||||
|
Period ended October 31, 2025(g) (Unaudited) |
Period ended April 30, 2025(a) | |||
| PER SHARE DATA: | ||||
| Net asset value, beginning of period | $17.25 | $10.00 | ||
| INVESTMENT OPERATIONS: | ||||
| Net investment loss(b) | (0.02) | (0.03) | ||
| Net realized and unrealized gain (loss) on investments(c) | 35.55 | 7.28 | ||
| Total from investment operations | 35.53 | 7.25 | ||
| – | – | |||
| Net asset value, end of period | $52.78 | $17.25 | ||
| TOTAL RETURN(d) | 205.95% | 72.50% | ||
| SUPPLEMENTAL DATA AND RATIOS: | ||||
| Net assets, end of period (in thousands) | $225,885 | $24,153 | ||
| Ratio of expenses to average net assets(e) | 1.35% | 1.29% | ||
| Ratio of interest expense to average net assets(e) | 0.06% | –% | ||
| Ratio of operational expenses to average net assets excluding interest expense(e) | 1.29% | 1.29% | ||
| Ratio of net investment income (loss) to average net assets(e) | (1.19)% | (1.13)% | ||
| Portfolio turnover rate(d)(f) | 32,862% | 314% |
| (a) | Inception date of the Fund was March 11, 2025. |
| (b) | Net investment income per share has been calculated based on average shares outstanding during the period. |
| (c) | Realized and unrealized gains and losses per share in the caption are balancing amounts necessary to reconcile the change in net asset value per share for the periods, and may not reconcile with the aggregate gains and losses in the Statement of Operations due to share transactions for the periods. |
| (d) | Not annualized for periods less than one year. |
| (e) | Annualized for periods less than one year. |
| (f) | Portfolio turnover rate excludes in-kind transactions, if any. |
| (g) | After the period ended October 31, 2025, the Fund effected the following stock split: December 9, 2025, 2 for 1. All historical per share information has been retroactively adjusted to reflect this stock split. |
71
The accompanying notes are an integral part of these financial statements.
| Financial Highlights | Defiance ETFs |
For a share outstanding throughout the periods presented.
| Defiance Daily Target 2X Long IREN ETF | ||
|
Period ended October 31, 2025(a) (Unaudited) | ||
| PER SHARE DATA: | ||
| Net asset value, beginning of period | $20.00 | |
| INVESTMENT OPERATIONS: | ||
| Net investment loss(b) | (0.01) | |
| Net realized and unrealized gain (loss) on investments(c) | 0.16 | |
| Total from investment operations | 0.15 | |
| – | ||
| Net asset value, end of period | $20.15 | |
| TOTAL RETURN(d) | 0.75% | |
| SUPPLEMENTAL DATA AND RATIOS: | ||
| Net assets, end of period (in thousands) | $110,604 | |
| Ratio of expenses to average net assets(e) | 1.30% | |
| Ratio of interest expense to average net assets(e) | 0.01% | |
| Ratio of operational expenses to average net assets excluding interest expense(e) | 1.29% | |
| Ratio of net investment income (loss) to average net assets(e) | (0.95)% | |
| Portfolio turnover rate(d)(f) | –% |
| (a) | Inception date of the Fund was October 20, 2025. |
| (b) | Net investment income per share has been calculated based on average shares outstanding during the period. |
| (c) | Realized and unrealized gains and losses per share in the caption are balancing amounts necessary to reconcile the change in net asset value per share for the periods, and may not reconcile with the aggregate gains and losses in the Statement of Operations due to share transactions for the periods. |
| (d) | Not annualized for periods less than one year. |
| (e) | Annualized for periods less than one year. |
| (f) | Portfolio turnover rate excludes in-kind transactions, if any. |
72
The accompanying notes are an integral part of these financial statements.
| Financial Highlights | Defiance ETFs |
For a share outstanding throughout the periods presented.
Defiance Daily Target 2X Long JPM ETF
| Period ended | ||
| October 31, | ||
| 2025(a) | ||
| (Unaudited) | ||
| PER SHARE DATA: | ||
| Net asset value, beginning of period | $20.00 | |
| INVESTMENT OPERATIONS: | ||
| Net investment income(b) | 0.04 | |
| Net realized and unrealized gain (loss) on investments(c) | 1.32 | |
| Total from investment operations | 1.36 | |
| – | ||
| Net asset value, end of period | $21.36 | |
| TOTAL RETURN(d) | 6.78% | |
| SUPPLEMENTAL DATA AND RATIOS: | ||
| Net assets, end of period (in thousands) | $2,776 | |
| Ratio of expenses to average net assets(e) | 1.29% | |
| Ratio of net investment income (loss) to average net assets(e) | 0.66% | |
| Portfolio turnover rate(d)(f) | 1,292% |
| (a) | Inception date of the Fund was July 23, 2025. |
| (b) | Net investment income per share has been calculated based on average shares outstanding during the period. |
| (c) | Realized and unrealized gains and losses per share in the caption are balancing amounts necessary to reconcile the change in net asset value per share for the periods, and may not reconcile with the aggregate gains and losses in the Statement of Operations due to share transactions for the periods. |
| (d) | Not annualized for periods less than one year. |
| (e) | Annualized for periods less than one year. |
| (f) | Portfolio turnover rate excludes in-kind transactions, if any. |
73
The accompanying notes are an integral part of these financial statements.
| Financial Highlights | Defiance ETFs |
For a share outstanding throughout the periods presented.
Defiance Daily Target 2X Long LLY ETF
| Period ended | ||||
| October 31, | Period ended | |||
| 2025 | April 30, | |||
| (Unaudited) | 2025(a) | |||
| PER SHARE DATA: | ||||
| Net asset value, beginning of period | $22.23 | $20.00 | ||
| INVESTMENT OPERATIONS: | ||||
| Net investment loss(b) | (0.06) | (0.15) | ||
| Net realized and unrealized gain (loss) on investments(c) | (4.79) | 2.38 | ||
| Total from investment operations | (4.85) | 2.23 | ||
| – | – | |||
| Net asset value, end of period | $17.38 | $22.23 | ||
| TOTAL RETURN(d) | -21.83% | 11.16% | ||
| SUPPLEMENTAL DATA AND RATIOS: | ||||
| Net assets, end of period (in thousands) | $56,391 | $19,230 | ||
| Ratio of expenses to average net assets(e) | 1.29% | 1.31% | ||
| Ratio of interest expense to average net assets(e) | 0.00%(f) | 0.02% | ||
| Ratio of operational expenses to average net assets excluding interest expense(e) | 1.29% | 1.29% | ||
| Ratio of net investment income (loss) to average net assets(e) | (0.92)% | (0.99)% | ||
| Portfolio turnover rate(d)(g) | 6,730% | 1,232% |
| (a) | Inception date of the Fund was August 7, 2024. |
| (b) | Net investment income per share has been calculated based on average shares outstanding during the periods. |
| (c) | Realized and unrealized gains and losses per share in the caption are balancing amounts necessary to reconcile the change in net asset value per share for the periods, and may not reconcile with the aggregate gains and losses in the Statement of Operations due to share transactions for the periods. |
| (d) | Not annualized for periods less than one year. |
| (e) | Annualized for periods less than one year. |
| (f) | Amount represents less than 0.005%. |
| (g) | Portfolio turnover rate excludes in-kind transactions, if any. |
74
The accompanying notes are an integral part of these financial statements.
| Financial Highlights | Defiance ETFs |
For a share outstanding throughout the periods presented.
Defiance Daily Target 2X Long LMND ETF
| Period ended | ||
| October 31, | ||
| 2025(a) | ||
| (Unaudited) | ||
| PER SHARE DATA: | ||
| Net asset value, beginning of period | $20.00 | |
| INVESTMENT OPERATIONS: | ||
| Net investment loss(b) | (0.01) | |
| Net realized and unrealized gain (loss) on investments(c) | 5.08 | |
| Total from investment operations | 5.07 | |
| – | ||
| Net asset value, end of period | $25.07 | |
| TOTAL RETURN(d) | 25.34% | |
| SUPPLEMENTAL DATA AND RATIOS: | ||
| Net assets, end of period (in thousands) | $1,755 | |
| Ratio of expenses to average net assets(e) | 1.51% | |
| Ratio of interest expense to average net assets(e) | 0.22% | |
| Ratio of operational expenses to average net assets excluding interest(e) | 1.29% | |
| Ratio of net investment income (loss) to average net assets(e) | (1.24)% | |
| Portfolio turnover rate(d)(f) | 43% |
| (a) | Inception date of the Fund was October 15, 2025. |
| (b) | Net investment income per share has been calculated based on average shares outstanding during the period. |
| (c) | Realized and unrealized gains and losses per share in the caption are balancing amounts necessary to reconcile the change in net asset value per share for the periods, and may not reconcile with the aggregate gains and losses in the Statement of Operations due to share transactions for the periods. |
| (d) | Not annualized for periods less than one year. |
| (e) | Annualized for periods less than one year. |
| (f) | Portfolio turnover rate excludes in-kind transactions, if any. |
75
The accompanying notes are an integral part of these financial statements.
| Financial Highlights | Defiance ETFs |
For a share outstanding throughout the periods presented.
Defiance Daily Target 2X Long MP ETF
| Period ended | ||
| October 31, | ||
| 2025(a) | ||
| (Unaudited) | ||
| PER SHARE DATA: | ||
| Net asset value, beginning of period | $20.00 | |
| INVESTMENT OPERATIONS: | ||
| Net investment loss(b) | (0.01) | |
| Net realized and unrealized gain (loss) on investments(c) | (8.79) | |
| Total from investment operations | (8.80) | |
| – | ||
| Net asset value, end of period | $11.20 | |
| TOTAL RETURN(d) | -44.00% | |
| SUPPLEMENTAL DATA AND RATIOS: | ||
| Net assets, end of period (in thousands) | $7,391 | |
| Ratio of expenses to average net assets(e) | 3.06% | |
| Ratio of interest expense to average net assets(e) | 1.77% | |
| Ratio of operational expenses to average net assets excluding interest expense(e) | 1.29% | |
| Ratio of net investment income (loss) to average net assets(e) | (2.68)% | |
| Portfolio turnover rate(d)(f) | –% |
| (a) | Inception date of the Fund was October 20, 2025. |
| (b) | Net investment income per share has been calculated based on average shares outstanding during the period. |
| (c) | Realized and unrealized gains and losses per share in the caption are balancing amounts necessary to reconcile the change in net asset value per share for the periods, and may not reconcile with the aggregate gains and losses in the Statement of Operations due to share transactions for the periods. |
| (d) | Not annualized for periods less than one year. |
| (e) | Annualized for periods less than one year. |
| (f) | Portfolio turnover rate excludes in-kind transactions, if any. |
76
The accompanying notes are an integral part of these financial statements.
| Financial Highlights | Defiance ETFs |
For a share outstanding throughout the periods presented.
Defiance Daily Target 2X Long MSTR ETF
| Period ended | ||||
| October 31, | Period ended | |||
| 2025 | April 30, | |||
| (Unaudited) | 2025(a) | |||
| PER SHARE DATA: | ||||
| Net asset value, beginning of period | $39.14 | $20.00 | ||
| INVESTMENT OPERATIONS: | ||||
| Net investment loss(b) | (0.18) | (0.25) | ||
| Net realized and unrealized gain (loss) on investments(c) | (25.12) | 33.82 | ||
| Total from investment operations | (25.30) | 33.57 | ||
| LESS DISTRIBUTIONS FROM: | ||||
| Net investment income | – | (14.43) | ||
| Total distributions | – | (14.43) | ||
| Net asset value, end of period | $13.84 | $39.14 | ||
| TOTAL RETURN(d) | -64.63% | 175.98% | ||
| SUPPLEMENTAL DATA AND RATIOS: | ||||
| Net assets, end of period (in thousands) | $582,042 | $1,666,424 | ||
| Ratio of expenses to average net assets(e) | 1.29% | 1.30% | ||
| Ratio of interest expense to average net assets(e) | 0.00%(f) | 0.01% | ||
| Ratio of operational expenses to average net assets excluding interest (e) | 1.29% | 1.29% | ||
| Ratio of net investment income (loss) to average net assets(e) | (1.10)% | (0.83)% | ||
| Portfolio turnover rate(d)(g) | 3,157% | 4,006% |
| (a) | Inception date of the Fund was August 14, 2024. |
| (b) | Net investment income per share has been calculated based on average shares outstanding during the periods. |
| (c) | Realized and unrealized gains and losses per share in the caption are balancing amounts necessary to reconcile the change in net asset value per share for the periods, and may not reconcile with the aggregate gains and losses in the Statement of Operations due to share transactions for the periods. |
| (d) | Not annualized for periods less than one year. |
| (e) | Annualized for periods less than one year. |
| (f) | Amount represents less than 0.005%. |
| (g) | Portfolio turnover rate excludes in-kind transactions, if any. |
77
The accompanying notes are an integral part of these financial statements.
| Financial Highlights | Defiance ETFs |
For a share outstanding throughout the periods presented.
Defiance Daily Target 2X Long NVO ETF
| Period ended | ||||
| October 31, | Period ended | |||
| 2025(h) | April 30, | |||
| (Unaudited) | 2025(a) | |||
| PER SHARE DATA: | ||||
| Net asset value, beginning of period | $50.16 | $160.00 | ||
| INVESTMENT OPERATIONS: | ||||
| Net investment loss(b) | (0.12) | (0.08) | ||
| Net realized and unrealized gain (loss) on investments(c) | (28.14) | (109.76) | ||
| Total from investment operations | (28.26) | (109.84) | ||
| – | – | |||
| Net asset value, end of period | $21.90 | $50.16 | ||
| TOTAL RETURN(d) | -56.33% | -68.70% | ||
| SUPPLEMENTAL DATA AND RATIOS: | ||||
| Net assets, end of period (in thousands) | $82,018 | $3,415 | ||
| Ratio of expenses to average net assets(e) | 1.29% | 1.29% | ||
| Ratio of interest expense to average net assets(e) | 0.00%(f) | –% | ||
| Ratio of net investment income (loss) to average net assets(e) | (0.82)% | (0.29)% | ||
| Portfolio turnover rate(d)(g) | 1,504% | 508% |
| (a) | Inception date of the Fund was December 2, 2024. |
| (b) | Net investment income per share has been calculated based on average shares outstanding during the period. |
| (c) | Realized and unrealized gains and losses per share in the caption are balancing amounts necessary to reconcile the change in net asset value per share for the periods, and may not reconcile with the aggregate gains and losses in the Statement of Operations due to share transactions for the periods. |
| (d) | Not annualized for periods less than one year. |
| (e) | Annualized for periods less than one year. |
| (f) | Amount represents less than 0.005%. |
| (g) | Portfolio turnover rate excludes in-kind transactions, if any. |
| (h) | After the year ended October 31, 2025, the Fund effected the following reverse stock split: December 1, 2025, 1 for 8. All historical per share information has been retroactively adjusted to reflect this reverse stock split. |
78
The accompanying notes are an integral part of these financial statements.
| Financial Highlights | Defiance ETFs |
For a share outstanding throughout the periods presented.
Defiance Daily Target 2X Long OKLO ETF
| Period ended | ||
| October 31, | ||
| 2025(a) | ||
| (Unaudited) | ||
| PER SHARE DATA: | ||
| Net asset value, beginning of period | $20.00 | |
| INVESTMENT OPERATIONS: | ||
| Net investment loss(b) | (0.25) | |
| Net realized and unrealized gain (loss) on investments(c) | 54.05 | |
| Total from investment operations | 53.80 | |
| – | ||
| Net asset value, end of period | $73.80 | |
| TOTAL RETURN(d) | 268.98% | |
| SUPPLEMENTAL DATA AND RATIOS: | ||
| Net assets, end of period (in thousands) | $204,048 | |
| Ratio of expenses to average net assets(e) | 1.53% | |
| Ratio of interest to average net assets(e) | 0.24% | |
| Ratio of operational expenses to average net assets excluding interest expense(e) | 1.29% | |
| Ratio of net investment income (loss) to average net assets(e) | (1.38)% | |
| Portfolio turnover rate(d)(f) | 55,683% |
| (a) | Inception date of the Fund was June 23, 2025. |
| (b) | Net investment income per share has been calculated based on average shares outstanding during the period. |
| (c) | Realized and unrealized gains and losses per share in the caption are balancing amounts necessary to reconcile the change in net asset value per share for the periods, and may not reconcile with the aggregate gains and losses in the Statement of Operations due to share transactions for the periods. |
| (d) | Not annualized for periods less than one year. |
| (e) | Annualized for periods less than one year. |
| (f) | Portfolio turnover rate excludes in-kind transactions, if any. |
79
The accompanying notes are an integral part of these financial statements.
| Financial Highlights | Defiance ETFs |
For a share outstanding throughout the periods presented.
Defiance Daily Target 2X Long ORCL ETF
| Period ended | ||||
| October 31, | Period ended | |||
| 2025 | April 30, | |||
| (Unaudited) | 2025(a) | |||
| PER SHARE DATA: | ||||
| Net asset value, beginning of period | $12.25 | $20.00 | ||
| INVESTMENT OPERATIONS: | ||||
| Net investment loss(b) | (0.20) | (0.02) | ||
| Net realized and unrealized gain (loss) on investments(c) | 21.39 | (7.73) | ||
| Total from investment operations | 21.19 | (7.75) | ||
| – | – | |||
| Net asset value, end of period | $33.44 | $12.25 | ||
| TOTAL RETURN(d) | 172.95% | -38.74% | ||
| SUPPLEMENTAL DATA AND RATIOS: | ||||
| Net assets, end of period (in thousands) | $246,092 | $2,818 | ||
| Ratio of expenses to average net assets(e) | 1.31% | 1.36% | ||
| Ratio of interest expense to average net assets(e) | 0.02% | 0.07% | ||
| Ratio of operational expenses to average net assets excluding interest expense(e) | 1.29% | 1.29% | ||
| Ratio of net investment income (loss) to average net assets(e) | (1.02)% | (0.68)% | ||
| Portfolio turnover rate(d)(f) | 1,829% | 541% |
| (a) | Inception date of the Fund was February 6, 2025. |
| (b) | Net investment income per share has been calculated based on average shares outstanding during the period. |
| (c) | Realized and unrealized gains and losses per share in the caption are balancing amounts necessary to reconcile the change in net asset value per share for the periods, and may not reconcile with the aggregate gains and losses in the Statement of Operations due to share transactions for the periods. |
| (d) | Not annualized for periods less than one year. |
| (e) | Annualized for periods less than one year. |
| (f) | Portfolio turnover rate excludes in-kind transactions, if any. |
80
The accompanying notes are an integral part of these financial statements.
| Financial Highlights | Defiance ETFs |
For a share outstanding throughout the periods presented.
Defiance Daily Target 2X Long OSCR ETF
| Period ended | ||
| October 31, | ||
| 2025(a) | ||
| (Unaudited) | ||
| PER SHARE DATA: | ||
| Net asset value, beginning of period | $20.00 | |
| INVESTMENT OPERATIONS: | ||
| Net investment loss(b) | (0.02) | |
| Net realized and unrealized gain (loss) on investments(c) | (2.52) | |
| Total from investment operations | (2.54) | |
| – | ||
| Net asset value, end of period | $17.46 | |
| TOTAL RETURN(d) | -12.70% | |
| SUPPLEMENTAL DATA AND RATIOS: | ||
| Net assets, end of period (in thousands) | $8,206 | |
| Ratio of expenses to average net assets(e) | 1.29% | |
| Ratio of net investment income (loss) to average net assets(e) | (0.98)% | |
| Portfolio turnover rate(d)(f) | 6,599% |
| (a) | Inception date of the Fund was September 24, 2025. |
| (b) | Net investment income per share has been calculated based on average shares outstanding during the period. |
| (c) | Realized and unrealized gains and losses per share in the caption are balancing amounts necessary to reconcile the change in net asset value per share for the periods, and may not reconcile with the aggregate gains and losses in the Statement of Operations due to share transactions for the periods. |
| (d) | Not annualized for periods less than one year. |
| (e) | Annualized for periods less than one year. |
| (f) | Portfolio turnover rate excludes in-kind transactions, if any. |
81
The accompanying notes are an integral part of these financial statements.
| Financial Highlights | Defiance ETFs |
For a share outstanding throughout the periods presented.
Defiance Daily Target 2X Long PM ETF
| Period ended | ||
| October 31, | ||
| 2025(a) | ||
| (Unaudited) | ||
| PER SHARE DATA: | ||
| Net asset value, beginning of period | $20.00 | |
| INVESTMENT OPERATIONS: | ||
| Net investment loss(b) | (0.03) | |
| Net realized and unrealized gain (loss) on investments(c) | (4.52) | |
| Total from investment operations | (4.55) | |
| – | ||
| Net asset value, end of period | $15.45 | |
| TOTAL RETURN(d) | -22.73% | |
| SUPPLEMENTAL DATA AND RATIOS: | ||
| Net assets, end of period (in thousands) | $463 | |
| Ratio of expenses to average net assets(e) | 1.34% | |
| Ratio of interest expense to average net assets(e) | 0.05% | |
| Ratio of operational expenses to average net assets excluding interest expense(e) | 1.29% | |
| Ratio of net investment income (loss) to average net assets(e) | (1.03)% | |
| Portfolio turnover rate(d)(f) | 8,609% |
| (a) | Inception date of the Fund was September 3, 2025. |
| (b) | Net investment income per share has been calculated based on average shares outstanding during the period. |
| (c) | Realized and unrealized gains and losses per share in the caption are balancing amounts necessary to reconcile the change in net asset value per share for the periods, and may not reconcile with the aggregate gains and losses in the Statement of Operations due to share transactions for the periods. |
| (d) | Not annualized for periods less than one year. |
| (e) | Annualized for periods less than one year. |
| (f) | Portfolio turnover rate excludes in-kind transactions, if any. |
82
The accompanying notes are an integral part of these financial statements.
| Financial Highlights | Defiance ETFs |
For a share outstanding throughout the periods presented.
Defiance Daily Target 2X Long QS ETF
| Period ended | ||
| October 31, | ||
| 2025(a) | ||
| (Unaudited) | ||
| PER SHARE DATA: | ||
| Net asset value, beginning of period | $20.00 | |
| INVESTMENT OPERATIONS: | ||
| Net investment income(b) | (0.00)(c) | |
| Net realized and unrealized gain (loss) on investments(d) | 4.17 | |
| Total from investment operations | 4.17 | |
| – | ||
| Net asset value, end of period | $24.17 | |
| TOTAL RETURN(e) | 20.84% | |
| SUPPLEMENTAL DATA AND RATIOS: | ||
| Net assets, end of period (in thousands) | $9,909 | |
| Ratio of expenses to average net assets(f) | 1.30% | |
| Ratio of interest expense to average net assets(f) | 0.01% | |
| Ratio of operational expenses to average net assets excluding interest expense(f) | 1.29% | |
| Ratio of net investment income (loss) to average net assets(f) | (0.82)% | |
| Portfolio turnover rate(e)(g) | –% |
| (a) | Inception date of the Fund was October 20, 2025. |
| (b) | Net investment income per share has been calculated based on average shares outstanding during the period. |
| (c) | Amount represents less than $0.005 per share. |
| (d) | Realized and unrealized gains and losses per share in the caption are balancing amounts necessary to reconcile the change in net asset value per share for the periods, and may not reconcile with the aggregate gains and losses in the Statement of Operations due to share transactions for the periods. |
| (e) | Not annualized for periods less than one year. |
| (f) | Annualized for periods less than one year. |
| (g) | Portfolio turnover rate excludes in-kind transactions, if any. |
83
The accompanying notes are an integral part of these financial statements.
| Financial Highlights | Defiance ETFs |
For a share outstanding throughout the periods presented.
Defiance Daily Target 2X Long RGTI ETF
| Period ended | ||||
| October 31, | Period ended | |||
| 2025 | April 30, | |||
| (Unaudited) | 2025(a) | |||
| PER SHARE DATA: | ||||
| Net asset value, beginning of period | $5.70 | $5.00 | ||
| INVESTMENT OPERATIONS: | ||||
| Net investment loss(b) | (0.14) | (0.00)(f) | ||
| Net realized and unrealized gain (loss) on investments(c) | 59.11 | 0.70 | ||
| Total from investment operations | 58.97 | 0.70 | ||
| – | – | |||
| Net asset value, end of period | $64.67 | $5.70 | ||
| TOTAL RETURN(d) | 1035.12% | 13.95% | ||
| SUPPLEMENTAL DATA AND RATIOS: | ||||
| Net assets, end of period (in thousands) | $147,455 | $2,279 | ||
| Ratio of expenses to average net assets(e) | 1.55% | 1.29% | ||
| Ratio of interest expense to average net assets(e) | 0.26% | –% | ||
| Ratio of operational expenses to average net assets excluding interest expense(e) | 1.29% | 1.29% | ||
| Ratio of net investment income (loss) to average net assets(e) | (1.40)% | (0.67)% | ||
| Portfolio turnover rate(d)(f) | 118,871% | 273% |
| (a) | Inception date of the Fund was March 31, 2025. |
| (b) | Net investment income per share has been calculated based on average shares outstanding during the period. |
| (c) | Realized and unrealized gains and losses per share in the caption are balancing amounts necessary to reconcile the change in net asset value per share for the periods, and may not reconcile with the aggregate gains and losses in the Statement of Operations due to share transactions for the periods. |
| (d) | Not annualized for periods less than one year. |
| (e) | Annualized for periods less than one year. |
| (f) | Portfolio turnover rate excludes in-kind transactions, if any. |
| (g) | After the year ended October 31, 2025, the Fund effected the following stock split: December 9, 2025, 4 for 1. All historical per share information has been retroactively adjusted to reflect this stock split. |
| (f) | Amount represents less than $0.005. |
84
The accompanying notes are an integral part of these financial statements.
| Financial Highlights | Defiance ETFs |
For a share outstanding throughout the periods presented.
Defiance Daily Target 2X Long RIOT ETF
| Period ended | ||||
| October 31, | Period ended | |||
| 2025 | April 30, | |||
| (Unaudited) | 2025(a) | |||
| PER SHARE DATA: | ||||
| Net asset value, beginning of period | $6.88 | $20.00 | ||
| INVESTMENT OPERATIONS: | ||||
| Net investment loss(b) | (0.09) | (0.02) | ||
| Net realized and unrealized gain (loss) on investments(c) | 25.47 | (13.10) | ||
| Total from investment operations | 25.38 | (13.12) | ||
| – | – | |||
| Net asset value, end of period | $32.26 | $6.88 | ||
| TOTAL RETURN(d) | 368.88% | -65.65% | ||
| SUPPLEMENTAL DATA AND RATIOS: | ||||
| Net assets, end of period (in thousands) | $42,098 | $14,072 | ||
| Ratio of expenses to average net assets(e) | 1.18% | 0.95% | ||
| Ratio of interest expense to average net assets(e) | 0.23% | 0.00%(f) | ||
| Ratio of operational expenses to average net assets excluding interest expense(e) | 0.95% | 0.95% | ||
| Ratio of net investment income (loss) to average net assets(e) | (0.96)% | (0.60)% | ||
| Portfolio turnover rate(d)(g) | 34,085% | 749% |
| (a) | Inception date of the Fund was January 2, 2025. |
| (b) | Net investment income per share has been calculated based on average shares outstanding during the period. |
| (c) | Realized and unrealized gains and losses per share in the caption are balancing amounts necessary to reconcile the change in net asset value per share for the periods, and may not reconcile with the aggregate gains and losses in the Statement of Operations due to share transactions for the periods. |
| (d) | Not annualized for periods less than one year. |
| (e) | Annualized for periods less than one year. |
| (f) | Amount represents less than 0.005%. |
| (g) | Portfolio turnover rate excludes in-kind transactions, if any. |
85
The accompanying notes are an integral part of these financial statements.
| Financial Highlights | Defiance ETFs |
For a share outstanding throughout the periods presented.
Defiance Daily Target 2X Long RKLB ETF
| Period ended | ||||
| October 31, | Period ended | |||
| 2025(h) | April 30, | |||
| (Unaudited) | 2025(a) | |||
| PER SHARE DATA: | ||||
| Net asset value, beginning of period | $8.16 | $6.67 | ||
| INVESTMENT OPERATIONS: | ||||
| Net investment loss(b) | (0.14) | (0.01) | ||
| Net realized and unrealized gain (loss) on investments(c) | 37.31 | 1.50 | ||
| Total from investment operations | 37.17 | 1.49 | ||
| – | – | |||
| Net asset value, end of period | $45.33 | $8.16 | ||
| TOTAL RETURN(d) | 455.28% | 22.50% | ||
| SUPPLEMENTAL DATA AND RATIOS: | ||||
| Net assets, end of period (in thousands) | $107,430 | $7,348 | ||
| Ratio of expenses to average net assets: | ||||
| Before expense reimbursement/recoupment(e) | 1.29% | –% | ||
| After expense reimbursement/recoupment(e) | 1.29% | 1.29% | ||
| Ratio of interest expense to average net assets(e) | 0.00%(f) | –% | ||
| Ratio of net investment income (loss) to average net assets(e) | (1.01)% | (0.68)% | ||
| Portfolio turnover rate(d)(g) | 69,322% | 416% |
| (a) | Inception date of the Fund was March 12, 2025. |
| (b) | Net investment income per share has been calculated based on average shares outstanding during the period. |
| (c) | Realized and unrealized gains and losses per share in the caption are balancing amounts necessary to reconcile the change in net asset value per share for the periods, and may not reconcile with the aggregate gains and losses in the Statement of Operations due to share transactions for the periods. |
| (d) | Not annualized for periods less than one year. |
| (e) | Annualized for periods less than one year. |
| (f) | Amount represents less than 0.005%. |
| (g) | Portfolio turnover rate excludes in-kind transactions, if any. |
| (h) | After the year ended October 31, 2025, the Fund effected the following stock split: December 1, 2025, 3 for 1. All historical per share information has been retroactively adjusted to reflect this stock split. |
86
The accompanying notes are an integral part of these financial statements.
| Financial Highlights | Defiance ETFs |
For a share outstanding throughout the periods presented.
Defiance Daily Target 2X Long SMCI ETF
| Period ended | ||||
| October 31, | Period ended | |||
| 2025 | April 30, | |||
| (Unaudited) | 2025(a) | |||
| PER SHARE DATA: | ||||
| Net asset value, beginning of period | $24.51 | $400.00 | ||
| INVESTMENT OPERATIONS: | ||||
| Net investment loss(b) | (0.23) | (0.35) | ||
| Net realized and unrealized gain (loss) on investments(c) | 17.87 | (375.14) | ||
| Total from investment operations | 17.64 | (375.49) | ||
| – | – | |||
| Net asset value, end of period | $42.15 | $24.51 | ||
| TOTAL RETURN(d) | 71.96% | -93.87% | ||
| SUPPLEMENTAL DATA AND RATIOS: | ||||
| Net assets, end of period (in thousands) | $239,918 | $233,301 | ||
| Ratio of expenses to average net assets: | ||||
| Before expense reimbursement/recoupment(e) | 1.31% | –% | ||
| After expense reimbursement/recoupment(e) | 1.31% | 1.42% | ||
| Ratio of interest expense to average net assets(e) | 0.02% | 0.13% | ||
| Ratio of operational expenses to average net assets excluding interest expense(e) | 1.29% | 1.29% | ||
| Ratio of net investment income (loss) to average net assets(e) | (1.13)% | (1.09)% | ||
| Portfolio turnover rate(d)(f) | 8,386% | 2,869% |
| (a) | Inception date of the Fund was August 21, 2024. |
| (b) | Net investment income per share has been calculated based on average shares outstanding during the periods. |
| (c) | Realized and unrealized gains and losses per share in the caption are balancing amounts necessary to reconcile the change in net asset value per share for the periods, and may not reconcile with the aggregate gains and losses in the Statement of Operations due to share transactions for the periods. |
| (d) | Not annualized for periods less than one year. |
| (e) | Annualized for periods less than one year. |
| (f) | Portfolio turnover rate excludes in-kind transactions, if any. |
87
The accompanying notes are an integral part of these financial statements.
| Financial Highlights | Defiance ETFs |
For a share outstanding throughout the periods presented.
Defiance Daily Target 2X Long SOFI ETF
| Period ended | ||||
| October 31, | Period ended | |||
| 2025 | April 30, | |||
| (Unaudited) | 2025(a) | |||
| PER SHARE DATA: | ||||
| Net asset value, beginning of period | $10.22 | $20.00 | ||
| INVESTMENT OPERATIONS: | ||||
| Net investment loss(b) | (0.13) | (0.03) | ||
| Net realized and unrealized gain (loss) on investments(c) | 35.81 | (9.75) | ||
| Total from investment operations | 35.68 | (9.78) | ||
| – | – | |||
| Net asset value, end of period | $45.90 | $10.22 | ||
| TOTAL RETURN(d) | 349.14% | -48.85% | ||
| SUPPLEMENTAL DATA AND RATIOS: | ||||
| Net assets, end of period (in thousands) | $102,820 | $19,325 | ||
| Ratio of expenses to average net assets: | ||||
| Before expense reimbursement/recoupment(e) | 1.29% | –% | ||
| After expense reimbursement/recoupment(e) | 1.29% | 1.29% | ||
| Ratio of interest expense to average net assets(e) | 0.00%(f) | –% | ||
| Ratio of net investment income (loss) to average net assets(e) | (0.91)% | (0.89)% | ||
| Portfolio turnover rate(d)(g) | 72,985% | 458% |
| (a) | Inception date of the Fund was January 15, 2025. |
| (b) | Net investment income per share has been calculated based on average shares outstanding during the period. |
| (c) | Realized and unrealized gains and losses per share in the caption are balancing amounts necessary to reconcile the change in net asset value per share for the periods, and may not reconcile with the aggregate gains and losses in the Statement of Operations due to share transactions for the periods. |
| (d) | Not annualized for periods less than one year. |
| (e) | Annualized for periods less than one year. |
| (f) | Amount represents less than 0.005%. |
| (g) | Portfolio turnover rate excludes in-kind transactions, if any. |
88
The accompanying notes are an integral part of these financial statements.
| Financial Highlights | Defiance ETFs |
For a share outstanding throughout the periods presented.
Defiance Daily Target 2X Long SOUN ETF
| Period ended | ||
| October 31, | ||
| 2025(a) | ||
| (Unaudited) | ||
| PER SHARE DATA: | ||
| Net asset value, beginning of period | $20.00 | |
| INVESTMENT OPERATIONS: | ||
| Net investment loss(b) | (0.16) | |
| Net realized and unrealized gain (loss) on investments(c) | 27.74 | |
| Total from investment operations | 27.58 | |
| – | ||
| Net asset value, end of period | $47.58 | |
| TOTAL RETURN(d) | 137.73% | |
| SUPPLEMENTAL DATA AND RATIOS: | ||
| Net assets, end of period (in thousands) | $38,067 | |
| Ratio of expenses to average net assets(e) | 1.30% | |
| Ratio of interest expense to average net assets(e) | 0.01% | |
| Ratio of operational expenses to average net assets excluding interest expense(e) | 1.29% | |
| Ratio of net investment income (loss) to average net assets(e) | (1.06)% | |
| Portfolio turnover rate(d)(f) | 40,021% |
| (a) | Inception date of the Fund was June 23, 2025. |
| (b) | Net investment income per share has been calculated based on average shares outstanding during the period. |
| (c) | Realized and unrealized gains and losses per share in the caption are balancing amounts necessary to reconcile the change in net asset value per share for the periods, and may not reconcile with the aggregate gains and losses in the Statement of Operations due to share transactions for the periods. |
| (d) | Not annualized for periods less than one year. |
| (e) | Annualized for periods less than one year. |
| (f) | Portfolio turnover rate excludes in-kind transactions, if any. |
89
The accompanying notes are an integral part of these financial statements.
| Financial Highlights | Defiance ETFs |
For a share outstanding throughout the periods presented.
Defiance Daily Target 2X Long VST ETF
| Period ended | ||
| October 31, | ||
| 2025(a) | ||
| (Unaudited) | ||
| PER SHARE DATA: | ||
| Net asset value, beginning of period | $20.00 | |
| INVESTMENT OPERATIONS: | ||
| Net investment loss(b) | (0.01) | |
| Net realized and unrealized gain (loss) on investments(c) | (1.93) | |
| Total from investment operations | (1.94) | |
| – | ||
| Net asset value, end of period | $18.06 | |
| TOTAL RETURN(d) | -9.71% | |
| SUPPLEMENTAL DATA AND RATIOS: | ||
| Net assets, end of period (in thousands) | $6,682 | |
| Ratio of expenses to average net assets(e) | 1.29% | |
| Ratio of net investment income (loss) to average net assets(e) | (0.13)% | |
| Portfolio turnover rate(d)(f) | 1,452% |
| (a) | Inception date of the Fund was July 21, 2025. |
| (b) | Net investment income per share has been calculated based on average shares outstanding during the period. |
| (c) | Realized and unrealized gains and losses per share in the caption are balancing amounts necessary to reconcile the change in net asset value per share for the periods, and may not reconcile with the aggregate gains and losses in the Statement of Operations due to share transactions for the periods. |
| (d) | Not annualized for periods less than one year. |
| (e) | Annualized for periods less than one year. |
| (f) | Portfolio turnover rate excludes in-kind transactions, if any. |
90
The accompanying notes are an integral part of these financial statements.
| Financial Highlights | Defiance ETFs |
For a share outstanding throughout the periods presented.
Defiance Daily Target 2X Short IONQ ETF
| Period ended | ||
| October 31, | ||
| 2025(a)(h) | ||
| (Unaudited) | ||
| PER SHARE DATA: | ||
| Net asset value, beginning of period | $120.00 | |
| INVESTMENT OPERATIONS: | ||
| Net investment loss(b) | (0.08) | |
| Net realized and unrealized gain (loss) on investments(c) | (100.04) | |
| Total from investment operations | (100.12) | |
| – | ||
| Net asset value, end of period | $19.88 | |
| TOTAL RETURN(d) | -83.43% | |
| SUPPLEMENTAL DATA AND RATIOS: | ||
| Net assets, end of period (in thousands) | $44,202 | |
| Ratio of expenses to average net assets(e) | 1.29% | |
| Ratio of interest expense to average net assets(e) | 0.00%(f) | |
| Ratio of net investment income (loss) to average net assets(e) | (0.95)% | |
| Portfolio turnover rate(d)(g) | –% |
| (a) | Inception date of the Fund was June 23, 2025. |
| (b) | Net investment income per share has been calculated based on average shares outstanding during the period. |
| (c) | Realized and unrealized gains and losses per share in the caption are balancing amounts necessary to reconcile the change in net asset value per share for the periods, and may not reconcile with the aggregate gains and losses in the Statement of Operations due to share transactions for the periods. |
| (d) | Not annualized for periods less than one year. |
| (e) | Annualized for periods less than one year. |
| (f) | Amount represents less than 0.005%. |
| (g) | Portfolio turnover rate excludes in-kind transactions, if any. |
| (h) | After the period ended October 31, 2025, the Fund effected the following reverse stock split: December 9, 2025, 1 for 6. All historical per share information has been retroactively adjusted to reflect this stock split. |
91
The accompanying notes are an integral part of these financial statements.
| Financial Highlights | Defiance ETFs |
For a share outstanding throughout the periods presented.
Defiance Daily Target 2X Short LLY ETF
| Period ended | ||
| October 31, | ||
| 2025(a) | ||
| (Unaudited) | ||
| PER SHARE DATA: | ||
| Net asset value, beginning of period | $20.00 | |
| INVESTMENT OPERATIONS: | ||
| Net investment loss(b) | (0.01) | |
| Net realized and unrealized gain (loss) on investments(c) | (6.18) | |
| Total from investment operations | (6.19) | |
| – | ||
| Net asset value, end of period | $13.81 | |
| TOTAL RETURN(d) | -30.93% | |
| SUPPLEMENTAL DATA AND RATIOS: | ||
| Net assets, end of period (in thousands) | $1,381 | |
| Ratio of expenses to average net assets(e) | 1.31% | |
| Ratio of interest expense to average net assets(e) | 0.02% | |
| Ratio of operational expenses to average net assets excluding interest expense(e) | 1.29% | |
| Ratio of net investment income (loss) to average net assets(e) | (0.30)% | |
| Portfolio turnover rate(d)(f) | –% |
| (a) | Inception date of the Fund was September 2, 2025. |
| (b) | Net investment income per share has been calculated based on average shares outstanding during the period. |
| (c) | Realized and unrealized gains and losses per share in the caption are balancing amounts necessary to reconcile the change in net asset value per share for the periods, and may not reconcile with the aggregate gains and losses in the Statement of Operations due to share transactions for the periods. |
| (d) | Not annualized for periods less than one year. |
| (e) | Annualized for periods less than one year. |
| (f) | Portfolio turnover rate excludes in-kind transactions, if any. |
92
The accompanying notes are an integral part of these financial statements.
| Financial Highlights | Defiance ETFs |
For a share outstanding throughout the periods presented.
Defiance Daily Target 2X Short MSTR ETF
| Period ended | ||||
| October 31, | Period ended | |||
| 2025(h) | April 30, | |||
| (Unaudited) | 2025(a) | |||
| PER SHARE DATA: | ||||
| Net asset value, beginning of period | $30.16 | $2,000.00 | ||
| INVESTMENT OPERATIONS: | ||||
| Net investment loss(b) | (0.10) | (0.24) | ||
| Net realized and unrealized gain (loss) on investments(c) | 6.80 | (1,969.60) | ||
| Total from investment operations | 6.71 | (1,969.84) | ||
| – | – | |||
| Net asset value, end of period | $36.87 | $30.16 | ||
| TOTAL RETURN(d) | 22.08% | -98.48% | ||
| SUPPLEMENTAL DATA AND RATIOS: | ||||
| Net assets, end of period (in thousands) | $21,493 | $41,744 | ||
| Ratio of expenses to average net assets(e) | 1.29% | 1.29% | ||
| Ratio of interest expense to average net assets(e) | 0.00%(f) | 0.00%(f) | ||
| Ratio of net investment income (loss) to average net assets(e) | (0.75)% | (0.38)% | ||
| Portfolio turnover rate(d)(g) | –% | –% |
| (a) | Inception date of the Fund was August 20, 2024. |
| (b) | Net investment income per share has been calculated based on average shares outstanding during the periods. |
| (c) | Realized and unrealized gains and losses per share in the caption are balancing amounts necessary to reconcile the change in net asset value per share for the periods, and may not reconcile with the aggregate gains and losses in the Statement of Operations due to share transactions for the periods. |
| (d) | Not annualized for periods less than one year. |
| (e) | Annualized for periods less than one year. |
| (f) | Amount represents less than 0.005%. |
| (g) | Portfolio turnover rate excludes in-kind transactions, if any. |
| (h) | During the period ended October 31, 2025, the Fund effected the following reverse stock split: May 23, 2025, 1 for 20. All historical per share information has been retroactively adjusted to reflect this reverse stock split. See Note 8 in the Notes to Financial Statements. |
93
The accompanying notes are an integral part of these financial statements.
| Financial Highlights | Defiance ETFs |
For a share outstanding throughout the periods presented.
Defiance Daily Target 2X Short PLTR ETF
| Period ended | ||
| October 31, | ||
| 2025(a)(g) | ||
| (Unaudited) | ||
| PER SHARE DATA: | ||
| Net asset value, beginning of period | $80.00 | |
| INVESTMENT OPERATIONS: | ||
| Net investment loss(b) | (0.07) | |
| Net realized and unrealized gain (loss) on investments(c) | (57.48) | |
| Total from investment operations | (57.55) | |
| – | ||
| Net asset value, end of period | $22.45 | |
| TOTAL RETURN(d) | -71.93% | |
| SUPPLEMENTAL DATA AND RATIOS: | ||
| Net assets, end of period (in thousands) | $68,623 | |
| Ratio of expenses to average net assets(e) | 1.28% | |
| Ratio of interest expense to average net assets(e) | 0.01% | |
| Ratio of operational expenses to average net assets excluding interest expense(e) | 1.27% | |
| Ratio of net investment income (loss) to average net assets(e) | (0.58)% | |
| Portfolio turnover rate(d)(f) | –% |
| (a) | Inception date of the Fund was June 5, 2025. |
| (b) | Net investment income per share has been calculated based on average shares outstanding during the period. |
| (c) | Realized and unrealized gains and losses per share in the caption are balancing amounts necessary to reconcile the change in net asset value per share for the periods, and may not reconcile with the aggregate gains and losses in the Statement of Operations due to share transactions for the periods. |
| (d) | Not annualized for periods less than one year. |
| (e) | Annualized for periods less than one year. |
| (f) | Portfolio turnover rate excludes in-kind transactions, if any. |
| (g) | After the year ended October 31, 2025, the Fund effected the following reverse stock split: December 1, 2025, 1 for 8. All historical per share information has been retroactively adjusted to reflect this reverse stock split. |
94
The accompanying notes are an integral part of these financial statements.
| Financial Highlights | Defiance ETFs |
For a share outstanding throughout the periods presented.
Defiance Daily Target 2X Short QBTS ETF
| Period ended | ||
| October 31, | ||
| 2025(a) | ||
| (Unaudited) | ||
| PER SHARE DATA: | ||
| Net asset value, beginning of period | $20.00 | |
| INVESTMENT OPERATIONS: | ||
| Net investment loss(b) | (0.01) | |
| Net realized and unrealized gain (loss) on investments(c) | (9.49) | |
| Total from investment operations | (9.50) | |
| – | ||
| Net asset value, end of period | $10.50 | |
| TOTAL RETURN(d) | -47.48% | |
| SUPPLEMENTAL DATA AND RATIOS: | ||
| Net assets, end of period (in thousands) | $37,397 | |
| Ratio of expenses to average net assets(e) | 1.32% | |
| Ratio of interest expense to average net assets(e) | 0.03% | |
| Ratio of operational expenses to average net assets excluding interest expense(e) | 1.29% | |
| Ratio of net investment income (loss) to average net assets(e) | (1.11)% | |
| Portfolio turnover rate(d)(f) | –% |
| (a) | Inception date of the Fund was October 6, 2025. |
| (b) | Net investment income per share has been calculated based on average shares outstanding during the period. |
| (c) | Realized and unrealized gains and losses per share in the caption are balancing amounts necessary to reconcile the change in net asset value per share for the periods, and may not reconcile with the aggregate gains and losses in the Statement of Operations due to share transactions for the periods. |
| (d) | Not annualized for periods less than one year. |
| (e) | Annualized for periods less than one year. |
| (f) | Portfolio turnover rate excludes in-kind transactions, if any. |
95
The accompanying notes are an integral part of these financial statements.
| Financial Highlights | Defiance ETFs |
For a share outstanding throughout the periods presented.
Defiance Daily Target 2X Short RGTI ETF
| Period ended | ||
| October 31, | ||
| 2025(a) | ||
| (Unaudited) | ||
| PER SHARE DATA: | ||
| Net asset value, beginning of period | $20.00 | |
| INVESTMENT OPERATIONS: | ||
| Net investment loss(b) | (0.01) | |
| Net realized and unrealized gain (loss) on investments(c) | (8.87) | |
| Total from investment operations | (8.88) | |
| – | ||
| Net asset value, end of period | $11.12 | |
| TOTAL RETURN(d) | -44.38% | |
| SUPPLEMENTAL DATA AND RATIOS: | ||
| Net assets, end of period (in thousands) | $77,864 | |
| Ratio of expenses to average net assets(e) | 1.29% | |
| Ratio of interest expense to average net assets(e) | 0.00%(f) | |
| Ratio of net investment income (loss) to average net assets(e) | (1.06)% | |
| Portfolio turnover rate(d)(g) | –% |
| (a) | Inception date of the Fund was October 8, 2025. |
| (b) | Net investment income per share has been calculated based on average shares outstanding during the period. |
| (c) | Realized and unrealized gains and losses per share in the caption are balancing amounts necessary to reconcile the change in net asset value per share for the periods, and may not reconcile with the aggregate gains and losses in the Statement of Operations due to share transactions for the periods. |
| (d) | Not annualized for periods less than one year. |
| (e) | Annualized for periods less than one year. |
| (f) | Amount represents less than 0.005%. |
| (g) | Portfolio turnover rate excludes in-kind transactions, if any. |
96
The accompanying notes are an integral part of these financial statements.
| Financial Highlights | Defiance ETFs |
For a share outstanding throughout the periods presented.
Defiance Daily Target 2X Short SMCI ETF
| Period ended | ||||
| October 31, | Period ended | |||
| 2025(h) | April 30, | |||
| (Unaudited) | 2025(a) | |||
| PER SHARE DATA: | ||||
| Net asset value, beginning of period | $136.48 | $160.00 | ||
| INVESTMENT OPERATIONS: | ||||
| Net investment loss(b) | (0.17) | (0.08) | ||
| Net realized and unrealized gain (loss) on investments(c) | (112.91) | (23.44) | ||
| Total from investment operations | (113.08) | (23.52) | ||
| – | – | |||
| Net asset value, end of period | $23.40 | $136.48 | ||
| TOTAL RETURN(d) | -82.85% | -14.70% | ||
| SUPPLEMENTAL DATA AND RATIOS: | ||||
| Net assets, end of period (in thousands) | $5,938 | $3,839 | ||
| Ratio of expenses to average net assets: | ||||
| Before expense reimbursement/recoupment(e) | 1.29% | –% | ||
| After expense reimbursement/recoupment(e) | 1.29% | 1.29% | ||
| Ratio of interest expense to average net assets(e) | 0.00%(f) | –% | ||
| Ratio of net investment income (loss) to average net assets(e) | (0.92)% | (0.80)% | ||
| Portfolio turnover rate(d)(g) | –% | –% |
| (a) | Inception date of the Fund was March 31, 2025. |
| (b) | Net investment income per share has been calculated based on average shares outstanding during the period. |
| (c) | Realized and unrealized gains and losses per share in the caption are balancing amounts necessary to reconcile the change in net asset value per share for the periods, and may not reconcile with the aggregate gains and losses in the Statement of Operations due to share transactions for the periods. |
| (d) | Not annualized for periods less than one year. |
| (e) | Annualized for periods less than one year. |
| (f) | Amount represents less than 0.005%. |
| (g) | Portfolio turnover rate excludes in-kind transactions, if any. |
| (h) | After the year ended October 31, 2025, the Fund effected the following reverse stock split: December 1, 2025, 1 for 8. All historical per share information has been retroactively adjusted to reflect this reverse stock split. |
97
The accompanying notes are an integral part of these financial statements.
| Notes to the Financial Statements | Defiance ETFs |
NOTE 1 – ORGANIZATION
The Defiance ETFs (defined below) (each a “Fund”, and collectively the “Funds”) are each a non-diversified series of Tidal Trust II (the “Trust”). The Trust was organized as a Delaware statutory trust on January 13, 2022. The Trust is registered with the Securities and Exchange Commission (the “SEC”) under the Investment Company Act of 1940, as amended (the “1940 Act”), as an open-end management investment company and the offering of the Funds’ shares (“Shares”) is registered under the Securities Act of 1933, as amended. The Trust is governed by the Board of Trustees (the “Board”). Tidal Investments LLC (“Tidal Investments” or the “Adviser”), a Tidal Financial Group company, serves as investment adviser to the Funds. Each Fund is an investment company and accordingly follows the investment company accounting and reporting guidance of the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification Topic 946 “Financial Services – Investment Companies”.
| Fund: | Commencement Date: |
| Defiance 2X Daily Long Pure Quantum ETF (the “QPUX ETF”) | August 6, 2025 |
| Defiance Daily Target 2X Long ANET ETF (the “ANEL ETF”) | September 3, 2025 |
| Defiance Daily Target 2X Long AVAV ETF (the “AVXX ETF”) | October 23, 2025 |
| Defiance Daily Target 2X Long AVGO ETF (the “AVGX ETF”) | August 21, 2024 |
| Defiance Daily Target 2X Long CVNA ETF (the “CVNX ETF”) | May 28, 2025 |
| Defiance Daily Target 2X Long DKNG ETF (the “DKNX ETF”) | July 30, 2025 |
| Defiance Daily Target 2X Long HIMS ETF (the “HIMZ ETF”) | March 12, 2025 |
| Defiance Daily Target 2X Long HOOD ETF (the “HOOX ETF”) | March 18, 2025 |
| Defiance Daily Target 2X Long IONQ ETF (the “IONX ETF”) | March 11, 2025 |
| Defiance Daily Target 2X Long IREN ETF (the “IRE ETF”) | October 20, 2025 |
| Defiance Daily Target 2X Long JPM ETF (the “JPX ETF”) | July 23, 2025 |
| Defiance Daily Target 2X Long LLY ETF (the “LLYX ETF”) | August 7, 2024 |
| Defiance Daily Target 2X Long LMND ETF (the “LMNX ETF”) | October 15, 2025 |
| Defiance Daily Target 2X Long MP ETF (the “MPL ETF”) | October 20, 2025 |
| Defiance Daily Target 2X Long MSTR ETF (the “MSTX ETF”) | August 14, 2024 |
| Defiance Daily Target 2X Long NVO ETF (the “NVOX ETF”) | December 2, 2024 |
| Defiance Daily Target 2X Long OKLO ETF (the “OKLL ETF”) | June 23, 2025 |
| Defiance Daily Target 2X Long ORCL ETF (the “ORCX ETF”) | February 6, 2025 |
| Defiance Daily Target 2X Long OSCR ETF (the “OSCX ETF”) | September 24, 2025 |
| Defiance Daily Target 2X Long PM ETF (the “XPM ETF”) | September 3, 2025 |
| Defiance Daily Target 2X Long QS ETF (the “QSU ETF”) | October 20, 2025 |
| Defiance Daily Target 2X Long RGTI ETF (the “RGTX ETF”) | March 31, 2025 |
| Defiance Daily Target 2X Long RIOT ETF (the “RIOX ETF”) | January 2, 2025 |
| Defiance Daily Target 2X Long RKLB ETF (the “RKLX ETF”) | March 12, 2025 |
| Defiance Daily Target 2X Long SMCI ETF (the “SMCX ETF”) | August 21, 2024 |
| Defiance Daily Target 2X Long SOFI ETF (the “SOFX ETF”) | January 15, 2025 |
| Defiance Daily Target 2X Long SOUN ETF (the “SOUX ETF”) | June 23, 2025 |
| Defiance Daily Target 2X Long VST ETF (the “VSTL ETF”) | July 21, 2025 |
| Defiance Daily Target 2X Short IONQ ETF (the “IONZ ETF”) | June 23, 2025 |
| Defiance Daily Target 2X Short LLY ETF (the “LLYZ ETF”) | September 2, 2025 |
| Defiance Daily Target 2X Short MSTR ETF (the “SMST ETF”) | August 20, 2024 |
| Defiance Daily Target 2X Short PLTR ETF (the “PLTZ ETF”) | June 5, 2025 |
| Defiance Daily Target 2X Short QBTS ETF (the “QBTZ ETF”) | October 6, 2025 |
| Defiance Daily Target 2X Short RGTI ETF (the “RGTZ ETF”) | October 8, 2025 |
| Defiance Daily Target 2X Short SMCI ETF (the “SMCZ ETF”) | March 31, 2025 |
The QPUX ETF’s primary investment objective is to seek daily leveraged investment results, before fees and expenses, of two times (200%) the the performance of an actively-managed group of “pure quantum” company securities. The Fund does not seek to achieve its stated investment objective for a period other than a single trading day.
The ANEL ETF’s primary investment objective is to seek daily leveraged investment results, before fees and expenses, of two times (200%) the daily percentage change in the share price of Arista Networks, Inc. The Fund does not seek to achieve its stated investment objective for a period other than a single trading day.
The AVXX ETF’s primary investment objective is to seek daily leveraged investment results, before fees and expenses, of two times (200%) the daily percentage change in the share price of AeroVironment Inc. The Fund does not seek to achieve its stated investment objective for a period other than a single trading day.
98
| Notes to the Financial Statements | Defiance ETFs |
The AVGX ETF’s primary investment objective is to seek daily leveraged investment results, before fees and expenses, of two times (200%) the daily percentage change in the share price of Broadcom, Inc. The Fund does not seek to achieve its stated investment objective for a period other than a single trading day.
The CVNX ETF’s primary investment objective is to seek daily leveraged investment results, before fees and expenses, of two times (200%) the daily percentage change in the share price of Carvana Co. The Fund does not seek to achieve its stated investment objective for a period other than a single trading day.
The DKNX ETF’s primary investment objective is to seek daily leveraged investment results, before fees and expenses, of two times (200%) the daily percentage change in the share price of DraftKings, Inc. The Fund does not seek to achieve its stated investment objective for a period other than a single trading day.
The HIMZ ETF’s primary investment objective is to seek daily leveraged investment results, before fees and expenses, of two times (200%) the daily percentage change in the share price of Hims & Hers Health, Inc. The Fund does not seek to achieve its stated investment objective for a period other than a single trading day.
The HOOX ETF’s primary investment objective is to seek daily leveraged investment results, before fees and expenses, of two times (200%) the daily percentage change in the share price of Robinhood Markets, Inc. The Fund does not seek to achieve its stated investment objective for a period other than a single trading day.
The IONX ETF’s primary investment objective is to seek daily leveraged investment results, before fees and expenses, of two times (200%) the daily percentage change in the share price of IonQ, Inc. The Fund does not seek to achieve its stated investment objective for a period other than a single trading day.
The IRE ETF’s primary investment objective is to seek daily leveraged investment results, before fees and expenses, of two times (200%) the daily percentage change in the share price of IREN Ltd. The Fund does not seek to achieve its stated investment objective for a period other than a single trading day.
The JPX ETF’s primary investment objective is to seek daily leveraged investment results, before fees and expenses, of two times (200%) the daily percentage change in the share price of JPMorgan Chase & Co. The Fund does not seek to achieve its stated investment objective for a period other than a single trading day.
The LLYX ETF’s primary investment objective is to seek daily leveraged investment results, before fees and expenses, of two times (200%) the daily percentage change in the share price of Eli Lilly & Co. The Fund does not seek to achieve its stated investment objective for a period other than a single trading day.
The LMNX ETF’s primary investment objective is to seek daily leveraged investment results, before fees and expenses, of two times (200%) the daily percentage change in the share price of Lemonade, Inc. The Fund does not seek to achieve its stated investment objective for a period other than a single trading day.
The MPL ETF’s primary investment objective is to seek daily leveraged investment results, before fees and expenses, of two times (200%) the daily percentage change in the share price of MP Materials Corp. The Fund does not seek to achieve its stated investment objective for a period other than a single trading day.
The MSTX ETF’s primary investment objective is to seek daily leveraged investment results, before fees and expenses, of two times (200%) the daily percentage change in the share price of Strategy, Inc. The Fund does not seek to achieve its stated investment objective for a period other than a single trading day.
The NVOX ETF’s primary investment objective is to seek daily leveraged investment results, before fees and expenses, of two times (200%) the daily percentage change in the share price of NOVO Nordisk AS - ADR. The Fund does not seek to achieve its stated investment objective for a period other than a single trading day.
The OKLL ETF’s primary investment objective is to seek daily leveraged investment results, before fees and expenses, of two times (200%) the daily percentage change in the share price of Oklo, Inc. The Fund does not seek to achieve its stated investment objective for a period other than a single trading day.
The ORCX ETF’s primary investment objective is to seek daily leveraged investment results, before fees and expenses, of two times (200%) the daily percentage change in the share price of Oracle Corp. The Fund does not seek to achieve its stated investment objective for a period other than a single trading day.
99
| Notes to the Financial Statements | Defiance ETFs |
The OSCX ETF’s primary investment objective is to seek daily leveraged investment results, before fees and expenses, of two times (200%) the daily percentage change in the share price of Oscar Health, Inc. The Fund does not seek to achieve its stated investment objective for a period other than a single trading day.
The XPM ETF’s primary investment objective is to seek daily leveraged investment results, before fees and expenses, of two times (200%) the daily percentage change in the share price of Phillip Morris International, Inc. The Fund does not seek to achieve its stated investment objective for a period other than a single trading day.
The QSU ETF’s primary investment objective is to seek daily leveraged investment results, before fees and expenses, of two times (200%) the daily percentage change in the share price of QuantumScape Corp. The Fund does not seek to achieve its stated investment objective for a period other than a single trading day.
The RGTX ETF’s primary investment objective is to seek daily leveraged investment results, before fees and expenses, of two times (200%) the daily percentage change in the share price of Rigetti Computing, Inc. The Fund does not seek to achieve its stated investment objective for a period other than a single trading day.
The RIOX ETF’s primary investment objective is to seek daily leveraged investment results, before fees and expenses, of two times (200%) the daily percentage change in the share price of Riot Platforms, Inc. The Fund does not seek to achieve its stated investment objective for a period other than a single trading day.
The RKLX ETF’s primary investment objective is to seek daily leveraged investment results, before fees and expenses, of two times (200%) the daily percentage change in the share price of Rocket Lab USA, Inc. The Fund does not seek to achieve its stated investment objective for a period other than a single trading day.
The SMCX ETF’s primary investment objective is to seek daily leveraged investment results, before fees and expenses, of two times (200%) the daily percentage change in the share price of Super Micro Computer, Inc. The Fund does not seek to achieve its stated investment objective for a period other than a single trading day.
The SOFX ETF’s primary investment objective is to seek daily leveraged investment results, before fees and expenses, of two times (200%) the daily percentage change in the share price of SoFi Technologies, Inc. The Fund does not seek to achieve its stated investment objective for a period other than a single trading day.
The SOUX ETF’s primary investment objective is to seek daily leveraged investment results, before fees and expenses, of two times (200%) the daily percentage change in the share price of SoundHound AI, Inc. The Fund does not seek to achieve its stated investment objective for a period other than a single trading day.
The VSTL ETF’s primary investment objective is to seek daily leveraged investment results, before fees and expenses, of two times (200%) the daily percentage change in the share price of Vistra Corp. The Fund does not seek to achieve its stated investment objective for a period other than a single trading day.
The IONZ ETF’s primary investment objective is to seek daily leveraged inverse investment results, before fees and expenses, of negative two times (-200%) the daily percentage change in the share price of IonQ, Inc. The Fund does not seek to achieve its stated investment objective for a period other than a single trading day.
The LLYZ ETF’s primary investment objective is to seek daily leveraged inverse investment results, before fees and expenses, of negative two times (-200%) the daily percentage change in the share price of Eli Lilly & Co. The Fund does not seek to achieve its stated investment objective for a period other than a single trading day.
The SMST ETF’s primary investment objective is to seek daily leveraged inverse investment results, before fees and expenses, of negative two times (-200%) the daily percentage change in the share price of Strategy, Inc. The Fund does not seek to achieve its stated investment objective for a period other than a single trading day.
The PLTZ ETF’s primary investment objective is to seek daily leveraged inverse investment results, before fees and expenses, of negative two times (-200%) the daily percentage change in the share price of Palantir Technologies, Inc. The Fund does not seek to achieve its stated investment objective for a period other than a single trading day.
The QBTZ ETF’s primary investment objective is to seek daily leveraged inverse investment results, before fees and expenses, of negative two times (-200%) the daily percentage change in the share price of D-Wave Quantum, Inc. The Fund does not seek to achieve its stated investment objective for a period other than a single trading day.
100
| Notes to the Financial Statements | Defiance ETFs |
The RGTZ ETF’s primary investment objective is to seek daily leveraged inverse investment results, before fees and expenses, of negative two times (-200%) the daily percentage change in the share price of Rigetti Computing, Inc. The Fund does not seek to achieve its stated investment objective for a period other than a single trading day.
The SMCZ ETF’s primary investment objective is to seek daily leveraged inverse investment results, before fees and expenses, of negative two times (-200%) the daily percentage change in the share price of Super Micro Computer, Inc. The Fund does not seek to achieve its stated investment objective for a period other than a single trading day.
Arista Networks, Inc. (“ANET”), AeroVironment, Inc. (“AVAV”), Broadcom, Inc. (“AVGO”), Carvana Co. (“CVNA”), DraftKings, Inc. (“DKNG”), Hims & Hers Health, Inc. (“HIMS”), Robinhood Markets, Inc. (“HOOD”), IonQ, Inc. (“IONQ”), IREN Ltd. (“IREN”), Eli Lilly & Co. (“LLY”), Lemonade, Inc. (“LMND”), MP Materials Corp. (“MP”), Strategy, Inc. (“MSTR”), Super Micro Computer, Inc. (“SMCI”), NOVO Nordisk AS – ADR (“NVO”), Oklo, Inc. (“OKLO”), Oracle Corp. (“ORCL”), Oscar Health, Inc. (“OSCR”), Phillip Morris International, Inc. (“PM”), Rigetti Computing, Inc. (“RGTI”), Riot Platforms, Inc. (“RIOT”), Rocket Lab USA, Inc. (“RKLB”), SoFi Technologies, Inc. (“SOFI”), SoundHound AI, Inc. (“SOUN”), Vistra Corp. (“VST”), Palantir Technologies, Inc. (“PLTR”), and D-Wave Quantum, Inc. (“QBTS”) (each an “Underlying Security” and collectively the “Underlying Securities”).
NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES
The following is a summary of significant accounting policies consistently followed by the Funds. These policies are in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”).
A. Security Valuation. Equity securities listed on a securities exchange, market or automated quotation system for which quotations are readily available (except for securities traded on The Nasdaq Stock Market, LLC ( “The NASDAQ”)), including securities traded over-the-counter, are valued at the last quoted sale price on the primary exchange or market (foreign or domestic) on which they are traded on the valuation date (or at approximately 4:00 p.m. EST if a security’s primary exchange is normally open at that time), or, if there is no such reported sale on the valuation date, at the most recent quoted bid price or mean between the most recent quoted bid and ask prices for long and short positions. For a security that trades on multiple exchanges, the primary exchange will generally be considered the exchange on which the security is generally most actively traded. For securities traded on The NASDAQ, The NASDAQ Official Closing Price will be used. Prices of securities traded on the securities exchange will be obtained from recognized independent pricing agents each day that the Funds are open for business.
Debt securities are valued by using an evaluated mean of the bid and ask prices provided by independent pricing agents. The independent pricing agents may employ methodologies that utilize actual market transactions (if the security is actively traded), broker-dealer supplied valuations, or other methodologies designed to identify the market value for such securities. In arriving at valuations, such methodologies generally consider factors such as security prices, yields, maturities, call features, ratings and developments relating to specific securities.
Swap contract terms are agreed among the counterparty and the Adviser. Total return swap contracts are valued using the closing price of the underlying benchmark that the contract is tracking.
Options contracts are valued using the mean/mid of quoted bid and ask spread prices, as provided by independent pricing vendors. FLexible EXchange® Options (“FLEX Options”) listed on an exchange will typically be valued at a model-based price provided by the exchange at the official close of that exchange’s trading day. However, when the Funds’ options have a same-day market trade price, this same-day market trade price will be used for FLEX Option values instead of the exchange’s model-based price. If the exchange on which the option is traded is unable to provide a model price, model-based FLEX Options prices will additionally be provided by a backup third-party pricing provider. In selecting the model prices, the Adviser may provide a review of the calculation of model prices provided by each vendor, and may note to such vendors of any data errors observed, or where an underlying component value of the model pricing package may be missing or incorrect, prior to publication by the vendor of the model pricing to the Fund Accounting Agent for purposes of that day’s net asset value (“NAV”). If either pricing vendor is not available to provide a model price for that day, the value of a FLEX Option will be determined by the Valuation Designee in accordance with the Valuation Procedures (as defined below). In instances where in the same trading day a particular FLEX Option is both represented in an all-cash basket (either a creation unit or redemption unit), as well as in an in-kind basket (either a creation unit or redemption unit), for valuation purposes that trading day the Funds will default to use the trade price for both instances, rather than using the model price otherwise available for the in-kind transaction.
Under Rule 2a-5 of the 1940 Act, a fair value will be determined by the Valuation Designee (as defined in Rule 2a-5) in accordance with the Pricing and Valuation Policy and Fair Value Procedures, as applicable, of the Adviser, subject to oversight by the Board. When a security is “fair valued,” consideration is given to the facts and circumstances relevant to the particular situation, including a review of various factors set forth in the Adviser’s Pricing and Valuation Policy and Fair Value Procedures, as applicable. Fair value pricing is
101
| Notes to the Financial Statements | Defiance ETFs |
an inherently subjective process, and no single standard exists for determining fair value. Different funds could reasonably arrive at different values for the same security.
As described above, the Funds utilize various methods to measure the fair value of its investments on a recurring basis. U.S. GAAP establishes a hierarchy that prioritizes inputs to valuation methods. The three levels of inputs are:
Level 1 – Unadjusted quoted prices in active markets for identical assets or liabilities that the Funds have the ability to access.
Level 2 – Observable inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. These inputs may include quoted prices for the identical instrument on an inactive market, prices for similar instruments, interest rates, prepayment speeds, credit risk, yield curves, default rates and similar data.
Level 3 – Unobservable inputs for the asset or liability, to the extent relevant observable inputs are not available; representing the Funds’ own assumptions about the assumptions a market participant would use in valuing the asset or liability and would be based on the best information available.
The availability of observable inputs can vary from security to security and is affected by a wide variety of factors, including, for example, the type of security, whether the security is new and not yet established in the marketplace, the liquidity of markets, and other characteristics particular to the security. To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised in determining fair value is greatest for instruments categorized in Level 3.
The inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the level in the fair value hierarchy within which the fair value measurement falls in its entirety, is determined based on the lowest level input that is significant to the fair value measurement in its entirety.
The following is a summary of the inputs used to value each Fund’s investments as of October 31, 2025:
QPUX ETF
| Level 1 | Level 2 | Level 3 | Total | |||||||||||||
| Investments: | ||||||||||||||||
| U.S. Treasury Bills | $ | – | $ | 2,071,208 | $ | – | $ | 2,071,208 | ||||||||
| Money Market Funds | 823,899 | – | – | 823,899 | ||||||||||||
| Total Investments | $ | 823,899 | $ | 2,071,208 | $ | – | $ | 2,895,107 | ||||||||
| Other Financial Instruments: | ||||||||||||||||
| Total Return Swaps* | $ | – | $ | 3,176,065 | $ | – | $ | 3,176,065 | ||||||||
| Total Other Financial Instruments | $ | – | $ | 3,176,065 | $ | – | $ | 3,176,065 | ||||||||
ANEL ETF
|
Level 1 |
Level 2 | Level 3 | Total | |||||||||||||
| Investments: | ||||||||||||||||
| U.S. Treasury Bills | $ | – | $ | 1,028,117 | $ | – | $ | 1,028,117 | ||||||||
| Money Market Funds | 190,760 | – | – | 190,760 | ||||||||||||
| Total Investments | $ | 190,760 | $ | 1,028,117 | $ | – | $ | 1,218,877 | ||||||||
102
| Notes to the Financial Statements | Defiance ETFs |
| Other Financial Instruments: | ||||||||||||||||
| Total Return Swaps* | $ | – | $ | 1,146,225 | $ | – | $ | 1,146,225 | ||||||||
| Total Other Financial Instruments | $ | – | $ | 1,146,225 | $ | – | $ | 1,146,225 | ||||||||
AVXX ETF
| Level 1 | Level 2 | Level 3 | Total | |||||||||||||
| Investments: | ||||||||||||||||
| U.S. Treasury Bills | $ | – | $ | 49,909 | $ | – | $ | 49,909 | ||||||||
| Money Market Funds | 17,245 | – | – | 17,245 | ||||||||||||
| Total Investments | $ | 17,245 | $ | 49,909 | $ | – | $ | 67,154 | ||||||||
| Other Financial Instruments: | ||||||||||||||||
| Total Return Swaps* | $ | – | $ | 408 | $ | – | $ | 408 | ||||||||
| Total Other Financial Instruments | $ | – | $ | 408 | $ | – | $ | 408 | ||||||||
AVGX ETF
| Level 1 | Level 2 | Level 3 | Total | |||||||||||||
| Investments: | ||||||||||||||||
| U.S. Treasury Bills | $ | – | $ | 16,719,389 | $ | – | $ | 16,719,389 | ||||||||
| Money Market Funds | 5,752,533 | – | – | 5,752,533 | ||||||||||||
| Total Investments | $ | 5,752,533 | $ | 16,719,389 | $ | – | $ | 22,471,922 | ||||||||
| Other Financial Instruments: | ||||||||||||||||
| Total Return Swaps* | $ | – | $ | 43,076,161 | $ | – | $ | 43,076,161 | ||||||||
| Total Other Financial Instruments | $ | – | $ | 43,076,161 | $ | – | $ | 43,076,161 | ||||||||
103
| Notes to the Financial Statements | Defiance ETFs |
CVNX ETF
| Level 1 | Level 2 | Level 3 | Total | |||||||||||||
| Investments: | ||||||||||||||||
| U.S. Treasury Bills | $ | – | $ | 677,759 | $ | – | $ | 677,759 | ||||||||
| Money Market Funds | 53,317 | – | – | 53,317 | ||||||||||||
| Total Investments | $ | 53,317 | $ | 677,759 | $ | – | $ | 731,076 | ||||||||
| Other Financial Instruments: | ||||||||||||||||
| Total Return Swaps* | $ | – | $ | 27,422 | $ | – | $ | 27,422 | ||||||||
| Total Other Financial Instruments | $ | – | $ | 27,422 | $ | – | $ | 27,422 | ||||||||
DKNX ETF
| Level 1 | Level 2 | Level 3 | Total | |||||||||||||
| Investments: | ||||||||||||||||
| U.S. Treasury Bills | $ | – | $ | 773,584 | $ | – | $ | 773,584 | ||||||||
| Money Market Funds | 149,894 | – | – | 149,894 | ||||||||||||
| Total Investments | $ | 149,894 | $ | 773,584 | $ | – | $ | 923,478 | ||||||||
| Other Financial Instruments: | ||||||||||||||||
| Total Return Swaps* | $ | – | $ | 209,941 | $ | – | $ | 209,941 | ||||||||
| Total Other Financial Instruments | $ | – | $ | 209,941 | $ | – | $ | 209,941 | ||||||||
HIMZ ETF
| Level 1 | Level 2 | Level 3 | Total | |||||||||||||
| Assets: | ||||||||||||||||
| Investments: | ||||||||||||||||
| U.S. Treasury Bills | $ | – | $ | 26,376,708 | $ | – | $ | 26,376,708 | ||||||||
| Money Market Funds | 334,821 | – | – | 334,821 | ||||||||||||
| Total Investments | $ | 334,821 | $ | 26,376,708 | $ | – | $ | 26,711,529 | ||||||||
104
| Notes to the Financial Statements | Defiance ETFs |
| Other Financial Instruments: | ||||||||||||||||
| Total Return Swaps* | $ | – | $ | 9,696,344 | $ | – | $ | 9,696,344 | ||||||||
| Total Other Financial Instruments | $ | – | $ | 9,696,344 | $ | – | $ | 9,696,344 | ||||||||
HOOX ETF
| Level 1 | Level 2 | Level 3 | Total | |||||||||||||
| Investments: | ||||||||||||||||
| Common Stocks | $ | 1,054,174 | $ | – | $ | – | $ | 1,054,174 | ||||||||
| U.S. Treasury Bills | – | 1,741,811 | – | 1,741,811 | ||||||||||||
| Money Market Funds | 739,901 | – | – | 739,901 | ||||||||||||
| Total Investments | $ | 1,794,075 | $ | 1,741,811 | $ | – | $ | 3,535,886 | ||||||||
| Other Financial Instruments: | ||||||||||||||||
| Total Return Swaps* | $ | – | $ | 9,081,906 | $ | – | $ | 9,081,906 | ||||||||
| Total Other Financial Instruments | $ | – | $ | 9,081,906 | $ | – | $ | 9,081,906 | ||||||||
IONX ETF
| Level 1 | Level 2 | Level 3 | Total | |||||||||||||
| Investments: | ||||||||||||||||
| Common Stocks | $ | 7,121,426 | $ | – | $ | – | $ | 7,121,426 | ||||||||
| U.S. Treasury Bills | – | 13,550,192 | – | 13,550,192 | ||||||||||||
| Money Market Funds | 2,044,792 | – | – | 2,044,792 | ||||||||||||
| Total Investments | $ | 9,166,218 | $ | 13,550,192 | $ | – | $ | 22,716,410 | ||||||||
| Other Financial Instruments: | ||||||||||||||||
| Total Return Swaps* | $ | – | $ | 55,984,829 | $ | – | $ | 55,984,829 | ||||||||
| Total Other Financial Instruments | $ | – | $ | 55,984,829 | $ | – | $ | 55,984,829 | ||||||||
105
| Notes to the Financial Statements | Defiance ETFs |
IRE ETF
| Level 1 | Level 2 | Level 3 | Total | |||||||||||||
| Investments: | ||||||||||||||||
| Common Stocks | $ | 330,662 | $ | – | $ | – | $ | 330,662 | ||||||||
| U.S. Treasury Bills | – | 10,206,314 | – | 10,206,314 | ||||||||||||
| Money Market Funds | 58,173 | – | – | 58,173 | ||||||||||||
| Total Investments | $ | 388,835 | $ | 10,206,314 | $ | – | $ | 10,595,149 | ||||||||
| Other Financial Instruments: | ||||||||||||||||
| Total Return Swaps* | $ | – | $ | 4,241,832 | $ | – | $ | 4,241,832 | ||||||||
| Total Other Financial Instruments | $ | – | $ | 4,241,832 | $ | – | $ | 4,241,832 | ||||||||
JPX ETF
| Level 1 | Level 2 | Level 3 | Total | |||||||||||||
| Investments: | ||||||||||||||||
| Common Stocks | $ | 46,357 | $ | – | $ | – | $ | 46,357 | ||||||||
| U.S. Treasury Bills | – | 863,419 | – | 863,419 | ||||||||||||
| Money Market Funds | 22,439 | – | – | 22,439 | ||||||||||||
| Total Investments | $ | 68,796 | $ | 863,419 | $ | – | $ | 932,215 | ||||||||
| Other Financial Instruments: | ||||||||||||||||
| Total Return Swaps* | $ | – | $ | 121,512 | $ | – | $ | 121,512 | ||||||||
| Total Other Financial Instruments | $ | – | $ | 121,512 | $ | – | $ | 121,512 | ||||||||
LLYX ETF
| Level 1 | Level 2 | Level 3 | Total | |||||||||||||
| Investments: | ||||||||||||||||
| U.S. Treasury Bills | $ | – | $ | 9,033,461 | $ | – | $ | 9,033,461 | ||||||||
| Money Market Funds | 705,273 | – | – | 705,273 | ||||||||||||
| Total Investments | $ | 705,273 | $ | 9,033,461 | $ | – | $ | 9,738,734 | ||||||||
106
| Notes to the Financial Statements | Defiance ETFs |
| Other Financial Instruments: | ||||||||||||||||
| Total Return Swaps* | $ | – | $ | 18,522,882 | $ | – | $ | 18,522,882 | ||||||||
| Total Other Financial Instruments | $ | – | $ | 18,522,882 | $ | – | $ | 18,522,882 | ||||||||
LMNX ETF
| Level 1 | Level 2 | Level 3 | Total | |||||||||||||
| Investments: | ||||||||||||||||
| Common Stocks | $ | 41,996 | $ | – | $ | – | $ | 41,996 | ||||||||
| Money Market Funds | 191,371 | – | – | 191,371 | ||||||||||||
| U.S. Treasury Bills | – | 64,881 | – | 64,881 | ||||||||||||
| Total Investments | $ | 233,367 | $ | 64,881 | $ | – | $ | 298,248 | ||||||||
| Other Financial Instruments: | ||||||||||||||||
| Total Return Swaps* | $ | – | $ | 446,804 | $ | – | $ | 446,804 | ||||||||
| Total Other Financial Instruments | $ | – | $ | 446,804 | $ | – | $ | 446,804 | ||||||||
MPL ETF
| Level 1 | Level 2 | Level 3 | Total | |||||||||||||
| Assets: | ||||||||||||||||
| Investments: | ||||||||||||||||
| U.S. Treasury Bills | $ | – | $ | 374,315 | $ | – | $ | 374,315 | ||||||||
| Money Market Funds | 22,245 | – | – | 22,245 | ||||||||||||
| Total Investments | $ | 22,245 | $ | 374,315 | $ | – | $ | 396,560 | ||||||||
| Liabilities: | ||||||||||||||||
| Other Financial Instruments: | ||||||||||||||||
| Total Return Swaps* | $ | – | $ | (251,284 | ) | $ | – | $ | (251,284 | ) | ||||||
| Total Other Financial Instruments | $ | – | $ | (251,284 | ) | $ | – | $ | (251,284 | ) | ||||||
107
| Notes to the Financial Statements | Defiance ETFs |
MSTX ETF
| Level 1 | Level 2 | Level 3 | Total | |||||||||||||
| Investments: | ||||||||||||||||
| U.S. Treasury Bills | $ | – | $ | 80,851,973 | $ | – | $ | 80,851,973 | ||||||||
| Money Market Funds | 8,895,013 | – | – | 8,895,013 | ||||||||||||
| Total Investments | $ | 8,895,013 | $ | 80,851,973 | $ | – | $ | 89,746,986 | ||||||||
| Other Financial Instruments: | ||||||||||||||||
| Total Return Swaps* | $ | – | $ | 29,899,465 | $ | – | $ | 29,899,465 | ||||||||
| Total Other Financial Instruments | $ | – | $ | 29,899,465 | $ | – | $ | 29,899,465 | ||||||||
NVOX ETF
| Level 1 | Level 2 | Level 3 | Total | |||||||||||||
| Assets: | ||||||||||||||||
| Investments: | ||||||||||||||||
| Common Stocks | $ | 1,799,157 | $ | – | $ | – | $ | 1,799,157 | ||||||||
| U.S. Treasury Bills | – | 12,177,704 | – | 12,177,704 | ||||||||||||
| Money Market Funds | 33,955 | – | – | 33,955 | ||||||||||||
| Total Investments | $ | 1,833,112 | $ | 12,177,704 | $ | – | $ | 14,010,816 | ||||||||
| Liabilities: | ||||||||||||||||
| Other Financial Instruments: | ||||||||||||||||
| Total Return Swaps* | $ | – | $ | (2,262,227 | ) | $ | – | $ | (2,262,227 | ) | ||||||
| Total Other Financial Instruments | $ | – | $ | (2,262,227 | ) | $ | – | $ | (2,262,227 | ) | ||||||
108
| Notes to the Financial Statements | Defiance ETFs |
OKLL ETF
| Level 1 | Level 2 | Level 3 | Total | |||||||||||||
| Investments: | ||||||||||||||||
| Common Stocks | $ | 6,212,840 | $ | – | $ | – | $ | 6,212,840 | ||||||||
| U.S. Treasury Bills | – | 22,149,448 | – | 22,149,448 | ||||||||||||
| Money Market Funds | 8,499 | – | – | 8,499 | ||||||||||||
| Total Investments | $ | 6,221,339 | $ | 22,149,448 | $ | – | $ | 28,370,787 | ||||||||
| Other Financial Instruments: | ||||||||||||||||
| Total Return Swaps* | $ | – | $ | 55,572,095 | $ | – | $ | 55,572,095 | ||||||||
| Total Other Financial Instruments | $ | – | $ | 55,572,095 | $ | – | $ | 55,572,095 | ||||||||
ORCX ETF
| Level 1 | Level 2 | Level 3 | Total | |||||||||||||
| Investments: | ||||||||||||||||
| U.S. Treasury Bills | $ | – | $ | 22,808,242 | $ | – | $ | 22,808,242 | ||||||||
| Money Market Funds | 11,917 | – | – | 11,917 | ||||||||||||
| Total Investments | $ | 11,917 | $ | 22,808,242 | $ | – | $ | 22,820,159 | ||||||||
| Other Financial Instruments: | ||||||||||||||||
| Total Return Swaps* | $ | – | $ | 8,337,246 | $ | – | $ | 8,337,246 | ||||||||
| Total Other Financial Instruments | $ | – | $ | 8,337,246 | $ | – | $ | 8,337,246 | ||||||||
OSCX ETF
| Level 1 | Level 2 | Level 3 | Total | |||||||||||||
| Assets: | ||||||||||||||||
| Investments: | ||||||||||||||||
| U.S. Treasury Bills | $ | – | $ | 613,877 | $ | – | $ | 613,877 | ||||||||
| Money Market Funds | 20,381 | – | – | 20,381 | ||||||||||||
| Total Investments | $ | 20,381 | $ | 613,877 | $ | – | $ | 634,258 | ||||||||
109
| Notes to the Financial Statements | Defiance ETFs |
| Liabilities: | ||||||||||||||||
| Other Financial Instruments: | ||||||||||||||||
| Total Return Swaps* | $ | – | $ | (52,801 | ) | $ | – | $ | (52,801 | ) | ||||||
| Total Other Financial Instruments | $ | – | $ | (52,801 | ) | $ | – | $ | (52,801 | ) | ||||||
XPM ETF
| Level 1 | Level 2 | Level 3 | Total | |||||||||||||
| Assets: | ||||||||||||||||
| Investments: | ||||||||||||||||
| U.S. Treasury Bills | $ | – | $ | 39,927 | $ | – | $ | 39,927 | ||||||||
| Money Market Funds | 10,502 | – | – | 10,502 | ||||||||||||
| Total Investments | $ | 10,502 | $ | 39,927 | $ | – | $ | 50,429 | ||||||||
| Liabilities: | ||||||||||||||||
| Other Financial Instruments: | ||||||||||||||||
| Total Return Swaps* | $ | – | $ | (38,295 | ) | $ | – | $ | (38,295 | ) | ||||||
| Total Other Financial Instruments | $ | – | $ | (38,295 | ) | $ | – | $ | (38,295 | ) | ||||||
QSU ETF
| Level 1 | Level 2 | Level 3 | Total | |||||||||||||
| Investments: | ||||||||||||||||
| U.S. Treasury Bills | $ | – | $ | 499,086 | $ | – | $ | 499,086 | ||||||||
| Money Market Funds | 140,152 | – | – | 140,152 | ||||||||||||
| Total Investments | $ | 140,152 | $ | 499,086 | $ | – | $ | 639,238 | ||||||||
| Other Financial Instruments: | ||||||||||||||||
| Total Return Swaps* | $ | – | $ | 3,256,001 | $ | – | $ | 3,256,001 | ||||||||
| Total Other Financial Instruments | $ | – | $ | 3,256,001 | $ | – | $ | 3,256,001 | ||||||||
110
| Notes to the Financial Statements | Defiance ETFs |
RGTX ETF
| Level 1 | Level 2 | Level 3 | Total | |||||||||||||
| Investments: | ||||||||||||||||
| U.S. Treasury Bills | $ | – | $ | 10,655,491 | $ | – | $ | 10,655,491 | ||||||||
| Money Market Funds | 89,340 | – | – | 89,340 | ||||||||||||
| Total Investments | $ | 89,340 | $ | 10,655,491 | $ | – | $ | 10,744,831 | ||||||||
| Other Financial Instruments: | ||||||||||||||||
| Total Return Swaps* | $ | – | $ | 100,019,308 | $ | – | $ | 100,019,308 | ||||||||
| Total Other Financial Instruments | $ | – | $ | 100,019,308 | $ | – | $ | 100,019,308 | ||||||||
RIOX ETF
| Level 1 | Level 2 | Level 3 | Total | |||||||||||||
| Assets: | ||||||||||||||||
| Investments: | ||||||||||||||||
| Common Stocks | $ | 1,192,042 | $ | – | $ | – | $ | 1,192,042 | ||||||||
| U.S. Treasury Bills | – | 2,445,522 | – | 2,445,522 | ||||||||||||
| Money Market Funds | 186,553 | – | – | 186,553 | ||||||||||||
| Total Investments | $ | 1,378,595 | $ | 2,445,522 | $ | – | $ | 3,824,117 | ||||||||
| Other Financial Instruments: | ||||||||||||||||
| Total Return Swaps* | $ | – | $ | 20,378,276 | $ | – | $ | 20,378,276 | ||||||||
| Total Other Financial Instruments | $ | – | $ | 20,378,276 | $ | – | $ | 20,378,276 | ||||||||
| Liabilities: | ||||||||||||||||
| Other Financial Instruments: | ||||||||||||||||
| Total Return Swaps* | $ | – | $ | (237,700 | ) | $ | – | $ | (237,700 | ) | ||||||
| Total Other Financial Instruments | $ | – | $ | (237,700 | ) | $ | – | $ | (237,700 | ) | ||||||
111
| Notes to the Financial Statements | Defiance ETFs |
RKLX ETF
| Level 1 | Level 2 | Level 3 | Total | |||||||||||||
| Investments: | ||||||||||||||||
| Common Stocks | $ | 2,038,474 | $ | – | $ | – | $ | 2,038,474 | ||||||||
| U.S. Treasury Bills | – | 8,933,644 | – | 8,933,644 | ||||||||||||
| Money Market Funds | 971,828 | – | – | 971,828 | ||||||||||||
| Total Investments | $ | 3,010,302 | $ | 8,933,644 | $ | – | $ | 11,943,946 | ||||||||
| Other Financial Instruments: | ||||||||||||||||
| Total Return Swaps* | $ | – | $ | 44,184,367 | $ | – | $ | 44,184,367 | ||||||||
| Total Other Financial Instruments | $ | – | $ | 44,184,367 | $ | – | $ | 44,184,367 | ||||||||
SMCX ETF
| Level 1 | Level 2 | Level 3 | Total | |||||||||||||
| Investments: | ||||||||||||||||
| Common Stocks | $ | 80,746 | $ | – | $ | – | $ | 80,746 | ||||||||
| U.S. Treasury Bills | – | 25,702,942 | – | 25,702,942 | ||||||||||||
| Money Market Funds | 1,310,126 | – | – | 1,310,126 | ||||||||||||
| Total Investments | $ | 1,390,872 | $ | 25,702,942 | $ | – | $ | 27,093,814 | ||||||||
| Other Financial Instruments: | ||||||||||||||||
| Total Return Swaps* | $ | – | $ | 102,602,150 | $ | – | $ | 102,602,150 | ||||||||
| Total Other Financial Instruments | $ | – | $ | 102,602,150 | $ | – | $ | 102,602,150 | ||||||||
SOFX ETF
| Level 1 | Level 2 | Level 3 | Total | |||||||||||||
| Investments: | ||||||||||||||||
| U.S. Treasury Bills | $ | – | $ | 15,671,309 | $ | – | $ | 15,671,309 | ||||||||
| Money Market Funds | 271,113 | – | – | 271,113 | ||||||||||||
| Total Investments | $ | 271,113 | $ | 15,671,309 | $ | – | $ | 15,942,422 | ||||||||
112
| Notes to the Financial Statements | Defiance ETFs |
| Other Financial Instruments: | ||||||||||||||||
| Total Return Swaps* | $ | – | $ | 41,049,936 | $ | – | $ | 41,049,936 | ||||||||
| Total Other Financial Instruments | $ | – | $ | 41,049,936 | $ | – | $ | 41,049,936 | ||||||||
SOUX ETF
| Level 1 | Level 2 | Level 3 | Total | |||||||||||||
| Investments: | ||||||||||||||||
| Common Stocks | $ | 864,437 | $ | – | $ | – | $ | 864,437 | ||||||||
| U.S. Treasury Bills | – | 2,670,111 | – | 2,670,111 | ||||||||||||
| Money Market Funds | 16,452 | – | – | 16,452 | ||||||||||||
| Total Investments | $ | 880,889 | $ | 2,670,111 | $ | – | $ | 3,551,000 | ||||||||
| Other Financial Instruments: | ||||||||||||||||
| Total Return Swaps* | $ | – | $ | 9,746,142 | $ | – | $ | 9,746,142 | ||||||||
| Total Other Financial Instruments | $ | – | $ | 9,746,142 | $ | – | $ | 9,746,142 | ||||||||
VSTL ETF
| Level 1 | Level 2 | Level 3 | Total | |||||||||||||
| Assets: | ||||||||||||||||
| Investments: | ||||||||||||||||
| Common Stocks | $ | 155,912 | $ | – | $ | – | $ | 155,912 | ||||||||
| U.S. Treasury Bills | – | 1,357,515 | – | 1,357,515 | ||||||||||||
| Money Market Funds | 560,932 | – | – | 560,932 | ||||||||||||
| Total Investments | $ | 716,844 | $ | 1,357,515 | $ | – | $ | 2,074,359 | ||||||||
| Other Financial Instruments: | ||||||||||||||||
| Total Return Swaps* | $ | – | $ | 51,344 | $ | – | $ | 51,344 | ||||||||
| Total Other Financial Instruments | $ | – | $ | 51,344 | $ | – | $ | 51,344 | ||||||||
113
| Notes to the Financial Statements | Defiance ETFs |
IONZ ETF
| Level 1 | Level 2 | Level 3 | Total | |||||||||||||
| Assets: | ||||||||||||||||
| Investments: | ||||||||||||||||
| U.S. Treasury Bills | $ | – | $ | 4,751,301 | $ | – | $ | 4,751,301 | ||||||||
| Money Market Funds | 410,546 | – | – | 410,546 | ||||||||||||
| Total Investments | $ | 410,546 | $ | 4,751,301 | $ | – | $ | 5,161,847 | ||||||||
| Other Financial Instruments: | ||||||||||||||||
| Total Return Swaps* | $ | – | $ | 793,104 | $ | – | $ | 793,104 | ||||||||
| Total Other Financial Instruments | $ | – | $ | 793,104 | $ | – | $ | 793,104 | ||||||||
| Liabilities: | ||||||||||||||||
| Other Financial Instruments: | ||||||||||||||||
| Total Return Swaps* | $ | – | $ | (3,066,520 | ) | $ | – | $ | (3,066,520 | ) | ||||||
| Total Other Financial Instruments | $ | – | $ | (3,066,520 | ) | $ | – | $ | (3,066,520 | ) | ||||||
LLYZ ETF
| Level 1 | Level 2 | Level 3 | Total | |||||||||||||
| Assets: | ||||||||||||||||
| Investments: | ||||||||||||||||
| U.S. Treasury Bills | $ | – | $ | 314,424 | $ | – | $ | 314,424 | ||||||||
| Money Market Funds | 43,045 | – | – | 43,045 | ||||||||||||
| Total Investments | $ | 43,045 | $ | 314,424 | $ | – | $ | 357,469 | ||||||||
| Other Financial Instruments: | ||||||||||||||||
| Total Return Swaps* | $ | – | $ | 6 | $ | – | $ | 6 | ||||||||
| Total Other Financial Instruments | $ | – | $ | 6 | $ | – | $ | 6 | ||||||||
114
| Notes to the Financial Statements | Defiance ETFs |
| Liabilities: | ||||||||||||||||
| Other Financial Instruments: | ||||||||||||||||
| Total Return Swaps* | $ | – | $ | (81,832 | ) | $ | – | $ | (81,832 | ) | ||||||
| Total Other Financial Instruments | $ | – | $ | (81,832 | ) | $ | – | $ | (81,832 | ) | ||||||
SMST ETF
| Level 1 | Level 2 | Level 3 | Total | |||||||||||||
| Investments: | ||||||||||||||||
| U.S. Treasury Bills | $ | – | $ | 2,525,376 | $ | – | $ | 2,525,376 | ||||||||
| Money Market Funds | 125,532 | – | – | 125,532 | ||||||||||||
| Total Investments | $ | 125,532 | $ | 2,525,376 | $ | – | $ | 2,650,908 | ||||||||
| Other Financial Instruments: | ||||||||||||||||
| Total Return Swaps* | $ | – | $ | 1,431,555 | $ | – | $ | 1,431,555 | ||||||||
| Total Other Financial Instruments | $ | – | $ | 1,431,555 | $ | – | $ | 1,431,555 | ||||||||
PLTZ ETF
| Level 1 | Level 2 | Level 3 | Total | |||||||||||||
| Assets: | ||||||||||||||||
| Investments: | ||||||||||||||||
| U.S. Treasury Bills | $ | – | $ | 15,222,130 | $ | – | $ | 15,222,130 | ||||||||
| Money Market Funds | 175,949 | – | – | 175,949 | ||||||||||||
| Total Investments | $ | 175,949 | $ | 15,222,130 | $ | – | $ | 15,398,079 | ||||||||
| Other Financial Instruments: | ||||||||||||||||
| Total Return Swaps* | $ | – | $ | 14 | $ | – | $ | 14 | ||||||||
| Total Other Financial Instruments | $ | – | $ | 14 | $ | – | $ | 14 | ||||||||
115
| Notes to the Financial Statements | Defiance ETFs |
| Liabilities: | ||||||||||||||||
| Other Financial Instruments: | ||||||||||||||||
| Total Return Swaps* | $ | – | $ | (1,451,430 | ) | $ | – | $ | (1,451,430 | ) | ||||||
| Total Other Financial Instruments | $ | – | $ | (1,451,430 | ) | $ | – | $ | (1,451,430 | ) | ||||||
QBTZ ETF
| Level 1 | Level 2 | Level 3 | Total | |||||||||||||
| Assets: | ||||||||||||||||
| Investments: | ||||||||||||||||
| Money Market Funds | $ | 2,265,248 | $ | – | $ | – | $ | 2,265,248 | ||||||||
| U.S. Treasury Bills | – | 1,627,021 | – | 1,627,021 | ||||||||||||
| Total Investments | $ | 2,265,248 | $ | 1,627,021 | $ | – | $ | 3,892,269 | ||||||||
| Liabilities: | ||||||||||||||||
| Other Financial Instruments: | ||||||||||||||||
| Total Return Swaps* | $ | – | $ | (4,768,375 | ) | $ | – | $ | (4,768,375 | ) | ||||||
| Total Other Financial Instruments | $ | – | $ | (4,768,375 | ) | $ | – | $ | (4,768,375 | ) | ||||||
RGTZ ETF
| Level 1 | Level 2 | Level 3 | Total | |||||||||||||
| Assets: | ||||||||||||||||
| Investments: | ||||||||||||||||
| U.S. Treasury Bills | $ | – | $ | 18,566,009 | $ | – | $ | 18,566,009 | ||||||||
| Money Market Funds | 230,630 | – | – | 230,630 | ||||||||||||
| Total Investments | $ | 230,630 | $ | 18,566,009 | $ | – | $ | 18,796,639 | ||||||||
|
Liabilities:
|
||||||||||||||||
| Other Financial Instruments: | ||||||||||||||||
| Total Return Swaps* | $ | – | $ | (15,520,601 | ) | $ | – | $ | (15,520,601 | ) | ||||||
| Total Other Financial Instruments | $ | – | $ | (15,520,601 | ) | $ | – | $ | (15,520,601 | ) | ||||||
116
| Notes to the Financial Statements | Defiance ETFs |
SMCZ ETF
| Level 1 | Level 2 | Level 3 | Total | |||||||||||||
| Assets: | ||||||||||||||||
| Investments: | ||||||||||||||||
| U.S. Treasury Bills | $ | – | $ | 768,592 | $ | – | $ | 768,592 | ||||||||
| Money Market Funds | 26,964 | – | – | 26,964 | ||||||||||||
| Total Investments | $ | 26,964 | $ | 768,592 | $ | – | $ | 795,556 | ||||||||
| Other Financial Instruments: | ||||||||||||||||
| Total Return Swaps* | $ | – | $ | 520,309 | $ | – | $ | 520,309 | ||||||||
| Total Other Financial Instruments | $ | – | $ | 520,309 | $ | – | $ | 520,309 | ||||||||
| Liabilities: | ||||||||||||||||
| Other Financial Instruments: | ||||||||||||||||
| Total Return Swaps* | $ | – | $ | (21,382 | ) | $ | – | $ | (21,382 | ) | ||||||
| Total Other Financial Instruments | $ | – | $ | (21,382 | ) | $ | – | $ | (21,382 | ) | ||||||
* The fair value of the Fund's investment represents the unrealized appreciation (depreciation) as of October 31, 2025.
Refer to the Schedules of Investments for further disaggregation of investment categories.
B. Derivative Instruments. As the buyer of a call option, the Funds have a right to buy the underlying reference instrument (e.g., a currency or security) at the exercise price at any time during the option period (for American style options). The Funds may enter into closing sale transactions with respect to call options, exercise them, or permit them to expire. For example, the Funds may buy call options on underlying reference instruments that they intend to buy with the goal of limiting the risk of a substantial increase in their market price before the purchase is affected. Unless the price of the underlying reference instrument changes sufficiently, a call option purchased by the Funds may expire without any value to the Funds, in which case the Funds would experience a loss to the extent of the premium paid for the option plus related transaction costs.
As the buyer of a put option, the Funds have the right to sell the underlying reference instrument at the exercise price at any time during the option period (for American style options). Like a call option, the Funds may enter into closing sale transactions with respect to put options, exercise them, or permit them to expire. The Funds may buy a put option on an underlying reference instrument owned by the Funds (a protective put) as a hedging technique in an attempt to protect against an anticipated decline in the market value of the underlying reference instrument. Such hedge protection is provided only during the life of the put option when the Funds, as the buyer of the put option, are able to sell the underlying reference instrument at the put exercise price, regardless of any decline in the underlying instrument’s market price. The Funds may also seek to offset a decline in the value of the underlying reference instrument through appreciation in the value of the put option. Put options may also be purchased with the intent of protecting unrealized appreciation of an instrument when the Adviser deems it desirable to continue to hold the instrument because of tax or other considerations. The premium paid for the put option and any transaction costs would reduce any short-term capital gain that may be available for distribution when
117
| Notes to the Financial Statements | Defiance ETFs |
the instrument is eventually sold. Buying put options at a time when the buyer does not own the underlying reference instrument allows the buyer to benefit from a decline in the market price of the underlying reference instrument, which generally increases the value of the put option.
If a put option is not terminated in a closing sale transaction when it has remaining value, and if the market price of the underlying reference instrument remains equal to or greater than the exercise price during the life of the put option, the buyer would not make any gain upon exercise of the option and would experience a loss to the extent of the premium paid for the option plus related transaction costs. In order for the purchase of a put option to be profitable, the market price of the underlying reference instrument must decline sufficiently below the exercise price to cover the premium and transaction costs.
Writing options may permit the writer to generate additional income in the form of the premium received for writing the option. The writer of an option may have no control over when the underlying reference instruments must be sold (in the case of a call option) or purchased (in the case of a put option) because the writer may be notified of exercise at any time prior to the expiration of the option (for American style options). In general, though, options are infrequently exercised prior to expiration. Whether or not an option expires unexercised, the writer retains the amount of the premium. Writing “covered” call options means that the writer owns the underlying reference instrument that is subject to the call option. Call options may also be written on reference instruments that the writer does not own.
If the Funds write a covered call option, any underlying reference instruments that are held by the Funds and are subject to the call option will be earmarked on the books of such Funds as segregated to satisfy its obligations under the option. The Funds will be unable to sell the underlying reference instruments that are subject to the written call option until it either effects a closing transaction with respect to the written call, or otherwise satisfies the conditions for release of the underlying reference instruments from segregation. As the writer of a covered call option, each Fund gives up the potential for capital appreciation above the exercise price of the option should the underlying reference instrument rise in value. If the value of the underlying reference instrument rises above the exercise price of the call option, the reference instrument will likely be “called away,” requiring the Funds to sell the underlying instrument at the exercise price. In that case, the Funds will sell the underlying reference instrument to the option buyer for less than its market value, and such Funds will experience a loss (which will be offset by the premium received by the Funds as the writer of such option). If a call option expires unexercised, the Funds will realize a gain in the amount of the premium received. If the market price of the underlying reference instrument decreases, the call option will not be exercised and the Funds will be able to use the amount of the premium received to hedge against the loss in value of the underlying reference instrument. The exercise price of a call option will be chosen based upon the expected price movement of the underlying reference instrument. The exercise price of a call option may be below, equal to (at-the-money), or above the current value of the underlying reference instrument at the time the option is written.
As the writer of a put option, each Fund has a risk of loss should the underlying reference instrument decline in value. If the value of the underlying reference instrument declines below the exercise price of the put option and the put option is exercised, the Funds, as the writer of the put option, will be required to buy the instrument at the exercise price, which will exceed the market value of the underlying reference instrument at that time. Each Fund will incur a loss to the extent that the current market value of the underlying reference instrument is less than the exercise price of the put option. However, the loss will be offset in part by the premium received from the buyer of the put. If a put option written by the Funds expires unexercised, such Fund will realize a gain in the amount of the premium received.
Each Fund may enter into total return swap agreements in an attempt to gain exposure to the securities in a market without actually purchasing those securities, or to hedge a position. A total return swap is a contract in which one party agrees to make periodic payments to another party based on the change in market value of the assets underlying the contract, which may include a specified security, basket of securities, or securities indices during the specified period, in return for periodic payments based on a fixed or variable interest rate or the total return from other underlying assets. Swap agreements will usually be done on a net basis, i.e., where the two parties make net payments with a Fund receiving or paying, as the case may be, only the net amount of the two payments. The net amount of the excess, if any, of a Fund’s obligations over its entitlements with respect to each swap is accrued on a daily basis and an amount of cash or equivalents having an aggregate value at least equal to the accrued excess is maintained by the Funds. By virtue of each Fund’s investments in option contracts, equity ETFs and equity indices, each Fund is exposed to common stocks indirectly which subjects the Funds to equity market risk. Common stocks are generally exposed to greater risk than other types of securities, such as preferred stock and debt obligations, because common stockholders generally have inferior rights to receive payment from specific issuers. Equity securities may experience sudden, unpredictable drops in value or long periods of decline in value. This may occur because of factors that affect securities markets generally or factors affecting specific issuers, industries, or sectors in which the Funds invest.
The Funds have adopted financial reporting rules and regulations that require enhanced disclosure regarding derivatives and hedging activity intending to improve financial reporting of derivative instruments by enabling investors to understand how an entity uses derivatives, how derivatives are accounted for, and how derivative instruments affect an entity’s results of operations and financial position.
118
| Notes to the Financial Statements | Defiance ETFs |
For the periods ended October 31, 2025, each Fund’s monthly average notional value is described below:
| Fund | Instrument | Average Notional Amount | ||
| QPUX ETF | Total Return Swaps | $ | 49,305,870 | |
| ANEL ETF | Total Return Swaps | 13,621,049 | ||
| AVXX ETF | Total Return Swaps | 1,636,852 | ||
| AVGX ETF | Total Return Swaps | 204,031,773 | ||
| CVNX ETF | Total Return Swaps | 4,254,208 | ||
| DKNX ETF | Total Return Swaps | 5,927,382 | ||
| HIMZ ETF | Total Return Swaps | 239,732,667 | ||
| HOOX ETF | Total Return Swaps | 38,387,474 | ||
| IONX ETF | Total Return Swaps | 212,628,470 | ||
| IRE ETF | Total Return Swaps | 220,524,262 | ||
| JPX ETF | Total Return Swaps | 3,956,894 | ||
| LLYX ETF | Total Return Swaps | 96,217,940 | ||
| LMNX ETF | Total Return Swaps | 3,423,118 | ||
| MPL ETF | Total Return Swaps | 14,761,735 | ||
| MSTX ETF | Purchased Options | - | (a) | |
| Total Return Swaps | 1,864,760,917 | |||
| NVOX ETF | Total Return Swaps | 101,059,475 | ||
| OKLL ETF | Total Return Swaps | 177,551,383 | ||
| ORCX ETF | Total Return Swaps | 203,184,842 | ||
| OSCX ETF | Total Return Swaps | 9,439,721 | ||
| XPM ETF | Total Return Swaps | 1,240,498 | ||
| QSU ETF | Total Return Swaps | 19,784,811 | ||
| RGTX ETF | Total Return Swaps | 127,109,636 | ||
| RIOX ETF | Total Return Swaps | 63,692,394 | ||
119
| Notes to the Financial Statements | Defiance ETFs |
| RKLX ETF | Total Return Swaps | 137,774,816 | ||
| SMCX ETF | Total Return Swaps | 584,879,673 | ||
| SOFX ETF | Total Return Swaps | 118,263,957 | ||
| SOUX ETF | Total Return Swaps | 38,021,908 | ||
| VSTL ETF | Total Return Swaps | 7,675,071 | ||
| IONZ ETF | Total Return Swaps | (66,220,045 | ) | |
| LLYZ ETF | Total Return Swaps | (2,842,915 | ) | |
| SMST ETF | Total Return Swaps | (62,221,885 | ) | |
| PLTZ ETF | Total Return Swaps | (93,562,311 | ) | |
| QBTZ ETF | Total Return Swaps | (74,271,983 | ) | |
| RGTZ ETF | Total Return Swaps | (154,313,134 | ) | |
| SMCZ ETF | Total Return Swaps | (25,686,132 | ) |
| (a) | During the period ended October 31, 2025, exposure to purchased options contracts was minimal. |
Statements of Assets and Liabilities
Fair value of derivative instruments as of October 31, 2025:
| Asset Derivatives | Liability Derivatives | |||||||
|
Fund: |
Instrument |
Balance Sheet |
Instrument |
Balance Sheet |
||||
|
Unrealized appreciation on Swap contracts |
Unrealized depreciation on Swap contracts |
|||||||
| Total Return Swaps | Total Return Swaps | |||||||
| QPUX ETF | Equity Risk | $ | 3,176,065 | Equity Risk | $ | - | ||
| ANEL ETF | Equity Risk | 1,146,225 | Equity Risk | - | ||||
| AVXX ETF | Equity Risk | 408 | Equity Risk | - | ||||
| AVGX ETF | Equity Risk | 43,076,161 | Equity Risk | - | ||||
| CVNX ETF | Equity Risk | 27,422 | Equity Risk | - | ||||
| DKNX ETF | Equity Risk | 209,941 | Equity Risk | - | ||||
| HIMZ ETF | Equity Risk | 9,696,344 | Equity Risk | - | ||||
| HOOX ETF | Equity Risk | 9,081,906 | Equity Risk | - | ||||
120
| Notes to the Financial Statements | Defiance ETFs |
| IONX ETF | Equity Risk | 55,984,829 | Equity Risk | - | ||||
| IRE ETF | Equity Risk | 4,241,832 | Equity Risk | - | ||||
| JPX ETF | Equity Risk | 121,512 | Equity Risk | - | ||||
| LLYX ETF | Equity Risk | 18,522,882 | Equity Risk | - | ||||
| LMNX ETF | Equity Risk | 446,903 | Equity Risk | - | ||||
| MPL ETF | Equity Risk | - | Equity Risk | 251,284 | ||||
| MSTX ETF | Equity Risk | 29,899,465 | Equity Risk | - | ||||
| NVOX ETF | Equity Risk | - | Equity Risk | 2,262,227 | ||||
| OKLL ETF | Equity Risk | 55,572,095 | Equity Risk | - | ||||
| ORCX ETF | Equity Risk | 8,337,246 | Equity Risk | - | ||||
| OSCX ETF | Equity Risk | - | Equity Risk | 52,801 | ||||
| XPM ETF | Equity Risk | - | Equity Risk | 38,295 | ||||
| QSU ETF | Equity Risk | 3,256.001 | Equity Risk | - | ||||
| RGTX ETF | Equity Risk | 100,019,308 | Equity Risk | - | ||||
| RIOX ETF | Equity Risk | 20,378,576 | Equity Risk | 237,700 | ||||
| RKLX ETF | Equity Risk | 44,184,367 | Equity Risk | - | ||||
| SMCX ETF | Equity Risk | 102,602,150 | Equity Risk | - | ||||
| SOFX ETF | Equity Risk | 41,049,936 | Equity Risk | - | ||||
| SOUX ETF | Equity Risk | 9,746,142 | Equity Risk | - | ||||
| VSTL ETF | Equity Risk | 51,344 | Equity Risk | - | ||||
| IONZ ETF | Equity Risk | 793,104 | Equity Risk | 3,066,520 | ||||
| LLYZ ETF | Equity Risk | - | Equity Risk | 86,781 | ||||
| SMST ETF | Equity Risk | 1,431,555 | Equity Risk | - | ||||
| PLTZ ETF | Equity Risk | - | Equity Risk | 1,453,130 | ||||
| QBTZ ETF | Equity Risk | - | Equity Risk | 4,768,375 | ||||
| RGTZ ETF | Equity Risk | - | Equity Risk | 15,520,601 | ||||
| SMCZ ETF | Equity Risk | 520,309 | Equity Risk | 21,382 |
121
| Notes to the Financial Statements | Defiance ETFs |
Statements of Operations
The effect of derivative instruments on the Statements of Operations for the periods ended October 31, 2025:
| Realized | Change in Unrealized | ||||||
| Fund: | Instrument: | Location: | Instrument: | Location: | |||
| Net realized gain (loss) from Swap contracts |
Net change in unrealized appreciation (depreciation) on Swap contracts | ||||||
| Swap contracts | Swap Contracts | ||||||
| QPUX ETF | Equity Risk | $ | 5,337,155 | Equity Risk | $ | 3,176,065 | |
| ANEL ETF | Equity Risk | 185,863 | Equity Risk | 1,146,225 | |||
| AVXX ETF | Equity Risk | 34,432 | Equity Risk | 408 | |||
| AVGX ETF | Equity Risk | 58,955,299 | Equity Risk | 46,745,673 | |||
| CVNX ETF | Equity Risk | (1,444,998) | Equity Risk | 27,422 | |||
| DKNX ETF | Equity Risk | (2,327,229) | Equity Risk | 209,941 | |||
| HIMZ ETF | Equity Risk | 16,956,500 | Equity Risk | 9,696,344 | |||
| HOOX ETF | Equity Risk | 21,187,472 | Equity Risk | 9,081,906 | |||
| IONX ETF | Equity Risk | 50,510,537 | Equity Risk | 55,984,829 | |||
| IRE ETF | Equity Risk | (1,573,734) | Equity Risk | 4,241,832 | |||
| JPX ETF | Equity Risk | 113,564 | Equity Risk | 121,512 | |||
| LLYX ETF | Equity Risk | 15,027,534 | Equity Risk | 17,425,569 | |||
| LMNX ETF | Equity Risk | (53,378) | Equity Risk | 446,903 | |||
| MPL ETF | Equity Risk | (1,574,426) | Equity Risk | (251,284) | |||
| MSTX ETF | Equity Risk | (310,697,836) | Equity Risk | (422,783,569) | |||
| NVOX ETF | Equity Risk | (17,007,734) | Equity Risk | (1,799,355) | |||
| OKLL ETF | Equity Risk | 38,981,247 | Equity Risk | 55,572,095 | |||
| ORCX ETF | Equity Risk | (52,262,006) | Equity Risk | 8,212,302 | |||
| OSCX ETF | Equity Risk | (2,560,427) | Equity Risk | (52,801) | |||
| XPM ETF | Equity Risk | (117,504) | Equity Risk | (38,295) | |||
| QSU ETF | Equity Risk | (346,348) | Equity Risk | 3,256,001 | |||
| RGTX ETF | Equity Risk | 48,769,849 | Equity Risk | 100,019,308 | |||
| RIOX ETF | Equity Risk | 25,174,916 | Equity Risk | 20,244,526 | |||
| RKLX ETF | Equity Risk | 70,398,539 | Equity Risk | 44,184,367 | |||
| SMCX ETF | Equity Risk | 89,578,645 | Equity Risk | 126,306,614 | |||
| SOFX ETF | Equity Risk | 33,809,483 | Equity Risk | 42,223,036 | |||
| SOUX ETF | Equity Risk | 9,081,986 | Equity Risk | 9,746,142 | |||
122
| Notes to the Financial Statements | Defiance ETFs |
| VSTL ETF | Equity Risk | (1,076,075) | Equity Risk | 51,344 | |||
| IONZ ETF | Equity Risk | (4,159,875) | Equity Risk | (2,273,416) | |||
| LLYZ ETF | Equity Risk | (423,906) | Equity Risk | (86,781) | |||
| SMST ETF | Equity Risk | 6,507,992 | Equity Risk | 2,692,932 | |||
| PLTZ ETF | Equity Risk | (22,623,730) | Equity Risk | (1,453,130) | |||
| QBTZ ETF | Equity Risk | 688,806 | Equity Risk | (4,768,375) | |||
| RGTZ ETF | Equity Risk | 36,262,164 | Equity Risk | (15,520,601) | |||
| SMCZ ETF | Equity Risk | (1,758,965) | Equity Risk | 498,927 |
The total return swap contracts are subject to master netting agreements, which are agreements between the Funds and their counterparties that provide for the net settlement of all transactions and collateral with the Funds through a single payment, in the event of default or termination. Amounts presented on the Schedules of Total Return Swap Contracts are gross settlement amounts.
Under the master netting agreements, collateral is routinely transferred if the total net exposure to certain transactions (net of existing collateral already in place) governed under the relevant master netting agreements with a counterparty in a given account exceeds a specified threshold depending on the counterparty and the type of master netting agreements.
The following table presents the Funds’ gross derivative assets and liabilities by counterparty and contract type, net of amounts available for offset under a master netting agreement and the related collateral received or pledged by the Funds as of October 31, 2025.
| Description | Counterparty | Investment Type | Gross Amounts | Gross Amounts Offset in the Statement of Assets and Liabilities | Net Amounts Presented in the Statements of Assets and Liabilities | Financial Instruments | Cash Collateral Pledged (Received) | Net Amount | |||||||
| Total Return | |||||||||||||||
| Swap Contracts | |||||||||||||||
| QPUX ETF | |||||||||||||||
| Assets | Clear Street LLC | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | ||
| Marex Capital Markets, Inc. | $ | 3,176,065 | $ | - | $ | 3,176,065 | $ | - | $ | - | $ | 3,176,065 | |||
| Liabilities | Clear Street LLC | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | ||
| Marex Capital Markets, Inc. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| ANEL ETF | |||||||||||||||
| Assets | Cantor Fitzgerald & Co. | $ | 526,993 | $ | - | $ | 526,993 | $ | - | $ | - | $ | 526,993 | ||
| Clear Street LLC | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Marex Capital Markets, Inc. | $ | 619,232 | $ | - | $ | 619,232 | $ | - | $ | - | $ | 619,232 | |||
| Liabilities | Cantor Fitzgerald & Co. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | ||
| Clear Street LLC | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Marex Capital Markets, Inc. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| AVXX ETF | |||||||||||||||
| Assets | Clear Street LLC | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | ||
| Marex Capital Markets, Inc. | $ | 408 | $ | - | $ | 408 | $ | - | $ | - | $ | 408 | |||
| Liabilities | Clear Street LLC | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | ||
| Marex Capital Markets, Inc. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| AVGX ETF | |||||||||||||||
| Assets | BMO Capital Markets Corp. | $ | 9,133,210 | $ | - | $ | 9,133,210 | $ | - | $ | - | $ | 9,133,210 | ||
| Cantor Fitzgerald & Co. | $ | 16,242,352 | $ | - | $ | 16,242,352 | $ | - | $ | - | $ | 16,242,352 | |||
123
| Notes to the Financial Statements | Defiance ETFs |
| Clear Street LLC | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Marex Capital Markets, Inc. | $ | 5,716,791 | $ | - | $ | 5,716,791 | $ | - | $ | - | $ | 5,716,791 | |||
| Morgan Stanley | $ | 764,376 | $ | - | $ | 764,376 | $ | - | $ | - | $ | 764,376 | |||
| Nomura Sercurities International, Inc. | $ | 11,219,432 | $ | - | $ | 11,219,432 | $ | - | $ | - | $ | 11,219,432 | |||
| Liabilities | BMO Capital Markets Corp. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | ||
| Cantor Fitzgerald & Co. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Clear Street LLC | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Marex Capital Markets, Inc. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Morgan Stanley | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Nomura Sercurities International, Inc. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - |
| CVNX ETF | |||||||||||||||
| Assets | Cantor Fitzgerald & Co. | $ | 13,659 | $ | - | $ | 13,659 | $ | - | $ | - | $ | 13,659 | ||
| Clear Street LLC | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Marex Capital Markets, Inc. | $ | 6,192 | $ | - | $ | 6,192 | $ | - | $ | - | $ | 6,192 | |||
| Nomura Sercurities International, Inc. | $ | 7,571 | $ | - | $ | 7,571 | $ | - | $ | - | $ | 7,571 | |||
| Liabilities | Cantor Fitzgerald & Co. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | ||
| Clear Street LLC | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Marex Capital Markets, Inc. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Nomura Sercurities International, Inc. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| DKNX ETF | |||||||||||||||
| Assets | Cantor Fitzgerald & Co. | $ | 69,625 | $ | - | $ | 69,625 | $ | - | $ | - | $ | 69,625 | ||
| Marex Capital Markets, Inc. | $ | 50,247 | $ | - | $ | 50,247 | $ | - | $ | - | $ | 50,247 | |||
| Nomura Sercurities International, Inc. | $ | 90,069 | $ | - | $ | 90,069 | $ | - | $ | - | $ | 90,069 | |||
| Liabilities | Cantor Fitzgerald & Co. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | ||
| Marex Capital Markets, Inc. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Nomura Sercurities International, Inc. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| HIMZ ETF | |||||||||||||||
| Assets | BMO Capital Markets Corp. | $ | 3,815,350 | $ | - | $ | 3,815,350 | $ | - | $ | - | $ | 3,815,350 | ||
| Cantor Fitzgerald & Co. | $ | 1,773,171 | $ | - | $ | 1,773,171 | $ | - | $ | - | $ | 1,773,171 | |||
| Clear Street LLC | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Marex Capital Markets, Inc. | $ | 2,651,823 | $ | - | $ | 2,651,823 | $ | - | $ | - | $ | 2,651,823 | |||
| Nomura Sercurities International, Inc. | $ | 1,456,000 | $ | - | $ | 1,456,000 | $ | - | $ | - | $ | 1,456,000 | |||
| Liabilities | BMO Capital Markets Corp. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | ||
| Cantor Fitzgerald & Co. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Clear Street LLC | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Marex Capital Markets, Inc. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Nomura Sercurities International, Inc. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| HOOX ETF | |||||||||||||||
| Assets | BMO Capital Markets Corp. | $ | 2,095,635 | $ | - | $ | 2,095,635 | $ | - | $ | - | $ | 2,095,635 | ||
| Cantor Fitzgerald & Co. | $ | 1,466,630 | $ | - | $ | 1,466,630 | $ | - | $ | - | $ | 1,466,630 | |||
| Clear Street LLC | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - |
124
| Notes to the Financial Statements | Defiance ETFs |
| Marex Capital Markets, Inc. | $ | 2,779,841 | $ | - | $ | 2,779,841 | $ | - | $ | - | $ | 2,779,841 | |||
| Nomura Sercurities International, Inc. | $ | 2,739,800 | $ | - | $ | 2,739,800 | $ | - | $ | - | $ | 2,739,800 | |||
| Liabilities | BMO Capital Markets Corp. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | ||
| Cantor Fitzgerald & Co. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Clear Street LLC | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Marex Capital Markets, Inc. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Nomura Sercurities International, Inc. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| IONX ETF | |||||||||||||||
| Assets | BMO Capital Markets Corp. | $ | 14,762,825 | $ | - | $ | 14,762,825 | $ | - | $ | - | $ | 14,762,825 | ||
| Cantor Fitzgerald & Co. | $ | 19,191,804 | $ | - | $ | 19,191,804 | $ | - | $ | - | $ | 19,191,804 | |||
| Clear Street LLC | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Marex Capital Markets, Inc. | $ | 19,258,200 | $ | - | $ | 19,258,200 | $ | - | $ | - | $ | 19,258,200 | |||
| Nomura Sercurities International, Inc. | $ | 2,772,000 | $ | - | $ | 2,772,000 | $ | - | $ | - | $ | 2,772,000 | |||
| Liabilities | BMO Capital Markets Corp. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | ||
| Cantor Fitzgerald & Co. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Clear Street LLC | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Marex Capital Markets, Inc. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Nomura Sercurities International, Inc. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| IRE ETF | |||||||||||||||
| Assets | Cantor Fitzgerald & Co. | $ | 1,952,146 | $ | - | $ | 1,952,146 | $ | - | $ | - | $ | 1,952,146 | ||
| Clear Street LLC | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Marex Capital Markets, Inc. | $ | 1,916,018 | $ | - | $ | 1,916,018 | $ | - | $ | - | $ | 1,916,018 | |||
| Nomura Sercurities International, Inc. | $ | 373,668 | $ | - | $ | 373,668 | $ | - | $ | - | $ | 373,668 | |||
| Liabilities | Cantor Fitzgerald & Co. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | ||
| Clear Street LLC | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Marex Capital Markets, Inc. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Nomura Sercurities International, Inc. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| JPX ETF | |||||||||||||||
| Assets | Clear Street LLC | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | ||
| Marex Capital Markets, Inc. | $ | 121,512 | $ | - | $ | 121,512 | $ | - | $ | - | $ | 121,512 | |||
| Liabilities | Clear Street LLC | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | ||
| Marex Capital Markets, Inc. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| LLYX ETF | |||||||||||||||
| Assets | BMO Capital Markets Corp. | $ | 155,933 | $ | - | $ | 155,933 | $ | - | $ | - | $ | 155,933 | ||
| Cantor Fitzgerald & Co. | $ | 5,848,481 | $ | - | $ | 5,848,481 | $ | - | $ | - | $ | 5,848,481 | |||
| Clear Street LLC | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Marex Capital Markets, Inc. | $ | 3,273,205 | $ | - | $ | 3,273,205 | $ | - | $ | - | $ | 3,273,205 | |||
| Morgan Stanley | $ | 128,117 | $ | - | $ | 128,117 | $ | - | $ | - | $ | 128,117 | |||
| Nomura Sercurities International, Inc. | $ | 9,117,146 | $ | - | $ | 9,117,146 | $ | - | $ | - | $ | 9,117,146 | |||
| Liabilities | BMO Capital Markets Corp. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | ||
| Cantor Fitzgerald & Co. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Clear Street LLC | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Marex Capital Markets, Inc. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - |
125
| Notes to the Financial Statements | Defiance ETFs |
| Morgan Stanley | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Nomura Sercurities International, Inc. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| LMNX ETF | |||||||||||||||
| Assets | Cantor Fitzgerald & Co. | $ | 428,721 | $ | - | $ | 428,721 | $ | - | $ | - | $ | 428,721 | ||
| Clear Street LLC | $ | 99 | $ | - | $ | 99 | $ | - | $ | - | $ | 99 | |||
| Marex Capital Markets, Inc. | $ | 18,083 | $ | - | $ | 18,083 | $ | - | $ | - | $ | 18,083 | |||
| Liabilities | Cantor Fitzgerald & Co. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | ||
| Clear Street LLC | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Marex Capital Markets, Inc. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| MPL ETF | |||||||||||||||
| Assets | Cantor Fitzgerald & Co. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | ||
| Clear Street LLC | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Marex Capital Markets, Inc. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Liabilities | Cantor Fitzgerald & Co. | $ | 144,350 | $ | - | $ | 144,350 | $ | - | $ | 144,350 | $ | - | ||
| Clear Street LLC | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Marex Capital Markets, Inc. | $ | 106,934 | $ | - | $ | 106,934 | $ | - | $ | 106,934 | $ | - | |||
| MSTX ETF | |||||||||||||||
| Assets | BMO Capital Markets Corp. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | ||
| Cantor Fitzgerald & Co. | $ | 15,730,190 | $ | - | $ | 15,730,190 | $ | - | $ | - | $ | 15,730,190 | |||
| Clear Street LLC | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Marex Capital Markets, Inc. | $ | 14,169,275 | $ | - | $ | 14,169,275 | $ | - | $ | - | $ | 14,169,275 | |||
| Liabilities | BMO Capital Markets Corp. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | ||
| Cantor Fitzgerald & Co. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Clear Street LLC | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Marex Capital Markets, Inc. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| NVOX ETF | |||||||||||||||
| Assets | Cantor Fitzgerald & Co. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | ||
| Clear Street LLC | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Marex Capital Markets, Inc. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Morgan Stanley | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Nomura Sercurities International, Inc. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Liabilities | Cantor Fitzgerald & Co. | $ | 410,684 | $ | - | $ | 410,684 | $ | - | $ | 410,684 | $ | - | ||
| Clear Street LLC | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Marex Capital Markets, Inc. | $ | 170,664 | $ | - | $ | 170,664 | $ | - | $ | 170,664 | $ | - | |||
| Morgan Stanley | $ | 1,201,973 | $ | - | $ | 1,201,973 | $ | - | $ | 1,201,973 | $ | - | |||
| Nomura Sercurities International, Inc. | $ | 478,906 | $ | - | $ | 478,906 | $ | - | $ | 478,906 | $ | - | |||
| OKLL ETF | |||||||||||||||
| Assets | Cantor Fitzgerald & Co. | $ | 13,385,613 | $ | - | $ | 13,385,613 | $ | - | $ | - | $ | 13,385,613 | ||
| Clear Street LLC | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Marex Capital Markets, Inc. | $ | 40,956,128 | $ | - | $ | 40,956,128 | $ | - | $ | - | $ | 40,956,128 | |||
| Nomura Sercurities International, Inc. | $ | 1,230,354 | $ | - | $ | 1,230,354 | $ | - | $ | - | $ | 1,230,354 | |||
| Liabilities | Cantor Fitzgerald & Co. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - |
126
| Notes to the Financial Statements | Defiance ETFs |
| Clear Street LLC | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Marex Capital Markets, Inc. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Nomura Sercurities International, Inc. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - |
| ORCX ETF | |||||||||||||||
| Assets | BMO Capital Markets Corp. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | ||
| Cantor Fitzgerald & Co. | $ | 4,574,724 | $ | - | $ | 4,574,724 | $ | - | $ | - | $ | 4,574,724 | |||
| Clear Street LLC | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Marex Capital Markets, Inc. | $ | 950,869 | $ | - | $ | 950,869 | $ | - | $ | - | $ | 950,869 | |||
| Nomura Sercurities International, Inc. | $ | 2,811,653 | $ | - | $ | 2,811,653 | $ | - | $ | - | $ | 2,811,653 | |||
| Liabilities | BMO Capital Markets Corp. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | ||
| Cantor Fitzgerald & Co. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Clear Street LLC | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Marex Capital Markets, Inc. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Nomura Sercurities International, Inc. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| OSCX ETF | |||||||||||||||
| Assets | Clear Street LLC | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | ||
| Marex Capital Markets, Inc. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Nomura Sercurities International, Inc. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Liabilities | Clear Street LLC | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | ||
| Marex Capital Markets, Inc. | $ | 30,301 | $ | - | $ | 30,301 | $ | - | $ | 30,301 | $ | - | |||
| Nomura Sercurities International, Inc. | $ | 22,500 | $ | - | $ | 22,500 | $ | - | $ | 22,500 | $ | - | |||
| XPM ETF | |||||||||||||||
| Assets | Cantor Fitzgerald & Co. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | ||
| Clear Street LLC | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Marex Capital Markets, Inc. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Liabilities | Cantor Fitzgerald & Co. | $ | 38,048 | $ | - | $ | 38,048 | $ | - | $ | 38,048 | $ | - | ||
| Clear Street LLC | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Marex Capital Markets, Inc. | $ | 247 | $ | - | $ | 247 | $ | - | $ | 247 | $ | - | |||
| QSU ETF | |||||||||||||||
| Assets | Cantor Fitzgerald & Co. | $ | 858,201 | $ | - | $ | 858,201 | $ | - | $ | - | $ | 858,201 | ||
| Clear Street LLC | $ | 324,927 | $ | - | $ | 324,927 | $ | - | $ | - | $ | 324,927 | |||
| Marex Capital Markets, Inc. | $ | 1,362,711 | $ | - | $ | 1,362,711 | $ | - | $ | - | $ | 1,362,711 | |||
| Nomura Sercurities International, Inc. | $ | 710,162 | $ | - | $ | 710,162 | $ | - | $ | - | $ | 710,162 | |||
| Liabilities | Cantor Fitzgerald & Co. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | ||
| Clear Street LLC | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Marex Capital Markets, Inc. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Nomura Sercurities International, Inc. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| RGTX ETF | |||||||||||||||
| Assets | BMO Capital Markets Corp. | $ | 14,435,950 | $ | - | $ | 14,435,950 | $ | - | $ | - | $ | 14,435,950 | ||
| Cantor Fitzgerald & Co. | $ | 38,938,332 | $ | - | $ | 38,938,332 | $ | - | $ | - | $ | 38,938,332 | |||
| Clear Street LLC | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - |
127
| Notes to the Financial Statements | Defiance ETFs |
| Marex Capital Markets, Inc. | $ | 38,964,570 | $ | - | $ | 38,964,570 | $ | - | $ | - | $ | 38,964,570 | |||
| Nomura Sercurities International, Inc. | $ | 7,680,456 | $ | - | $ | 7,680,456 | $ | - | $ | - | $ | 7,680,456 | |||
| Liabilities | BMO Capital Markets Corp. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | ||
| Cantor Fitzgerald & Co. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Clear Street LLC | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Marex Capital Markets, Inc. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Nomura Sercurities International, Inc. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| RIOX ETF | |||||||||||||||
| Assets | BMO Capital Markets Corp. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | ||
| Cantor Fitzgerald & Co. | $ | 14,509,668 | $ | - | $ | 14,509,668 | $ | - | $ | - | $ | 14,509,668 | |||
| Clear Street LLC | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Marex Capital Markets, Inc. | $ | 5,868,608 | $ | - | $ | 5,868,608 | $ | - | $ | - | $ | 5,868,608 | |||
| Liabilities | BMO Capital Markets Corp. | $ | 237,700 | $ | - | $ | 237,700 | $ | - | $ | 237,700 | $ | - | ||
| Cantor Fitzgerald & Co. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Clear Street LLC | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Marex Capital Markets, Inc. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| RKLX ETF | |||||||||||||||
| Assets | BMO Capital Markets Corp. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | ||
| Cantor Fitzgerald & Co. | $ | 15,465,317 | $ | - | $ | 15,465,317 | $ | - | $ | - | $ | 15,465,317 | |||
| Clear Street LLC | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Marex Capital Markets, Inc. | $ | 26,478,353 | $ | - | $ | 26,478,353 | $ | - | $ | - | $ | 26,478,353 | |||
| Nomura Sercurities International, Inc. | $ | 2,240,697 | $ | - | $ | 2,240,697 | $ | - | $ | - | $ | 2,240,697 | |||
| Liabilities | BMO Capital Markets Corp. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | ||
| Cantor Fitzgerald & Co. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Clear Street LLC | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Marex Capital Markets, Inc. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Nomura Sercurities International, Inc. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| SMCX ETF | |||||||||||||||
| Assets | BMO Capital Markets Corp. | $ | 5,188,300 | $ | - | $ | 5,188,300 | $ | - | $ | - | $ | 5,188,300 | ||
| Cantor Fitzgerald & Co. | $ | 28,910,784 | $ | - | $ | 28,910,784 | $ | - | $ | - | $ | 28,910,784 | |||
| Clear Street LLC | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Marex Capital Markets, Inc. | $ | 5,993,155 | $ | - | $ | 5,993,155 | $ | - | $ | - | $ | 5,993,155 | |||
| Morgan Stanley | $ | 5,297,095 | $ | - | $ | 5,297,095 | $ | - | $ | - | $ | 5,297,095 | |||
| Nomura Sercurities International, Inc. | $ | 57,212,816 | $ | - | $ | 57,212,816 | $ | - | $ | - | $ | 57,212,816 | |||
| Liabilities | BMO Capital Markets Corp. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | ||
| Cantor Fitzgerald & Co. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Clear Street LLC | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Marex Capital Markets, Inc. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Nomura Sercurities International, Inc. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Morgan Stanley | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| SOFX ETF | |||||||||||||||
| Assets | BMO Capital Markets Corp. | $ | 649,500 | $ | - | $ | 649,500 | $ | - | $ | - | $ | 649,500 | ||
| Cantor Fitzgerald & Co. | $ | 25,504,427 | $ | - | $ | 25,504,427 | $ | - | $ | - | $ | 25,504,427 |
128
| Notes to the Financial Statements | Defiance ETFs |
| Clear Street LLC | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Marex Capital Markets, Inc. | $ | 6,438,193 | $ | - | $ | 6,438,193 | $ | - | $ | - | $ | 6,438,193 | |||
| Nomura Sercurities International, Inc. | $ | 8,457,816 | $ | - | $ | 8,457,816 | $ | - | $ | - | $ | 8,457,816 | |||
| Liabilities | BMO Capital Markets Corp. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | ||
| Cantor Fitzgerald & Co. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Clear Street LLC | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Marex Capital Markets, Inc. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Nomura Sercurities International, Inc. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| SOUX ETF | |||||||||||||||
| Assets | Cantor Fitzgerald & Co. | $ | 3,859,875 | $ | - | $ | 3,859,875 | $ | - | $ | - | $ | 3,859,875 | ||
| Clear Street LLC | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Marex Capital Markets, Inc. | $ | 4,286,488 | $ | - | $ | 4,286,488 | $ | - | $ | - | $ | 4,286,488 | |||
| Nomura Sercurities International, Inc. | $ | 1,599,779 | $ | - | $ | 1,599,779 | $ | - | $ | - | $ | 1,599,779 | |||
| Liabilities | Cantor Fitzgerald & Co. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | ||
| Clear Street LLC | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Marex Capital Markets, Inc. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Nomura Sercurities International, Inc. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| VSTL ETF | |||||||||||||||
| Assets | Clear Street LLC | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | ||
| Marex Capital Markets, Inc. | $ | 31,984 | $ | - | $ | 31,984 | $ | - | $ | - | $ | 31,984 | |||
| Nomura Sercurities International, Inc. | $ | 19,360 | $ | - | $ | 19,360 | $ | - | $ | - | $ | 19,360 | |||
| Liabilities | Clear Street LLC | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | ||
| Marex Capital Markets, Inc. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Nomura Sercurities International, Inc. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| IONZ ETF | |||||||||||||||
| Assets | Cantor Fitzgerald & Co. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | ||
| Clear Street LLC | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Marex Capital Markets, Inc. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Nomura Sercurities International, Inc. | $ | 793,104 | $ | - | $ | 793,104 | $ | - | $ | - | $ | 793,104 | |||
| Liabilities | Cantor Fitzgerald & Co. | $ | 2,075,955 | $ | - | $ | 2,075,955 | $ | - | $ | 2,075,955 | $ | - | ||
| Clear Street LLC | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Marex Capital Markets, Inc. | $ | 990,565 | $ | - | $ | 990,565 | $ | - | $ | 990,565 | $ | - | |||
| Nomura Sercurities International, Inc. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| LLYZ ETF | |||||||||||||||
| Assets | Cantor Fitzgerald & Co. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | ||
| Clear Street LLC | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Marex Capital Markets, Inc. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Liabilities | Cantor Fitzgerald & Co. | $ | 48,802 | $ | - | $ | 48,802 | $ | - | $ | 48,802 | $ | - | ||
| Clear Street LLC | $ | 4,949 | $ | - | $ | 4,949 | $ | - | $ | 4,949 | $ | - | |||
| Marex Capital Markets, Inc. | $ | 33,030 | $ | - | $ | 33,030 | $ | - | $ | 33,030 | $ | - | |||
| SMST ETF | |||||||||||||||
| Assets | Cantor Fitzgerald & Co. | $ | 638,308 | $ | - | $ | 638,308 | $ | - | $ | - | $ | 638,308 | ||
| Marex Capital Markets, Inc. | $ | 793,247 | $ | - | $ | 793,247 | $ | - | $ | - | $ | 793,247 |
129
| Notes to the Financial Statements | Defiance ETFs |
| Liabilities | Cantor Fitzgerald & Co. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | ||
| Marex Capital Markets, Inc. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| PLTZ ETF | |||||||||||||||
| Assets | Cantor Fitzgerald & Co. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | ||
| Clear Street LLC | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Marex Capital Markets, Inc. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Liabilities | Cantor Fitzgerald & Co. | $ | 793,861 | $ | - | $ | 793,861 | $ | - | $ | 793,861 | $ | - | ||
| Clear Street LLC | $ | 1,700 | $ | - | $ | 1,700 | $ | - | $ | 1,700 | $ | - | |||
| Marex Capital Markets, Inc. | $ | 657,569 | $ | - | $ | 657,569 | $ | - | $ | 657,569 | $ | - | |||
| PLTZ ETF | |||||||||||||||
| Assets | Cantor Fitzgerald & Co. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | ||
| Clear Street LLC | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Marex Capital Markets, Inc. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Liabilities | Cantor Fitzgerald & Co. | $ | 305,555 | $ | - | $ | 305,555 | $ | - | $ | 305,555 | $ | - | ||
| Clear Street LLC | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Marex Capital Markets, Inc. | $ | 4,462,820 | $ | - | $ | 4,462,820 | $ | - | $ | 4,462,820 | $ | - | |||
| RGTZ ETF | |||||||||||||||
| Assets | Cantor Fitzgerald & Co. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | ||
| Clear Street LLC | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Marex Capital Markets, Inc. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Nomura Sercurities International, Inc. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Liabilities | Cantor Fitzgerald & Co. | $ | 784,425 | $ | - | $ | 784,425 | $ | - | $ | 784,425 | $ | - | ||
| Clear Street LLC | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Marex Capital Markets, Inc. | $ | 13,309,926 | $ | - | $ | 13,309,926 | $ | - | $ | 13,309,926 | $ | - | |||
| Nomura Sercurities International, Inc. | $ | 1,426,250 | $ | - | $ | 1,426,250 | $ | - | $ | 1,426,250 | $ | - | |||
| SMCZ ETF | |||||||||||||||
| Assets | Cantor Fitzgerald & Co. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | ||
| Marex Capital Markets, Inc. | $ | 49,909 | $ | - | $ | 49,909 | $ | - | $ | - | $ | 49,909 | |||
| Nomura Sercurities International, Inc. | $ | 470,400 | $ | - | $ | 470,400 | $ | - | $ | - | $ | 470,400 | |||
| Liabilities | Cantor Fitzgerald & Co. | $ | 21,382 | $ | - | $ | 21,382 | $ | - | $ | 21,382 | $ | - | ||
| Marex Capital Markets, Inc. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||
| Nomura Sercurities International, Inc. | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - |
C. Federal Income Taxes. Each Fund has elected to be taxed as a regulated investment company (“RIC”) and intends to distribute substantially all taxable income to its shareholders and otherwise comply with the provisions of the Internal Revenue Code applicable to RICs. Therefore, no provision for federal income taxes or excise taxes has been made.
In order to avoid imposition of the excise tax applicable to RICs, the Funds intend to declare as dividends in each calendar year at least 98% of its net investment income (earned during the calendar year) and at least 98.2% of its net realized capital gains (earned during the twelve months ended October 31) plus undistributed amounts, if any, from prior years. As a RIC, each Fund is subject to a 4% excise tax that is imposed if a Fund does not distribute by the end of any calendar year at least the sum of (i) 98% of its ordinary income (not taking into account any capital gain or loss) for the calendar year and (ii) 98.2% of its capital gain in excess of its capital loss (adjusted for certain ordinary losses) for a one year period generally ending on October 31 of the calendar year (unless an election is made to use the Funds’ fiscal year). The Funds generally intend to distribute income and capital gains in the manner necessary to minimize (but not
130
| Notes to the Financial Statements | Defiance ETFs |
necessarily eliminate) the imposition of such excise tax. The Funds may retain income or capital gains and pay excise tax when it is determined that doing so is in the best interest of shareholders. Management evaluates the costs of the excise tax relative to the benefits of retaining income and capital gains, including that such undistributed amounts (net of the excise tax paid) remain available for investment by the Funds and are available to supplement future distributions. Tax expense is disclosed in the Statements of Operations, if applicable.
As of October 31, 2025, the Funds did not have any tax positions that did not meet the threshold of being sustained by the applicable tax authority. Generally, tax authorities can examine all the tax returns filed for the last three years. The Funds identify their major tax jurisdiction as U.S. Federal and the Commonwealth of Delaware; however, the Funds are not aware of any tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will change materially. The Funds recognize interest and penalties, if any, related to unrecognized tax benefits on uncertain tax positions as income tax expense in the Statements of Operations.
D. Securities Transactions and Investment Income. Investment securities transactions are accounted for on the trade date. Gains and losses realized on sales of securities are determined on a specific identification basis. Discounts/premiums on debt securities purchased are accreted/amortized over the life of the respective securities using the effective interest method. Dividend income is recorded on the ex-dividend date. Interest income is recorded on an accrual basis. Other non-cash dividends are recognized as investment income at the fair value of the property received. Withholding taxes on foreign dividends have been provided for in accordance with the Funds’ understanding of the applicable country’s tax rules and rates.
E. Distributions to Shareholders. Distributions to shareholders from net investment income, if any, for the Funds are declared and paid at least annually. Distributions to shareholders from net realized gains on securities, if any, for the Funds normally are declared and paid at least annually. Distributions are recorded on the ex-dividend date.
F. Use of Estimates. The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of increases and decreases in net assets from operations during the reporting period. Actual results could differ from those estimates.
G. Share Valuation. The NAV per Share of each Fund is calculated by dividing the sum of the value of the securities held by each Fund, plus cash or other assets, minus all liabilities by the total number of Shares outstanding for each Fund, rounded to the nearest cent. The QPUX ETF, ANEL ETF, AVXX ETF, AVGX ETF, CVNX ETF, DKNX ETF, HIMZ ETF, HOOX ETF, IONX ETF, IRE ETF, JPX ETF, LMNX ETF, MPL ETF, MSTX ETF, OKLL ETF, ORCX ETF, OSCX ETF, XPM ETF, QSU ETF, RGTX ETF, RKLX ETF, SMCX ETF, SOFX ETF, SOUX ETF, VSTL ETF, IONZ ETF, LLYZ ETF, SMST ETF, PLTZ ETF, QBTZ ETF, RGTZ ETF and SMCZ ETF Shares will not be priced on the days on which The NASDAQ is closed for trading. The LLYX ETF, NVOX ETF, and RIOX ETF Shares will not be priced on the days on which the NYSE Arca, Inc. (“NYSE”) is closed for trading.
H. Guarantees and Indemnifications. In the normal course of business, the Funds enter into contracts with service providers that contain general indemnification clauses. The Funds’ maximum exposure under these arrangements is unknown as this would involve future claims that may be made against the Funds that have not yet occurred. However, based on experience, the Funds expect the risk of loss to be remote.
I. Illiquid Securities. Pursuant to Rule 22e-4 under the 1940 Act, the Funds have adopted a Board-approved Liquidity Risk Management Program (the “Program”) that requires, among other things, that the Funds limit their illiquid investments that are assets to no more than 15% of the value of each Fund’s net assets. An illiquid investment is any security that the Funds reasonably expect cannot be sold or disposed of in current market conditions in seven calendar days or less without the sale or disposition significantly changing the market value of the investment. If a Fund should be in a position where the value of illiquid investments held by each Fund exceeds 15% of each Fund’s net assets, the Funds will take such steps as set forth in the Program.
J. Derivatives Transactions. Pursuant to Rule 18f-4 under the 1940 Act, the SEC imposes limits on the amount of derivatives a fund can enter into, eliminates the asset segregation and cover framework arising from prior SEC guidance for covering derivatives and certain financial instruments currently used by funds to comply with Section 18 of the 1940 Act and treats derivatives as senior securities. Under Rule 18f-4, a fund’s derivatives exposure is limited through a value-at-risk test. The Funds whose use of derivatives is more than a limited specified exposure amount are required to establish and maintain a comprehensive derivatives risk management program, subject to oversight by a fund’s board of trustees, and appoint a derivatives risk manager. The Funds implemented a Rule 18f-4 Derivative Risk Management Program that complies with Rule 18f-4.
131
| Notes to the Financial Statements | Defiance ETFs |
NOTE 3 – PRINCIPAL INVESTMENT RISKS
Compounding and Market Volatility Risk. Each Fund has a daily leveraged investment objective and a Fund’s performance for periods greater than a trading day will be the result of each day’s returns compounded over the period, which is very likely to differ from two times (200%) the respective Underlying Security’s performance, before a Fund’s management fee and other expenses. Compounding affects all investments but has a more significant impact on funds that aim to replicate leveraged daily returns and that rebalance daily. For each Fund aiming to replicate two times the daily performance of its Underlying Security, if adverse daily performance of the Underlying Security reduces the amount of a shareholder’s investment, any further adverse daily performance will lead to a smaller dollar loss because the shareholder’s investment had already been reduced by the prior adverse performance. Equally, however, if favorable daily performance of the Underlying Security increases the amount of a shareholder’s investment, the dollar amount lost due to future adverse performance will increase because the shareholder’s investment has increased. The effect of compounding becomes more pronounced as an Underlying Security’s volatility and the holding period increase. The effect of compounding will impact each shareholder differently depending on the period of time an investment in a Fund is held and the volatility of the respective Underlying Security during a shareholder’s holding period of an investment in each Fund.
Daily Correlation/Tracking Risk. There is no guarantee that the Funds will achieve a high degree of leveraged correlation to the Target Portfolio and therefore achieve their daily leveraged investment objective. To achieve a high degree of leveraged correlation with the Target Portfolio, each Fund seeks to rebalance their portfolio daily to keep exposure consistent with their daily leveraged investment objective. The possibility of the Funds being materially over- or under-exposed to the Target Portfolio increases on days when the Target Portfolio is volatile near the close of the trading day. Additionally, if securities within the Target Portfolio exhibit unexpected or heightened correlations, each Fund’s ability to achieve their daily investment objective may be adversely impacted as overlapping exposures may reduce potential diversification benefits and amplify the effects of market movements. Market disruptions, regulatory restrictions and extreme volatility will also adversely affect each Fund’s ability to adjust exposure to the required levels. If there is a significant intra-day market event and/or the Target Portfolio experiences a significant increase or decline, each Fund may not meet their investment objective, be able to rebalance their portfolio appropriately, or may experience significant premiums or discounts, or widened bid-ask spreads. Each Fund may have difficulty achieving their daily leveraged investment objective due to fees, expenses, transaction costs, financing costs related to the use of derivatives, investments in ETFs, directly or indirectly, income items, valuation methodology, accounting standards and disruptions or illiquidity in the markets for the securities or derivatives held by the Funds. The Funds may also be impacted by large movements of assets into and out of the Funds, potentially resulting in the Funds being over- or under-exposed to the Target Portfolio. The Funds may take or refrain from taking positions to improve the tax efficiency or to comply with various regulatory restrictions, either of which may negatively impact each Fund’s leveraged correlation to the Target Portfolio. Finally, during periods of high volatility, compounding effects and correlation shifts between securities in the Target Portfolio may cause each Fund’s returns to deviate materially from two times (2X) the daily performance of the Target Portfolio.
Leverage Risk. The Funds obtain investment exposure in excess of their net assets by utilizing leverage and may lose more money in market conditions that are adverse to their investment objective than a fund that does not utilize leverage. An investment in each Fund is exposed to the risk that a decline in the daily performance of the Target Portfolio will be magnified. This means that an investment in each Fund will be reduced by an amount equal to 2% for every 1% daily decline in the share price of the Target Portfolio, not including the costs of financing leverage and other operating expenses, which would further reduce its value. The Funds could theoretically lose an amount greater than their net assets in the event the share price of the Target Portfolio declines more than 50%. Leverage will also have the effect of magnifying any differences in each Fund’s performances correlation with the Target Portfolio’s share price.
ANET Risks. The ANEL ETF invests in swap contracts and options that are based on the share price of ANET. This subjects the Fund to certain of the same risks as if it owned shares of ANET, even though it does not. By virtue of the Fund’s investments in swap contracts and options that are based on the value of ANET, the Fund may also be subject to the following risks:
Indirect Investment in ANET Risk. ANET is not affiliated with the Trust, the Fund, or the Adviser, or their respective affiliates and is not involved with this offering in any way and has no obligation to consider your Shares in taking any corporate actions that might affect the value of Shares. Investors in the Fund will not have voting rights and will not be able to influence management of ANET but will be exposed to the performance of ANET (the Underlying Security). Investors in the Fund will not have the right to receive dividends or other distributions or any other rights with respect to the Underlying Security but will be subject to declines in the performance of the Underlying Security.
132
| Notes to the Financial Statements | Defiance ETFs |
ANET Trading Risk. The trading price of ANET may be subject to volatility and could experience wide fluctuations due to various factors. Short sellers may also play a significant role in trading ANET, potentially affecting the supply and demand dynamics and contributing to market price volatility. Public perception and external factors beyond the company’s control may influence ANET’s stock price disproportionately. Additionally, following periods of market volatility, companies have faced securities class action litigation. Any adverse judgment or future stockholder litigation could result in substantial costs and divert management’s attention and resources. In the event of a halt in trading of ANET, trading in shares of related funds may be impacted, either temporarily or indefinitely.
ANET Performance Risk. ANET may fail to meet its publicly announced guidelines or other expectations about its business, which could cause the price of ANET to decline. ANET provides guidance regarding its expected financial and business performance, such as projections regarding sales and production, as well as anticipated future revenues, gross margins, profitability and cash flows. Correctly identifying key factors affecting business conditions and predicting future events is inherently an uncertain process, and the guidance ANET provides may not ultimately be accurate. If ANET’s guidance is not accurate or varies from actual results due to its inability to meet the assumptions or the impact on its financial performance that could occur as a result of various risks and uncertainties, the market value of common stock issued by ANET could decline significantly.
Communications Equipment Industry Risks. The communications equipment industry can be significantly affected by failure to obtain, or delays in obtaining, financing or regulatory approval, intense competition, product compatibility, consumer preferences, corporate capital expenditures, and rapid obsolescence. Communications services companies are subject to extensive government regulation. The costs of complying with governmental regulations, delays or failure to receive required regulatory approvals, or the enactment of new adverse regulatory requirements may adversely affect the business of such companies. These companies can also be significantly affected by intense competition, including competition with alternative technologies such as wireless communications (including with 5G and other technologies), product compatibility, consumer preferences, rapid product obsolescence, and research and development of new products. Technological innovations may make the products and services of such companies obsolete.
Limited Customer Risk. ANET expects large purchases by a limited number of customers to continue to represent a substantial portion of its revenue, and any loss, delay, decline or other change in expected purchases could result in material quarter-to quarter fluctuations of its revenue or otherwise adversely affect its results of operations. ANET may be unable to sustain or increase its revenue from its large customers, grow revenue with new or other existing customers at the rate it anticipates or at all, or offset a decline or discontinuation of concentrated purchases by larger customers with purchases by new or existing customers.
Intellectual Property Risks: ANET’s success and ability to compete depends substantially upon its core technology and intellectual property. ANET relies on patent, trademark and copyright laws, trade secret protection and confidentiality agreements with its employees, customers, resellers, systems integrators, manufacturers, and others to protect its intellectual property rights. ANET’s industry is characterized by the existence of a large number of patents and frequent claims and related litigation regarding patent and other intellectual property rights. If ANET becomes more successful, it believes that competitors will be more likely to try to develop similar products that may infringe its proprietary rights. Further, from time to time, third parties may assert patent, copyright, trademark and other intellectual property rights against ANET. Successful claims of infringement by a third-party, if any, could prevent ANET from distributing certain products or performing certain services, require ANET to expend time and money to develop non-infringing solutions or force ANET to pay substantial damages, royalties or other fees.
International Business Risks: ANET’s ability to grow its business and its future success will depend to a significant extent on its ability to expand its operations and customer base worldwide. Many of ANET’s customers, resellers, partners, suppliers and manufacturers operate around the world. Operating in a global marketplace, ANET is subject to risks associated with having an international reach and compliance and regulatory requirements.
AVAV Risks. The AVXX ETF invests in swap contracts and options that are based on the share price of AVAV. This subjects the Fund to certain of the same risks as if it owned shares of AVAV, even though it does not. By virtue of the Fund’s investments in swap contracts and options that are based on the value of AVAV, the Fund may also be subject to the following risks:
Indirect Investment in AVAV Risk. AVAV is not affiliated with the Trust, the Fund, or the Adviser, or their respective affiliates and is not involved with this offering in any way and has no obligation to consider your Shares in taking any corporate actions that might affect the value of Shares. Investors in the Fund will not have voting rights or influence over the management of AVAV but will be exposed to the performance of AVAV. Investors will also not have the right to receive dividends or other
133
| Notes to the Financial Statements | Defiance ETFs |
distributions from AVAV, but will remain subject to price fluctuations and other risks associated with ownership of the Underlying Security.
AVAV Trading Risk. The trading price of AVAV may be subject to heightened volatility influenced by various factors, including defense sector procurement cycles, geopolitical tensions, and regulatory developments affecting aerospace and unmanned systems. AVAV’s stock performance could also be impacted by investor sentiment around defense spending, drone technologies, and U.S. foreign policy, particularly in regions where AVAV’s products are deployed. Public scrutiny of military technology applications may further exacerbate market fluctuations. Additionally, the presence of short sellers or speculative trading activity may amplify volatility. In the event of a trading halt, delisting, or significant disruption in the market for AVAV shares, the Fund may experience difficulty entering, modifying, or liquidating its exposures. These conditions could impair the Fund’s ability to achieve its investment objective, result in significant tracking error, or, in extreme cases, force the Fund to liquidate entirely.
AVAV Performance Risk. AVAV’s ability to meet financial forecasts and strategic objectives depends on a range of execution risks, including the timely receipt of government contracts, successful product testing and field deployment, and competition from emerging drone or robotics platforms. Delays in procurement processes, budgetary constraints, or contract cancellations could materially affect AVAV’s revenues and margins. Moreover, reliance on a limited number of key contracts or clients introduces concentration risk. Any failure to innovate or adapt to evolving defense requirements may weaken investor confidence and lead to substantial declines in AVAV’s stock price.
Aerospace & Defense Industry Risks. Companies in the aerospace and defense industry are subject to risks stemming from their reliance on government budgets and spending priorities, which can fluctuate due to political and economic pressures. These companies often operate in highly competitive markets and may face challenges from both domestic and international competitors. The aerospace and defense industry is also affected by geopolitical tensions, trade policies, and regulatory changes that can impact market access and operational efficiency. Aerospace and defense companies typically rely on complex supply chains for specialized components and materials. Disruptions in these supply chains, whether due to shortages, price increases, or geopolitical factors, can significantly affect production and profitability. Additionally, technological advancements are critical for maintaining competitiveness in this sector, but the high cost and uncertain outcomes of research and development efforts may pose financial risks. Companies in this industry face heightened cybersecurity risks due to the sensitive nature of their technologies, and breaches can lead to operational disruptions, reputational damage, and regulatory scrutiny. Long-term fixed-cost contracts, which are common in this sector, may expose companies to financial losses if costs exceed estimates. Furthermore, environmental and safety regulations, as well as export controls, tariffs, and trade restrictions, impose significant compliance costs and may limit market opportunities. The aerospace and defense industry is inherently cyclical and influenced by global political and economic developments, which can contribute to earnings volatility and investment risks.
AVAV Government Contract Risk. A substantial portion of AVAV’s revenue is derived from contracts with the U.S. government, particularly agencies within the Department of Defense (DoD). Reductions in government defense budgets, shifts in procurement priorities, or delays in contract awards could materially impact AVAV’s business, thereby affecting the value of the Fund’s investment exposure.
AVAV Market Adoption Risk. AVAV’s growth is dependent on the continued development and adoption of uncrewed aircraft systems and loitering munitions systems. If these technologies fail to achieve broader acceptance, or if demand from domestic and international customers weakens, AVAV’s financial results could suffer. 26
AVAV Technology and R&D Risk. The markets in which AVAV competes are subject to rapid technological change. The company invests heavily in research and development, which may not always yield commercially viable products. If AVAV is unable to keep pace with evolving technologies or competitors, its performance could decline.
AVAV Operational Risk. AVAV faces risks related to scaling manufacturing operations, managing inventory, and securing critical components. Disruptions in its supply chain, inefficiencies in production, or volatility in input materials may hinder its ability to meet customer expectations and could negatively impact margins. AVAV’s products rely on rare earth metals for their manufacturing, of which a significant majority are sourced from China. In January 2024, China imposed sanctions on AeroVironment in response to sales of military equipment by the U.S. Government to Taiwan. Additionally, in March 2025, China’s Ministry of Commerce placed AeroVironment on China’s export control list. Although AVAV has not experienced a material negative impact on its business as a result of the announced sanctions and export restrictions, there may be material negative impacts on its business in the future.
134
| Notes to the Financial Statements | Defiance ETFs |
AVAV Regulatory and Legal Risk. AVAV is subject to complex government regulations and compliance obligations, including export controls, regulatory approvals, data security laws, and cybersecurity protocols. Breaches, noncompliance, or adverse legal rulings could result in penalties, reputational damage, or limits on AVAV’s ability to operate in key markets.
AVAV Intellectual Property Risk. AVAV depends on proprietary technologies for competitive differentiation. Failure to adequately protect its intellectual property, or litigation involving alleged infringement, could divert resources, increase costs, or constrain future product development.
AVAV Volatility Risk. The share price of AVAV may be volatile due to its exposure to geopolitical events, defense spending cycles, supply chain challenges, and shifts in global security dynamics. Periods of heightened market uncertainty or changes in public sentiment toward defense and aerospace contractors may lead to outsized movements in AVAV’s stock, which could adversely impact the Fund.
AVGO Risks. The AVGX ETF invests in swap contracts that are based on the share price of AVGO. This subjects the Fund to certain of the same risks as if it owned shares of AVGO, even though it does not. By virtue of the Fund’s investments in swap contracts that are based on the value of AVGO, the Fund may also be subject to the following risks:
Indirect Investment in AVGO Risk. AVGO is not affiliated with the Trust, the Fund, or the Adviser, or their respective affiliates and is not involved with this offering in any way and has no obligation to consider your Shares in taking any corporate actions that might affect the value of Shares. Investors in the Fund will not have voting rights and will not be able to influence management of AVGO but will be exposed to the performance of AVGO. Investors in the Fund will not have the right to receive dividends or other distributions or any other rights with respect to AVGO but will be subject to declines in the performance of AVGO.
AVGO Trading Risk. The trading price of AVGO may be subject to volatility and could experience wide fluctuations due to various factors. The semiconductors industry, including AVGO, operates within a market that has historically witnessed significant price and volume fluctuations, sometimes unrelated to the companies’ operating performance. Short sellers may also play a significant role in trading AVGO, potentially affecting the supply and demand dynamics and contributing to market price volatility. Public perception and external factors beyond the company’s control may influence AVGO’s share price disproportionately, as AVGO often receives heightened public attention regardless of its operational performance. Additionally, following periods of market volatility, companies, including AVGO, have faced securities class action litigation. AVGO has been subject to such litigation in the past and continues to defend against such actions. However, any adverse judgment or future stockholder litigation could result in substantial costs and divert management’s attention and resources. In the event of a halt in trading of AVGO, trading in shares of related funds may be impacted, either temporarily or indefinitely.
AVGO Performance Risk. AVGO may fail to meet its publicly announced guidelines or other expectations about its business, which could cause the price of AVGO to decline. AVGO provides guidance regarding its expected financial and business performance, such as projections regarding sales and production, as well as anticipated future revenues, gross margins, profitability and cash flows. Correctly identifying key factors affecting business conditions and predicting future events is inherently an uncertain process, and the guidance AVGO provides may not ultimately be accurate and has in the past been inaccurate in certain respects, such as the timing of new product manufacturing ramps. The guidance is based on certain assumptions such as those relating to global and local economic conditions, anticipated production and sales volumes (which generally are not linear throughout a given period), average sales prices, supplier and commodity costs, and planned cost reductions. If AVGO’s guidance is not accurate or varies from actual results due to its inability to meet the assumptions or the impact on its financial performance that could occur as a result of various risks and uncertainties, the market value of common stock issued by AVGO could decline significantly.
Business and Operational Risks. AVGO faces numerous business and operational risks, including adverse global economic conditions that could negatively impact operations. Compliance with governmental regulations and trade restrictions may result in significant expenses, and failure to comply could lead to the cessation of product manufacture and distribution, administrative proceedings, and civil or criminal penalties. Global political and economic instability, along with the failure to realize expected benefits from the VMware, LLC merger, further pose challenges. The company also encounters risks related to acquisitions, investments, joint ventures, and dispositions, which could adversely affect financial results. Additionally, dependency on senior management and the ability to attract and retain qualified personnel are critical to executing AVGO’s business strategy effectively.
135
| Notes to the Financial Statements | Defiance ETFs |
Technological and Cybersecurity Risks. AVGO is subject to technological and cybersecurity risks, including potential impairments to the confidentiality, integrity, or availability of IT systems and those of corporate infrastructure vendors, which could have a material adverse effect on the business. Operating in the highly cyclical semiconductor industry, AVGO’s sales are largely dependent on a small number of customers, and any reduction in demand or loss of significant customers could adversely affect the business. Reliance on contract manufacturing and suppliers of critical components within the supply chain, along with the need to purchase materials from a limited number of suppliers, may impact AVGO’s ability to bring products to market. Furthermore, failure to adjust manufacturing and supply chains to meet customer demand accurately could adversely affect operational results.
Legal, Environmental, and Market Risks. AVGO is involved in various legal proceedings, including intellectual property, securities litigation, and employee-related claims, which could adversely affect the business. The company’s growth in the software segment depends on customer acceptance of newer products and services, and incompatibility with operating environments or third-party products could decrease demand. Failure to enter into satisfactory software license agreements and the availability of licensed third-party software are additional concerns. Environmental, social, and governance (ESG) matters, compliance with privacy and data security laws, and adherence to environmental, health, and safety regulations could increase costs and restrict operations. Rapidly decreasing average selling prices of semiconductor products and fluctuations in foreign exchange rates also pose significant risks.
Financial and Stock-Related Risks. AVGO’s financial health is affected by substantial indebtedness, which could hinder the ability to execute business strategies. Instruments governing indebtedness impose restrictions, and servicing debt requires significant cash flows, potentially impacting business operations. The volatility of AVGO’s stock price may result in substantial losses for investors and trigger class action litigation against the company and its management. Stock repurchase fluctuations, the concentration of stock held by a small number of large investors, and uncertainties regarding the continuation of cash dividends further contribute to financial risks. Changes in tax legislation, the maintenance of tax concessions, and potential tax liabilities from VMware’s former association with Dell also significantly impact AVGO’s financial position and operating results.
CVNA Risks. The CVNX ETF invests in swap contracts and options that are based on the share price of CVNA. This subjects the Fund to certain of the same risks as if it owned shares of CVNA, even though it does not. By virtue of the Fund’s investments in swap contracts and options that are based on the value of CVNA, the Fund may also be subject to the following risks:
Indirect Investment in CVNA Risk. CVNA is not affiliated with the Trust, the Fund, or the Adviser, or their respective affiliates and is not involved with this offering in any way and has no obligation to consider your Shares in taking any corporate actions that might affect the value of Shares. Investors in the Fund will not have voting rights and will not be able to influence management of CVNA but will be exposed to the performance of CVNA (the Underlying Security). Investors in the Fund will not have the right to receive dividends or other distributions or any other rights with respect to the Underlying Security but will be subject to declines in the performance of the Underlying Security.
CVNA Trading Risk. The trading price of CVNA may be subject to volatility and could experience wide fluctuations due to various factors. Short sellers may also play a significant role in trading CVNA, potentially affecting the supply and demand dynamics and contributing to market price volatility. Public perception and external factors beyond the company’s control may influence CVNA’s stock price disproportionately. Additionally, following periods of market volatility, companies have faced securities class action litigation. Any adverse judgment or future stockholder litigation could result in substantial costs and divert management’s attention and resources. In the event of a halt in trading of CVNA, trading in shares of related funds may be impacted, either temporarily or indefinitely.
CVNA Performance Risk. CVNA may fail to meet its publicly announced guidelines or other expectations about its business, which could cause the price of CVNA to decline. CVNA provides guidance regarding its expected financial and business performance, such as projections regarding sales and production, as well as anticipated future revenues, gross margins, profitability and cash flows. Correctly identifying key factors affecting business conditions and predicting future events is inherently an uncertain process, and the guidance CVNA provides may not ultimately be accurate. If CVNA’s guidance is not accurate or varies from actual results due to its inability to meet the assumptions or the impact on its financial performance that could occur as a result of various risks and uncertainties, the market value of common stock issued by CVNA could decline significantly.
Automotive Industry Risk. The automotive retail industry is subject to significant risks that can impact both profitability and competitiveness. The industry is highly dependent on consumer demand, which can be influenced by various factors such as
136
| Notes to the Financial Statements | Defiance ETFs |
economic conditions, consumer confidence, fuel prices, and preferences for particular vehicle types. Economic downturns or decreases in consumer spending can lead to reduced vehicle sales, impacting the profitability of automotive retailers. Effective inventory management is essential to avoid excess holding costs, obsolescence, and missed sales opportunities. Additionally, the industry’s reliance on auto lending and financing means that changes in interest rates, lending standards, and credit availability can greatly influence consumer purchasing behavior. Regulatory compliance is another crucial aspect, as automotive retailers must adhere to various consumer protection, advertising, financing, and environmental standards, with non-compliance resulting in substantial fines, legal costs, and reputational damage.
Business Risks. CVNA has experienced rapid growth, requiring substantial capital investment and placing significant demands on its management, infrastructure, and financial resources. Its ability to sustain growth depends on efficiently managing inventory, scaling operations, and improving profitability, while challenges in sourcing and selling vehicles, along with reliance on automotive finance receivables, expose it to credit market disruptions and regulatory risks. Operating in a highly competitive industry, CVNA’s success relies on maintaining strong customer experiences, enhancing its brand, and staying innovative, with 37 failure to do so risking market share and growth. Macroeconomic factors, including fluctuating demand, supply chain disruptions, rising interest rates, and inflation, further impact its financial stability, alongside dependencies on key logistics and lender partnerships. Additionally, heavy reliance on proprietary technology systems poses operational and reputational risks from potential failures or cybersecurity breaches.
DKNG Risks. The DKNX ETF invests in swap contracts and options that are based on the share price of DKNG. This subjects the Fund to certain of the same risks as if it owned shares of DKNG, even though it does not. By virtue of the Fund’s investments in swap contracts and options that are based on the value of DKNG, the Fund may also be subject to the following risks:
Indirect Investment in DKNG Risk. DKNG is not affiliated with the Trust, the Fund, or the Adviser, or their respective affiliates and is not involved with this offering in any way and has no obligation to consider your Shares in taking any corporate actions that might affect the value of Shares. Investors in the Fund will not have voting rights and will not be able to influence management of DKNG but will be exposed to the performance of DKNG (the Underlying Security). Investors in the Fund will not have the right to receive dividends or other distributions or any other rights with respect to the Underlying Security but will be subject to declines in the performance of the Underlying Security.
DKNG Trading Risk. The trading price of DKNG may be subject to volatility and could experience wide fluctuations due to various factors. Short sellers may also play a significant role in trading DKNG, potentially affecting the supply and demand dynamics and contributing to market price volatility. Public perception and external factors beyond the company’s control may influence DKNG’s stock price disproportionately. Additionally, following periods of market volatility, companies have faced securities class action litigation. Any adverse judgment or future stockholder litigation could result in substantial costs and divert management’s attention and resources. In the event of a halt in trading of DKNG, trading in shares of related funds may be impacted, either temporarily or indefinitely.
DKNG Performance Risk. DKNG may fail to meet its publicly announced guidelines or other expectations about its business, which could cause the price of DKNG to decline. DKNG provides guidance regarding its expected financial and business performance, such as projections regarding sales and production, as well as anticipated future revenues, gross margins, profitability and cash flows. Correctly identifying key factors affecting business conditions and predicting future events is inherently an uncertain process, and the guidance DKNG provides may not ultimately be accurate. If DKNG’s guidance is not accurate or varies from actual results due to its inability to meet the assumptions or the impact on its financial performance that could occur as a result of various risks and uncertainties, the market value of common stock issued by DKNG could decline significantly.
Gaming Sub-Industry Risks: The global gaming industry faces intense competition from alternative entertainment options such as television, movies, and sporting events, potentially reducing the popularity of gaming offerings. Success in sports betting and iGaming depends on factors beyond DKNG’s control, including sport outcomes, which can impact product performance. Additionally, partnerships with casinos, tribes, and horse-tracks are crucial for offering gaming products in specific jurisdictions, and failure to establish or manage these partnerships could hinder DKNG’s gaming business. Moreover, growth prospects are contingent upon the uncertain legalization status of real-money gaming, which may face regulatory restrictions or delays, affecting gaming operations. Obtaining and maintaining gaming licenses in multiple jurisdictions is vital for business growth, and failure to do so could impair DKNG’s ability to operate gaming platforms. Negative events or media coverage related to gaming, such as sports betting and iGaming, could also adversely affect user engagement and acquisition, potentially impacting gaming revenues.
137
| Notes to the Financial Statements | Defiance ETFs |
Hotels, Restaurants & Leisure Industry Risks: The hotels, restaurants & leisure industry includes owners and operators of casinos and gaming facilities, hotels, resorts and cruise-ships, other leisure facilities (e.g., sport and fitness centers, stadiums, golf courses and amusement parks), and restaurants, bars, pubs, fast-food or take-out facilities. The hotels, restaurants & leisure industry is highly competitive and relies heavily on consumer spending for success. The prices of securities of companies in the hotels, restaurants & leisure industry may fluctuate widely due to general economic conditions, consumer spending and the availability of disposable income, and consumer tastes, preferences, and demographics. Companies involved in the hotels, restaurants & leisure industry may be affected by the availability and expense of liability insurance. Legislative or regulatory changes and increased government supervision also may affect companies in the hotels, restaurants & leisure industry.
General Risks. Economic downturns or reductions in discretionary consumer spending could adversely affect DKNG’s gaming revenue, as gaming relies heavily on consumer spending. Risks associated with information technology systems, including failures, errors, or disruptions, pose a threat to DKNG’s brand and reputation, as well as disrupting gaming operations. Despite security measures, DKNG’s IT infrastructure is vulnerable to cyberattacks or breaches, potentially compromising user data and damaging reputation. Operating in a complex regulatory environment exposes DKNG to legal and regulatory risks, with changes in laws or regulations potentially impacting gaming operations and expansion plans. Investing in or acquiring other gaming businesses poses integration risks, affecting DKNG’s overall performance. Being subject to taxation in multiple jurisdictions exposes DKNG to additional tax liabilities due to changes in tax laws or interpretations, affecting financial performance. The company’s stock price may experience volatility, risking potential loss for investors due to fluctuations in market conditions. Additionally, as a controlled company, shareholders may lack certain corporate governance protections, potentially impacting investor confidence.
HIMS Risks. The HIMZ ETF invests in swap contracts and options that are based on the share price of HIMS. This subjects the Fund to certain of the same risks as if it owned shares of HIMS, even though it does not. By virtue of the Fund’s investments in swap contracts and options that are based on the value of HIMS, the Fund may also be subject to the following risks:
Indirect Investment in HIMS Risk. HIMS is not affiliated with the Trust, the Fund, or the Adviser, or their respective affiliates and is not involved with this offering in any way and has no obligation to consider your Shares in taking any corporate actions that might affect the value of Shares. Investors in the Fund will not have voting rights and will not be able to influence management of HIMS but will be exposed to the performance of HIMS. Investors in the Fund will not have the right to receive dividends or other distributions or any other rights with respect to HIMS but will be subject to declines in the performance of HIMS.
HIMS Trading Risk. The trading price of HIMS may be subject to volatility and could experience wide fluctuations due to various factors. Short sellers may also play a significant role in trading HIMS, potentially affecting the supply and demand dynamics and contributing to market price volatility. Public perception and external factors beyond the company’s control may influence HIMS’s stock price disproportionately. Additionally, following periods of market volatility, companies have faced securities class action litigation. Any adverse judgment or future stockholder litigation could result in substantial costs and divert management’s attention and resources. In the event of a halt in trading of HIMS, trading in shares of related funds may be impacted, either temporarily or indefinitely.
HIMS Performance Risk. HIMS may fail to meet its publicly announced guidelines or other expectations about its business, which could cause the price of HIMS to decline. HIMS provides guidance regarding its expected financial and business performance, such as projections regarding sales and production, as well as anticipated future revenues, gross margins, profitability and cash flows. Correctly identifying key factors affecting business conditions and predicting future events is inherently an uncertain process, and the guidance HIMS provides may not ultimately be accurate. If HIMS’s guidance is not accurate or varies from actual results due to its inability to meet the assumptions or the impact on its financial performance that could occur as a result of various risks and uncertainties, the market value of common stock issued by HIMS could decline significantly.
Healthcare Providers & Services Industry Risks. The healthcare providers and services industry can be significantly affected by changing economic conditions, evolving patient demographics, and fluctuations in demand for healthcare services. Profitability in this industry is often dependent on reimbursement rates from government programs and private payors, as well as the ability to manage operational costs effectively. Changes in healthcare regulations and policies, including those related to insurance coverage and reimbursement, can materially impact the industry. Companies in the healthcare providers and services industry are subject to extensive and frequently changing government regulation, which may affect the scope of
138
| Notes to the Financial Statements | Defiance ETFs |
their activities, the rates they can charge for services, and their compliance costs. Additionally, the industry faces risks related to litigation, operational disruptions, and evolving technologies that may alter traditional service delivery models.
Business Risks. HIMS’s limited operating history and evolving business model make it difficult to evaluate its prospects, and fluctuations in its operational results and key performance metrics could lead to unmet investor expectations. The ability to expand offerings, attract and retain customers, and navigate evolving privacy, healthcare, and regulatory frameworks is critical; failure in these areas could materially and adversely impact HIMS’s business and financial condition. HIMS operates in highly competitive markets, facing challenges from established healthcare providers, retailers, pharmaceutical companies, and technology firms, which may affect its competitive position. Additionally, the success of HIMS is heavily reliant on its brand reputation, relationships with healthcare providers and medical groups, and compliance with complex healthcare and pharmacy regulations. Security breaches, data loss, legal proceedings, or regulatory changes could harm its operations and reputation. HIMS may require additional capital to support growth, which may not be available on favorable terms. Furthermore, its dual-class stock structure concentrates voting power with the company’s CEO, limiting investors’ influence on critical decisions.
HOOD Risks. The HOOX ETF invests in swap contracts and options that are based on the share price of HOOD. This subjects the Fund to certain of the same risks as if it owned shares of HOOD, even though it does not. By virtue of the Fund’s investments in swap contracts and options that are based on the value of HOOD, the Fund may also be subject to the following risks:
Indirect Investment in HOOD Risk. HOOD is not affiliated with the Trust, the Fund, or the Adviser, or their respective affiliates and is not involved with this offering in any way and has no obligation to consider your Shares in taking any corporate actions that might affect the value of Shares. Investors in the Fund will not have voting rights and will not be able to influence management of HOOD but will be exposed to the performance of HOOD. Investors in the Fund will not have the right to receive dividends or other distributions or any other rights with respect to HOOD but will be subject to declines in the performance of HOOD.
HOOD Trading Risk. The trading price of HOOD may be subject to volatility and could experience wide fluctuations due to various factors. Short sellers may also play a significant role in trading HOOD, potentially affecting the supply and demand dynamics and contributing to market price volatility. Public perception and external factors beyond the company’s control may influence HOOD’s stock price disproportionately. Additionally, following periods of market volatility, companies have faced securities class action litigation. Any adverse judgment or future stockholder litigation could result in substantial costs and divert management’s attention and resources. In the event of a halt in trading of HOOD, trading in shares of related funds may be impacted, either temporarily or indefinitely.
HOOD Performance Risk. HOOD may fail to meet its publicly announced guidelines or other expectations about its business, which could cause the price of HOOD to decline. HOOD provides guidance regarding its expected financial and business performance, such as projections regarding sales and production, as well as anticipated future revenues, gross margins, profitability and cash flows. Correctly identifying key factors affecting business conditions and predicting future events is inherently an uncertain process, and the guidance HOOD provides may not ultimately be accurate. If HOOD’s guidance is not accurate or varies from actual results due to its inability to meet the assumptions or the impact on its financial performance that could occur as a result of various risks and uncertainties, the market value of common stock issued by HOOD could decline significantly.
HOOD Operational Risks. HOOD’s plans to venture into new international markets introduces significant uncertainties that may not yield desired outcomes. Operations are subject to complex and evolving laws, with non-compliance posing threats to HOOD’s business. Past and potential future regulatory investigations, settlements, and litigation could lead to substantial costs and reputational damage. Intense competition from rivals with greater resources threatens HOOD’s market position and revenue. Failure to retain existing customers or attract new ones, coupled with reduced usage of products and services, may result in declining revenue. Moreover, failure to develop and monetize innovative offerings could diminish competitiveness and revenue streams.
Dependence on complex software and systems entails the risk of interruptions, instability, and flaws, potentially disrupting operations. Reliance on third-party entities for critical functions exposes the company to risks associated with their performance. Additionally, incorporating AI technologies presents business, compliance, and reputational risks. Cybersecurity breaches targeting the company’s systems or customer data could lead to significant financial and reputational damage. Failure to maintain required net capital levels may result in restrictions and regulatory actions.
139
| Notes to the Financial Statements | Defiance ETFs |
Risks associated with the effectiveness of compliance and risk management policies and procedures may impact operations under different market conditions. Operating in the highly volatile cryptocurrency market exposes the company to uncertainties and fluctuations affecting trading volumes and revenues.
Regulatory uncertainties surrounding cryptocurrency classification and compliance could lead to scrutiny, fines, and penalties. The complexity of rapidly evolving and difficult-to-interpret cryptocurrency laws and regulations poses challenges and compliance risks. Offering payment and spending services introduces risks related to illegal payments, customer asset loss, disputes, and liabilities. Future issuances of stock may lead to significant dilution, impacting shareholder value. Lastly, concentrated voting power with founders and multi-class stock structures limit shareholder influence over company decisions.
Financial Exchanges and Data Industry Risks. The industry is highly susceptible to fluctuations in economic conditions, changes in market sentiment, and regulatory alterations, which can significantly affect market volatility and trading volumes. Technological disruptions or failures, including cybersecurity breaches, could compromise user data and disrupt trading activities, potentially leading to financial losses for both the company and its users. Additionally, the competitive landscape, with rapid technological advancements and the emergence of new competitors, could impact HOOD’s market share and profitability. Such factors could adversely affect HOOD’s business performance and stock price and, in turn, negatively impact the Fund.
Global Crypto Asset Trading Platform Risks. HOOD has announced plans to expand its crypto asset business. Such an expansion will subject HOOD to risks related to regulatory compliance, such as the potential for increased scrutiny, enhanced anti-money laundering (AML) and know your customer (KYC) requirements, and the need for additional licenses in various jurisdictions. Operational risks will also arise from the complexities of integrating the new platform’s operations, technology, and culture, as well as the need to bolster system security and manage a more extensive technology infrastructure. Market risks, including high volatility and liquidity management challenges, will become more pronounced. Reputational risks could emerge from potential security breaches, operational failures, or regulatory violations, affecting customer trust and market perception. Legal risks may increase due to potential litigation and intellectual property issues. Additionally, HOOD will be subject to financial risks associated with the capital investment required for the expansion.
IONQ Risks. The IONX ETF invests in swap contracts and options that are based on the share price of IONQ. This subjects the Fund to certain of the same risks as if it owned shares of IONQ, even though it does not. By virtue of the Fund’s investments in swap contracts and options that are based on the value of IONQ, the Fund may also be subject to the following risks:
Indirect Investment in IONQ Risk. IONQ is not affiliated with the Trust, the Fund, or the Adviser, or their respective affiliates and is not involved with this offering in any way and has no obligation to consider your Shares in taking any corporate actions that might affect the value of Shares. Investors in the Fund will not have voting rights and will not be able to influence management of IONQ but will be exposed to the performance of IONQ. Investors in the Fund will not have the right to receive dividends or other distributions or any other rights with respect to IONQ but will be subject to declines in the performance of IONQ.
IONQ Trading Risk. The trading price of IONQ may be subject to volatility and could experience wide fluctuations due to various factors. Short sellers may also play a significant role in trading IONQ, potentially affecting the supply and demand dynamics and contributing to market price volatility. Public perception and external factors beyond the company’s control may influence IONQ’s stock price disproportionately. Additionally, following periods of market volatility, companies have faced securities class action litigation. Any adverse judgment or future stockholder litigation could result in substantial costs and divert management’s attention and resources. In the event of a halt in trading of IONQ, trading in shares of related funds may be impacted, either temporarily or indefinitely.
IONQ Performance Risk. IONQ may fail to meet its publicly announced guidelines or other expectations about its business, which could cause the price of IONQ to decline. IONQ provides guidance regarding its expected financial and business performance, such as projections regarding sales and production, as well as anticipated future revenues, gross margins, profitability and cash flows. Correctly identifying key factors affecting business conditions and predicting future events is inherently an uncertain process, and the guidance IONQ provides may not ultimately be accurate. If IONQ’s guidance is not accurate or varies from actual results due to its inability to meet the assumptions or the impact on its financial performance that could occur as a result of various risks and uncertainties, the market value of common stock issued by IONQ could decline significantly.
140
| Notes to the Financial Statements | Defiance ETFs |
Technology Hardware, Storage & Peripherals Risks. Companies in the technology hardware, storage, and peripherals industry may face intense competition, both domestically and internationally, which can pressure profit margins and market share. These companies often rely on complex supply chains and third-party providers for components, manufacturing, and services. Supply chain disruptions, including the unavailability of critical materials or components, price increases, or delays in production, can adversely affect operations. Many companies in this industry depend on a limited number of suppliers or suppliers concentrated in specific geographic regions, which may increase vulnerability to geopolitical risks, natural disasters, or regulatory changes. Identifying and qualifying alternative suppliers can be time-consuming and costly, with no guarantee of availability. Additionally, operations may be impacted by resource constraints, including shortages of electricity, rare earth elements, or other essential materials. Companies in this industry are also exposed to cybersecurity threats, intellectual property risks, and evolving technological standards, which may increase operational costs and hinder competitiveness.
Business Risks. IONQ is an early-stage business with a limited operating history, a history of operating losses, and an expectation of significant expenses and losses for the foreseeable future. IONQ faces challenges scaling its business, managing growth, and effectively executing its strategies in a nascent and volatile quantum computing industry. The company’s success is highly dependent on its ability to develop scalable quantum computing systems, achieve cost reductions, and maintain competitive positioning in a rapidly evolving market. There is no assurance that IONQ’s technology will achieve broad market adoption, particularly given the technical and economic challenges of the quantum computing sector.
IONQ’s reliance on key employees and its ability to retain talent with specialized knowledge is critical to its operations. Additionally, much of its revenue is concentrated among a few customers, making the business vulnerable to contract terminations or customer loss. Dependence on proprietary ion trap technology and specific isotopic materials introduces supply chain risks, while compatibility with industry-standard software and hardware remains a concern. Intellectual property risks, including the loss or compromise of trade secrets, inability to maintain patent protections, or litigation claims, could harm the company’s competitive edge.
IONQ is also exposed to risks related to international expansion, government contracts, and regulatory changes, including tariffs and trade restrictions. Operational disruptions, cybersecurity threats, and adverse global economic conditions could further impact IONQ’s growth and profitability. If IONQ fails to meet market expectations or achieve forecasted growth, its stock price and long-term prospects could be materially affected.
IREN Risks. The IRE ETF invests in swap contracts and options that are based on the share price of IREN. This subjects the Fund to certain of the same risks as if it owned shares of IREN, even though it does not. By virtue of the Fund’s investments in swap contracts and options that are based on the value of IREN, the Fund may also be subject to the following risks:
Indirect Investment in IREN Risk. IREN is not affiliated with the Trust, the Fund, or the Adviser, or their respective affiliates and is not involved with this offering in any way and has no obligation to consider your Shares in taking any corporate actions that might affect the value of Shares. Investors in the Fund will not have voting rights or influence over the management of IREN but will be exposed to the performance of IREN (the Underlying Security). Investors will also not have the right to receive dividends or other distributions from IREN, but will remain subject to price fluctuations and other risks associated with ownership of the Underlying Security.
IREN Trading Risk. The trading price of IREN may be subject to volatility and could experience wide fluctuations due to various factors. Short sellers may also influence IREN’s trading activity, contributing to market instability. Public perception and external factors beyond the company’s control may influence IREN’s stock price disproportionately. Additionally, following periods of market volatility, companies have faced securities class action litigation. Any adverse judgment or future stockholder litigation could result in substantial costs and divert management’s attention and resources. In the event of a trading halt, delisting, or significant disruption in the market for IREN’s shares, the Fund may experience difficulty entering, modifying, or liquidating its exposures. These conditions could impair the Fund’s ability to achieve its investment objective, result in significant tracking error, or, in extreme cases, force the Fund to liquidate entirely.
IREN Performance Risk. IREN may fail to meet its publicly announced guidelines or other expectations about its business, which could cause the price of IREN to decline. Correctly identifying key factors affecting business conditions and predicting future events is inherently an uncertain process, and the guidance IREN provides may not ultimately be accurate. If IREN’s guidance is not accurate or varies from actual results due to its inability to meet the assumptions or the impact on its financial performance that could occur as a result of various risks and uncertainties, the market value of common stock issued by IREN could decline significantly.
141
| Notes to the Financial Statements | Defiance ETFs |
Software Industry Risks. The software industry can be significantly affected by intense competition, aggressive pricing, technological innovations, and product obsolescence. Companies in the software industry are subject to significant competitive pressures, such as aggressive pricing, new market entrants, competition for market share, short product cycles due to an accelerated rate of technological developments and the potential for limited earnings and/or falling profit margins. These companies also face the risks that new services, equipment or technologies will not be accepted by consumers and businesses or will become rapidly obsolete. These factors can affect the profitability of these companies and, as a result, the value of their securities. Also, patent protection is integral to the success of many companies in this industry, and profitability can be affected materially by, among other things, the cost of obtaining (or failing to obtain) patent approvals, the cost of litigating patent infringement and the loss of patent protection for products (which significantly increases pricing pressures and can materially reduce profitability with respect to such products). In addition, many software companies have limited operating histories. Prices of these companies’ securities historically have been more volatile than other securities, especially over the short term.
Financial Reporting Controls Risk. In connection with its review of the internal control structure related to the preparation of the restated financial statements for the fiscal years as of and for the fiscal years ended June 30, 2024, 2023 and 2022, IREN has identified a material weakness in its internal control over financial reporting relating to its improper classification of proceeds from the sale of bitcoin mined as cash flows from operating activities rather than cash flows from investing activities. If IREN is not able to successfully remediate this material weakness, it may not be able to accurately report its financial results in a timely manner, which may adversely affect investor confidence in IREN and materially and adversely affect IREN’s business and operating results. In addition, should IREN fail to comply with required timelines governing its financial reporting, it’s possible IREN stock could be delisted, which would prevent the Fund from continuing to operate.
Limited Operating History Risk. IREN has a limited operating history, with operating losses as the business has grown. If IREN cannot sustain greater revenues than its operating costs, IREN will incur operating losses, which could adversely impact IREN’s operations, strategy and financial performance.
Data Center Operations Risks. Certain key pieces of electrical or data center equipment may represent single points of failure for some or all of the power capacity at IREN’s operating sites. Any failure or imminent risk of failure of such equipment may result in IREN’s inability to utilize some or all of its equipment in an affected location for the duration of time it takes to repair or remediate equipment, or procure and install replacement parts. Due to the long-lead times required to acquire some of the equipment used in its operations, the failure of such parts could result in lengthy outages at an affected location, and could materially impact IREN’s operations (including impacts on hosting high performance computing (HPC) solutions (including AI Cloud Services) customers), financial results and financial condition.
Energy Risks. IREN targets markets with high levels of renewable energy penetration and IREN’s energy is primarily sourced from renewable sources, whether from clean or renewable sources, as reported by BC Hydro, or through the purchase of renewable energy certificates (RECs). While renewable energy generally is less exposed to carbon pricing and underlying commodity price risks of fossil fuels, there is a risk that regulatory constraints placed on energy-intensive industries may restrict or ban the operation of, or increase the cost of operating, data centers and bitcoin mining or high performance computing (HPC) activities.
Bitcoin Risk. While the Fund will not directly invest in digital assets, it will be subject to the risks associated with bitcoin by virtue of its exposure to IREN. IREN primarily generates its revenue from the sale of bitcoin as a result of rewards and transaction fees received in exchange for contributing computational power to mining pools to validate transactions on the bitcoin network. Similarly, IREN’s operating cash flow substantially depends on its ability to sell bitcoin for fiat currency as needed. In developing its business plan and operating budget, as well as expansion plans, IREN makes certain assumptions regarding future bitcoin prices. The prices that IREN receives for its bitcoin depend on numerous market factors beyond its control. Accordingly, some underlying bitcoin price assumptions IREN relies on may materially change and actual bitcoin prices may differ materially from those expected, which could adversely impact IREN’s operations financial performance.
Additional risks related to bitcoin include uncertainty surrounding new technology, limited evaluation due to bitcoin’s short trading history, and the potential decline in adoption and value over the long term. The extreme volatility of bitcoin’s price is also a risk factor. Regulatory uncertainties, such as potential government interventions and conflicting regulations across jurisdictions, can impact the demand for bitcoin and restrict its usage. Additionally, risks associated with the sale of newly mined bitcoin, bitcoin trading platforms, competition from alternative digital assets, mining operations, network modifications, and intellectual property claims pose further challenges to bitcoin-linked investments.
142
| Notes to the Financial Statements | Defiance ETFs |
Foreign Issuer Risk: IREN is an Australian company. Because the Fund has indirect exposure to a foreign company, the Fund may be subject to risks associated with foreign investments.
Currency Risk: Indirect exposure to foreign currencies subjects the Fund to the risk that currencies will decline in value relative to the U.S. dollar. Currency rates in foreign countries may fluctuate significantly over short periods of time for a number of reasons, including changes in interest rates and the imposition of currency controls or other political developments in the U.S. or abroad.
Foreign Securities Risk: Investments in securities of non-U.S. issuers involve certain risks that may not be present with investments in securities of U.S. issuers, such as risk of loss due to foreign currency fluctuations or to political or economic instability, as well as varying regulatory requirements applicable to investments in non-U.S. issuers. There may be less information publicly available about a non-U.S. issuer than a U.S. issuer. Non-U.S. issuers may also be subject to different regulatory, accounting, auditing, financial reporting and investor protection standards than U.S. issuers.
JPM Risks. The JPX ETF invests in swap contracts and options that are based on the share price of JPM. This subjects the Fund to certain of the same risks as if it owned shares of JPM, even though it does not. By virtue of the Fund’s investments in swap contracts and options that are based on the value of JPM, the Fund may also be subject to the following risks:
Indirect Investment in JPM Risk. JPM is not affiliated with the Trust, the Fund, or the Adviser, or their respective affiliates and is not involved with this offering in any way and has no obligation to consider your Shares in taking any corporate actions that might affect the value of Shares. Investors in the Fund will not have voting rights and will not be able to influence management of JPM but will be exposed to the performance of JPM (the Underlying Security). Investors in the Fund will not have the right to receive dividends or other distributions or any other rights with respect to the Underlying Security but will be subject to declines in the performance of the Underlying Security.
JPM Trading Risk. The trading price of JPM may be subject to volatility and could experience wide fluctuations due to various factors. Short sellers may also play a significant role in trading JPM, potentially affecting the supply and demand dynamics and contributing to market price volatility. Public perception and external factors beyond the company’s control may influence JPM’s stock price disproportionately. Additionally, following periods of market volatility, companies have faced securities class action litigation. Any adverse judgment or future stockholder litigation could result in substantial costs and divert management’s attention and resources. In the event of a halt in trading of JPM, trading in shares of related funds may be impacted, either temporarily or indefinitely.
JPM Performance Risk. JPM may fail to meet its publicly announced guidelines or other expectations about its business, which could cause the price of JPM to decline. JPM provides guidance regarding its expected financial and business performance, such as projections regarding sales and production, as well as anticipated future revenues, gross margins, profitability and cash flows. Correctly identifying key factors affecting business conditions and predicting future events is inherently an uncertain process, and the guidance JPM provides may not ultimately be accurate. If JPM’s guidance is not accurate or varies from actual results due to its inability to meet the assumptions or the impact on its financial performance that could occur as a result of various risks and uncertainties, the market value of common stock issued by JPM could decline significantly.
Banking Industry Risk. Banks depend upon being able to obtain funds at reasonable costs and upon liquidity in the capital and credit markets to finance their lending and other operations which makes banks sensitive to changes in money market and general economic conditions. When a bank’s borrowers have financial trouble, their failure to repay the bank will adversely affect the bank’s financial situation. Banks are also highly regulated. Decisions by regulators may limit the loans banks make and the interest rates and fees they charge, and may reduce a bank’s profitability. Banks may also be subject to severe price competition. Competition is high among banking companies and failure to maintain or increase market share may result in lost market value. Events involving limited liquidity, defaults, non-performance or other adverse developments that have affected the financial services industry have in the past and may in the future lead to market-wide liquidity problems, and could negatively affect the value and of Banks. For example, in March 2023, several financial institutions experienced a larger-than expected decline in deposits and two regional banks, Silicon Valley Bank and Signature Bank, were placed into receivership. Although the Federal Reserve, the U.S. Department of Treasury, and the Federal Deposit Insurance Corporation have taken measures to stabilize the financial system, uncertainty and liquidity concerns in the broader financial services industry remains. Additionally, should there be additional systemic pressure on the financial system and capital markets, there can be no assurances of the response of any government or regulator, and any response may not be as favourable to industry participants as the measures currently being pursued.
143
| Notes to the Financial Statements | Defiance ETFs |
Business Risks. JPM faces significant risks including regulatory and compliance challenges inherent in the highly regulated financial services industry, which can lead to increased costs and operational constraints due to changes in laws, regulations, or their enforcement. Economic and market conditions—such as fluctuations in interest rates, credit spreads, and economic instability—can adversely affect the firm’s consumer and wholesale banking activities, investment positions, liquidity, and capital levels. Credit risks from adverse changes in the financial condition of clients, customers, and counterparties, as well as declines in collateral values, may result in financial losses. Operational risks, including dependence on complex systems, cybersecurity threats, and the ability to attract and retain qualified employees, pose significant challenges. Reputational risks arising from employee misconduct, compliance failures, or failure to meet stakeholder expectations—including those related to environmental, social, and governance (ESG) concerns—can impact the firm’s relationships and competitive position. Additionally, liquidity and capital risks, such as market-wide disruptions or the inability to meet regulatory capital requirements, could limit JPM’s ability to fund operations or support business activities.
LLY Risks. The LLYX ETF invests in swap contracts that are based on the share price of LLY. This subjects the Fund to certain of the same risks as if it owned shares of LLY, even though it does not. By virtue of the Fund’s investments in swap contracts that are based on the value of LLY, the Fund may also be subject to the following risks:
Indirect Investment in LLY Risk. LLY is not affiliated with the Trust, the Fund, or the Adviser, or their respective affiliates and is not involved with this offering in any way and has no obligation to consider your Shares in taking any corporate actions that might affect the value of Shares. Investors in the Fund will not have voting rights and will not be able to influence management of LLY but will be exposed to the performance of LLY. Investors in the Fund will not have the right to receive dividends or other distributions or any other rights with respect to LLY but will be subject to declines in the performance of LLY.
LLY Trading Risk. The trading price of LLY may be subject to volatility and could experience wide fluctuations due to various factors. The pharmaceutical industry, including LLY, operates within a market that has historically witnessed significant price and volume fluctuations, sometimes unrelated to the companies’ operating performance. Short sellers may also play a significant role in trading LLY, potentially affecting the supply and demand dynamics and contributing to market price volatility. Public perception and external factors beyond the company’s control may influence LLY’s stock price disproportionately, as LLY often receives heightened public attention regardless of its operational performance. Additionally, following periods of market volatility, companies, including LLY, have faced securities class action litigation. LLY has been subject to such litigation in the past and continues to defend against such actions. However, any adverse judgment or future stockholder litigation could result in substantial costs and divert management’s attention and resources. In the event of a halt in trading of LLY, trading in shares of related funds may be impacted, either temporarily or indefinitely.
LLY Performance Risk. LLY may fail to meet its publicly announced guidelines or other expectations about its business, which could cause the price of LLY to decline. LLY provides guidance regarding its expected financial and business performance, such as projections regarding sales and production, as well as anticipated future revenues, gross margins, profitability and cash flows. Correctly identifying key factors affecting business conditions and predicting future events is inherently an uncertain process, and the guidance LLY provides may not ultimately be accurate and has in the past been inaccurate in certain respects, such as the timing of new product manufacturing ramps. The guidance is based on certain assumptions such as those relating to global and local economic conditions, anticipated production and sales volumes (which generally are not linear throughout a given period), average sales prices, supplier and commodity costs, and planned cost reductions. If LLY’s guidance is not accurate or varies from actual results due to its inability to meet the assumptions or the impact on its financial performance that could occur as a result of various risks and uncertainties, the market value of common stock issued by LLY could decline significantly.
Pharmaceutical Industry Risks: Pharmaceutical research and development are very costly and highly uncertain; LLY may not succeed in developing, licensing, or acquiring commercially successful products sufficient in number or value to replace revenues of products that have lost or will lose intellectual property protection or are displaced by competing products or therapies. LLY and LLY’s products face intense competition from multinational pharmaceutical companies, biotechnology companies, and lower-cost generic and biosimilar manufacturers, and such competition could have a material adverse effect on LLY’s business. LLY’s business is subject to increasing government price controls and other public and private restrictions on pricing, reimbursement, and access for LLY’s drugs, which could have a material adverse effect on LLY’s results of operations, reputation or business. Pharmaceutical products can develop safety or efficacy concerns, which could have a material adverse effect on LLY’s revenues, income, and reputation.
Intellectual Property Risks: LLY derives a significant percentage of its total revenue from relatively few products and sells products through increasingly consolidated supply chain entities, which may subject LLY to, or exacerbate, various risks.
144
| Notes to the Financial Statements | Defiance ETFs |
LLY depends on products with intellectual property protection for most of LLY’s revenues, cash flows, and earnings; the loss of effective intellectual property protection for certain of LLY’s products has resulted, and in the future is likely to continue to result, in rapid and severe declines in revenues for those products. LLY’s long-term success depends on intellectual property protection; if LLY’s intellectual property rights are invalidated, circumvented, or weakened, LLY’s business will be adversely affected.
Operations Risks: Failure, inadequacy, breach of, or unauthorized access to, LLY’s IT systems or those of LLY’s third-party service providers, unauthorized access to LLY’s confidential information, or violations of data protection laws, could each result in material harm to LLY’s business and reputation. Manufacturing, quality, or supply chain difficulties, disruptions, or shortages could lead to product supply problems. Reliance on third-party relationships and outsourcing arrangements could adversely affect LLY’s business. LLY’s use of artificial intelligence or other emerging technologies could adversely impact LLY’s business and financial results.
Intellectual Property Risks: LLY derives a significant percentage of its total revenue from relatively few products and sells products through increasingly consolidated supply chain entities, which may subject LLY to, or exacerbate, various risks. LLY depends on products with intellectual property protection for most of LLY’s revenues, cash flows, and earnings; the loss of effective intellectual property protection for certain of LLY’s products has resulted, and in the future is likely to continue to result, in rapid and severe declines in revenues for those products. LLY’s long-term success depends on intellectual property protection; if LLY’s intellectual property rights are invalidated, circumvented, or weakened, LLY’s business will be adversely affected.
Government Regulation and Litigation Risks: LLY faces litigation and investigations related to its products, how LLY price or commercialize its products, and other aspects of LLY’s business, which could adversely affect LLY’s business, and LLY is self-insured for such matters. LLY is subject to evolving and complex tax laws, which may result in additional liabilities and affect LLY’s results of operations. Regulatory compliance problems could be damaging to LLY.
LMND Risks. The LMNX ETF invests in swap contracts and options that are based on the share price of LMND. This subjects the Fund to certain of the same risks as if it owned shares of LMND, even though it does not. By virtue of the Fund’s investments in swap contracts and options that are based on the value of LMND, the Fund may also be subject to the following risks:
Limited Operating History and Profitability Risk. LMND is a relatively young company in the insurance industry, having launched its operations in 2016. It has a limited track record of generating consistent revenues and has incurred net losses each year since inception. The company has yet to demonstrate sustained profitability and may not do so in the foreseeable future. Its ability to execute its growth strategy, including expanding into new markets, launching new product lines and retaining and expanding customer base, may face significant hurdles, including customer acquisition costs, regulatory complexities, and underwriting losses.
Indirect Investment in LMND Risk. LMND is not affiliated with the Trust, the Fund, or the Adviser, or their respective affiliates, and is not involved with this offering in any way and has no obligation to consider your Shares in taking any corporate actions that might affect the value of Shares. Investors in the Fund will not have voting rights and will not be able to influence management of LMND but will be exposed to the performance of LMND. Investors in the Fund will not have the right to receive dividends or other distributions or any other rights with respect to the Underlying Security but will be subject to declines in the performance of the Underlying Security.
LMND Trading Risk. LMND’s share price may experience substantial volatility due to factors such as underwriting results, consumer adoption of digital insurance models, technological disruptions, and broader sentiment toward “insurance-tech” companies. Public perception, media coverage, or unexpected developments in the traditional insurance industry may also cause disproportionate movements in the stock price. In the event of a trading halt, delisting, or significant disruption in the market for LMND shares, the Fund may experience difficulty entering, modifying, or liquidating its exposures. These conditions could impair the Fund’s ability to achieve its investment objective, result in significant tracking error, or, in extreme cases, force the Fund to liquidate entirely.
LMND Performance Risk. LMND’s business performance is tied to its ability to price risk effectively using AI (artificial intelligence)-driven models, maintain low loss ratios, and scale efficiently. If LMND underestimates risk, overestimates customer retention, or faces adverse claims trends (e.g., due to climate events or inflation in repair costs), financial results may suffer. Additionally, its dependence on reinsurance arrangements to manage risk exposure introduces uncertainty if those counterparties fail to perform or renew terms on favorable conditions.
145
| Notes to the Financial Statements | Defiance ETFs |
Insurance Industry Risk. The insurance industry is subject to a broad set of financial, operational, and regulatory risks that can materially affect profitability and business performance. Insurers rely heavily on accurate underwriting, actuarial modeling, and risk selection to remain solvent and competitive; adverse claim trends, catastrophic events, or unexpected loss development can significantly impact earnings. Investment performance is also a key driver of results, and fluctuations in interest rates, credit markets, or equity valuations may affect portfolio returns and capital adequacy. The industry is highly regulated, requiring strict compliance with solvency, reporting, and consumer protection rules; failure to comply may result in fines, license restrictions, or reputational damage. Additionally, pricing pressures, policyholder behavior, and evolving coverage needs—particularly in areas like cyber risk or climate-related exposures, require continuous product innovation and disciplined risk management to maintain market relevance and profitability.
Technology and AI Model Risk. LMND’s platform relies heavily on artificial intelligence, machine learning, and chatbots to underwrite policies, handle claims, and manage customer interactions. Errors in model development, unanticipated algorithmic bias, or technological breakdowns could result in underwriting inaccuracies, reputational damage, or regulatory scrutiny. Overreliance on automation may also reduce flexibility in responding to complex or evolving insurance scenarios. LMND employs third-party licensed software for use in LMND’s business, and the inability to maintain these licenses, errors in the licensed software or the terms of open source licenses could result in increased costs or reduced service levels.
Regulatory and Compliance Risk. LMND operates across multiple U.S. states and international jurisdictions, each with its own insurance regulations and licensing requirements. Regulatory regimes in these regions can change frequently and may impose burdensome capital, solvency, or consumer protection requirements. Failure to comply with applicable laws could lead to fines, business restrictions, or reputational harm. In particular, expansion into new markets or product categories could expose LMND to unfamiliar regulatory landscapes.
Competitive Risk. LMND competes with established insurance providers that have larger customer bases, deeper financial resources, and entrenched distribution networks. These traditional insurers may respond to LMND’s entry with aggressive pricing, marketing, or lobbying efforts. Additionally, other digital-native insurance startups may emerge with superior technology, lower costs, or more attractive product offerings. Increased competition may constrain LMND’s growth or compress margins.
Reinsurance and Risk Transfer Risk. A significant portion of LMND’s underwriting exposure is transferred to third-party reinsurers. While this strategy helps limit volatility, it also introduces counterparty risk. Any disruption in reinsurance capacity, pricing, or willingness to renew terms could force LMND to retain more risk or reduce underwriting volume. Reinsurance treaties may also include provisions that could negatively impact expected recoveries during periods of elevated claims.
Weather and Catastrophe Exposure Risk. LMND underwrites homeowners, renters, and pet insurance, products that are inherently vulnerable to weather-related losses. Severe natural catastrophes such as hurricanes, wildfires, or floods could lead to a surge in claims and materially affect results. Climate change may increase the frequency or severity of such events, challenging LMND’s ability to accurately model or price risk over time.
Capital Needs and Dilution Risk. LMND has historically relied on equity financing to fund operations and may need to raise additional capital to support future growth, meet regulatory requirements, or offset underwriting losses. If market conditions are unfavorable, LMND may be unable to raise capital on attractive terms, limiting strategic flexibility or operational continuity.
MP Risks. The MPL ETF invests in swap contracts and options that are based on the share price of MP. This subjects the Fund to certain of the same risks as if it owned shares of MP, even though it does not. By virtue of the Fund’s investments in swap contracts and options that are based on the value of MP, the Fund may also be subject to the following risks:
Indirect Investment in MP Risk. MP is not affiliated with the Trust, the Fund, or the Adviser, or their respective affiliates and is not involved with this offering in any way and has no obligation to consider your Shares in taking any corporate actions that might affect the value of Shares. Investors in the Fund will not have voting rights or influence over the management of MP but will be exposed to the performance of MP (the Underlying Security). Investors will also not have the right to receive dividends or other distributions from MP, but will remain subject to price fluctuations and other risks associated with ownership of the Underlying Security.
146
| Notes to the Financial Statements | Defiance ETFs |
MP Trading Risk. The trading price of MP may be subject to volatility and could experience wide fluctuations due to various factors. Short sellers may also influence MP’s trading activity, contributing to market instability. Public perception and external factors beyond the company’s control may influence MP’s stock price disproportionately. Additionally, following periods of market volatility, companies have faced securities class action litigation. Any adverse judgment or future stockholder litigation could result in substantial costs and divert management’s attention and resources. In the event of a trading halt, delisting, or significant disruption in the market for MP’s shares, the Fund may experience difficulty entering, modifying, or liquidating its exposures. These conditions could impair the Fund’s ability to achieve its investment objective, result in significant tracking error, or, in extreme cases, force the Fund to liquidate entirely.
MP Performance Risk. MP may fail to meet its publicly announced guidelines or other expectations about its business, which could cause the price of MP to decline. Correctly identifying key factors affecting business conditions and predicting future events is inherently an uncertain process, and the guidance MP provides may not ultimately be accurate. If MP’s guidance is not accurate or varies from actual results due to its inability to meet the assumptions or the impact on its financial performance that could occur as a result of various risks and uncertainties, the market value of common stock issued by MP could decline significantly.
Metals and Mining Industry Risks. Metals and mining companies can be significantly affected by events relating to international political and economic developments, energy conservation, the success of exploration projects, commodity prices, and tax and other government regulations. Investments in metals and mining companies may be speculative and may be subject to greater price volatility than investments in other types of companies. Risks of metals and mining investments include: changes in international monetary policies or economic and political conditions that can affect the supply of precious metals and consequently the value of metals and mining company investments; the United States or foreign governments may pass laws or regulations limiting metals investments for strategic or other policy reasons; and increased environmental or labor costs may depress the value of metals and mining investments.
Rare Earth Elements Risks. Because MP’s revenue is, and will be for the foreseeable future, from the sale of rare earth products, changes in demand for, and the market price of (including taxes and other tariffs and fees imposed upon) rare earth elements (REE) and magnet materials could significantly affect MP’s profitability. MP’s financial results may be significantly adversely affected by declines in our realized prices for REE and magnet materials. REE and magnet material prices may fluctuate and are affected by numerous factors beyond MP’s control such as interest rates, exchange rates, taxes, inflation or deflation, fluctuation in the relative value of the U.S. dollar against foreign currencies on the world market, shipping and other transportation and logistics costs, global and regional supply and demand for rare earth minerals and products, potential industry trends, such as competitor consolidation or other integration methodologies, and the political and economic conditions of countries that produce and procure REE and magnet materials.
The rare earth mining and processing and magnet manufacturing industry is capital intensive with competitive market dynamics. Production of REE and magnet products is dominated by Chinese competitors. These competitors may have greater financial resources, as well as other strategic advantages to operate, maintain, improve, and possibly expand their facilities. Additionally, MP’s Chinese competitors have historically been able to produce at relatively low costs due to domestic economic and regulatory factors, including less stringent environmental and governmental regulations and lower labor and benefit costs. If MP is not able to achieve consistent product quality at its anticipated costs of production, then any strategic advantages that MP’s competitors may have, including, without limitation, lower labor, compliance, and production costs, could have a material adverse effect on MP’s business.
Innovation Risks. Technology changes rapidly in the industries and end-markets that utilize MP’s materials. If these industries introduce new technologies or products that no longer require the rare earth materials or NdFeB magnets that MP produces or may produce in the future, or suitable substitutes become available, this could result in a decline in demand for MP’s rare earth materials or NdFeB magnets, which would have a material adverse effect on MP’s business and the results of its operations.
Key Customer Risks. MP currently sells the vast majority of its rare earth concentrate to Shenghe, which then typically sells that product to refiners in China. Demand for rare earth concentrate is currently constrained to a relatively limited number of refiners, a significant majority of which are based in China. While Shenghe is obligated under an agreement to purchase all of the rare earth concentrate product meeting certain minimum specifications on a “take-or-pay” basis (such that they are obliged to pay for product even if they are unable or unwilling to take delivery), MP cannot guarantee that Shenghe will continue to purchase all of the products that it is contractually bound to purchase or that they will purchase products that do not meet these specifications. Further, Shenghe sells the rare earth concentrate it acquires to customers in China who separate
147
| Notes to the Financial Statements | Defiance ETFs |
and extract the individual rare earth elements. MP does not control the amount and timing of resources that Shenghe will dedicate to their sales efforts. Therefore, any decline or delay in Shenghe’s sales efforts could reduce sales prices or sales volumes, which could have an adverse impact on MP’s results of operations.
Environmental and Regulatory Risks. MP is subject to numerous and detailed federal, state and local environmental laws, certifications, regulations, permits, and other legal requirements applicable to the mining and mineral processing industry, including, without limitation, those pertaining to employee health and safety, air emissions, water usage, wastewater and stormwater discharges, air quality standards, emissions, waste management, plant and wildlife protection, handling and disposal of hazardous and radioactive substances and waste, remediation of soil and groundwater contamination, land use, reclamation and restoration of properties, the discharge of materials into the environment, procurement of certain materials used in MP’s operations, and groundwater quality and availability. These requirements may result in significant costs, liabilities and obligations, impose conditions that are difficult to achieve or otherwise delay, limit or prohibit current or planned operations and future growth.
MSTR Risks. The MSTX ETF invests in swaps and options contracts that are based on the value of MSTR. This subjects the Funds to certain of the same risks as if they owned shares of MSTR, even though they do not. By virtue of each Fund’s investments in options contracts that are based on the value of MSTR, the Funds may also be subject to the following risks:
Indirect Investment in MSTR Risk. MSTR is not affiliated with the Trust, the Funds, the Adviser, or their respective affiliates and is not involved with this offering in any way and has no obligation to consider your Shares in taking any corporate actions that might affect the value of Shares. Investors in the Funds will not have voting rights and will not be able to influence management of MSTR but will be exposed to the performance of MSTR. Investors in the Funds will not have rights to receive dividends or other distributions or any other rights with respect to MSTR but will be subject to declines in the performance of MSTR.
MSTR Trading Risk. The trading price of MSTR may be highly volatile and could continue to be subject to wide fluctuations in response to various factors. The stock market in general, and the market for technology companies in particular, has experienced extreme price and volume fluctuations that have often been unrelated or disproportionate to the operating performance of those companies. In particular, a large proportion of MSTR may be traded by short sellers which may put pressure on the supply and demand for the common stock of MSTR, further influencing volatility in its market price. Public perception and other factors outside of the control of MSTR may additionally impact MSTR’s share price due to MSTR garnering a disproportionate degree of public attention, regardless of actual operating performance. In addition, in the past, following periods of volatility in the overall market and the market price of a particular company’s securities, securities class action litigation has often been instituted against companies such as these. Moreover, stockholder litigation like this has been filed against MSTR in the past. While MSTR continues to defend such actions, any judgment against MSTR, or any future stockholder litigation could result in substantial costs and a diversion of the management of MSTR’s attention and resources. If MSTR trading is halted, trading in Shares of the Funds may be impacted, either temporarily or indefinitely.
MSTR Performance Risk. MSTR may fail to meet its publicly announced guidelines or other expectations about its business, which could cause the price of MSTR to decline. MSTR provides guidance regarding its expected financial and business performance, such as projections regarding sales and production, as well as anticipated future revenues, gross margins, profitability and cash flows. Correctly identifying key factors affecting business conditions and predicting future events is inherently an uncertain process, and the guidance MSTR provides may not ultimately be accurate and has in the past been inaccurate in certain respects, such as the timing of new product manufacturing ramps. The guidance is based on certain assumptions such as those relating to global and local economic conditions, anticipated production and sales volumes (which generally are not linear throughout a given period), average sales prices, supplier and commodity costs, and planned cost reductions. If MSTR’s guidance is not accurate or varies from actual results due to its inability to meet the assumptions or the impact on its financial performance that could occur as a result of various risks and uncertainties, the market value of common stock issued by MSTR could decline significantly.
Software Industry Risk. The software industry can be significantly affected by intense competition, aggressive pricing, technological innovations, and product obsolescence. Companies in the software industry are subject to significant competitive pressures, such as aggressive pricing, new market entrants, competition for market share, short product cycles due to an accelerated rate of technological developments and the potential for limited earnings and/or falling profit margins. These companies also face the risks that new services, equipment or technologies will not be accepted by consumers and businesses or will become rapidly obsolete. These factors can affect the profitability of these companies and, as a result, the value of their securities. Also, patent protection is integral to the success of many companies in this industry, and profitability
148
| Notes to the Financial Statements | Defiance ETFs |
can be affected materially by, among other things, the cost of obtaining (or failing to obtain) patent approvals, the cost of litigating patent infringement and the loss of patent protection for products (which significantly increases pricing pressures and can materially reduce profitability with respect to such products). In addition, many software companies have limited operating histories. Prices of these companies’ securities historically have been more volatile than other securities, especially over the short term.
Bitcoin Risk. While the Funds will not directly invest in digital assets, they will be subject to the risks associated with Bitcoin by virtue of their investments in options contracts that reference MSTR. Investing in Bitcoin exposes investors (such as MSTR and, in turn, MSTR shareholders) to significant risks that are not typically present in other investments. These risks include the uncertainty surrounding new technology, limited evaluation due to Bitcoin’s short trading history, and the potential decline in adoption and value over the long term. The extreme volatility of Bitcoin’s price is also a risk factor. Regulatory uncertainties, such as potential government interventions and conflicting regulations across jurisdictions, can impact the demand for Bitcoin and restrict its usage. Additionally, risks associated with the sale of newly mined Bitcoin, Bitcoin exchanges, competition from alternative digital assets, mining operations, network modifications, and intellectual property claims pose further challenges to Bitcoin-linked investments.
NVO Risks. The NVOX ETF invests in swap contracts that are based on the share price of NVO. In turn, the share price of NVO is based on the performance of NVO Nordisk. This subjects the Fund to certain of the same risks as if it owned shares of NVO (or NVO Nordisk), even though it does not. By virtue of the Fund’s investments in swap contracts that are based on the value of NVO, the Fund may also be subject to the following risks:
Indirect Investment in NVO Nordisk Risk. NVO Nordisk is not affiliated with the Trust, the Fund, or the Adviser, or their respective affiliates and is not involved with this offering in any way and has no obligation to consider your Shares in taking any corporate actions that might affect the value of Shares. Investors in the Fund will not have voting rights and will not be able to influence management of NVO Nordisk but will be exposed indirectly to the performance of NVO Nordisk (via NVO). Investors in the Fund will not have the right to receive dividends or other distributions or any other rights with respect to NVO but will be subject to declines in the performance of NVO.
NVO Trading Risk. The trading price of the Underlying Security may exhibit volatility and significant fluctuations due to various factors inherent in the semiconductor industry. This sector is susceptible to price and volume fluctuations, which may not always correlate with the companies’ operational performance. Short sellers may exert influence on trading dynamics, potentially impacting supply and demand dynamics and contributing to market price volatility. The Underlying Security’s share price may also be disproportionately affected by public perception and external factors beyond NVO Nordisk’s control, given its prominence in the industry. Such attention can lead to heightened market reactions regardless of NVO Holding’s operational performance. Furthermore, following periods of market volatility, NVO Nordisk and similar companies may face securities class action litigation, diverting management attention and resources. NVO Holding’s historical exposure to such litigation underscores the potential risks, as adverse judgments or future stockholder actions could result in significant costs. Moreover, in the event of a trading halt for the Underlying Security, trading in Shares of the Fund may be impacted, either temporarily or indefinitely.
NVO Performance Risk. NVO may fail to meet its publicly announced guidelines or other expectations about its business, which could cause the price of NVO to decline. NVO provides guidance regarding its expected financial and business performance, such as projections regarding sales and production, as well as anticipated future revenues, gross margins, profitability and cash flows. Correctly identifying key factors affecting business conditions and predicting future events is inherently an uncertain process, and the guidance NVO provides may not ultimately be accurate and has in the past been inaccurate in certain respects, such as the timing of new product manufacturing ramps. The guidance is based on certain assumptions such as those relating to global and local economic conditions, anticipated production and sales volumes (which generally are not linear throughout a given period), average sales prices, supplier and commodity costs, and planned cost reductions. If NVO’s guidance is not accurate or varies from actual results due to its inability to meet the assumptions or the impact on its financial performance that could occur as a result of various risks and uncertainties, the market value of common stock issued by NVO could decline significantly.
Pharmaceutical Industry Risks. Pharmaceutical research and development are very costly and highly uncertain; NVO may not succeed in developing, licensing, or acquiring commercially successful products sufficient in number or value to replace revenues of products that have lost or will lose intellectual property protection or are displaced by competing products or therapies. NVO and NVO’s products face intense competition from multinational pharmaceutical companies, biotechnology companies, and lower-cost generic and biosimilar manufacturers, and such competition could have a material adverse effect
149
| Notes to the Financial Statements | Defiance ETFs |
on NVO’s business. NVO’s business is subject to increasing government price controls and other public and private restrictions on pricing, reimbursement, and access for NVO’s drugs, which could have a material adverse effect on NVO’s results of operations, reputation or business. Pharmaceutical products can develop safety or efficacy concerns, which could have a material adverse effect on NVO’s revenues, income, and reputation.
Intellectual Property Risks. NVO derives a significant percentage of its total revenue from relatively few products and sells products through increasingly consolidated supply chain entities, which may subject NVO to, or exacerbate, various risks. NVO depends on products with intellectual property protection for most of NVO’s revenues, cash flows, and earnings; the loss of effective intellectual property protection for certain of NVO’s products has resulted, and in the future is likely to continue to result, in rapid and severe declines in revenues for those products. NVO’s long-term success depends on intellectual property protection; if NVO’s intellectual property rights are invalidated, circumvented, or weakened, NVO’s business will be adversely affected.
Operations Risks. Failure, inadequacy, breach of, or unauthorized access to, NVO’s IT systems or those of NVO’s third-party service providers, unauthorized access to NVO’s confidential information, or violations of data protection laws, could each result in material harm to NVO’s business and reputation. Manufacturing, quality, or supply chain difficulties, disruptions, or shortages could lead to product supply problems. Reliance on third-party relationships and outsourcing arrangements could adversely affect NVO’s business. NVO’s use of artificial intelligence or other emerging technologies could adversely impact NVO’s business and financial results.
International Business Risks. Uneven economic growth or downturns or international trade and other global disruptions, geopolitical tensions, or disputes could adversely affect NVO’s business and operating results. Changes in foreign currency rates, interest rate risks, and inflation could affect NVO’s results of operations.
Government Regulation and Litigation Risks. NVO faces litigation and investigations related to its products, how NVO prices or commercializes its products, and other aspects of NVO’s business, which could adversely affect NVO’s business, and NVO is self-insured for such matters. NVO is subject to evolving and complex tax laws, which may result in additional liabilities and affect NVO’s results of operations. Regulatory compliance problems could be damaging to NVO.
OKLO Risks. The OKLL ETF invests in swap contracts and options that are based on the share price of OKLO. This subjects the Fund to certain of the same risks as if it owned shares of OKLO, even though it does not. By virtue of the Fund’s investments in swap contracts and options that are based on the value of OKLO, the Fund may also be subject to the following risks:
Limited Operating History Risk. OKLO has not yet constructed any powerhouses or entered into any binding contract with any customer to operate a plant or deliver electricity or heat, and there is no guarantee that it will be able to do so in the future. OKLO’s limited commercial operating history and limited experience in operating a company presents risks and challenges. OKLO is an early-stage company with a history of financial losses, and it expects to incur significant expenses and continuing financial losses.
Indirect Investment in OKLO Risk. OKLO is not affiliated with the Trust, the Fund, or the Adviser, or their respective affiliates and is not involved with this offering in any way and has no obligation to consider your Shares in taking any corporate actions that might affect the value of Shares. Investors in the Fund will not have voting rights and will not be able to influence management of OKLO but will be exposed to the performance of OKLO (the Underlying Security). Investors in the Fund will not have the right to receive dividends or other distributions or any other rights with respect to the Underlying Security but will be subject to declines in the performance of the Underlying Security.
OKLO Trading Risk. The trading price of OKLO may be subject to volatility and could experience wide fluctuations due to various factors. Short sellers may also play a significant role in trading OKLO, potentially affecting the supply and demand dynamics and contributing to market price volatility. Public perception and external factors beyond the company’s control may influence OKLO’s stock price disproportionately. Additionally, following periods of market volatility, companies have faced securities class action litigation. Any adverse judgment or future stockholder litigation could result in substantial costs and divert management’s attention and resources. In the event of a halt in trading of OKLO, trading in shares of related funds may be impacted, either temporarily or indefinitely.
OKLO Performance Risk. OKLO may fail to meet its publicly announced guidelines or other expectations about its business, which could cause the price of OKLO to decline. OKLO provides guidance regarding its expected financial and business performance, such as projections regarding sales and production, as well as anticipated future revenues, gross margins,
150
| Notes to the Financial Statements | Defiance ETFs |
profitability and cash flows. Correctly identifying key factors affecting business conditions and predicting future events is inherently an uncertain process, and the guidance OKLO provides may not ultimately be accurate. If OKLO’s guidance is not accurate or varies from actual results due to its inability to meet the assumptions or the impact on its financial performance that could occur as a result of various risks and uncertainties, the market value of common stock issued by OKLO could decline significantly.
Electric Utilities Industry Risks. The electric utilities industry includes companies that produce or distribute electricity, including both nuclear and non-nuclear. The prices of securities in the electric utilities industry may fluctuate significantly due to supply and demand, governmental regulation and environmental issues, economic conditions generally affecting electric and utilities companies, competitive pressures due to deregulation in the electric and utilities industry, increased sensitivity to the cost of energy production, and environmental factors such as conservation of natural resources or pollution control. Legislative or regulatory changes and increased government supervision also may negatively affect companies in the electric utilities industry.
Supply Risks. OKLO’s fission powerhouses, like many advanced fission reactors, are expected to rely on high-assay low enriched uranium (“HALEU”), in part or for a period of time until recycled waste fuel is available. HALEU is not currently available at scale. Access to a domestic supply of HALEU requires regulatory approval, and may require additional third-party development and investment and/or significant government assistance. If OKLO is unable to access HALEU or recycled waste fuel, its ability to manufacture fuel and to produce power will be adversely affected, which could have a material adverse effect on OKLO’s business prospects, financial condition, results of operations and cash flows.
Facility Risks. Costs associated with building fuel fabrication and fuel recycling facilities may ultimately be significantly higher than current estimates, which may affect the marketability, capital and operational costs of OKLO’s business model and its expectations with respect to its business plan and future profitability. This could materially and adversely affect OKLO’s business prospects, financial condition, results of operations and cash flows.
ORCL Risks. The ORCX ETF invests in swap contracts and options that are based on the share price of ORCL. This subjects the Fund to certain of the same risks as if it owned shares of ORCL, even though it does not. By virtue of the Fund’s investments in swap contracts and options that are based on the value of ORCL, the Fund may also be subject to the following risks:
Indirect Investment in ORCL Risk. ORCL is not affiliated with the Trust, the Fund, or the Adviser, or their respective affiliates and is not involved with this offering in any way and has no obligation to consider your Shares in taking any corporate actions that might affect the value of Shares. Investors in the Fund will not have voting rights and will not be able to influence management of ORCL but will be exposed to the performance of ORCL. Investors in the Fund will not have the right to receive dividends or other distributions or any other rights with respect to ORCL but will be subject to declines in the performance of ORCL.
ORCL Trading Risk. The trading price of ORCL may be subject to volatility and could experience wide fluctuations due to various factors. Short sellers may also play a significant role in trading ORCL, potentially affecting the supply and demand dynamics and contributing to market price volatility. Public perception and external factors beyond the company’s control may influence ORCL’s stock price disproportionately. Additionally, following periods of market volatility, companies have faced securities class action litigation. Any adverse judgment or future stockholder litigation could result in substantial costs and divert management’s attention and resources. In the event of a halt in trading of ORCL, trading in shares of related funds may be impacted, either temporarily or indefinitely.
ORCL Performance Risk. ORCL may fail to meet its publicly announced guidelines or other expectations about its business, which could cause the price of ORCL to decline. ORCL provides guidance regarding its expected financial and business performance, such as projections regarding sales and production, as well as anticipated future revenues, gross margins, profitability and cash flows. Correctly identifying key factors affecting business conditions and predicting future events is inherently an uncertain process, and the guidance ORCL provides may not ultimately be accurate. If ORCL’s guidance is not accurate or varies from actual results due to its inability to meet the assumptions or the impact on its financial performance that could occur as a result of various risks and uncertainties, the market value of common stock issued by ORCL could decline significantly.
Software Industry Risk. The software industry can be significantly affected by intense competition, aggressive pricing, technological innovations, and product obsolescence. Companies in the software industry are subject to significant competitive pressures, such as aggressive pricing, new market entrants, competition for market share, short product cycles
151
| Notes to the Financial Statements | Defiance ETFs |
due to an accelerated rate of technological developments and the potential for limited earnings and/or falling profit margins. These companies also face the risks that new services, equipment or technologies will not be accepted by consumers and businesses or will become rapidly obsolete. These factors can affect the profitability of these companies and, as a result, the value of their securities. Also, patent protection is integral to the success of many companies in this industry, and profitability can be affected materially by, among other things, the cost of obtaining (or failing to obtain) patent approvals, the cost of litigating patent infringement and the loss of patent protection for products (which significantly increases pricing pressures and can materially reduce profitability with respect to such products). In addition, many software companies have limited operating histories. Prices of these companies’ securities historically have been more volatile than other securities, especially over the short term.
Operations and Business Risks. ORCL may be unsuccessful in developing and selling new products and services, integrating acquired products and services and enhancing its existing products and services. ORCL’s industry is characterized by rapid technological advances, intense competition, changing delivery models, evolving standards in communications infrastructure, increasingly sophisticated customer needs and frequent new product introductions and enhancements. If ORCL is unable to develop new or sufficiently differentiated products and services, enhance and improve its product offerings and support services in a timely manner or position and price its products and services to meet demand, customers may not purchase or subscribe to ORCL’s license, hardware or cloud offerings or renew license support, hardware support or cloud subscriptions contracts.
Data Security Risks. If ORCL’s security measures for its products and services are compromised and as a result, its data, its customers’ data or its IT systems are accessed improperly, made unavailable, or improperly modified, ORCL’s products and services may be perceived as vulnerable, its brand and reputation could be damaged, the IT services ORCL provides to its customers could be disrupted, and customers may stop using ORCL’s products and services, any of which could reduce ORCL’s revenue and earnings, increase its expenses and expose it to legal claims and regulatory actions.
Intellectual Property Risks. ORCL relies on copyright, trademark, patent and trade secret laws, confidentiality procedures, controls and contractual commitments to protect its intellectual property. Despite ORCL’s efforts, these protections may be limited. Unauthorized third parties may try to copy or reverse engineer ORCL products or otherwise use its intellectual property. ORCL patents may be invalidated or circumvented. Any of ORCL’s pending or future patent applications may not be issued with the claim scope it seeks, if at all. In addition, the laws of some countries do not provide the same level of intellectual property protection as U.S. laws and courts. If ORCL cannot protect its intellectual property against unauthorized copying or use, or other misappropriation, ORCL may not remain competitive.
OSCR Risks. The OSCX ETF invests in swap contracts and options that are based on the share price of OSCR. This subjects the Fund to certain of the same risks as if it owned shares of OSCR, even though it does not. By virtue of the Fund’s investments in swap contracts and options that are based on the value of OSCR, the Fund may also be subject to the following risks:
Indirect Investment in OSCR Risk. OSCR is not affiliated with the Trust, the Fund, or the Adviser, or their respective affiliates, and is not involved with this offering in any way and has no obligation to consider your Shares in taking any corporate actions that might affect the value of Shares. Investors in the Fund will not have voting rights and will not be able to influence management of OSCR but will be exposed to the performance of OSCR’s publicly traded stock. Investors in the Fund will not have the right to receive dividends or other distributions or any other rights with respect to the Underlying Security but will be subject to declines in the performance of the Underlying Security.
OSCR Trading Risk. OSCR’s share price may experience substantial volatility due to factors such as healthcare policy changes, membership trends, regulatory developments, and investor sentiment toward health-tech and insurance technology companies. Public announcements related to changes in government subsidies, regulatory audits, or shifts in reimbursement structures could materially impact stock performance. In the event of a trading halt, delisting, or significant disruption in the market for OSCR shares, the Fund may experience difficulty entering, modifying, or liquidating its exposures. These conditions could impair the Fund’s ability to achieve its investment objective, result in significant tracking error, or, in extreme cases, force the Fund to liquidate entirely.
OSCR Performance Risk. OSCR’s financial performance is closely tied to its ability to manage medical loss ratios, scale its technology platform, and secure favorable contracts with healthcare providers. Unexpected increases in healthcare utilization, changes in government reimbursement models, or failures in its technology infrastructure could adversely affect its operating results. Additionally, OSCR’s heavy reliance on federal premium subsidies and the risk adjustment program introduces
152
| Notes to the Financial Statements | Defiance ETFs |
financial exposure to policy changes or administrative delays beyond its control. Additionally, OSCR has a history of net losses and may not achieve or sustain profitability.
Insurance Industry Risk. The insurance industry is subject to a broad set of financial, operational, and regulatory risks that can materially affect profitability and business performance. Insurers rely heavily on accurate underwriting, actuarial modeling, and risk selection to remain solvent and competitive; adverse claim trends, catastrophic events, or unexpected loss development can significantly impact earnings. Investment performance is also a key driver of results, and fluctuations in interest rates, credit markets, or equity valuations may affect portfolio returns and capital adequacy. The industry is highly regulated, requiring strict compliance with solvency, reporting, and consumer protection rules; failure to comply may result in fines, license restrictions, or reputational damage. Additionally, pricing pressures, policyholder behavior, and evolving coverage needs, particularly in areas like cyber risk or climate-related exposures, require continuous product innovation and disciplined risk management to maintain market relevance and profitability.
Regulatory and Policy Risk. Changes to the Affordable Care Act (ACA), federal or state healthcare regulations, or government funding mechanisms such as premium subsidies or risk adjustment programs could materially impact OSCR’s revenue, member enrollment, and operating model. Such changes may occur rapidly due to political shifts and could reduce market stability or require costly adjustments to OSCR’s product offerings and pricing strategy.
Profitability and Medical Cost Management Risk. OSCR may face challenges achieving and maintaining profitability due to variability in medical claims costs, difficulty predicting utilization patterns, and constraints on premium pricing imposed by medical loss ratio (MLR) requirements and regulatory rate approvals. A failure to accurately forecast or control medical expenses could result in significant operating losses and reduced capital flexibility.
Technology and Cybersecurity Risk. As a technology-driven company, OSCR is highly dependent on its proprietary platforms and data systems. Operational disruptions, data breaches, or cybersecurity incidents could negatively affect business continuity, consumer trust, and compliance with privacy laws, potentially resulting in regulatory penalties, litigation, or reputational damage.
Market Concentration and Competition Risk. OSCR’s revenue is concentrated in specific geographic markets and heavily reliant on individual market enrollment. Increased competition from larger, better-capitalized insurers or new entrants, along with potential market exits by OSCR, could limit growth, reduce pricing power, or result in loss of market share. 92 ● Operational Execution and Scalability Risk. OSCR’s ability to scale its insurance and technology operations effectively depends on successful execution in areas such as provider contracting, customer service, care coordination, and administrative cost management. Any missteps in scaling operations or managing internal complexity may lead to cost overruns, member dissatisfaction, or failure to meet performance targets.
Reliance on Government Payments. A substantial portion of OSCR’s revenue comes from government-administered programs, including premium tax credits. Any disruption, delay, or change in these funding mechanisms—whether due to administrative error, litigation, or legislative action—could impair liquidity and financial stability.
PM Risks. The XPM ETF invests in swap contracts and options that are based on the share price of PM. This subjects the Fund to certain of the same risks as if it owned shares of PM, even though it does not. By virtue of the Fund’s investments in swap contracts and options that are based on the value of PM, the Fund may also be subject to the following risks:
Indirect Investment in PM Risk. PM is not affiliated with the Trust, the Fund, or the Adviser, or their respective affiliates and is not involved with this offering in any way and has no obligation to consider your Shares in taking any corporate actions that might affect the value of Shares. Investors in the Fund will not have voting rights and will not be able to influence management of PM but will be exposed to the performance of PM (the Underlying Security). Investors in the Fund will not have the right to receive dividends or other distributions or any other rights with respect to the Underlying Security but will be subject to declines in the performance of the Underlying Security.
PM Trading Risk. The trading price of PM may be subject to volatility and could experience wide fluctuations due to various factors. Short sellers may also play a significant role in trading PM, potentially affecting the supply and demand dynamics and contributing to market price volatility. Public perception and external factors beyond the company’s control may influence PM’s stock price disproportionately. Additionally, following periods of market volatility, companies have faced securities class action litigation. Any adverse judgment or future stockholder litigation could result in substantial costs and
153
| Notes to the Financial Statements | Defiance ETFs |
divert management’s attention and resources. In the event of a halt in trading of PM, trading in shares of related funds may be impacted, either temporarily or indefinitely.
PM Performance Risk. PM may fail to meet its publicly announced guidelines or other expectations about its business, which could cause the price of PM to decline. PM provides guidance regarding its expected financial and business performance, such as projections regarding sales and production, as well as anticipated future revenues, gross margins, profitability and cash flows. Correctly identifying key factors affecting business conditions and predicting future events is inherently an uncertain process, and the guidance PM provides may not ultimately be accurate. If PM’s guidance is not accurate or varies from actual results due to its inability to meet the assumptions or the impact on its financial performance that could occur as a result of various risks and uncertainties, the market value of common stock issued by PM could decline significantly.
Tobacco Industry Risks: Companies in this industry may experience: changes in demand for products, demographic and product trends and general economic conditions; effects of competitive pricing, environmental factors, marketing campaigns and consumer boycotts; and adverse effects from governmental regulation and oversight. This industry may also be affected by additional risks, including: smoking and health litigation; governmental and private bans and restrictions on smoking; and actual and proposed price controls on tobacco products. The beverage and tobacco industry may also be affected by risks that affect the broader consumer staples industry.
New Business Risks. PM’s key strategic priorities are to: (i) continue developing and commercializing products that present less risk of harm to adult smokers who switch to smoke-free products versus continued cigarette smoking; and (ii) encourage and educate current adult smokers who would otherwise continue to smoke cigarettes to switch to those products. PM may be unsuccessful in its attempts to introduce, commercialize, and grow smoke-free products in existing and new markets, and regulators may prohibit or significantly restrict the commercialization of these products or the communication of scientifically substantiated information and claims.
Regulatory Risks. Governmental actions, combined with the diminishing social acceptance of smoking and private actions to restrict smoking, have resulted in reduced industry volumes for PM’s products in many of its markets, and PM expects that such factors will continue to reduce consumption levels and will increase down-trading and the risk of counterfeiting, contraband, illicit trade and cross-border purchases. Significant regulatory developments will continue to take place over the next few years in most of PM’s markets. PM’s financial results could be materially affected by regulatory initiatives resulting in a significant decrease in demand for its brands.
Litigation Risks: There is litigation related to tobacco products and/or nicotine products pending in certain jurisdictions in which PM operates. Damages claimed in some tobacco-related litigation are significant and, in certain cases, range into the billions of U.S. dollars. PM anticipates that new cases will continue to be filed. It is possible that PM’s consolidated results of operations, cash flows or financial position could be materially adversely affected in a particular fiscal quarter or fiscal year by an unfavorable outcome or settlement of certain pending litigation.
QS Risks. The QSU ETF invests in swap contracts and options that are based on the share price of QS. This subjects the Fund to certain of the same risks as if it owned shares of QS, even though it does not. By virtue of the Fund’s investments in swap contracts and options that are based on the value of QS, the Fund may also be subject to the following risks:
QS Operating Loss Risk. QS has incurred an accumulated deficit of approximately $3.4 billion from its inception in 2010 through December 31, 2024. QS believes that it will continue to incur operating losses each quarter until at least the time significant production of its lithium-metal solid-state batteries begins, and such production is not expected to begin in the near future. QS expects the rate at which it will incur losses to be significantly higher in future periods as QS, among other things, continues to incur significant expenses in connection with the design, development and manufacturing of its batteries; expand its research and development activities; invest in manufacturing capabilities; build up inventories of components for its batteries; increase sales and marketing activities; develop distribution infrastructure; and increase general and administrative functions to support its growing operations.
Indirect Investment in QS Risk. QS is not affiliated with the Trust, the Fund, or the Adviser, or their respective affiliates and is not involved with this offering in any way and has no obligation to consider your Shares in taking any corporate actions that might affect the value of Shares. Investors in the Fund will not have voting rights or influence over the management of QS but will be exposed to the performance of QS (the Underlying Security). Investors will also not have the right to receive dividends or other distributions from QS but will remain subject to price fluctuations and other risks associated with ownership of the Underlying Security.
154
| Notes to the Financial Statements | Defiance ETFs |
QS Trading Risk. The trading price of QS may be subject to volatility and could experience wide fluctuations due to various factors. Short sellers may also influence QS’s trading activity, contributing to market instability. Public perception and external factors beyond the company’s control may influence QS’s stock price disproportionately. Additionally, following periods of market volatility, companies have faced securities class action litigation. Any adverse judgment or future stockholder litigation could result in substantial costs and divert management’s attention and resources. In the event of a trading halt, delisting, or significant disruption in the market for QS’s shares, the Fund may experience difficulty entering, modifying, or liquidating its exposures. These conditions could impair the Fund’s ability to achieve its investment objective, result in significant tracking error, or, in extreme cases, force the Fund to liquidate entirely.
QS Performance Risk. QS may fail to meet its publicly announced guidelines or other expectations about its business, which could cause the price of QS to decline. Correctly identifying key factors affecting business conditions and predicting future events is inherently an uncertain process, and the guidance QS provides may not ultimately be accurate. If QS’s guidance is not accurate or varies from actual results due to its inability to meet the assumptions or the impact on its financial performance that could occur as a result of various risks and uncertainties, the market value of common stock issued by QS could decline significantly.
Automobile Components Industry Risks. Companies operating in the automobile components industry, particularly those related to EVs, are subject to various risks, including but not limited to, part supplier constraints or delays, consumer demand for EVs and competition from existing competitors. Governmental policies affecting the automotive industry, such as taxes, tariffs, duties, subsidies, and import and export restrictions on automotive products can influence industry profitability. In addition, such companies must comply with environmental laws and regulations, for which there may be severe consequences for noncompliance.
Business Risks. Developing lithium-metal solid-state batteries that meet the requirements for wide adoption by automotive original equipment manufacturers (OEMs) is a difficult undertaking and, as far as QS is aware, has never been done before. QS is still in the development stage and faces significant challenges in completing the development of its battery cells and in producing battery cells in commercial volumes with acceptable performance, quality, consistency, reliability, throughput, safety, and costs. Delays or failures in accomplishing QS’ development objectives may delay or prevent successful commercialization of QS’ technology and negatively impact QS’ business. QS’s future growth and success is also dependent upon consumers’ willingness to adopt elective vehicles.
Competition Risk. The battery market in which QS competes continues to evolve and is highly competitive. To date, QS has focused its efforts on its lithium-metal solid-state battery technology, which is being designed to outperform conventional lithium-ion battery technology. However, lithium-ion battery technology has been widely adopted and QS’ current competitors have, and future competitors may have, greater resources than QS does and may also be able to devote greater resources to the development of their current and future technologies. QS must continue to commit significant resources to develop its battery technology to establish a competitive position, and these commitments will be made without knowing whether such investments will result in products potential customers will find acceptable. There is no assurance QS will successfully identify new customer requirements, develop and bring its batteries to market on a timely basis, or that products and technologies developed by others will not render QS’ batteries obsolete or noncompetitive, any of which would adversely affect QS’ business and operating results.
Collaboration Risk. In July 2024, QS entered into a collaboration agreement with PowerCo SE (“PowerCo”), a battery cell company wholly owned by Volkswagen, with the goal of industrializing the solid-state lithium-metal battery technology it intends to use in its first planned product—the QSE-5. There is no assurance that QS will be able to complete the development of the solid-state battery cells or achieve the technical milestones in the time frame required by the collaboration agreement or to satisfy PowerCo’s business needs. If QS does not complete this development in a timely manner, PowerCo may terminate the collaboration agreement, which could result in a material adverse effect on QE’s business and financial results.
Regulatory Risk. QS’ batteries, and the sale of EVs and motor vehicles in general, are subject to substantial regulation under international, federal, state and local laws, including export control laws. QS expects to incur significant costs in complying with these regulations. Regulations related to the battery and EV industry and alternative energy are currently evolving and QS faces risks associated with changes to these regulations as well as potential for heightened regulatory scrutiny. For example, laws and regulations may be passed that make manufacturers financially responsible for the collection, treatment, recycling and disposal of certain products, including batteries for EVs. The costs of complying with such requirements, as they now exist or as may be introduced in the future, and the associated administrative burden, could adversely affect QS’ financial condition and results of operations, particularly if QS is unable to pass on such costs to its customers.
155
| Notes to the Financial Statements | Defiance ETFs |
RGTI Risks. The RGTX ETF invests in swap contracts and options that are based on the share price of RGTI. This subjects the Fund to certain of the same risks as if it owned shares of RGTI, even though it does not. By virtue of the Fund’s investments in swap contracts and options that are based on the value of RGTI, the Fund may also be subject to the following risks:
Indirect Investment in RGTI Risk. RGTI is not affiliated with the Trust, the Fund, or the Adviser, or their respective affiliates and is not involved with this offering in any way and has no obligation to consider your Shares in taking any corporate actions that might affect the value of Shares. Investors in the Fund will not have voting rights and will not be able to influence management of RGTI but will be exposed to the performance of RGTI. Investors in the Fund will not have the right to receive dividends or other distributions or any other rights with respect to RGTI but will be subject to declines in the performance of RGTI.
RGTI Trading Risk. The trading price of RGTI may be subject to volatility and could experience wide fluctuations due to various factors. Short sellers may also play a significant role in trading RGTI, potentially affecting the supply and demand dynamics and contributing to market price volatility. Public perception and external factors beyond the company’s control may influence RGTI’s stock price disproportionately. Additionally, following periods of market volatility, companies have faced securities class action litigation. Any adverse judgment or future stockholder litigation could result in substantial costs and divert management’s attention and resources. In the event of a halt in trading of RGTI, trading in shares of related funds may be impacted, either temporarily or indefinitely.
RGTI Performance Risk. RGTI may fail to meet its publicly announced guidelines or other expectations about its business, which could cause the price of RGTI to decline. RGTI provides guidance regarding its expected financial and business performance, such as projections regarding sales and production, as well as anticipated future revenues, gross margins, profitability and cash flows. Correctly identifying key factors affecting business conditions and predicting future events is inherently an uncertain process, and the guidance RGTI provides may not ultimately be accurate. If RGTI’s guidance is not accurate or varies from actual results due to its inability to meet the assumptions or the impact on its financial performance that could occur as a result of various risks and uncertainties, the market value of common stock issued by RGTI could decline significantly.
Semiconductors & Semiconductor Equipment Industry Risks. Competitive pressures may have a significant effect on the financial condition of semiconductor companies and, as product cycles shorten and manufacturing capacity increases, these companies may become increasingly subject to aggressive pricing, which hampers profitability. Reduced demand for end-user products, under-utilization of manufacturing capacity, and other factors could adversely impact the operating results of companies in the semiconductor sector. Semiconductor companies typically face high capital costs and may be heavily dependent on intellectual property rights. The semiconductor sector is highly cyclical, which may cause the operating results of many semiconductor companies to vary significantly. The industry is complex and global in nature, with manufacturing plants predominantly located in East Asia. Because of this, it is subject to numerous risks, including geopolitical tensions, earthquakes, and extreme weather events. The stock prices of companies in the semiconductor sector have been and likely will continue to be extremely volatile.
Business Risks. RGTI faces significant financial and operational risks, including the need to raise additional capital by mid 2025 to sustain its research and development efforts. As of the RGTI annual report filed March 2025, the firm’s risk factors note that the RGTI will require “a significant amount of cash for expenditures as it invest in ongoing research and development and business operations.” As this Fund’s annual update will file end of August 2025, we will consider whether to make adjustments at that time but will leave as is for now. With a history of operating losses, limited revenue, and reliance on public sector contracts, the company is vulnerable to economic downturns, market volatility, and delays in achieving key milestones such as the commercialization of its quantum systems. Failure to scale operations or successfully integrate new technologies could further impede growth and profitability. Material weaknesses in financial reporting controls and risks associated with complex financial instruments add to potential investor concerns.
The quantum computing industry’s competitive and evolving nature presents challenges, with barriers such as the need for technological breakthroughs and dependence on cloud providers, third-party suppliers, and government contracts. RGTI’s ability to protect its intellectual property, adapt to stringent regulatory environments, and address supply chain disruptions is critical. Additional risks include international sales challenges, exposure to environmental and safety regulations, and susceptibility to litigation, cybersecurity threats, and product liability claims. These factors, alongside the nascent stage of the quantum computing industry, pose significant uncertainties for the company’s long-term success.
156
| Notes to the Financial Statements | Defiance ETFs |
RIOT Risks. The RIOX ETF invests in swap contracts and options contracts that are based on the share price of RIOT. This subjects the Fund to certain of the same risks as if it owned shares of RIOT, even though it does not. By virtue of the Fund’s investments in swap contracts and options contracts that are based on the value of RIOT, the Fund may also be subject to the following risks:
Indirect Investment in RIOT Risk. RIOT is not affiliated with the Trust, the Fund, the Adviser, or their respective affiliates and is not involved with this offering in any way and has no obligation to consider your Shares in taking any corporate actions that might affect the value of Shares. Investors in the Fund will not have voting rights and will not be able to influence management of RIOT but will be exposed to the performance of RIOT. Investors in the Fund will not have rights to receive dividends or other distributions or any other rights with respect to RIOT but will be subject to declines in the performance of RIOT.
RIOT Trading Risk. The trading price of RIOT may be highly volatile and could continue to be subject to wide fluctuations in response to various factors. The stock market in general, and the market for technology companies in particular, has experienced extreme price and volume fluctuations that have often been unrelated or disproportionate to the operating performance of those companies. In particular, a large proportion of RIOT may be traded by short sellers which may put pressure on the supply and demand for the common stock of RIOT, further influencing volatility in its market price. Public perception and other factors outside of the control of RIOT may additionally impact RIOT’s share price due to RIOT garnering a disproportionate degree of public attention, regardless of actual operating performance. In addition, in the past, following periods of volatility in the overall market and the market price of a particular company’s securities, securities class action litigation has often been instituted against companies such as these. Any future stockholder litigation could result in substantial costs and a diversion of the management of RIOT’s attention and resources. If RIOT trading is halted, trading in Shares of the Fund may be impacted, either temporarily or indefinitely.
RIOT Performance Risk. RIOT may fail to meet its publicly announced guidelines or other expectations about its business, which could cause the price of RIOT to decline. RIOT provides guidance regarding its expected financial and business performance, such as projections regarding sales and production, as well as anticipated future revenues, gross margins, profitability and cash flows. Correctly identifying key factors affecting business conditions and predicting future events is inherently an uncertain process, and the guidance RIOT provides may not ultimately be accurate. If RIOT’s guidance is not accurate or varies from actual results due to its inability to meet the assumptions or the impact on its financial performance that could occur as a result of various risks and uncertainties, the market value of common stock issued by RIOT could decline significantly.
Industry Competition Risk. RIOT’s business is highly competitive and operates 24 hours a day, 7 days a week, on a global basis. The primary drivers of competition are demand for bitcoin, sufficient capital resources to acquire large quantities of high-quality miners, the ability to secure these miners from a limited number of suppliers on rapid delivery schedules, and the ability to execute on those miner deployments with the best-in-class mining infrastructure to generate the highest returns while incurring the lowest costs to mine. RIOT’s inability to maintain or improve market share versus its competitors could negatively impact its financial results.
Regulatory Risk. The digital asset exchanges on which bitcoin is traded are relatively new and largely unregulated. Many digital asset exchanges do not provide the public with significant information regarding their ownership structure, management teams, corporate practices, or regulatory compliance. As a result, the marketplace may lose confidence in, or may experience problems relating to, such digital asset exchanges, including prominent exchanges handling a significant portion of the volume of digital asset trading. A perceived lack of stability in the digital asset exchange market and the closure or temporary shutdown of digital asset exchanges due to business failure, hackers or malware, government-mandated regulation, or fraud may reduce confidence in digital asset networks and result in greater volatility in digital asset values, such as bitcoin.
Bitcoin Price. While the Fund will not directly invest in digital assets, it will be subject to the risks associated with bitcoin by virtue of its exposure to RIOT. Investing in bitcoin or having a business dependent on the price of bitcoin (such as RIOT and, in turn, RIOT shareholders) carries significant risks that are not typically present in other investments. These risks include the uncertainty surrounding new technology, limited evaluation due to bitcoin’s short trading history, and the potential decline in adoption and value over the long term. The extreme volatility of bitcoin’s price is also a risk factor. Regulatory uncertainties, such as potential government interventions and conflicting regulations across jurisdictions, can impact the demand for bitcoin and restrict its usage. Additionally, risks associated with the sale of newly mined bitcoin, bitcoin trading
157
| Notes to the Financial Statements | Defiance ETFs |
platforms, competition from alternative digital assets, mining operations, network modifications, and intellectual property claims pose further challenges to bitcoin-linked investments.
Bitcoin Halving. While Bitcoin prices have historically increased around halving events (a process designed to control the overall supply and reduce the risk of inflation in bitcoin, which uses a proof-of-work consensus algorithm and results in the mining reward being cut in half) there is no guarantee that the price change will be favorable or would compensate for the reduction in mining rewards. If a corresponding and proportionate increase in the price of Bitcoin does not follow future halving events, the revenue RIOT earns from its bitcoin mining operations would see a decrease, which could have a material adverse effect on RIOT’s results of operations and financial condition.
Hash Rate and Difficulty. As demand for bitcoin has increased, the global network hash rate (i.e., the aggregate amount of computing power devoted to supporting the bitcoin blockchain at a given time) has increased rapidly, and as greater adoption of bitcoin occurs, it is expected that demand for new bitcoin will likewise increase as more mining companies are drawn into the industry by this increased demand. Further, as a greater number of increasingly powerful miners have been deployed, the network difficulty for bitcoin has consequently also increased. A high difficulty means that more computing power will be required in order to solve a block and earn a new bitcoin reward, which, in turn, makes the bitcoin network more secure by limiting the possibility of one miner or mining pool gaining control of the network. Therefore, as new and existing miners deploy additional hash rate, the global network hash rate will continue to increase, meaning a miner’s share of the global network hash rate (and therefore its chance of earning bitcoin rewards) will decline if it fails to deploy additional hash rate at pace with the industry. If RIOT, in an effort to grow its hash rate, is unable to complete planned expansions on schedule and within anticipated cost estimates, deployment of newly purchased miners may be delayed, which could affect its competitiveness and results of operation, which could have a material adverse effect on RIOT’s financial condition and the market price for its securities.
Capital Markets Industry Risk. Capital markets companies may be significantly affected by stock and bank trading activity, changes in governmental regulation, continuing increases in price competition, decreases in fees or fee related business, including investment banking, brokerage, asset management and other servicing fees, fluctuation in interest rates and other factors which could adversely affect financial markets.
RKLB Risks. The RKLX ETF invests in swap contracts and options that are based on the share price of RKLB. This subjects the Fund to certain of the same risks as if it owned shares of RKLB, even though it does not. By virtue of the Fund’s investments in swap contracts and options that are based on the value of RKLB, the Fund may also be subject to the following risks:
Indirect Investment in RKLB Risk. RKLB is not affiliated with the Trust, the Fund, or the Adviser, or their respective affiliates and is not involved with this offering in any way and has no obligation to consider your Shares in taking any corporate actions that might affect the value of Shares. Investors in the Fund will not have voting rights and will not be able to influence management of RKLB but will be exposed to the performance of RKLB. Investors in the Fund will not have the right to receive dividends or other distributions or any other rights with respect to RKLB but will be subject to declines in the performance of RKLB.
RKLB Trading Risk. The trading price of RKLB may be subject to volatility and could experience wide fluctuations due to various factors. Short sellers may also play a significant role in trading RKLB, potentially affecting the supply and demand dynamics and contributing to market price volatility. Public perception and external factors beyond the company’s control may influence RKLB’s stock price disproportionately. Additionally, following periods of market volatility, companies have faced securities class action litigation. Any adverse judgment or future stockholder litigation could result in substantial costs and divert management’s attention and resources. In the event of a halt in trading of RKLB, trading in shares of related funds may be impacted, either temporarily or indefinitely.
RKLB Performance Risk. RKLB may fail to meet its publicly announced guidelines or other expectations about its business, which could cause the price of RKLB to decline. RKLB provides guidance regarding its expected financial and business performance, such as projections regarding sales and production. Correctly identifying key factors affecting business conditions and predicting future events is inherently an uncertain process, and the guidance RKLB provides may not ultimately be accurate. If RKLB’s guidance is not accurate or varies from actual results due to its inability to meet the assumptions or the impact on its financial performance that could occur as a result of various risks and uncertainties, the market value of common stock issued by RKLB could decline significantly.
158
| Notes to the Financial Statements | Defiance ETFs |
Aerospace & Defense Industry Risks. Companies in the aerospace and defense industry are subject to risks stemming from their reliance on government budgets and spending priorities, which can fluctuate due to political and economic pressures. These companies often operate in highly competitive markets and may face challenges from both domestic and international competitors. The aerospace and defense industry is also affected by geopolitical tensions, trade policies, and regulatory changes that can impact market access and operational efficiency. Aerospace and defense companies typically rely on complex supply chains for specialized components and materials. Disruptions in these supply chains, whether due to shortages, price increases, or geopolitical factors, can significantly affect production and profitability. Additionally, technological advancements are critical for maintaining competitiveness in this sector, but the high cost and uncertain outcomes of research and development efforts may pose financial risks. Companies in this industry face heightened cybersecurity risks due to the sensitive nature of their technologies, and breaches can lead to operational disruptions, reputational damage, and regulatory scrutiny. Long-term fixed-cost contracts, which are common in this sector, may expose companies to financial losses if costs exceed estimates. Furthermore, environmental and safety regulations, as well as export controls, tariffs, and trade restrictions, impose significant compliance costs and may limit market opportunities. The aerospace and defense industry is inherently cyclical and influenced by global political and economic developments, which can contribute to earnings volatility and investment risks.
Business Risks. RKLB has experienced rapid growth, with its employee base and operations expanding substantially in recent years, placing considerable demands on its management, operational infrastructure, and financial resources. Continued growth is dependent on RKLB’s ability to scale its revenue, improve operational efficiencies, and maintain profitability while effectively managing its increasingly complex organizational structure. Failure to integrate acquisitions, enhance business processes, or address evolving customer and market demands could adversely affect RKLB’s growth prospects.
RKLB operates in competitive markets for rocket launch services, mission services, spacecraft, and spacecraft components, facing challenges from established players and new entrants. RKLB’s success relies on its ability to anticipate and respond to macroeconomic and industry-specific changes, hire and retain talent, and maintain high levels of customer satisfaction. Additionally, interruptions from information technology failures, cybersecurity breaches, or other infrastructure issues could disrupt operations. RKLB’s ability to comply with applicable regulations and adapt to changes in the industry also presents ongoing risks.
While RKLB has demonstrated significant revenue growth in recent years, future revenue generation and growth are uncertain. Rising operating expenses may outpace revenue growth, potentially harming profitability and the company’s overall financial condition. Failure to address these risks could materially impact RKLB’s business and long-term prospects.
SMCI Risks. The SMCX ETF invests in swaps and options contracts that are based on the share price of SMCI. This subjects the Funds to certain of the same risks as if they owned shares of SMCI, even though they do not. By virtue of each Fund’s investments in swap contracts that are based on the value of SMCI, the Funds may also be subject to the following risks:
Indirect Investment in SMCI Risk. SMCI is not affiliated with the Trust, the Funds, or the Adviser, or their respective affiliates and is not involved with this offering in any way and has no obligation to consider your Shares in taking any corporate actions that might affect the value of Shares. Investors in the Funds will not have voting rights and will not be able to influence management of SMCI but will be exposed to the performance of SMCI. Investors in the Funds will not have the right to receive dividends or other distributions or any other rights with respect to SMCI but will be subject to declines in the performance of SMCI.
SMCI Trading Risk. The trading price of SMCI may demonstrate volatility and wide fluctuations due to various factors inherent in the technology industry. Unlike some other sectors, the technology industry, including SMCI, is prone to significant price and volume fluctuations, occasionally unrelated to operational performance. Short sellers may also play a significant role in trading SMCI, impacting supply and demand dynamics and contributing to market price volatility. Moreover, external factors and public perception may disproportionately influence SMCI’s share price within the technology sector, with heightened public attention notwithstanding operational performance. Furthermore, SMCI, like other tech companies, may encounter securities class action litigation during periods of market volatility, potentially resulting in substantial costs and diverting management’s attention and resources. In the event of a trading halt for SMCI, trading in Shares of the Funds may be impacted, either temporarily or indefinitely.
159
| Notes to the Financial Statements | Defiance ETFs |
SMCI Performance Risk. SMCI may fail to meet its publicly announced guidelines or other expectations about its business, which could cause the price of SMCI to decline. SMCI provides guidance regarding its expected financial and business performance, such as projections regarding sales and production, as well as anticipated future revenues, gross margins, profitability and cash flows. Correctly identifying key factors affecting business conditions and predicting future events is inherently an uncertain process, and the guidance SMCI provides may not ultimately be accurate and has in the past been inaccurate in certain respects, such as the timing of new product manufacturing ramps. The guidance is based on certain assumptions such as those relating to global and local economic conditions, anticipated production and sales volumes (which generally are not linear throughout a given period), average sales prices, supplier and commodity costs, and planned cost reductions. If SMCI’s guidance is not accurate or varies from actual results due to its inability to meet the assumptions or the impact on its financial performance that could occur as a result of various risks and uncertainties, the market value of common stock issued by SMCI could decline significantly.
Delisting Risk. SMCI (the “Company”) announced that on February 25, 2025 it received a notification letter from NASDAQ indicating that it now complies with NASDAQ Listing Rule 5250(c)(1), which requires timely filing of reports with the SEC and the matter is now closed.
Prior to its filing on February 25, 2025, the Company had received notification letters from NASDAQ on September 17, 2024 and February 21, 2025, stating that the Company was not in compliance with NASDAQ listing rule 5250(c)(1) as a result of the Company’s delay in filing its Quarterly Report on Form 10-Q for the period ending December 31, 2024 and its continued delay in filing its Annual Report on Form 10-K for the period ending June 30, 2024 Form 10-K and Quarterly Report on Form 10-Q for the period ending September 30, 2024. As previously announced, on February 25, 2025, the Company has filed each of such periodic reports such that it is now current with respect to its Securities Exchange Act reporting obligations.
Under the NASDAQ rules, SMCI has 60 days from the date of the notice either to file the Form 10-K or to submit a plan to NASDAQ to regain compliance with NASDAQ’s listing rules. If a plan is submitted and accepted, SMCI could be granted up to 180 days from the Form 10-K’s due date to regain compliance. If NASDAQ does not accept SMCI’s plan, then SMCI will have the opportunity to appeal that decision to a Nasdaq hearings panel.
Operational and Execution Risk. Adverse economic conditions may adversely affect SMCI’s business operations. Ongoing events in eastern Europe and the Taiwan Strait pose challenges and risks to SMCI, potentially impacting its business, financial condition, and operating results. Quarterly operating results have historically fluctuated and are likely to continue doing so in the future. Predicting revenue and margins for specific periods is challenging, and any revenue shortfall or margin decline may negatively impact SMCI’s operating results. As SMCI targets larger customers and sales opportunities, its customer base may become more concentrated, increasing costs, lowering margins, and exposing the company to inventory risks.
Strategic and Industry Risks. Failure to manage the expansion of international manufacturing capacity and business operations could harm SMCI’s business. Additionally, managing growth and expansion effectively is crucial for SMCI’s success. Expansion into markets outside the United States exposes SMCI to inherent risks associated with international business operations. Development of new products and enhancements to existing products is vital for SMCI’s growth; failure to predict or respond to emerging technological trends and changing customer needs may adversely affect its market share and operating results.
Legal and Regulatory Risks. SMCI is subject to complex and evolving laws and regulations concerning privacy, data protection, and other matters due to the nature of its products and services. Compliance with environmental, health, and safety laws and regulations is essential for SMCI due to its operations involving regulated materials. Failure to maintain effective internal control over financial reporting may lead to investor loss of confidence and decrease the market price of SMCI’s common stock.
Financial Risks. SMCI’s research and development expenditures are considerably higher than those of many competitors, impacting its financial performance. Future effective income tax rates could be affected by changes in operations and income among different geographic regions and changes in domestic and foreign income tax laws. Backlog does not significantly contribute to SMCI’s net sales in any quarter.
General Risks. SMCI’s products may not be perceived as supporting climate change mitigation efforts in the information technology sector. Natural disaster events, including those related to climate change, may impact SMCI’s business and operations. Risks associated with the use of AI by SMCI’s workforce may arise. Expectations regarding environmental,
160
| Notes to the Financial Statements | Defiance ETFs |
social, and governance considerations expose SMCI to potential liabilities, reputational harm, and other unforeseen adverse effects on its business.
SOFI Risks. The SOFX ETF invests in swap contracts and options that are based on the share price of SOFI. This subjects the Fund to certain of the same risks as if it owned shares of SOFI, even though it does not. By virtue of the Fund’s investments in swap contracts and options that are based on the value of SOFI, the Fund may also be subject to the following risks:
Indirect Investment in SOFI Risk. SOFI is not affiliated with the Trust, the Fund, or the Adviser, or their respective affiliates and is not involved with this offering in any way and has no obligation to consider your Shares in taking any corporate actions that might affect the value of Shares. Investors in the Fund will not have voting rights and will not be able to influence management of SOFI but will be exposed to the performance of SOFI. Investors in the Fund will not have the right to receive dividends or other distributions or any other rights with respect to SOFI but will be subject to declines in the performance of SOFI.
SOFI Trading Risk. The trading price of SOFI may be subject to volatility and could experience wide fluctuations due to various factors. Short sellers may also play a significant role in trading SOFI, potentially affecting the supply and demand dynamics and contributing to market price volatility. Public perception and external factors beyond the company’s control may influence SOFI’s stock price disproportionately. Additionally, following periods of market volatility, companies have faced securities class action litigation. Any adverse judgment or future stockholder litigation could result in substantial costs and divert management’s attention and resources. In the event of a halt in trading of SOFI, trading in shares of related funds may be impacted, either temporarily or indefinitely.
SOFI Performance Risk. SOFI may fail to meet its publicly announced guidelines or other expectations about its business, which could cause the price of SOFI to decline. SOFI provides guidance regarding its expected financial and business performance, such as projections regarding sales and production, as well as anticipated future revenues, gross margins, profitability and cash flows. Correctly identifying key factors affecting business conditions and predicting future events is inherently an uncertain process, and the guidance SOFI provides may not ultimately be accurate. If SOFI’s guidance is not accurate or varies from actual results due to its inability to meet the assumptions or the impact on its financial performance that could occur as a result of various risks and uncertainties, the market value of common stock issued by SOFI could decline significantly.
Consumer Finance Industry Risks: The consumer finance industry can be significantly affected by changing economic conditions, demand for consumer loans, and refinancing activity. Profitability can be largely dependent on the availability and cost of capital and the rate of consumer debt defaults, and can fluctuate significantly when interest rates change. Financial difficulties of borrowers can negatively affect the consumer finance industry. Companies in the consumer finance industry are subject to extensive government regulation, which can change frequently and may adversely affect the scope of their activities, the prices they can charge and the amount of capital they must maintain, or may affect them in other ways that are unforeseeable.
Interest Rate Risks. SOFI’s business is sensitive to interest rates and interest rates are highly sensitive to many factors that are beyond SOFI’s control, including global, domestic and local economic conditions and the policies of various governmental and regulatory agencies and, in particular, the Federal Reserve. SOFI is unable to predict future changes in interest rates. Changes to prevailing interest rates could influence not only the interest SOFI receives on loans and investments and the amount of interest it pays on deposits and borrowings, but could also affect (i) SOFI’s ability to originate loans at competitive rates and obtain deposits; (ii) the fair value of SOFI’s financial assets and liabilities; (iii) the average duration of SOFI’s loan portfolios and other interest-earning assets; (iv) the mix of lending products SOFI originates which is influenced by demand for refinancing products; and (v) the competition faced by its SoFi Money deposit product from other investment products which may become more attractive as interest rates rise.
Intellectual Property Risks: SOFI’s ability to provide products and services to its members and technology platform clients depends, in part, upon its proprietary technology. SOFI may be unable to protect its proprietary technology effectively, which would allow competitors to duplicate its business processes and know-how, and adversely affect its ability to compete with them. A third party may attempt to reverse engineer or otherwise obtain and use SOFI’s proprietary technology without its consent. The pursuit of a claim against a third party for infringement of intellectual property could be costly, and there can be no guarantee that any such efforts would be successful.
161
| Notes to the Financial Statements | Defiance ETFs |
Operations Risks: Failure, inadequacy, breach of, or unauthorized access to, SOFI’s IT systems or those of SOFI’s third-party service providers, unauthorized access to SOFI’s confidential information, or violations of data protection laws, could each result in material harm to SOFI’s business and reputation. SOFI’s use of artificial intelligence or other emerging technologies could adversely impact SOFI’s business and financial results.
International Business Risks: If SOFI fails to deploy or manage its operations successfully in international markets, its business and operations may suffer. In addition, SOFI is subject to a variety of risks inherent in doing business internationally, including risks related to government regulation, political, social and/or economic instability or military conflict, higher levels of credit risk and fraud, fluctuations in currency exchange rates and global market volatility, among others.
SOUN Risks. The SOUX ETF invests in swap contracts and options that are based on the share price of SOUN. This subjects the Fund to certain of the same risks as if it owned shares of SOUN, even though it does not. By virtue of the Fund’s investments in swap contracts and options that are based on the value of SOUN, the Fund may also be subject to the following risks:
Indirect Investment in SOUN Risk. SOUN is not affiliated with the Trust, the Fund, or the Adviser, or their respective affiliates and is not involved with this offering in any way and has no obligation to consider your Shares in taking any corporate actions that might affect the value of Shares. Investors in the Fund will not have voting rights and will not be able to influence management of SOUN but will be exposed to the performance of SOUN (the Underlying Security). Investors in the Fund will not have the right to receive dividends or other distributions or any other rights with respect to the Underlying Security but will be subject to declines in the performance of the Underlying Security.
SOUN Trading Risk. The trading price of SOUN may be subject to volatility and could experience wide fluctuations due to various factors. Short sellers may also play a significant role in trading SOUN, potentially affecting the supply and demand dynamics and contributing to market price volatility. Public perception and external factors beyond the company’s control may influence SOUN’s stock price disproportionately. Additionally, following periods of market volatility, companies have faced securities class action litigation. Any adverse judgment or future stockholder litigation could result in substantial costs and divert management’s attention and resources. In the event of a halt in trading of SOUN, trading in shares of related funds may be impacted, either temporarily or indefinitely. In particular, SOUN recently announced a delay in the filing of its annual financial statements, related to material weaknesses in SOUN’s internal control over financial reporting. This matter may contribute to increased volatility in the trading price of SOUN, and should the financial statements not be filed within required timelines, could result in SOUN stock being delisted.
Delisting Risk. SOUN announced on March 4, 2025 that it was unable to timely file its Annual Report on Form 10-K for the period ending December 31, 2024 (the “Form 10-K”) in accordance with the required deadline under the federal securities laws. Subsequently, on March 11, 2025, SOUN filed its Form 10-K. However, there can be no assurance that SOUN will continue to meet its reporting obligations in a timely manner in the future. Any future failure to complete timely filings could result in SOUN’s stock being delisted from NASDAQ, which would prevent the Fund from continuing to operate.
SOUN Performance Risk. SOUN may fail to meet its publicly announced guidelines or other expectations about its business, which could cause the price of SOUN to decline. SOUN provides guidance regarding its expected financial and business performance, such as projections regarding sales and production. Correctly identifying key factors affecting business conditions and predicting future events is inherently an uncertain process, and the guidance SOUN provides may not ultimately be accurate. If SOUN’s guidance is not accurate or varies from actual results due to its inability to meet the assumptions or the impact on its financial performance that could occur as a result of various risks and uncertainties, the market value of common stock issued by SOUN could decline significantly.
Software Industry Risks: The software industry can be significantly affected by intense competition, aggressive pricing, technological innovations, and product obsolescence. Companies in the software industry are subject to significant competitive pressures, such as aggressive pricing, new market entrants, competition for market share, short product cycles due to an accelerated rate of technological developments and the potential for limited earnings and/or falling profit margins. These companies also face the risks that new services, equipment or technologies will not be accepted by consumers and businesses or will become rapidly obsolete. These factors can affect the profitability of these companies and, as a result, the value of their securities. Also, patent protection is integral to the success of many companies in this industry, and profitability can be affected materially by, among other things, the cost of obtaining (or failing to obtain) patent approvals, the cost of litigating patent infringement and the loss of patent protection for products (which significantly increases pricing pressures and can materially reduce profitability with respect to such products). In addition, many software companies have limited
162
| Notes to the Financial Statements | Defiance ETFs |
operating histories. Prices of these companies’ securities historically have been more volatile than other securities, especially over the short term.
Business Risks. SOUN faces significant risks related to its financial condition and business operations, including a history of substantial net losses and negative cash flows, with no assurance of achieving profitability. The company’s reliance on a concentrated customer base exposes it to significant revenue risks if these relationships are disrupted. Competition in the rapidly evolving Voice AI (artificial intelligence) market, regulatory and legislative developments related to the use of AI and the potential inability to attract and retain key personnel further threaten its growth and operational stability. Additionally, cybersecurity incidents, interruptions in cloud services, and challenges in complying with complex domestic and international regulations could harm its business and client relationships.
Intellectual property risks include potential claims of infringement, unauthorized use of proprietary technology, and limitations imposed by open-source software usage exposing SOUN to significant litigation or licensing expenses or being prevented from selling SOUN’s products or making SOUN’s technologies available to its customers if such claims are successful. Governance risks stem from its dual-class stock structure, which concentrates voting control with Class B shareholders, limiting the influence of Class A shareholders. These governance dynamics, coupled with limited public company experience and identified material weaknesses in internal controls, may impact investor confidence. Tax-related risks, including limitations on the use of net operating loss carryforwards, add to the uncertainty surrounding SOUN’s financial outlook.
Third-Party Risks. SOUN relies on third-party telecommunications and internet service providers, including connectivity to its cloud software, and any failure by these service providers to provide reliable services could cause SOUN to lose customers and subject it to claims for credits or damages, among other things. SOUN’s customers rely on third-party telecommunications and internet service providers to provide them with access and connectivity to SOUN’s cloud software, and changes in how telecommunication and internet service providers handle and charge for access to telecommunications and the internet could materially harm SOUN’s customer relationships, business, financial condition and operations results. SOUN’s plans to expand upon and establish new public cloud-based data centers for its U.S. and international operations may be unsuccessful and may present execution and competitive risks.
VST Risks. The VSTL ETF invests in swap contracts and options that are based on the share price of VST. This subjects the Fund to certain of the same risks as if it owned shares of VST, even though it does not. By virtue of the Fund’s investments in swap contracts and options that are based on the value of VST, the Fund may also be subject to the following risks:
Indirect Investment in VST Risk. VST is not affiliated with the Trust, the Fund, or the Adviser, or their respective affiliates and is not involved with this offering in any way and has no obligation to consider your Shares in taking any corporate actions that might affect the value of Shares. Investors in the Fund will not have voting rights and will not be able to influence management of VST but will be exposed to the performance of VST (the Underlying Security). Investors in the Fund will not have the right to receive dividends or other distributions or any other rights with respect to the Underlying Security but will be subject to declines in the performance of the Underlying Security.
VST Trading Risk. The trading price of VST may be subject to volatility and could experience wide fluctuations due to various factors. Short sellers may also play a significant role in trading VST, potentially affecting the supply and demand dynamics and contributing to market price volatility. Public perception and external factors beyond the company’s control may influence VST’s stock price disproportionately. Additionally, following periods of market volatility, companies have faced securities class action litigation. Any adverse judgment or future stockholder litigation could result in substantial costs and divert management’s attention and resources. In the event of a halt in trading of VST, trading in shares of related funds may be impacted, either temporarily or indefinitely.
VST Performance Risk. VST may fail to meet its publicly announced guidelines or other expectations about its business, which could cause the price of VST to decline. VST provides guidance regarding its expected financial and business performance, such as projections regarding sales and production, as well as anticipated future revenues, gross margins, profitability and cash flows. Correctly identifying key factors affecting business conditions and predicting future events is inherently an uncertain process, and the guidance VST provides may not ultimately be accurate. If VST’s guidance is not accurate or varies from actual results due to its inability to meet the assumptions or the impact on its financial performance that could occur as a result of various risks and uncertainties, the market value of common stock issued by VST could decline significantly.
163
| Notes to the Financial Statements | Defiance ETFs |
Independent Power and Renewable Electricity Producers Industry Risks. This industry includes companies involved in the generation and sale of electricity from independent power plants and renewable energy facilities such as solar, wind, hydroelectric, and battery storage. The industry is highly competitive and influenced by factors such as electricity demand, energy prices, and technological advancements. The prices of securities of companies in this industry may fluctuate widely due to general economic conditions, changes in energy market dynamics, and regulatory developments. Companies in this industry are subject to risks related to fuel supply and costs, renewable energy resource availability, and transmission infrastructure constraints. Additionally, the industry may be affected by legislative or regulatory changes, including renewable energy incentives, environmental standards, and carbon emission requirements. Operational risks, such as equipment failures, weather related disruptions, and cybersecurity threats, can also have a significant impact on companies in this sector.
Business Risks. VST faces significant risks specific to its business operations, including exposure to fluctuations in wholesale power prices, fuel costs, and supply chain disruptions, which may adversely impact its revenues and financial performance. The company’s ability to manage commodity price risks is limited, and increased competition, regulatory changes, or government intervention in power markets could further challenge its profitability. Operating in a highly regulated industry, VST is subject to evolving environmental laws and climate change regulations that could impose substantial costs or constraints. Additionally, the capital-intensive nature of power generation, including the operation of the Comanche Peak nuclear facility, poses risks from cybersecurity threats, system failures, and extreme weather conditions. Changes in technology and energy efficiency initiatives could reduce electricity demand, impacting VST’s business model. The company also faces pressures from stakeholder expectations on environmental, social, and governance (ESG) issues, which may influence investor confidence and its stock performance. Further, litigation, legal proceedings, regulatory investigations or other administrative proceedings could expose VST to significant liabilities and reputational damage that could have a material adverse effect on VST.
IONQ Price Appreciation Risk. As part of the IONZ ETF’s inverse investment strategy, the Fund purchases and sells swap contracts and options contracts that are based on the share price of IONQ common stock (the “Underlying Security”). This strategy subjects the Fund to certain of the same risks as if it shorted shares of the Underlying Security, even though it does not. By virtue of the Fund’s indirect 2X exposure to changes in the share price of the Underlying Security, the Fund is subject to the risk that the Underlying Security’s share price increases. If the share price of the Underlying Security increases, the Fund will likely lose value and, as a result, the Fund may suffer significant losses. The Fund may also be subject to the following risks:
Indirect Investment in IONQ Risk. IONQ is not affiliated with the Trust, the Fund, the Adviser, or their respective affiliates and is not involved with this offering in any way and has no obligation to consider your Shares in taking any corporate actions that might affect the value of Shares. Investors in the Fund will not have voting rights and will not be able to influence the management of IONQ, but will be exposed to the performance of the Underlying Security. Investors in the Fund will not have rights to receive dividends or other distributions or any other rights with respect to the Underlying Security, but will be adversely impacted by increases in the share price of the Underlying Security.
IONQ Good Performance Risk. IONQ may meet or exceed its publicly announced expectations or guidelines regarding its business, which could potentially lead to a rise in the share price of the Underlying Security. IONQ regularly provides guidance concerning its anticipated financial and business performance, including sales and production projections, future revenues, gross margins, profitability, and cash flows. However, forecasting future events and identifying key factors affecting business conditions inherently involves uncertainty. IONQ’s guidance may ultimately prove accurate or may prove underestimated, as it relies on assumptions such as global and local economic conditions, anticipated production and sales volumes, average sales prices, supplier and commodity costs, and planned cost reductions. If IONQ’s guidance is accurate or varies positively from actual results, IONQ’s share price could increase significantly and, as a result, the Fund may suffer significant losses.
Industry Recognition and Analyst Coverage Risk. Positive recognition from industry analysts, awards for product excellence, or inclusion in prestigious industry reports can enhance IONQ’s reputation and credibility among investors. Favorable analyst ratings, upgrades, or bullish forecasts for the company’s future performance can drive investor enthusiasm and contribute to a rise in IONQ’s stock price.
Risks from Industry Growth and IONQ’s Business Success. IONQ operates in the emerging quantum computing industry, which has the potential for significant technological advancements and commercialization. If the company successfully develops its technology, secures major contracts, or benefits from broader industry adoption, its stock price may rise, leading to substantial losses for the Fund. Breakthroughs in quantum hardware, error correction, or algorithmic efficiency could
164
| Notes to the Financial Statements | Defiance ETFs |
enhance IONQ’s competitive position and drive investor confidence, potentially increasing its stock price. Additionally, strategic partnerships with cloud providers, enterprises, or government agencies could strengthen IONQ’s market presence and revenue growth, further contributing to stock appreciation. Government and institutional support, including funding, subsidies, or strategic backing, may accelerate the company’s development and drive increased investor optimism. Furthermore, speculative interest, media coverage, and overall market sentiment surrounding quantum computing advancements could lead to sharp increases in IONQ’s stock price, even if immediate revenue impacts remain uncertain. If IONQ benefits from these factors, its stock price may rise significantly, negatively affecting the Fund due to its inverse (2X) exposure.
LLY Price Appreciation Risk. As part of the LLYZ ETF’s inverse investment strategy, the Fund purchases and sells swap contracts that are based on the share price of LLY common stock (the “Underlying Security”). This strategy subjects the Fund to certain of the same risks as if it shorted shares of the Underlying Security, even though it does not. By virtue of the Fund’s indirect -2X exposure to changes in the share price of the Underlying Security, the Fund is subject to the risk that the Underlying Security’s share price increases. If the share price of the Underlying Security increases, the Fund will likely lose value and, as a result, the Fund may suffer significant losses. The Fund may also be subject to the following risks:
Indirect Investment in LLY Risk. Eli Lilly and Company is not affiliated with the Trust, the Fund, the Adviser, or their respective affiliates and is not involved with this offering in any way and has no obligation to consider your Shares in taking any corporate actions that might affect the value of Shares. Investors in the Fund will not have voting rights and will not be able to influence the management of Eli Lilly and Company, but will be exposed to the performance of the Underlying Security. Investors in the Fund will not have rights to receive dividends or other distributions or any other rights with respect to the Underlying Security, but will be adversely impacted by increases in the share price of the Underlying Security.
LLY Good Performance Risk. LLY may meet or exceed its publicly announced expectations or guidelines regarding its business, which could potentially lead to a rise in the share price of the Underlying Security. LLY regularly provides guidance concerning its anticipated financial and business performance, including sales and production projections, future revenues, gross margins, profitability, and cash flows. However, forecasting future events and identifying key factors affecting business conditions inherently involves uncertainty. LLY’s guidance may ultimately prove accurate or may prove underestimated, as it relies on assumptions such as global and local economic conditions, anticipated production and sales volumes, average sales prices, supplier and commodity costs, and planned cost reductions. If LLY’s guidance is accurate or varies positively from actual results, LLY’s share price could increase significantly and, as a result, the Fund may suffer significant losses.
Industry Recognition and Analyst Coverage Risk. Positive recognition from industry analysts, awards for product excellence, or inclusion in prestigious industry reports can enhance LLY’s reputation and credibility among investors. Favorable analyst ratings, upgrades, or bullish forecasts for the company’s future performance can drive investor enthusiasm and contribute to a rise in LLY’s stock price.
MSTR Price Appreciation Risks. As part of the SMST ETF’s inverse investment strategy, the Fund purchases and sells swap contracts that are based on the share price of MSTR. This strategy subjects the Fund to certain of the same risks as if it shorted shares of MSTR, even though it does not. By virtue of the Fund’s indirect -2X exposure to changes in the share price of MSTR, the Fund is subject to the risk that MSTR’s share price increases. If the share price of MSTR increases, the Fund will likely lose value and, as a result, the Fund may suffer significant losses. The Fund may also be subject to the following risks:
Indirect Investment in MSTR Risk. MSTR is not affiliated with the Trust, the Fund, the Adviser, or their respective affiliates and is not involved with this offering in any way and has no obligation to consider your Shares in taking any corporate actions that might affect the value of Shares. Investors in the Fund will not have voting rights and will not be able to influence management of MSTR but will be exposed to the performance of MSTR. Investors in the Fund will not have rights to receive dividends or other distributions or any other rights with respect to MSTR stock but will be subject to declines in the performance of MSTR stock.
MSTR Good Performance Risk. MSTR may meet or exceed its publicly announced expectations or guidelines regarding its business, which could potentially lead to a rise in the share price of MSTR. MSTR regularly provides guidance concerning its anticipated financial and business performance, including sales and production projections, future revenues, gross margins, profitability, and cash flows. However, forecasting future events and identifying key factors affecting business conditions inherently involves uncertainty. MSTR’s guidance may ultimately prove accurate or may prove underestimated, as it relies on assumptions such as global and local economic conditions, anticipated production and sales volumes, average sales prices,
165
| Notes to the Financial Statements | Defiance ETFs |
supplier and commodity costs, and planned cost reductions. If MSTR’s guidance is accurate or varies positively from actual results, MSTR’s share price could increase significantly and, as a result, the Fund may suffer significant losses.
Bitcoin Positive Performance Risk. MSTR’s significant investment in bitcoin has become a key driver of its stock price. Any positive movement in the price of Bitcoin, such as reaching new all-time highs, increased institutional adoption, or favorable regulatory developments, directly impacts MSTR’s balance sheet and investor perception. With MSTR holding a substantial amount of Bitcoin, its stock price tends to correlate with Bitcoin’s performance.
Analytics and Business Intelligence Market Growth Risk. MSTR operates in the analytics and business intelligence (BI) industry, which is experiencing robust growth due to increasing data volumes and the need for data-driven decision-making across various sectors. MSTR’s suite of BI software and analytics solutions positions it well to capitalize on this growth trend. Any indication of market expansion, such as growing demand for analytics tools or favorable industry forecasts, can drive investor optimism and push up MSTR’s stock price.
Product Innovation and Adoption Risk. MSTR continuously innovates its product offerings to stay competitive in the rapidly evolving analytics market. The company’s investments in cloud-based analytics platforms, mobile BI solutions, and AI-driven analytics capabilities demonstrate its commitment to meeting changing customer needs. Positive feedback or strong adoption rates for new products and features can signal to investors that MSTR remains at the forefront of technological advancements, potentially boosting its stock price.
Partnerships and Strategic Alliances Risk. MSTR frequently forms partnerships and strategic alliances with leading technology companies to enhance its product offerings and expand its market reach. For example, collaborations with cloud service providers can broaden MSTR’s customer base and drive revenue growth. Any announcements of significant partnerships or alliances that strengthen MSTR’s competitive position are likely to be viewed positively by investors and could lead to a stock price increase.
Industry Recognition and Analyst Coverage Risk. Positive recognition from industry analysts, awards for product excellence, or inclusion in prestigious industry reports can enhance MSTR’s reputation and credibility among investors. Favorable analyst ratings, upgrades, or bullish forecasts for the company’s future performance can drive investor enthusiasm and contribute to a rise in MSTR’s stock price.
PLTR Price Appreciation Risk. As part of the PLTZ ETF’s inverse investment strategy, the Fund purchases and sells swap contracts and options contracts that are based on the share price of PLTR common stock (the “Underlying Security”). This strategy subjects the Fund to certain of the same risks as if it shorted shares of the Underlying Security, even though it does not. By virtue of the Fund’s indirect 2X exposure to changes in the share price of the Underlying Security, the Fund is subject to the risk that the Underlying Security’s share 23 price increases. If the share price of the Underlying Security increases, the Fund will likely lose value and, as a result, the Fund may suffer significant losses. The Fund may also be subject to the following risks:
Indirect Investment in PLTR Risk. PLTR is not affiliated with the Trust, the Fund, the Adviser, or their respective affiliates and is not involved with this offering in any way and has no obligation to consider your Shares in taking any corporate actions that might affect the value of Shares. Investors in the Fund will not have voting rights and will not be able to influence the management of PLTR but will be exposed to the performance of the Underlying Security. Investors in the Fund will not have rights to receive dividends or other distributions or any other rights with respect to the Underlying Security but will be adversely impacted by increases in the share price of the Underlying Security.
PLTR Good Performance Risk. PLTR may meet or exceed its publicly announced expectations or guidelines regarding its business, which could potentially lead to a rise in the share price of the Underlying Security. PLTR regularly provides guidance concerning its anticipated financial and business performance, including sales and production projections, future revenues, gross margins, profitability, and cash flows. However, forecasting future events and identifying key factors affecting business conditions inherently involves uncertainty. PLTR’s guidance may ultimately prove accurate or may prove underestimated, as it relies on assumptions such as global and local economic conditions, anticipated production and sales volumes, average sales prices, supplier and commodity costs, and planned cost reductions. If PLTR’s guidance is accurate or varies positively from actual results, PLTR’s share price could increase significantly and, as a result, the Fund may suffer significant losses.
Industry Recognition and Analyst Coverage Risk. Positive recognition from industry analysts, awards for product excellence, or inclusion in prestigious industry reports can enhance PLTR’s reputation and credibility among investors. Favorable analyst
166
| Notes to the Financial Statements | Defiance ETFs |
ratings, upgrades, or bullish forecasts for the company’s future performance can drive investor enthusiasm and contribute to a rise in PLTR’s stock price.
Risks from Industry Growth and PLTR’s Business Success. PLTR develops software platforms designed to integrate data, enhance decision-making, and support operations for both commercial enterprises and government agencies, including the defense and intelligence sectors. PLTR has the potential for significant growth driven by increasing demand for advanced data analytics, artificial intelligence, and national security-related software solutions. If PLTR successfully expands its platform capabilities, secures major government or commercial contracts, or achieves technological advancements in artificial intelligence, machine learning, or cloud-based data integration, its stock price may rise, leading to substantial losses for the Fund. Enhancements to PLTR’s software platforms could strengthen its competitive position and drive investor confidence, contributing to stock appreciation. Additionally, strategic partnerships with government agencies, defense contractors, and major enterprises could accelerate revenue growth and further solidify its market presence. Increased funding or policy support from government entities such as the Department of Defense, intelligence agencies, or international allies could further drive stock price gains. Moreover, speculative interest, media coverage, and overall market enthusiasm for artificial intelligence (AI), big data analytics, and security-focused software could lead to sharp increases in PLTR’s stock price, even if near-term profitability remains uncertain. If PLTR benefits from these factors, its stock price may rise significantly, negatively affecting the Fund due to its inverse (-2X) exposure.
QBTS Price Appreciation Risk. As part of the QBTZ ETF’s inverse investment strategy, the Fund purchases and sells swap contracts and options contracts that are based on the share price of QBTS common stock (the “Underlying Security”). This strategy subjects the Fund to certain of the same risks as if it shorted shares of the Underlying Security, even though it does not. By virtue of the Fund’s indirect 2X exposure to changes in the share price of the Underlying Security, the Fund is subject to the risk that the Underlying Security’s share price increases. If the share price of the Underlying Security increases, the Fund will likely lose value and, as a result, the Fund may suffer significant losses. The Fund may also be subject to the following risks:
Indirect Investment in QBTS Risk. D-Wave Quantum Inc. is not affiliated with the Trust, the Fund, the Adviser, or their respective affiliates and is not involved with this offering in any way and has no obligation to consider your Shares in taking any corporate actions that might affect the value of Shares. Investors in the Fund will not have voting rights and will not be able to influence the management of D-Wave Quantum Inc., but will be exposed to the performance of the Underlying Security. Investors in the Fund will not have rights to receive dividends or other distributions or any other rights with respect to the Underlying Security, but will be adversely impacted by increases in the share price of the Underlying Security.
QBTS Good Performance Risk. QBTS may meet or exceed its publicly announced expectations or guidelines regarding its business, which could potentially lead to a rise in the share price of the Underlying Security. QBTS regularly provides guidance concerning its anticipated financial and business performance, including sales and production projections, future revenues, gross margins, profitability, and cash flows. However, forecasting future events and identifying key factors affecting business conditions inherently involves uncertainty. QBTS’s guidance may ultimately prove accurate or may prove underestimated, as it relies on assumptions such as global and local economic conditions, anticipated production and sales volumes, average sales prices, supplier and commodity costs, and planned cost reductions. If QBTS’s guidance is accurate or varies positively from actual results, QBTS’s share price could increase significantly and, as a result, the Fund may suffer significant losses.
Industry Recognition and Analyst Coverage Risk. Positive recognition from industry analysts, awards for product excellence, or inclusion in prestigious industry reports can enhance QBTS’s reputation and credibility among investors. Favorable analyst ratings, upgrades, or bullish forecasts for the company’s future performance can drive investor enthusiasm and contribute to a rise in QBTS’s stock price.
RGTI Price Appreciation Risk. As part of the Fund’s inverse investment strategy, the Fund purchases and sells swap contracts and options contracts that are based on the share price of RGTI common stock (the “Underlying Security”). This strategy subjects the Fund to certain of the same risks as if it shorted shares of the Underlying Security, even though it does not. By virtue of the Fund’s indirect 2X exposure to changes in the share price of the Underlying Security, the Fund is subject to the risk that the Underlying Security’s share price increases. If the share price of the Underlying Security increases, the Fund will likely lose value and, as a result, the Fund may suffer significant losses. The Fund may also be subject to the following risks:
Indirect Investment in RGTI Risk. Rigetti Computing, Inc. is not affiliated with the Trust, the Fund, the Adviser, or their respective affiliates and is not involved with this offering in any way and has no obligation to consider your Shares in taking any corporate actions that might affect the value of Shares. Investors in the Fund will not have voting rights and will not be
167
| Notes to the Financial Statements | Defiance ETFs |
able to influence the management of Rigetti Computing, Inc., but will be exposed to the performance of the Underlying Security. Investors in the Fund will not have rights to receive dividends or other distributions or any other rights with respect to the Underlying Security, but will be adversely impacted by increases in the share price of the Underlying Security.
RGTI Good Performance Risk. RGTI may meet or exceed its publicly announced expectations or guidelines regarding its business, which could potentially lead to a rise in the share price of the Underlying Security. RGTI regularly provides guidance concerning its anticipated financial and business performance, including sales and production projections, future revenues, gross margins, profitability, and cash flows. However, forecasting future events and identifying key factors affecting business conditions inherently involves uncertainty. RGTI’s guidance may ultimately prove accurate or may prove underestimated, as it relies on assumptions such as global and local economic conditions, anticipated production and sales volumes, average sales prices, supplier and commodity costs, and planned cost reductions. If RGTI’s guidance is accurate or varies positively from actual results, RGTI’s share price could increase significantly and, as a result, the Fund may suffer significant losses.
Industry Recognition and Analyst Coverage Risk. Positive recognition from industry analysts, awards for product excellence, or inclusion in prestigious industry reports can enhance RGTI’s reputation and credibility among investors. Favorable analyst ratings, upgrades, or bullish forecasts for the company’s future performance can drive investor enthusiasm and contribute to a rise in RGTI’s stock price.
SMCI Price Appreciation Risk. As part of the SMCZ ETF’s inverse investment strategy, the Fund purchases and sells swap contracts that are based on the share price of SMCI common stock. This strategy subjects the Fund to certain of the same risks as if it shorted shares of SMCI, even though it does not. By virtue of the Fund’s indirect -2X exposure to changes in the share price of SMCI, the Fund is subject to the risk that SMCI’s share price increases. If the share price of SMCI increases, the Fund will likely lose value and, as a result, the Fund may suffer significant losses. The Fund may also be subject to the following risks:
Indirect Investment in SMCI Risk. Super Micro Computer, Inc. is not affiliated with the Trust, the Fund, the Adviser, or their respective affiliates and is not involved with this offering in any way and has no obligation to consider your Shares in taking any corporate actions that might affect the value of Shares. Investors in the Fund will not have voting rights and will not be able to influence the management of Super Micro Computer, Inc., but will be exposed to the performance of SMCI. Investors in the Fund will not have rights to receive dividends or other distributions or any other rights with respect to SMCI, but will be adversely impacted by increases in the share price of SMCI.
SMCI Good Performance Risk. SMCI may meet or exceed its publicly announced expectations or guidelines regarding its business, which could potentially lead to a rise in the share price of SMCI. SMCI regularly provides guidance concerning its anticipated financial and business performance, including sales and production projections, future revenues, gross margins, profitability, and cash flows. However, forecasting future events and identifying key factors affecting business conditions inherently involves uncertainty. SMCI’s guidance may ultimately prove accurate or may prove underestimated, as it relies on assumptions such as global and local economic conditions, anticipated production and sales volumes, average sales prices, supplier and commodity costs, and planned cost reductions. If SMCI’s guidance is accurate or varies positively from actual results, SMCI’s share price could increase significantly and, as a result, the Fund may suffer significant losses.
Industry Recognition and Analyst Coverage Risk. Positive recognition from industry analysts, awards for product excellence, or inclusion in prestigious industry reports can enhance SMCI’s reputation and credibility among investors. Favorable analyst ratings, upgrades, or bullish forecasts for the company’s future performance can drive investor enthusiasm and contribute to a rise in SMCI’s stock price.
Delisting Risk. SMCI has previously failed to timely file its required SEC reports, including its Form 10-K, and its prior auditor resigned, raising concerns about the company’s financial reporting and transparency. Additionally, SMCI has faced threats of delisting from NASDAQ due to noncompliance with exchange listing requirements. If SMCI continues to experience delays or deficiencies in its financial disclosures, investors may lack access to timely and reliable information necessary for informed decision-making, potentially increasing volatility in SMCI’s stock price and adversely affecting the Fund’s performance. A delisting event would further impair the Fund’s ability to achieve its investment objective and could lead to its closure and liquidation. The effective operation of leveraged inverse ETFs depends on stable and liquid trading markets for the underlying security. Any disruptions in SMCI’s liquidity, widening of bid-ask spreads, or market inefficiencies stemming from ongoing regulatory or financial issues could hinder the Fund’s ability to track its intended -2X inverse multiple. Furthermore, SMCI’s increased stock price volatility, combined with the Fund’s leveraged inverse structure,
168
| Notes to the Financial Statements | Defiance ETFs |
may amplify potential losses in the event of sharp upward price movements, particularly in the absence of consistent financial disclosures and stable market conditions.
Single Issuer Risk. Issuer-specific attributes may cause an investment in the Funds to be more volatile than a traditional pooled investment which diversifies risk or the market generally. The value of the Funds, which focus on an individual security, may be more volatile than a traditional pooled investment or the market as a whole and may perform differently from the value of a traditional pooled investment or the market as a whole. Additionally, the Funds will seek to employ their investment strategies as it relates to the underlying issuer regardless of whether the company has strong earnings reports, or provides positive future guidance, dividend increases, share buybacks, or engages in strategic acquisitions and product launches. Additionally, the Funds will seek to employ their investment strategy as they relate to the underlying issuer regardless of whether there are favorable industry trends, regulatory approvals, analyst upgrades, strategic partnerships, debt reduction, or improved economic conditions.
As with any investment, there is a risk that you could lose all or a portion of your principal investment in the Funds. The Funds are subject to the above principal risks which may adversely affect each Fund’s NAV, trading price, yield, total return and/or ability to meet their objectives. For more information about the risks of investing in the Funds, see the section in each Fund’s Prospectus titled “Additional Information About the Fund — Principal Investment Risks.”
| NOTE 4 – COMMITMENTS AND OTHER RELATED PARTY TRANSACTIONS |
The Adviser serves as investment adviser to the Funds pursuant to an investment advisory agreement between the Adviser and the Trust, on behalf of the Funds (the “Advisory Agreement”), and, pursuant to the Advisory Agreement, provides investment advice to the Funds and oversees the day-to-day operations of the Funds, subject to the direction and oversight of the Board. The Adviser is also responsible for trading portfolio securities for the Funds, including selecting broker-dealers to execute purchase and sale transactions, subject to the supervision of the Board.
Pursuant to the Advisory Agreement, each Fund pays the Adviser a unitary management fee (the “Investment Advisory Fee”) based on the average daily net assets of each Fund as follows:
| Investment Advisory | ||
| Fund | Fee | |
| QPUX ETF | 1.29% | |
| ANEL ETF | 1.29% | |
| AVXX ETF | 1.29% | |
| AVGX ETF | 1.29% | |
| CVNX ETF | 1.29% | |
| DKNX ETF | 1.29% | |
| HIMZ ETF | 1.29% | |
| HOOX ETF | 1.29% | |
| IONX ETF | 1.29% | |
| IRE ETF | 1.29% | |
| JPX ETF | 1.29% | |
| LLYX ETF | 1.29% | |
| LMNX ETF | 1.29% | |
| MPL ETF | 1.29% | |
| MSTX ETF | 1.29% | |
| NVOX ETF | 1.29% | |
| OKLL ETF | 1.29% | |
| ORCX ETF | 1.29% | |
| OSCX ETF | 1.29% | |
| XPM ETF | 1.29% | |
| QSU ETF | 1.29% | |
| RGTX ETF | 1.29% | |
| RIOX ETF | 0.95% | |
| RKLX ETF | 1.29% | |
| SMCX ETF | 1.29% | |
| SOFX ETF | 1.29% | |
| SOUX ETF | 1.29% | |
| VSTL ETF | 1.29% | |
| IONZ ETF | 1.29% | |
| LLYZ ETF | 1.29% | |
| SMST ETF | 1.29% | |
169
| Notes to the Financial Statements | Defiance ETFs |
| PLTZ ETF | 1.29% |
| QBTZ ETF | 1.29% |
| RGTZ ETF | 1.29% |
| SMCZ ETF | 1.29% |
Out of the Investment Advisory Fees, the Adviser is obligated to pay or arrange for the payment of substantially all expenses of the Funds, including the cost of transfer agency, custody, fund administration, and all other related services necessary for the Funds to operate. Under the Advisory Agreement, the Adviser has agreed to pay all expenses incurred by the Funds except for interest charges on any borrowings, dividends and other expenses on securities sold short, taxes, brokerage commissions and other expenses incurred in placing orders for the purchase and sale of securities and other investment instruments, acquired fund fees and expenses, accrued deferred tax liability, distribution fees and expenses paid by the Fund under any distribution plan adopted pursuant to Rule 12b-1 under the 1940 Act, (collectively, “Excluded Expenses”), and the Investment Advisory Fees payable to the Adviser. The Investment Advisory Fees incurred are paid monthly to the Adviser. Investment Advisory Fees for the periods ended October 31, 2025 are disclosed in the Statements of Operations.
Tidal ETF Services LLC (“Tidal”), a Tidal Financial Group company and an affiliate of the Adviser, serves as the Funds’ administrator and, in that capacity, performs various administrative and management services for the Funds. Tidal coordinates the payment of Fund-related expenses and manages the Trust’s relationships with its various service providers. As compensation for the services it provides, Tidal receives a fee based on each Fund’s average daily net assets, subject to a minimum annual fee. Tidal also is entitled to certain out-of-pocket expenses for the services mentioned above.
U.S. Bancorp Fund Services, LLC, doing business as U.S. Bank Global Fund Services (“Fund Services”), serves as the Funds’ sub-administrator, fund accountant and transfer agent. In those capacities, Fund Services performs various administrative and accounting services for the Funds. Fund Services prepares various federal and state regulatory filings, reports and returns for the Funds, including regulatory compliance monitoring and financial reporting; prepares reports and materials to be supplied to the Board; and monitors the activities of the Funds’ custodian. U.S. Bank N.A. (the “Custodian”), an affiliate of Fund Services, serves as the Funds’ custodian.
Foreside Fund Services, LLC (the “Distributor”) acts as the Funds’ principal underwriter in a continuous public offering of the Funds’ Shares.
Certain officers and a trustee of the Trust are affiliated with the Adviser. Neither the affiliated trustee nor the Trust’s officers receive compensation from the Funds.
The Board has adopted a Distribution (Rule 12b-1) Plan (the “Plan”) pursuant to Rule 12b-1 under the 1940 Act. In accordance with the Plan, each Fund is authorized to pay an amount up to 0.25% of their average daily net assets each year to pay distribution fees for the sale and distribution of its Shares. No Rule 12b-1 fees are currently paid by the Funds, and there are no plans to impose these fees. However, in the event Rule 12b-1 fees are charged in the future, because the fees are paid out of each Fund’s assets on an ongoing basis, over time these fees will increase the cost of your investment and may cost you more than certain other types of sales charges.
| NOTE 5 – SEGMENT REPORTING |
In accordance with the FASB Accounting Standards Update (ASU) 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, the Funds have evaluated their business activities and determined that they each operate as a single reportable segment.
Each Fund’s investment activities are managed by the Principal Financial Officer, which serves as the Chief Operating Decision Maker (“CODM”). The Principal Financial Officer is responsible for assessing each Fund’s financial performance and allocating resources. In making these assessments, the Principal Financial Officer evaluates each Fund’s financial results on an aggregated basis, rather than by separate segments. As such, the Funds do not allocate operating expenses or assets to multiple segments, and accordingly, no additional segment disclosures are required. There were no intra-entity sales or transfers during the reporting period.
The Funds primarily generate income through dividends, interest, and realized/unrealized gains on their investment portfolios. Expenses incurred, including management fees, Fund operating expenses, and transaction costs, are considered general Fund-level expenses and are not allocated to specific segments or business lines.
Management has determined that the Funds do not meet the criteria for disaggregated segment reporting under ASU 2023-07 and will continue to evaluate its reporting requirements in accordance with applicable accounting standards.
170
| Notes to the Financial Statements | Defiance ETFs |
| NOTE 6 – PURCHASES AND SALES OF SECURITIES |
For the fiscal periods ended October 31, 2025, the cost of purchases and proceeds from the sales or maturities of securities, excluding short-term investments, U.S. government securities, options contracts, and in-kind transactions, if any, were as follows:
| Fund: | Purchases | Sales | ||||
| QPUX ETF | $ | - | $ | — | ||
| ANEL ETF | 1,014,954 | 1,027,640 | ||||
| AVXX ETF | — | — | ||||
| AVGX ETF | 1,163,595,475 | 1,161,834,468 | ||||
| CVNX ETF | 13,472,485 | 13,461,852 | ||||
| DKNX ETF | 1,102,890 | 1,085,388 | ||||
| HIMZ ETF | 963,242,881 | 968,798,629 | ||||
| HOOX ETF | 252,977,616 | 255,745,683 | ||||
| IONX ETF | 1,153,234,316 | 1,134,665,991 | ||||
| IRE ETF | 300,481 | — | ||||
| JPX ETF | 626,712 | 581,043 | ||||
| LLYX ETF | 92,788,674 | 94,849,621 | ||||
| LMNX ETF | 52,172 | 18,017 | ||||
| MPL ETF | 27,047 | 24,061 | ||||
| MSTX ETF | 905,845,047 | 937,865,467 | ||||
| NVOX ETF | 19,080,244 | 17,460,960 | ||||
| OKLL ETF | 1,452,468,761 | 1,439,575,015 | ||||
| ORCX ETF | 44,783,675 | 44,330,065 | ||||
| OSCX ETF | 1,022,299 | 991,786 | ||||
| XPM ETF | 251,362 | 251,687 | ||||
| QSU ETF | 16,260 | 14,208 | ||||
| RGTX ETF | 1,216,119,535 | 1,253,335,588 | ||||
| RIOX ETF | 347,241,437 | 354,431,487 | ||||
| RKLX ETF | 1,281,564,400 | 1,323,275,528 | ||||
| SMCX ETF | 801,070,093 | 823,338,482 | ||||
| SOFX ETF | 893,685,358 | 916,367,958 | ||||
| SOUX ETF | 309,878,131 | 322,134,977 | ||||
| VSTL ETF | 1,724,436 | 1,532,376 | ||||
| IONZ ETF | — | — | ||||
| LLYZ ETF | — | — | ||||
| SMST ETF | — | — | ||||
| PLTZ ETF | — | — | ||||
| QBTZ ETF | — | — | ||||
| RGTZ ETF | — | — | ||||
| SMCZ ETF | — | — | ||||
For the fiscal periods ended October 31, 2025, there were no purchases or sales of long-term U.S. government securities for the Funds.
For the fiscal periods ended October 31, 2025, there were no in-kind transactions associated with creations or redemptions for the Funds.
| NOTE 7 – INCOME TAXES AND DISTRIBUTIONS TO SHAREHOLDERS |
The tax character of distributions paid during the periods ended October 31, 2025 (estimated) and the prior fiscal periods ended April 30, 2025 were as follows:
| Fund: | October 31, 2025 Ordinary Income | April 30, 2025 Ordinary Income | |||
| QPUX ETF | $ | — | $ | — | |
| ANEL ETF | — | — | |||
| AVXX ETF | — | — | |||
| AVGX ETF | — | 806,878 | |||
171
| Notes to the Financial Statements | Defiance ETFs |
| CVNX ETF | — | — |
| DKNX ETF | — | — |
| HIMZ ETF | — | — |
| HOOX ETF | — | — |
| IONX ETF | — | — |
| IRE ETF | — | — |
| JPX ETF | — | — |
| LLYX ETF | — | — |
| LMNX ETF | — | — |
| MPL ETF | — | — |
| MSTX ETF | — | 352,755,036 |
| NVOX ETF | — | — |
| OKLL ETF | — | — |
| ORCX ETF | — | — |
| OSCX ETF | — | — |
| XPM ETF | — | — |
| QSU ETF | — | — |
| RGTX ETF | — | — |
| RIOX ETF | — | — |
| RKLX ETF | — | — |
| SMCX ETF | — | — |
| SOFX ETF | — | — |
| SOUX ETF | — | — |
| VSTL ETF | — | — |
| IONZ ETF | — | — |
| LLYZ ETF | — | — |
| SMST ETF | — | — |
| PLTZ ETF | — | — |
| QBTZ ETF | — | — |
| RGTZ ETF | — | — |
| SMCZ ETF | — | — |
As of the prior fiscal periods ended April 30, 2025, components of the distributable earnings (accumulated losses) on a tax basis were as follows:
| AVGX ETF | HIMZ ETF | HOOX ETF | IONX ETF | LLYX ETF | MSTX ETF | |||||||||||||
| Investments including written | ||||||||||||||||||
| options, at cost | $ | 8,321,313 | $ | 2,104,321 | $ | 1,163,074 | $ | 2,316,995 | $ | 1,610,931 | $ | 517,130,971 | ||||||
| Gross tax unrealized | ||||||||||||||||||
| appreciation | 1,412,161 | 116,746 | 47,968 | 207,482 | 74,433 | 14,237,033 | ||||||||||||
| Gross tax unrealized | ||||||||||||||||||
| depreciation | (2,538,209 | ) | (80,916 | ) | (38,033 | ) | (87,195 | ) | (97,597 | ) | (49,149,488 | ) | ||||||
| Net tax unrealized appreciation | ||||||||||||||||||
| (depreciation) | (1,126,048 | ) | 35,830 | 9,935 | 120,287 | (23,164 | ) | (34,912,455 | ) | |||||||||
| Undistributed ordinary income | ||||||||||||||||||
| (loss) | — | 2,819,924 | 1,203,611 | 5,096,319 | 2,192,296 | 512,101,293 | ||||||||||||
| Undistributed long-term capital | ||||||||||||||||||
| gain (loss) | — | — | — | — | — | — | ||||||||||||
| Total distributable earnings | — | 2,819,924 | 1,203,611 | 5,096,319 | 2,192,296 | 512,101,293 | ||||||||||||
| Other accumulated gain | ||||||||||||||||||
| (loss) | (15,786,730 | ) | (752,706 | ) | (320,057 | ) | (1,771,057 | ) | (1,306,822 | ) | (877,548,964 | ) | ||||||
| Total distributable earnings | ||||||||||||||||||
| (accumulated losses) | $ | (16,912,778 | ) | $ | 2,103,048 | $ | 893,489 | $ | 3,445,549 | $ | 862,310 | $ | (400,360,126 | ) | ||||
172
| Notes to the Financial Statements | Defiance ETFs |
| NVOX ETF | ORCX ETF | RGTX ETF | RIOX ETF | RKLX ETF | SMCX ETF | |||||||||||||
| Investments including written | ||||||||||||||||||
| options, at cost | $ | 649,000 | $ | 898,333 | $ | 359,836 | $ | 2,012,798 | $ | 1,106,023 | $ | 47,576,408 | ||||||
| Gross tax unrealized | ||||||||||||||||||
| appreciation | 74,628 | 17,902 | 10,831 | 41,905 | 47,276 | 590,242 | ||||||||||||
| Gross tax unrealized | ||||||||||||||||||
| depreciation | (145,111 | ) | (61,587 | ) | (2,555 | ) | (739,982 | ) | (37,445 | ) | (7,019,298 | ) | ||||||
| Net tax unrealized appreciation | ||||||||||||||||||
| (depreciation) | (70,483 | ) | (43,685 | ) | 8,276 | (698,077 | ) | 9,831 | (6,429,056 | ) | ||||||||
| Undistributed ordinary income | ||||||||||||||||||
| (loss) | — | — | 446,523 | — | 914,641 | — | ||||||||||||
| Undistributed long-term capital | ||||||||||||||||||
| gain (loss) | — | — | — | — | — | — | ||||||||||||
| Total distributable earnings | — | — | 446,523 | — | 914,641 | — | ||||||||||||
| Other accumulated gain | ||||||||||||||||||
| (loss) | (1,811,135 | ) | (904,010 | ) | — | (16,056,964 | ) | (445,690 | ) | (133,489,389 | ) | |||||||
| Total distributable earnings | ||||||||||||||||||
| (accumulated losses) | $ | (1,881,618 | ) | $ | (947,695 | ) | $ | 454,799 | $ | (16,755,041 | ) | $ | 478,782 | $ | (139,918,445 | ) | ||
| SOFX ETF | SMST ETF | SMCZ ETF | |||||||
| Investments including written options, at cost | $ | 3,311,090 | $ | 6,145,672 | $ | 312,479 | |||
| Gross tax unrealized appreciation | 189,354 | — | — | ||||||
| Gross tax unrealized depreciation | (456,847 | ) | — | — | |||||
| Net tax unrealized appreciation (depreciation) | (267,493 | ) | — | — | |||||
| Undistributed ordinary income (loss) | — | — | 184,383 | ||||||
| Undistributed long-term capital gain (loss) | — | — | — | ||||||
| Total distributable earnings | — | — | 184,383 | ||||||
| Other accumulated gain (loss) | (6,485,582 | ) | (14,567,968 | ) | — | ||||
| Total distributable earnings (accumulated losses) | $ | (6,753,075 | ) | $ | (14,567,968 | ) | $ | 184,383 | |
Net capital losses incurred after October 31 (post-October losses) and net investment losses incurred after December 31 (late-year losses), and within the taxable year, may be elected to be deferred to the first business day of each Fund’s next taxable year. As of the prior fiscal periods ended April 30, 2025, the Funds have elected to defer the following post-October and late-year losses.
| Fund: | Post-October Capital Loss Deferral | Late-Year Loss Deferral | ||||
| AVGX ETF | $ | 5,484,708 | $ | 10,302,022 | ||
| HIMZ ETF | 752,706 | — | ||||
| HOOX ETF | 320,057 | — | ||||
| IONX ETF | 1,771,057 | — | ||||
| LLYX ETF | — | — | ||||
| MSTX ETF | 877,548,964 | — | ||||
| NVOX ETF | 774,234 | 1,036,901 | ||||
| ORCX ETF | 235,151 | 668,859 | ||||
| RGTX ETF | — | — | ||||
| RIOX ETF | 3,961,412 | 12,095,552 | ||||
| RKLX ETF | 445,690 | — | ||||
| SMCX ETF | — | 56,556,638 | ||||
| SOFX ETF | 2,825,551 | 3,660,031 | ||||
| SMST ETF | — | 14,567,968 | ||||
| SMCZ ETF | — | — |
173
| Notes to the Financial Statements | Defiance ETFs |
As of the prior fiscal periods ended April 30, 2025, the table below presents long-term and short-term capital loss carryovers, where applicable, which do not expire.
| Long-Term Capital | Short-Term Capital | ||||||
| Fund: | Loss Carryovers | Loss Carryovers | |||||
| AVGX ETF | $ | — | $ | — | |||
| HIMZ ETF | — | — | |||||
| HOOX ETF | — | — | |||||
| IONX ETF | — | — | |||||
| LLYX ETF | — | 1,306,822 | |||||
| MSTX ETF | — | — | |||||
| NVOX ETF | — | — | |||||
| ORCX ETF | — | — | |||||
| RGTX ETF | — | — | |||||
| RIOX ETF | — | — | |||||
| RKLX ETF | — | — | |||||
| SMCX ETF | — | 76,932,751 | |||||
| SOFX ETF | — | — | |||||
| SMST ETF | — | — | |||||
| SMCZ ETF | — | — | |||||
| NOTE 8 – REVERSE STOCK SPLIT |
During the period ended October 31 2025, the shares of SMST ETF were adjusted to reflect one reverse stock split. The effect of this reverse stock split was to reduce the number of shares outstanding in the Fund while maintaining the Fund’s and each shareholder’s aggregate NAV. All historical per share information has been retroactively adjusted to reflect this reverse stock split. Set forth below are details regarding the reverse stock split effected on May 23, 2025:
| Net Asset | Shares | Shares | ||||||||||
| Value Before | Net Asset Value | Outstanding | Outstanding | |||||||||
| Fund | Date | Rate | Split | After Split | Before Split | After Split | ||||||
| SMST ETF | 05/23/2025 | 1 for 20 | $1.31 | $26.20 | 29,259,985 | 1,462,999 |
| NOTE 9 – SHARES TRANSACTIONS |
Shares of the QPUX ETF, ANEL ETF, AVXX ETF, AVGX ETF, CVNX ETF, DKNX ETF, HIMZ ETF, HOOX ETF, IONX ETF, IRE ETF, JPX ETF, LMNX ETF, MPL ETF, MSTX ETF, OKLL ETF, ORCX ETF, OSCX ETF, XPM ETF, QSU ETF, RGTX ETF, RKLX ETF, SMCX ETF, SOFX ETF, SOUX ETF, VSTL ETF, IONZ ETF, LLYZ ETF, SMST ETF, PLTZ ETF, QBTZ ETF, RGTZ ETF and SMCZ ETF are listed and traded on The NASDAQ and Shares of the LLYX ETF, NVOX ETF, and RIOX ETF are listed on the NYSE. Market prices for the Shares may be different from their NAV. The Funds issue and redeem Shares on a continuous basis at NAV generally in large blocks of Shares, called Creation Units. Creation Units are issued and redeemed principally in-kind for securities included in a specified universe. Once created, Shares generally trade in the secondary market at market prices that change throughout the day. Except when aggregated in Creation Units, Shares are not redeemable securities of the Funds. Creation Units may only be purchased or redeemed by Authorized Participants. An Authorized Participant is either (i) a broker-dealer or other participant in the clearing process through the Continuous Net Settlement System of the National Securities Clearing Corporation or (ii) a Depository Trust Company participant and, in each case, must have executed a Participant Agreement with the Distributor. Most retail investors do not qualify as Authorized Participants nor have the resources to buy and sell whole Creation Units. Therefore, they are unable to purchase or redeem the Shares directly from the Funds. Rather, most retail investors may purchase Shares in the secondary market with the assistance of a broker and are subject to customary brokerage commissions or fees.
Each Fund currently offers one class of Shares, which has no front-end sales load, no deferred sales charge, and no redemption fee. A fixed transaction fee is imposed for the transfer and other transaction costs associated with the purchase or sale of Creation Units. The standard fixed transaction fee for each Fund is $300, payable to the Custodian. The fixed transaction fee may be waived on certain
174
| Notes to the Financial Statements | Defiance ETFs |
orders if the Funds’ Custodian has determined to waive some or all of the costs associated with the order or another party, such as the Adviser, has agreed to pay such fee. In addition, a variable fee may be charged on all cash transactions or substitutes for Creation Units and Redemption Units of up to a maximum of 2% of the value of the Creation Units and Redemption Units subject to the transaction. Variable fees are imposed to compensate the Funds for transaction costs associated with cash transactions. Variable fees received by the Funds, if any, are disclosed in the capital shares transactions section of the Statements of Changes in Net Assets. The Funds may issue an unlimited number of Shares of beneficial interest, with no par value. All Shares of the Funds have equal rights and privileges.
| NOTE 10 – RECENT MARKET EVENTS |
U.S. and international markets have experienced and may continue to experience significant periods of volatility in recent years and months due to a number of economic, political and global macro factors including uncertainty regarding inflation and central banks’ interest rate changes, the possibility of a national or global recession, trade tensions and tariffs, political events, armed conflict, war, and geopolitical conflict. These developments, as well as other events, could result in further market volatility and negatively affect financial asset prices, the liquidity of certain securities and the normal operations of securities exchanges and other markets, despite government efforts to address market disruptions. As a result, the risk environment remains elevated. The Adviser will monitor developments and seek to manage the Funds in a manner consistent with achieving the Fund’s investment objective, but there can be no assurance that they will be successful in doing so.
| NOTE 11 – SUBSEQUENT EVENTS |
In preparing these financial statements, management has evaluated events and transactions for potential recognition or disclosure through the date the financial statements were issued. Effective on the below date, the Shares of the below Funds were adjusted for a stock split or reverse stock split. The effect of these stock splits were to increase or decrease the number of Shares outstanding in the Funds while maintaining each Fund’s and shareholder’s aggregate NAV. Set forth below are details regarding the stock splits or reverse stock splits which have been retroactively applied to the financial statements.
| Net Asset | Shares | Shares | ||||||||||
| Value Before | Net Asset Value | Outstanding | Outstanding | |||||||||
| Fund | Date | Rate | Split | After Split | Before Split | After Split | ||||||
| HOOX ETF | 12/09/2025 | 4 for 1 | $178.94 | $44.73 | 165,000 | 660,000 | ||||||
| IONX ETF | 12/09/2025 | 2 for 1 | $105.56 | $52.78 | 2,140,000 | 4,280,000 | ||||||
| NVOX ETF | 12/09/2025 | 1 for 8 | $2.74 | $21.90 | 29,955,000 | 3,744,375 | ||||||
| RGTX ETF | 12/09/2025 | 4 for 1 | $258.70 | $64.67 | 570,000 | 2,280,000 | ||||||
| RKLX ETF | 12/09/2025 | 3 for 1 | $135.99 | $45.33 | 790,000 | 2,370,000 | ||||||
| IONZ ETF | 12/09/2025 | 1 for 6 | $3.31 | $19.88 | 13,340,000 | 2,223,333 | ||||||
| PLTZ ETF | 12/09/2025 | 1 for 4 | $5.61 | $22.45 | 12,225,000 | 3,056,250 | ||||||
| SMCZ ETF | 12/09/2025 | 1 for 8 | $2.93 | $23.40 | 2,030,000 | 253,750 |
Management has determined that there are no other subsequent events that would need to be recognized or disclosed in the Funds’ financial statements.
175